Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

 
þ	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934	
For the fiscal year ended December 31, 2013
or
 
¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934	
For the transition period from              to             .
Commission file number: 002-25577

DIODES INCORPORATED
(Exact name of registrant as specified in its charter)

 
 	 	 	
Delaware	 	95-2039518	
(State or other jurisdiction of
incorporation or organization)	 	(I.R.S. Employer
Identification No.)	
 	 	
4949 Hedgcoxe Road, Suite 200
Plano, Texas	 	75024	
(Address of principal executive offices)	 	(Zip Code)	
Registrant’s telephone number, including area code: (972) 987-3900
Securities registered pursuant to Section 12(b) of the Act:

Title of each class	 	Name of each exchange on which registered	
Common Stock, Par Value $0.66 2/3	 	The NASDAQ Stock Market LLC	
Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes   þ     No   ¨
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes   ¨     No   þ
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes   þ     No   ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes   þ     No   ¨
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.   ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	 	þ	  	Accelerated filer	 	¨	
Non-accelerated filer	 	¨  (Do not check if a smaller reporting company)	  	Smaller reporting company	 	¨	
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  ¨    No  þ
The aggregate market value of the 37,054,621 shares of Common Stock held by non-affiliates of the registrant, based on the closing price of $25.97 per share of the Common Stock on the Nasdaq Global Select Market on June 28, 2013, the last business day of the registrant’s most recently completed second fiscal quarter, was approximately $962,308,507.
The number of shares of the registrant’s Common Stock outstanding as of February 24, 2014 was 46,700,123.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the registrant’s definitive proxy statement to be filed with the United States Securities and Exchange Commission (“SEC”) pursuant to Regulation 14A in connection with the 2014 annual meeting of stockholders are incorporated by reference into Part III of this Annual Report. The proxy statement will be filed with the SEC not later than 120 days after the registrant’s fiscal year ended December 31, 2013.

 

Table of Contents
TABLE OF CONTENTS

 	 	 	  	Page	 	
PART I	  	
ITEM 1.	 	BUSINESS	  	 	1	  	
ITEM 1A.	 	RISK FACTORS	  	 	11	  	
ITEM 1B.	 	UNRESOLVED STAFF COMMENTS	  	 	32	  	
ITEM 2.	 	PROPERTIES	  	 	32	  	
ITEM 3.	 	LEGAL PROCEEDINGS	  	 	33	  	
ITEM 4.	 	MINE SAFETY DISCLOSURES	  	 	34	  	
 	
PART II	  	
ITEM 5.	 	MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES	  	 	35	  	
ITEM 6.	 	SELECTED FINANCIAL DATA	  	 	37	  	
ITEM 7.	 	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	  	 	38	  	
ITEM 7A.	 	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	  	 	54	  	
ITEM 8.	 	FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA	  	 	56	  	
ITEM 9.	 	CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE	  	 	56	  	
ITEM 9A.	 	CONTROLS AND PROCEDURES	  	 	56	  	
ITEM 9B.	 	OTHER INFORMATION	  	 	57	  	
 	
PART III	  	
ITEM 10.	 	DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE	  	 	58	  	
ITEM 11.	 	EXECUTIVE COMPENSATION	  	 	58	  	
ITEM 12.	 	SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS	  	 	58	  	
ITEM 13.	 	CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE	  	 	58	  	
ITEM 14.	 	PRINCIPAL ACCOUNTING FEES AND SERVICES	  	 	58	  	
 	
PART IV	  	
ITEM 15.	 	EXHIBITS, FINANCIAL STATEMENT SCHEDULES	  	 	59	  	

Table of Contents
PART I
 
Item 1.	Business.	
GENERAL
We are a leading global manufacturer and supplier of high-quality, application specific standard products within the broad discrete, logic and analog semiconductor markets, serving the consumer electronics, computing, communications, industrial and automotive markets. These products include diodes, rectifiers, transistors, MOSFETs, protection devices, functional specific arrays, single gate logic, amplifiers and comparators, Hall-effect and temperature sensors, power management devices, including LED drivers, AC-DC and DC-DC switching, linear voltage regulators, and voltage references along with special function devices, such as USB power switches, load switches, voltage supervisors, and motor controllers. The products are sold primarily throughout Asia, North America and Europe.
We design, manufacture and market these semiconductors for diverse end-use applications. Semiconductors, which provide electronic signal amplification and switching functions, are basic building-blocks that are incorporated into almost every electronic device. We believe that our focus on application-specific standard products utilizing innovative, highly efficient packaging and cost-effective process technologies, coupled with our collaborative, customer-focused product development, gives us a meaningful competitive advantage relative to other semiconductor companies.
Our product portfolio addresses the design needs of advanced electronic equipment, including high-volume consumer devices such as digital media players, smartphones, tablets, notebook computers, flat-panel displays, mobile handsets, digital cameras and set-top boxes. We believe that we have particular strength in designing innovative, highly power efficient semiconductors in miniature packaging for applications with a critical need to minimize product size while maximizing power density and overall performance, and at a lower cost than alternative solutions. Our product line includes over 9,250 products, and we shipped approximately 41 billion units, 32 billion units, and 29 billion units in 2013, 2012 and 2011, respectively. During 2013, we increased our number of products and units sold primarily due to acquisitions. From 2008 to 2013, our net sales grew from $433 million to $827 million, representing a compound annual growth rate of 14%.
We serve approximately 240 direct customers worldwide, which consist of original equipment manufacturers (“OEM”) and electronic manufacturing services (“EMS”) providers. Additionally, we have approximately 115 distributor customers worldwide, through which we indirectly serve over 12,000 customers. During 2013, we increased our number of direct customers and distributor customers primarily due to acquisitions. See “Business— Our Strategy—Pursue selective strategic acquisitions .”
We were incorporated in 1959 in California and reincorporated in Delaware in 1968. Our headquarters, logistics center, and sales office are located in Plano, Texas. Our design, marketing and engineering centers are located in Plano; San Jose, California; Taipei, Taiwan; Manchester, United Kingdom (“U.K”) and Neuhaus, Germany. We have two wafer fabrication facilities in Shanghai, China, one in Kansas City, Missouri and one in Manchester. We also have two manufacturing facilities located in Shanghai and two joint venture manufacturing facilities located in Chengdu, China, as well as manufacturing facilities located in Neuhaus and Taipei. Additional engineering, sales, warehouse and logistics offices are located in Fort Worth, Texas; Taipei; Hsinchu, Taiwan; Hong Kong; Manchester; Shanghai; Shenzhen, China; Seongnam-si, South Korea; Suwon, South Korea, Tokyo, Japan and Munich, Germany, with support offices located throughout the world.
BUSINESS OUTLOOK
Looking forward, we remain focused on achieving our goal of $1 billion in annual revenue with model profitability. The BCD Semiconductor Manufacturing Limited (“BCD”) acquisition has brought us one step closer toward achieving that goal. We have a solid pipeline of designs and expanded customer relationships
 
- 1 -

Table of Contents
across all regions and product lines. The success of our business depends, among other factors, on the strength of the global economy and the stability of the financial markets, our customers’ demand for our products, the ability of our customers to meet their payment obligations, the likelihood of customers canceling or deferring existing orders and end-user consumers’ demand for items containing our products in the end-markets we serve. We believe the long-term outlook for our business remains generally favorable despite the recent volatility in the global economy and the equity and credit markets as we continue to execute on the strategy that has proven successful for us over the years. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations— Business Outlook”  in Part II, Item 7 and “Risk Factors— The success of our business depends on the strength of the global economy and the stability of the financial markets, and any weaknesses in these areas may have a material adverse effect on our revenues, results of operations and financial condition. ” in Part I, Item 1A of this Annual Report for additional information.
SEGMENT INFORMATION AND ENTERPRISE-WIDE DISCLOSURES
For financial reporting purposes, we operate in a single segment, standard semiconductor products, through our various design, manufacturing and distribution facilities. We sell product primarily through our operations in Asia, North America and Europe. We aggregate our products in a single segment because the products have similar economic characteristics, are similar in production process and manufacturing flow, and share the same customers and target end-equipment markets. See Note 15 of “Notes to Consolidated Financial Statements” of this Annual Report for addition information.
OUR INDUSTRY
Semiconductors are critical components used in the manufacture of a broad range of electronic products and systems. Since the invention of the transistor in 1948, continuous improvements in semiconductor processes and design technologies have led to smaller, more complex and more reliable devices at a lower cost per function. The availability of low-cost semiconductors, together with increased customer demand for sophisticated electronic systems, has led to the proliferation of semiconductors in diverse end-use applications in the consumer electronics, computing, communications, industrial and automotive sectors.
OUR COMPETITIVE STRENGTHS
We believe our competitive strengths include the following:
Flexible, scalable and cost-effective manufacturing—Our manufacturing operations are a core element of our success, and we have designed our manufacturing base to allow us to respond quickly to changes in demand trends in the end-markets we serve. For example, we have structured our Shanghai, China packaging, assembly and test facilities to enable us to rapidly and efficiently add capacity and adjust product mix to meet shifts in customer demand and overall market trends. As a result, we have historically operated our Shanghai manufacturing facilities at near full capacity, while at the same time expanding that capacity to meet our growth objectives. In 2011, we established an additional manufacturing facility for semiconductor packaging, assembly and test in Chengdu, China. Additionally, the Shanghai and Chengdu locations of our manufacturing operations provide us with access to a workforce at a relatively low overall cost base while enabling us to better serve our leading customers, many of which are located in Asia. In 2012, we acquired approximately 51% of the outstanding common stock of Eris Technology Corporation (“Eris”), primarily to obtain its automatic manufacturing capabilities in test and assembly for various diode products. In 2013, we acquired BCD, which has in-house manufacturing capabilities in China, as well as a cost-effective development team that can be deployed across multiple product families. See “Risk Factors— During times of difficult market conditions, our fixed costs combined with lower revenues and lower profit margins may have a negative impact on our business, results of operations and financial condition. ” in Part I, Item 1A of this Annual Report for additional information.
Integrated packaging expertise—Our expertise in designing and manufacturing innovative and proprietary packaging solutions enables us to package a variety of different device functions into an assortment of packages ranging from miniature chip-scale packaging to packages that integrate multiple separate discrete and/or analog
 
- 2 -

Table of Contents
chips into a single semiconductor product called an array. Our ability to design and manufacture multi-chip semiconductor solutions as well as advanced integrated devices provides our customers with products of equivalent functionality with fewer individual parts, and at lower overall cost, than alternative products. This combination of integration, functionality and miniaturization makes our products well suited for high-volume consumer devices such as LED televisions, LCD panels, set-top boxes and consumer portables such as smartphones, tablets and notebooks.
Broad customer base and diverse end-markets—Our customers are comprised of leading OEMs as well as major EMS providers. Overall, we serve approximately 240 direct customers worldwide and over 12,000 additional customers through our distributors. Our products are ultimately used in end-products in a number of markets served by our broad customer base, which we believe makes us less susceptible to market fluctuations driven by either specific customers or specific end-user applications.
Customer focused product development—Effective collaboration with our customers and a commitment to customer service are essential elements of our business. We believe focusing on dependable delivery and support tailored to specific end-user applications has fostered deep customer relationships and created a key competitive advantage for us in the highly fragmented discrete, logic and analog semiconductor marketplace. We believe our close relationships with our customers have provided us with keener insight into our customers’ product needs. This results in a stronger demand for our product designs and often provides us with insight into additional opportunities for new design wins in our customers’ products. See “Risk Factors— We are and will continue to be under continuous pressure from our customers and competitors to reduce the price of our products, which could adversely affect our growth and profit margins ” in Part I, Item 1A of this Annual Report for additional information.
Management experience—The members of our executive team average over 30 years of industry experience, and the length of their service has created significant institutional insight into our markets, our customers and our operations. See “Risk Factors— We may fail to attract or retain the qualified technical, sales, marketing, finance and management personnel required to operate our business successfully, which could adversely affect on our business, results of operations and financial condition .” in Part I, Item 1A of this Annual Report for additional information.
OUR STRATEGY
Our strategy is to continue to enhance our position as a leading global designer, manufacturer and supplier of high-quality application specific standard semiconductor products, utilizing our innovative and cost-effective packaging technology and leveraging our process expertise and design excellence to achieve above-market profitable growth.
The principal elements of our strategy include the following:
Continue to rapidly introduce innovative discrete, logic and analog semiconductor products—We intend to maintain our rapid pace of new product introductions, especially for high-volume, high-growth applications with short design cycles, such as LCD and LED televisions and panels, set-top boxes, portables such as smartphones, tablets and notebooks along with other consumer electronics and computing devices. During 2013, we achieved many significant new design wins at OEMs. Although a design win from a customer does not necessarily guarantee future sales to that customer, we believe that continued introduction of new and well-defined product solutions is critically important in maintaining and extending our market share in the highly competitive semiconductor marketplace. See “Risk Factors— Obsolete inventories as a result of changes in demand for our products and change in life cycles of our products could adversely affect our business, results of operations and financial condition. ” in Part I, Item 1A of this Annual Report for additional information.
Expand our available market opportunities—We believe we have many paths to increasing our addressable market opportunity. From a product perspective, we intend to continue expanding our portfolio by developing derivative and enhanced performance devices that target adjacent markets and end-equipments. We
 
- 3 -

Table of Contents
will continue to cultivate new and emerging customers within our targeted markets, further increasing our already broad customer base. As we focus on new customers, we try to expand our product portfolio penetration within these new, as well as existing, customers. As we expand our extensive range of high power efficiency and small form factor packages, we plan to introduce new and existing product functions in these new packages to allow an even greater market range.
Maintain intense customer focus—We intend to continue to strengthen and deepen our customer relationships. We believe that continued focus on customer service is important and will help to increase our net sales, operating performance and overall market share. To accomplish this, we intend to continue to closely collaborate with our customers to design products that meet their specific needs. A critical element of this strategy is to further reduce our design cycle time in order to quickly provide our customers with innovative products. Additionally, to support our customer-focused strategy, we historically expand our sales force and field application engineers, particularly in Asia and Europe, during periods of growth. See “Risk Factors— We are and will continue to be under continuous pressure from our customers and competitors to reduce the price of our products, which could adversely affect our growth and profit margins. ” in Part I, Item 1A of this Annual Report for additional information.
Enhance cost competitiveness—A key element of our success is our overall low-cost manufacturing base. While we believe that our Shanghai manufacturing facilities are among the most efficient in the industry, we will continue to refine our proprietary manufacturing processes and technology to achieve additional cost efficiencies. In 2011, we expanded our capacity further by establishing an additional manufacturing facility for semiconductor packaging, assembly and test in Chengdu, China. Historically, we typically operate our Shanghai facilities at near full utilization rates and focus on increasing production yields, in order to achieve meaningful economies of scale.
Pursue selective strategic acquisitions—As part of our strategy to expand our semiconductor product offerings and to maximize our market opportunities, we may acquire discrete, logic, analog or mixed-signal technologies, product lines or companies in order to enhance our portfolio and accelerate our new product offerings. During 2011, we announced an agreement to invest in Eris and acquired approximately 30% of the outstanding common stock. During 2012, we increased our ownership in Eris to approximately 51%. The business scope for Eris comprises Schottky Diodes, TVS Diodes, Zener Diodes, Bridge Diodes, Wafers, LEDs and the relevant devices. Also in 2012, we completed the acquisition of Power Analog Microelectronics, Inc. (“PAM”), a provider of advanced analog and high-voltage power ICs, whose product portfolio includes Class D audio amplifiers, DC-DC converters and LED backlighting drivers. In 2013, we acquired BCD which, with its established presence in Asia and a particularly strong local market position in China, offers us an even greater penetration of the consumer, computing and communications markets. See “Risk Factors —Part of our growth strategy involves identifying and acquiring companies with complementary product lines or customers. We may be unable to identify suitable acquisition candidates or consummate desired acquisitions and, if we do make any acquisitions, we may be unable to successfully integrate any acquired companies with our operations, which could adversely affect our business, results of operations and financial condition ” in Part I, Item 1A and Note 17 of “Notes to Consolidated Financial Statements” of this Annual Report for additional information.
OUR PRODUCTS
Our product portfolio includes over 9,250 products that are designed for use in high-volume consumer devices such as LCD and LED televisions and LCD panels, set-top boxes, consumer portables such as smartphones, tablets and notebooks. We target and serve end-equipment markets that we believe have larger volumes than other end-market segments served by the overall semiconductor industry.
Our broad product line includes:
 
 	•	 	Discrete semiconductor products, including: performance Schottky rectifiers; performance Schottky diodes; Zener diodes and performance Zener diodes, including tight tolerance and low operating	
 
- 4 -

Table of Contents
 	current types; standard, fast, super-fast and ultra-fast recovery rectifiers; bridge rectifiers; switching diodes; small signal bipolar transistors; prebiased transistors; MOSFETs; thyristor surge protection devices; and transient voltage suppressors;	
 
 	•	 	Analog products, including: power management devices such as AC-DC and DC-DC converters, USB power switches, low dropout and linear voltage regulators; standard linear devices such as operational amplifiers and comparators, current monitors, voltage references, and reset generators; LED lighting drivers; and sensor products including Hall-effect sensors and motor drivers;	
 
 	•	 	Standard logic products, including low-voltage complementary metal–oxide–semiconductor (“CMOS”) and advanced high-speed CMOS devices;	
 
 	•	 	Complex discrete, analog and mixed technology arrays in miniature packages, including customer specific and function specific arrays; and	
 
 	•	 	Silicon wafers used in manufacturing these products.	
The following table lists the end-markets, some of the applications in which our products are used, and the percentage of net sales for each end-market for the last three years:

End-Markets	  	  2013    	 	 	    2012    	 	 	    2011    	 	 	End product applications	
Consumer Electronics	  	 	33	% 	 	 	33	% 	 	 	33	% 	 	Digital audio players and cameras, set-top boxes, LCD and LED TV’s, game consoles, portable GPS	
Computing	  	 	24	% 	 	 	28	% 	 	 	28	% 	 	Notebooks, tablets, LCD monitors, PDAs, printers	
Industrial	  	 	19	% 	 	 	19	% 	 	 	20	% 	 	Lighting, power supplies, DC-DC conversion, security systems, motor controls, DC fans, proximity sensors, solenoid and relay driving	
Communications	  	 	21	% 	 	 	16	% 	 	 	16	% 	 	Mobile handsets, smartphones, IP in gateways, routers, switches, hubs, fiber optics	
Automotive	  	 	3	% 	 	 	4	% 	 	 	3	% 	 	Comfort controls, lighting, audio/video players, GPS navigation, satellite radios, electronics	
PRODUCT PACKAGING
Our device packaging technology includes a wide variety of innovative surface-mounted packages. Our focus on the development of smaller, more thermally efficient, and increasingly integrated packaging, is a critical component of our product development. We provide a comprehensive offering of miniature high power density packaging, enabling us to fit our components into smaller and more efficient packages, while maintaining the same device functionality and power handling capabilities. Smaller packaging provides a reduction in the height, weight and board space required for our components; as such, our products are well suited for battery-powered, hand-held and wireless consumer applications and high-volume consumer devices such as LCD and LED televisions and LCD panels, set-top boxes and consumer portables such as smartphones, tablets and notebooks.
CUSTOMERS
We serve approximately 240 direct customers worldwide, including major OEMs and EMS companies. Additionally, we have approximately 115 distributor customers worldwide, through which we indirectly serve over 12,000 customers. Our customers include: (i) industry leading OEMs in a broad range of industries, such as Cisco Systems, Inc., Continental AG, Delta Electronics, Emerson, Hella, Ltd., LG Electronics, Inc., Motorola Mobility, Inc., Quanta Computer, Inc., Sagem Communication, and Samsung Electronics Co., Ltd.; (ii) leading EMS providers, such as Celestica, Inc., Flextronics International, Ltd., Hon Hai Precision Industry Co., Ltd., Inventec Corporation, Jabil Circuit, Inc., and Sanmina-SCI Corporation, who build end-market products incorporating our semiconductors for companies such as Apple, Inc., Dell, Inc., EMC Corporation, Intel
 
- 5 -

Table of Contents
Corporation, Microsoft Corporation, Thompson, Inc. and Roche Diagnostics; and (iii) leading distributors such as Arrow Electronics, Inc., Avnet, Inc., Future Electronics, Rutronic, Yosun Industrial Corporation, and Zenitron Corporation. For the years of 2013, 2012 and 2011, our OEM and EMS customers together accounted for 35%, 47% and 47%, respectively, of our net sales. The decrease in 2013 is mainly due to the fact that the majority of BCD net sales are to distributors.
No customer accounted for 10% or more of our net sales in 2013, 2012 and 2011. In addition, for information concerning our business with related parties, see “Business— Certain relationships and related party transactions. ”
We believe that our close relationships with our OEM and EMS customers have provided us with deeper insight into our customers’ product needs. In addition to seeking to expand relationships with our existing customers, our strategy is to pursue new customers and diversify our customer base by focusing on leading global consumer electronics companies and their EMS providers and distributors. See “Risk Factors— Our customers require our products to undergo a lengthy and expensive qualification process without any assurance of product sales, which could adversely affect our revenues, results of operations and financial condition ” in Part I, Item 1A of this Annual Report for additional information.
We generally warrant that products sold to our customers will, at the time of shipment, be free from defects in workmanship and materials and conform to our approved specifications. Subject to certain exceptions, our standard warranty extends for a period of one year from the date of shipment. Warranty expense has not been significant. Generally, our customers may cancel orders on short notice without incurring a penalty. See “Risk Factors— Our customer orders are subject to cancellation or modification usually with no penalty. High volumes of order cancellation or reduction in quantities ordered could adversely affect our results of operations and financial condition ” in Part I, Item 1A of this Annual Report for additional information.
Many of our customers are based in Asia or have manufacturing facilities in Asia. Net sales by country consists of sales to customers in that country based on the country to which products are shipped. Historically, the Company reported revenues “billed to” customers located in various countries. In 2013, the Company changed to net sales “shipped to” customer locations as it believes the change better represents where the Company’s customers business activities occur. For the year ended December 31, 2013, approximately 63%, 9%, 8%, 6%, 5%, 4% and 5% of our net sales were derived from China, United States (“U.S.”), Korea, Germany, Singapore, Taiwan, and all other markets, respectively, compared to 60%, 10%, 8%, 6%, 4%, 3% and 9% in 2012, respectively.
SALES AND MARKETING
We market and sell our products worldwide through a combination of direct sales and marketing personnel, independent sales representatives and distributors. We have direct sales personnel in the U.S., U.K., France, Germany, Korea, Taiwan and China. We also have independent sales representatives in the U.S., Japan, Korea, and Europe. We currently have distributors in the U.S., Europe and Asia.
As of December 31, 2013, our direct global sales and marketing organization consisted of approximately 190 employees operating out of 16 offices. We have sales and marketing offices or representatives in Taipei, Taiwan; Shanghai and Shenzhen, China; Beauzelle, France; Gyeonggi, South Korea; and Munich, Germany; and we have four regional sales offices in the U.S. As of December 31, 2013, we also had approximately 20 independent sales representative firms marketing our products.
Our marketing group focuses on our product strategy, product development roadmap, new product introduction process, demand assessment and competitive analysis. Our marketing programs include participation in industry tradeshows, technical conferences and technology seminars, sales training and public relations. The marketing group works closely with our sales and research and development groups to align our
 
- 6 -

Table of Contents
product development roadmap. The marketing group coordinates its efforts with our product development, operations and sales groups, as well as with our customers, sales representatives and distributors. We support our customers through our field application engineering and customer support organizations.
To support our global customer-base, our website is language-selectable into English, Chinese and Korean, giving us an effective marketing tool for worldwide markets. With its extensive online product catalog with advanced search capabilities, our website facilitates quick and easy product selection. Our website, www.diodes.com , provides easy access to our worldwide sales contacts and customer support, as well as incorporates a distributor-inventory check to provide component inventory availability. In addition, our website provides investors access to our financial and corporate governance information.
MANUFACTURING OPERATIONS AND FACILITIES
We operate two manufacturing facilities located in Shanghai, China, one in Neuhaus, Germany, one in Taipei, Taiwan and are developing two joint venture manufacturing facilities located in Chengdu, China. We have two wafer fabrication facilities located in Shanghai, one in Kansas City, Missouri and one in Manchester, U.K. Our manufacturing facilities in Shanghai, Neuhaus and Taipei are packaging, assembly and test manufacturing sites, as is the facility being developed in Chengdu. Our wafer fabrication facilities in Shanghai include two 150mm wafer fabrication centers, our Kansas City facility fabricates 125mm and 150mm wafers, and our Manchester facility fabricates 150mm wafers.
During 2010, we announced an investment agreement with the Management Committee of the Chengdu Hi-Tech Industrial Development Zone (the “CDHT”). Under this agreement, we have agreed to form a joint venture with a Chinese partner, Chengdu Ya Guang Electronic Company Limited, to establish a semiconductor manufacturing facility for surface-mounted component production, assembly and test in Chengdu, China. We initially will own at least 95% of the joint venture. The manufacturing facility will be developed in phases over a ten year period, and in order to qualify for certain financial incentives, we were obligated to contribute at least $48 million to the joint venture by December 31, 2013. The CDHT grants the joint venture a fifty year land lease, provides temporary facilities for up to three years at a subsidized rent while the joint venture builds the manufacturing facility and provides corporate and employee tax incentives, tax refunds, subsidies and other financial support to the joint venture and its qualified employees. This is a long-term, multi-year project that will provide us additional capacity as needed. As of December 31, 2013, we have invested $48 million, primarily for capital expenditures.
For the years ending December 31, 2013 and 2012, we invested approximately $32 million and $50 million, respectively, in plant and state-of-the-art equipment in China ($529 million total investment in China from inception, including costs for acquisitions). Our facilities in China manufacture product for sale by our U.S., Europe and Asia operations. For the years ending December 31, 2013 and 2012, our total capital expenditures were approximately $44 million and $60 million, respectively.
Our manufacturing processes use many raw materials, including silicon wafers, aluminum and copper lead frames, gold and copper wire and other metals, molding compounds and various chemicals and gases. We are continuously evaluating our raw material costs in order to reduce our gold consumption while protecting and maintaining product performance. We have no material agreements with any of our suppliers that impose minimum or continuing supply obligations. From time to time, suppliers may extend lead-times, limit supplies or increase prices due to capacity constraints or other factors. Although we believe that supplies of the raw materials we use are currently and will continue to be available, shortages could occur in various essential materials due to interruption of supply or increased demand in the industry. See “Risk Factors— We depend on third-party suppliers for timely deliveries of raw materials, parts and equipment, as well as finished products from other manufacturers, and our reputation with customers, results of operations and financial condition could be adversely affected if we are unable to obtain adequate supplies in a timely manner. ” in Part I, Item 1A of this Annual Report for additional information.
 
- 7 -

Table of Contents
Our corporate headquarters are located in a facility we own in Plano, Texas. We also lease or own properties around the world for use as sales and administrative offices, research and development centers, manufacturing facilities, warehouses and logistics centers. The size and/or location of these properties can change from time to time based on our business requirements. See “Properties” in Part I, Item 2 of this Annual Report for additional information.
BACKLOG
The amount of backlog to be shipped during any period is dependent upon various factors, and all orders are subject to cancellation or modification, usually with no penalty to the customer. Orders are generally booked from one month to greater than twelve months in advance of delivery. The rate of booking of new orders can vary significantly from month to month. We, and the industry as a whole, have been experiencing a trend towards shorter lead-times, and we expect this trend to continue. The amount of backlog at any date depends upon various factors, including the timing of the receipt of orders, fluctuations in orders of existing product lines, and the introduction of any new lines. Accordingly, we believe that the amount of our backlog at any date is not an accurate measure of our future sales. We strive to maintain proper inventory levels to support our customers’ just-in-time order expectations.
PATENTS, TRADEMARKS AND LICENSES
Historically, patents and trademarks have not been material to our operations, but we expect them to become more important, particularly as they relate to our miniature and power efficient packaging technologies.
Our initial product patent portfolio was primarily composed of discrete technologies. In the late 1990s, our engineers began to research and develop innovative packaging technologies, which produced several important breakthroughs and patents, such as the PowerDI ®  series of packaging technology to foster our growth in the semiconductor industry.
PowerDI is a registered trademark of Diodes Incorporated
We acquired Anachip Corp. in early 2006, a fabless semiconductor company, which initiated our presence in the analog product market with a portfolio of standard linear and low dropout regulator products, among others.
Through our acquisition of the assets of APD Semiconductor, Inc. in late 2006, we acquired the SBR® patents and trademark. SBR ®  is a state-of-the-art integrated circuit wafer processing technology, which is able to integrate and improve the benefits of the two existing rectifier technologies into a single device. The creation of a finite conduction cellular IC, combined with inherent design uniformity has allowed manufacturing costs to be kept competitive with the existing power device technology, and thus has produced a breakthrough in rectifier technology.
In 2008, we acquired Zetex, which subsequently increased our available discrete and analog technologies with patents and trademarks for bipolar transistors and power management products such as LED drivers. LED drivers support a wide range of applications for automotive, safety and security, architecture, and portable lighting and are highly efficient and cost effective.
In 2012, we acquired PAM, a provider of advanced analog and high-voltage power ICs. PAM’s product portfolio includes Class D audio amplifiers, DC-DC converters and LED backlighting drivers, which will strengthen our position as a global provider of high-quality and high-efficiency, space-saving analog products by expanding our product portfolio with innovative “filter-less” digital audio amplifiers, application-specific power management ICs, as well as high-performance LED drivers and DC-DC converters.
In 2013, we acquired BCD, a leading supplier of standard linear and power management devices. BCD has a solid product portfolio that includes AC/DC and DC/DC solutions for chargers and power adapters. BCD’s
 
- 8 -

Table of Contents
established presence in Asia, with a particularly strong local market position in China, offers us even greater participation into the consumer, computing and communications end-markets.
Currently, our licensing of patents to other companies is not material. We do, however, license certain product technology from other companies, but we do not consider any of the licensed technology currently to be material in terms of royalties. We believe the duration and other terms of the licenses are appropriate for our current needs. See “Risk Factors— We may be subject to claims of infringement of third-party intellectual property rights or demands that we license third-party technology, which could result in significant expense, reduction in our intellectual property rights and a negative impact on our business, results of operations and financial condition. ” in Part I, Item 1A of this Annual Report for additional information.
COMPETITION
Numerous semiconductor manufacturers and distributors serve the discrete, logic and analog semiconductor components market, making competition intense. Some of our larger competitors include Fairchild Semiconductor Corporation, Infineon Technologies A.G., International Rectifier Corporation, NXP Semiconductors N.V., ON Semiconductor Corporation, Rohm Electronics USA, LLC, Toshiba Corporation and Vishay Intertechnology, Inc., many of which have greater financial, marketing, distribution, brand name recognition, research and development, manufacturing and other resources. Accordingly, we from time to time may reposition product lines or decrease prices, which may affect our sales of, and profit margins on, such product lines. The price and quality of the products, and our ability to design products and deliver customer service in keeping with the customers’ needs, determine the competitiveness of our products. We believe that our product focus, packaging expertise and our flexibility and ability to quickly adapt to customer needs affords us competitive advantages. See “Risk Factors— The semiconductor business is highly competitive, and increased competition may harm our business, results of operations and financial condition. ” in Part I, Item 1A of this Annual Report for additional information.
ENGINEERING AND RESEARCH AND DEVELOPMENT
Our engineering and research and development groups consist of applications, circuit design, and product development engineers who assist in determining the direction of our future product lines. One of their key functions is to work closely with market-leading customers to further refine, expand and improve our product portfolio within our target product types and packages. In addition, customer requirements and acceptance of new package types are assessed and new, higher-density and more energy-efficient packages are developed to satisfy customers’ needs.
Product development engineers work directly with our semiconductor circuit design and layout engineers who develop die designs for products that match our customers’ requirements. We have the capability to capture the customers’ electrical and packaging requirements and translate those requirements into product specifications which can then be designed and manufactured to support customers’ end-system applications.
For the years ended December 31, 2013, 2012 and 2011, company-sponsored investment in research and development activities was approximately $48 million, $34 million and $27 million, respectively. As a percentage of net sales, research and development expense was approximately 6%, 5% and 4% for 2013, 2012 and 2011, respectively. The dollar amount and percentage increase in 2013 was primarily due to the acquisition of BCD.
EMPLOYEES
As of December 31, 2013, we employed a total of 6,151 employees, of which 5,339 of our employees were in Asia and includes approximately 1,950 independent contractors, 354 were in the U.S. and 458 were in Europe. None of our employees in Asia or the U.S. are subject to a collective bargaining agreement, but a majority of our
 
- 9 -

Table of Contents
employees in Europe are covered by local labor agreements. We consider our relations with our employees to be satisfactory. See “Risk Factors— We may fail to attract or retain the qualified technical, sales, marketing, finance and management personnel required to operate our business successfully, which could adversely affect on our business, results of operations and financial condition. ” in Part I, Item 1A of this Annual Report for additional information.
ENVIRONMENTAL MATTERS
We are subject to a variety of U.S. federal, state, local and foreign governmental laws, rules and regulations related to the use, storage, handling, discharge or disposal of certain toxic, volatile or otherwise hazardous chemicals used in our manufacturing process in China, the U.S. and the U.K. where our wafer fabrication facilities are located, and in China, Taiwan and Germany where our packaging, assembly and test facilities are located. Any of these regulations could require us to acquire equipment or to incur substantial other costs to comply with environmental regulations or remediate problems. For the years ended December 31, 2013, 2012 and 2011, our capital expenditures for environmental controls have not been material. As of December 31, 2013, there were no known environmental claims or recorded liabilities. See “Risk Factors— We are subject to many environmental laws and regulations that could result in significant expenses and could adversely affect our business, results of operations and financial condition. ” in Part I, Item 1A of this Annual Report for additional information.
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
We conduct business with one related party company, Lite-On Semiconductor Corporation and its subsidiaries and affiliates (collectively, “LSC”). LSC is our largest stockholder, owning approximately 18% of our outstanding Common Stock as of December 31, 2013. We also conduct business with one significant company, Keylink International (B.V.I.) Inc. and its subsidiaries and affiliates (collectively, “Keylink”). Keylink is a 5% joint venture partner in our Shanghai manufacturing facilities. The Audit Committee reviews all related party transactions for potential conflict of interest situations on an ongoing basis. We believe that all related party transactions are on terms no less favorable to us than would be obtained from unaffiliated third parties. For more information concerning our relationships with LSC and Keylink, see “Risk Factors— One of our largest external suppliers is also a related party. The loss of this supplier could harm our business, results of operations and financial condition. ” in Part I, Item 1A and Note 14 of “Notes to Consolidated Financial Statements” of this Annual Report for additional information.
SEASONALITY
Historically, our net sales have been affected by the cyclical nature of the semiconductor industry and the seasonal trends of related end-markets, specifically in the consumer and computing markets. See Note 18 (unaudited) of “Notes to Consolidated Financial Statements” of this Annual Report for additional information on our quarterly results.
AVAILABLE INFORMATION
Our website address ishttp://www.diodes.com. We make available, free of charge through our website, our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, proxy statements, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after such material is electronically filed with or furnished to the Securities and Exchange Commission (the “SEC”).
Our filings may also be read and copied at the SEC’s Public Reference Room at 100 F Street NE, Room 1580 Washington, DC 20549. Information on the operation of the Public Reference Room may be obtained by calling the SEC at 1-800-SEC-0330. The SEC also maintains an Internet site ( http://www.sec.gov ) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.
 
- 10 -

Table of Contents
Our website also provides investors access to financial and corporate governance information including our Code of Business Conduct, as well as press releases, and stock quotes. The contents of our website are not incorporated by reference into this Annual Report on Form 10-K.
Cautionary Statement for Purposes of the “Safe Harbor” Provision of the Private Securities Litigation Reform Act of 1995
Many of the statements included in this Annual Report on Form 10-K contain forward-looking statements and information relating to our company. We generally identify forward-looking statements by the use of terminology such as “may,” “will,” “could,” “should,” “potential,” “continue,” “expect,” “intend,” “plan,” “estimate,” “anticipate,” “believe,” “project,” or similar phrases or the negatives of such terms. We base these statements on our beliefs as well as assumptions we made using information currently available to us. Such statements are subject to risks, uncertainties and assumptions, including those identified in “Risk Factors,” as well as other matters not yet known to us or not currently considered material by us. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on such forward-looking statements. Forward-looking statements do not guarantee future performance and should not be considered as statements of fact.
You should not unduly rely on these forward-looking statements, which speak only as of the date of this Annual Report on Form 10-K. Unless required by law, we undertake no obligation to publicly update or revise any forward-looking statements to reflect new information or future events or otherwise. The Private Securities Litigation Reform Act of 1995 (the “Act”) provides certain “safe harbor” provisions for forward-looking statements. All forward-looking statements made on this Annual Report on Form 10-K are made pursuant to the Act.
 
Item 1A.	Risk Factors.	
Investing in our Common Stock involves a high degree of risk. You should carefully consider the following risks and other information in this report before you decide to buy our Common Stock. Our business, financial condition or operating results may suffer if any of the following risks are realized. Additional risks and uncertainties not currently known to us may also adversely affect our business, financial condition or operating results. If any of these risks or uncertainties occurs, the trading price of our Common Stock could decline and you could lose part or all of your investment.
RISKS RELATED TO OUR BUSINESS
The success of our business depends on the strength of the global economy and the stability of the financial markets, and any weaknesses in these areas may have a material adverse effect on our revenues, results of operations and financial condition.
Weaknesses in the global economy and financial markets can lead to lower consumer discretionary spending and demand for items that incorporate our products in the consumer electronics, computing, industrial, communications and the automotive sectors. A decline in end-user demand can affect our customers’ demand for our products, the ability of our customers to meet their payment obligations and the likelihood of customers canceling or deferring existing orders. Our revenues, operating results and financial condition could be negatively affected by such actions.
During times of difficult market conditions, our fixed costs combined with lower revenues and lower profit margins may have a negative impact on our business, results of operations and financial condition.
The semiconductor industry is characterized by high fixed costs. Notwithstanding our utilization of third-party manufacturing capacity, most of our production requirements are met by our own manufacturing facilities. In difficult economic environments, we could be faced with a decline in the utilization rates of our manufacturing
 
- 11 -

Table of Contents
facilities due to decreases in product demand. During such periods, our manufacturing facilities do not operate at full capacity and the costs associated with this excess capacity are expensed immediately and not capitalized into inventory. When our utilization rates decline to abnormally low production levels, we generally experience lower gross margins. The market conditions in the future may adversely affect our utilization rates and consequently our future gross margins, and this, in turn, could have a material negative impact on our business, results of operations and financial condition.
Downturns in the highly cyclical semiconductor industry and/or changes in end-market demand could adversely affect our results of operations and financial condition.
The semiconductor industry is highly cyclical, and periodically experiences significant economic downturns characterized by diminished product demand, production overcapacity and excess inventory, which can result in rapid erosion in average selling prices. From time to time, the semiconductor industry experiences order cancellations and reduced demand for products, resulting in significant revenue declines, due to excess inventories at end-equipment manufacturers and general economic conditions, especially in the technology sector. The market for semiconductors may experience renewed, and possibly more severe and prolonged downturns, which may harm our results of operations and financial condition.
In addition, we operate in a few narrow markets of the broader semiconductor market and, as a result, cyclical fluctuations may affect these segments to a greater extent than they do to the broader semiconductor market. This may cause us to experience greater fluctuations in our results of operations and financial condition than compared to some of our broad line semiconductor manufacturer competitors. In addition, we may experience significant changes in our profitability as a result of variations in sales, changes in product mix, changes in end-user markets and the costs associated with the introduction of new products. The markets for our products depend on continued demand in the consumer electronics, computing, communications, industrial and automotive sectors. These end-user markets also tend to be cyclical and may also experience changes in demand that could adversely affect our results of operations and financial condition.
The semiconductor business is highly competitive, and increased competition may harm our business, results of operations and financial condition.
The semiconductor industry in which we operate is highly competitive. We expect intensified competition from existing competitors and new entrants. Competition is based on price, product performance, product availability, quality, reliability and customer service. We compete in various markets with companies of various sizes, many of which are larger and have greater resources or capabilities as it relates to financial, marketing, distribution, brand name recognition, research and development, manufacturing and other resources than we have. As a result, they may be better able to develop new products, market their products, pursue acquisition candidates and withstand adverse economic or market conditions. Most of our current major competitors are broad line semiconductor manufacturers who often have a wider range of product types and technologies than we do. In addition, companies not currently in direct competition with us may introduce competing products in the future. Some of our current major competitors are Fairchild Semiconductor Corporation, Infineon Technologies A.G., International Rectifier Corporation, NXP Semiconductors N.V., ON Semiconductor Corporation, Rohm Electronics USA, LLC, Toshiba Corporation and Vishay Intertechnology, Inc. We may not be able to compete successfully in the future, and competitive pressures may harm our business, results of operations and financial condition.
One of our largest external suppliers is also a related party. The loss of this supplier could harm our business, results of operations and financial condition.
In 2013, 2012 and 2011, LSC, our largest stockholder, accounted for approximately 1%, of our net sales. LSC is also one of our largest suppliers, providing us with discrete semiconductor products for subsequent sale by us, which represented approximately 2%, 3% and 5%, respectively, of our net sales, in 2013, 2012 and 2011.
 
- 12 -

Table of Contents
The loss of LSC as a supplier, could materially harm our business, results of operations and financial condition.
Delays in initiation of production at facilities due to implementing new production techniques or resolving problems associated with technical equipment malfunctions could adversely affect our manufacturing efficiencies, results of operations and financial condition.
Our manufacturing efficiency has been and will be an important factor in our future profitability, and we may not be able to maintain or increase our manufacturing efficiency. Our manufacturing and testing processes are complex, require advanced and costly equipment and are continually being modified in our efforts to improve yields and product performance. Difficulties in the manufacturing process can lower yields. Technical or other problems could lead to production delays, order cancellations and lost revenue. In addition, any problems in achieving acceptable yields, construction delays, or other problems in upgrading or expanding existing facilities, building new facilities, bringing new manufacturing capacity to full production or changing our process technologies, could also result in capacity constraints, production delays and a loss of future revenues and customers. Our operating results also could be adversely affected by any increase in fixed costs and operating expenses related to increases in production capacity if net sales do not increase proportionately, or in the event of a decline in demand for our products.
Our wafer fabrication facilities are located in Shanghai, China, Kansas City, Missouri, and Manchester, United Kingdom (“U.K.”), while our manufacturing facilities in Shanghai, Taipei, Taiwan and Neuhaus, Germany, perform packaging, assembly and test functions and our manufacturing facilities in Chengdu, China are for surface-mounted component production, assembly and test functions. Any disruption of operations at these facilities could have a material adverse effect on our manufacturing efficiencies, results of operations and financial condition.
We are and will continue to be under continuous pressure from our customers and competitors to reduce the price of our products, which could adversely affect our growth and profit margins.
Prices for our products tend to decrease over their life cycle. There is substantial and continuing pressure from customers to reduce the total cost of purchasing our products. To remain competitive and retain our customers and gain new ones, we must continue to reduce our costs through product and manufacturing improvements. We must also strive to minimize our customers’ shipping and inventory financing costs and to meet their other goals for rationalization of supply and production. We experienced a decrease in average selling prices (“ASP”) for our products of 2% in 2011, a decrease of 10% in 2012 and an increase of 5% in 2013. At times, we may be required to sell our products at ASP below our manufacturing costs or purchase prices in order to remain competitive. Our growth and the profit margins of our products will suffer if we cannot effectively continue to reduce our costs and keep our product prices competitive.
Our customers require our products to undergo a lengthy and expensive qualification process without any assurance of product sales, which could adversely affect our revenues, results of operations and financial condition.
Prior to purchasing our products, our customers require that our products undergo an extensive qualification process, which involves rigorous reliability testing. This qualification process may continue for six months or longer. However, qualification of a product by a customer does not ensure any sales of the product to that customer. Even after successful qualification and sales of a product to a customer, a subsequent revision to the product, changes in the product’s manufacturing process or the selection of a new supplier by us may require a new qualification process, which may result in delays and in us holding excess or obsolete inventory. After our products are qualified, it can take an additional six months or more before the customer commences volume production of components or devices that incorporate our products. Despite these uncertainties, we devote substantial resources, including design, engineering, sales, marketing and management efforts, toward qualifying
 
- 13 -

Table of Contents
our products with customers in anticipation of sales. If we are unsuccessful or delayed in qualifying any of our products with a customer, such failure or delay would preclude or delay sales of such product to the customer, which may adversely affect our revenues, results of operations and financial condition.
Our customer orders are subject to cancellation or modification usually with no penalty. High volumes of order cancellation or reduction in quantities ordered could adversely affect our revenues, results of operations and financial condition.
All of our customer orders are subject to cancellation or modification, usually with no penalty to the customer. Orders are generally made on a purchase order basis, rather than pursuant to long-term supply contracts, and are booked from one to twelve months in advance of delivery. The rate of booking new orders can vary significantly from month to month. We, and the semiconductor industry as a whole, are experiencing a trend towards shorter lead-times, which is the amount of time between the date a customer places an order and the date the customer requires shipment. Furthermore, our industry is subject to rapid changes in customer outlook and periods of excess inventory due to changes in demand in the end-markets our industry serves. As a result, many of our purchase orders are revised, and may be cancelled, with little or no penalty and with little or no notice. However, we must still commit production and other resources to fulfilling these purchase orders even though they may ultimately be cancelled. If a significant number of purchase orders are cancelled or product quantities ordered are reduced, and we are unable to timely generate replacement orders, we may build up excess inventory and our revenues, results of operations and financial condition may suffer.
Production at our manufacturing facilities could be disrupted for a variety of reasons, including natural disasters and other extraordinary events, which could prevent us from producing enough of our products to maintain our sales and satisfy our customers’ demands and could adversely affect our results of operations and financial condition.
A disruption in production at our manufacturing facilities could have a material adverse effect on our business. Disruptions could occur for many reasons, including fire, floods, hurricanes, typhoons, droughts, tsunamis, volcanoes, earthquakes, disease or other similar natural disasters, unplanned maintenance or other manufacturing problems, labor shortages, power outages or shortages, telecommunications failures, strikes, transportation interruption, government regulation, terrorism or other extraordinary events. Such disruptions may cause direct injury or damage to our employees and property and related internal controls with significant indirect consequences. Alternative facilities with sufficient capacity or capabilities may not be available, may cost substantially more or may take a significant time to start production, each of which could negatively affect our business and financial performance. If one of our key manufacturing facilities is unable to produce our products for an extended period of time, our sales may be reduced by the shortfall caused by the disruption, and we may not be able to meet our customers’ needs, which could cause them to seek other suppliers. Such disruptions could have an adverse effect on our results of operations and financial condition.
New technologies could result in the development of new products by our competitors and a decrease in demand for our products, and we may not be able to develop new products to satisfy changes in demand, which would adversely affect our net sales, market share, results of operations and financial condition.
Our product range and new product development program are focused on discrete, logic and analog semiconductor products. Our failure to develop new technologies, or anticipate or react to changes in existing technologies, either within or outside of the semiconductor market, could materially delay development of new products, which could result in a decrease in our net sales and a loss of market share to our competitors. The semiconductor industry is characterized by rapidly changing technologies and industry standards, together with frequent new product introductions. This includes the development of new types of technology or the improvement of existing technologies, such as analog and digital technologies that compete with, or seek to replace, discrete semiconductor technology. Our financial performance depends on our ability to design, develop, manufacture, assemble, test, market and support new products and product enhancements on a timely and cost-
 
- 14 -

Table of Contents
effective basis. New products often command higher prices and, as a result, higher profit margins. We may not successfully identify new product opportunities or develop and bring new products to market or succeed in selling them into new customer applications in a timely and cost-effective manner.
Products or technologies developed by other companies may render our products or technologies obsolete or noncompetitive, and since we operate primarily in a narrower segment of the broader semiconductor industry, this may have a greater effect on us than it would if we were a broad-line semiconductor manufacturer with a wider range of product types and technologies. Many of our competitors are larger and more established international companies with greater engineering and research and development resources than us. Our failure to identify or capitalize on any fundamental shifts in technologies in our product markets, relative to our competitors, could harm our business, have a material adverse effect on our competitive position within our industry and harm our relationships with our customers. In addition, to remain competitive, we must continue to reduce package sizes, improve manufacturing yields and expand our sales. We may not be able to accomplish these goals, which would adversely affect our net sales, market share, results of operations and financial condition.
We may be adversely affected by any disruption in our information technology systems, which could adversely affect our cash flows, results of operations and financial condition.
Our operations are dependent upon our information technology systems, which encompass all of our major business functions. We rely upon such information technology systems to manage and replenish inventory, to fill and ship customer orders on a timely basis, to coordinate our sales activities across all of our products and services and to coordinate our administrative activities. A substantial disruption in our information technology systems for any prolonged time period (arising from, for example, system capacity limits from unexpected increases in our volume of business, outages or delays in our service) could result in delays in receiving inventory and supplies or filling customer orders and adversely affect our customer service and relationships. Our systems might be damaged or interrupted by natural or man-made events or by computer viruses, physical or electronic break-ins and similar disruptions affecting the global Internet. There can be no assurance that such delays, problems, or costs will not have a material adverse effect on our cash flows, results of operations and financial condition.
As our operations grow in both size and scope, we will continuously need to improve and upgrade our systems and infrastructure while maintaining the reliability and integrity of our systems and infrastructure. The expansion of our systems and infrastructure will require us to commit substantial financial, operational and technical resources before the volume of our business increases, with no assurance that the volume of business will increase. In particular, we have upgraded our financial reporting system and are currently seeking to upgrade other information technology systems. These and any other upgrades to our systems and information technology, or new technology, now and in the future, will require that our management and resources be diverted from our core business to assist in compliance with those requirements. There can be no assurance that the time and resources our management will need to devote to these upgrades, service outages or delays due to the installation of any new or upgraded technology (and customer issues therewith), or the impact on the reliability of our data from any new or upgraded technology will not have a material adverse effect on our cash flows, results of operations and financial condition.
A significant portion of our operations operate on a single Enterprise Resource Planning (ERP) platform. To manage our international operations efficiently and effectively, we rely heavily on our ERP system, internal electronic information and communications systems and on systems or support services from third parties. Any of these systems are subject to electrical or telecommunications outages, computer hacking or other general system failure. It is also possible that future acquisitions will operate on ERP systems different from ours and that we could face difficulties in integrating operational and accounting functions of new acquisitions. Difficulties in upgrading or expanding our ERP system or system-wide or local failures that affect our information processing could have a material adverse effect on our cash flows, results of operations and financial condition.
 
- 15 -

Table of Contents
We may be subject to claims of infringement of third-party intellectual property rights or demands that we license third-party technology, which could result in significant expense, reduction in our intellectual property rights and a negative impact on our business, results of operations and financial condition.
The semiconductor industry is characterized by vigorous protection and pursuit of intellectual property rights. From time to time, third parties have asserted, and may in the future assert, patent, copyright, trademark and other intellectual property rights to technology that is important to our business and have demanded, and may in the future demand, that we license their patents and technology. Any litigation to determine the validity of allegations that our products infringe or may infringe these rights, including claims arising through our contractual indemnification of our customers, or claims challenging the validity of our patents, regardless of its merit or resolution, could be costly and divert the efforts and attention of our management and technical personnel. We may not prevail in litigation given the complex technical issues and inherent uncertainties in intellectual property litigation. If litigation results in an adverse ruling, we could be required to:
 
 	•	 	pay substantial damages for past, present and future use of the infringing technology;	
 
 	•	 	cease manufacture, use or sale of infringing products;	
 
 	•	 	discontinue the use of infringing technology;	
 
 	•	 	expend significant resources to develop non-infringing technology;	
 
 	•	 	pay substantial damages to our customers or end-users to discontinue use or replace infringing technology with non-infringing technology;	
 
 	•	 	license technology from the third party claiming infringement, which license may not be available on commercially reasonable terms, or at all; or	
 
 	•	 	relinquish intellectual property rights associated with one or more of our patent claims, if such claims are held invalid or otherwise unenforceable.	
We depend on third-party suppliers for timely deliveries of raw materials, parts and equipment, as well as finished products from other manufacturers, and our reputation with customers, results of operations and financial condition could be adversely affected if we are unable to obtain adequate supplies in a timely manner.
Our manufacturing operations depend upon obtaining adequate supplies of raw materials, parts and equipment on a timely basis from third parties. Our results of operations could be adversely affected if we are unable to obtain adequate supplies of raw materials, parts and equipment in a timely manner or if the costs of raw materials, parts or equipment were to increase significantly. Our business could also be adversely affected if there is a significant degradation in the quality of raw materials used in our products, or if the raw materials give rise to compatibility or performance issues in our products, any of which could lead to an increase in customer returns or product warranty claims. Although we maintain rigorous quality control systems, errors or defects may arise from a supplied raw material and be beyond our detection or control. Any interruption in, or change in quality of, the supply of raw materials, parts or equipment needed to manufacture our products could adversely affect our reputation with customers, results of operations and financial condition.
In addition, we sell finished products from other manufacturers. Our business could also be adversely affected if there is a significant degradation in the quality of these products. From time to time, such manufacturers may extend lead-times, limit supplies or increase prices due to capacity constraints or other factors. We have no long-term purchase contracts with any of these manufacturers and, therefore, have no contractual assurances of continued supply, pricing or access to finished products that we sell, and any such manufacturer could discontinue supplying to us at any time. Additionally, some of our suppliers of finished products or wafers compete directly with us and may in the future choose not to supply products to us.
 
- 16 -

Table of Contents
If we do not succeed in continuing to vertically integrate our business, we will not realize the cost and other efficiencies we anticipate, which could adversely affect our ability to compete, results of operations and financial condition.
We are continuing to vertically integrate our business. Key elements of this strategy include continuing to expand the reach of our sales organization, expand our manufacturing capacity, expand our wafer foundry and research and development capability and expand our marketing, product development, package development and assembly/test operations in company-owned facilities or through the acquisition of established contractors. There are certain risks associated with our vertical integration strategy, including:
 
 	•	 	difficulties associated with owning a manufacturing business, including, but not limited to, the maintenance and management of manufacturing facilities, equipment, employees and inventories and limitations on the flexibility of controlling overhead;	
 
 	•	 	difficulties in continuing expansion of our operations in Asia and Europe, because of the distance from our United States (“U.S.”) headquarters and differing regulatory and cultural environments;	
 
 	•	 	the need for skills and techniques that are outside our traditional core expertise;	
 
 	•	 	less flexibility in shifting manufacturing or supply sources from one region to another;	
 
 	•	 	even when independent suppliers offer lower prices, we would continue to acquire wafers from our captive manufacturing facilities, which may result in us having higher costs than our competitors;	
 
 	•	 	difficulties developing and implementing a successful research and development team; and	
 
 	•	 	difficulties developing, protecting, and gaining market acceptance of, our proprietary technology.	
The risks of becoming a fully integrated manufacturer are amplified in an industry-wide slowdown because of the fixed costs associated with manufacturing facilities. In addition, we may not realize the cost, operating and other efficiencies that we expect from continued vertical integration. If we fail to successfully vertically integrate our business, our ability to compete, profit margins, results of operations and financial condition may suffer.
Part of our growth strategy involves identifying and acquiring companies with complementary product lines or customers. We may be unable to identify suitable acquisition candidates or consummate desired acquisitions and, if we do make any acquisitions, we may be unable to successfully integrate any acquired companies with our operations, which could adversely affect our business, results of operations and financial condition.
A significant part of our growth strategy involves acquiring companies with complementary product lines, customers or other capabilities. For example, (i) in 2000, we acquired FabTech, Inc., a wafer fabrication company, in order to have our own wafer manufacturing capabilities, (ii) in 2006, we acquired Anachip Corp. as an entry into the analog market, (iii) in 2006, we acquired the net operating assets of APD Semiconductor, Inc., (iv) in 2008, we acquired Zetex plc., (v) in 2012, we acquired over 50% of the outstanding common stock of Eris Technology Corporation, (vi) also in 2012, we acquired Power Analog Microelectronics, Inc., and (vii) in 2013, we acquired BCD Semiconductor Manufacturing Limited. In addition, from time to time, we may be in various stages of discussions with potential acquisition targets as we intend to continue to expand and diversify our operations by making further acquisitions. However, we may be unsuccessful in identifying suitable acquisition candidates, or we may be unable to consummate a desired acquisition. To the extent we do make acquisitions, if we are unsuccessful in integrating these companies or their operations or product lines with our operations, or if integration is more difficult than anticipated, we may experience disruptions that could have a material adverse effect on our business, results of operations and financial condition. In addition, we may not realize all of the benefits we anticipate from any such acquisitions. Some of the risks that may affect our ability to integrate or realize any anticipated benefits from acquisitions that we may make include those associated with:
 
 	•	 	unexpected losses of key employees or customers of the acquired company;	
 
 	•	 	bringing the acquired company’s standards, processes, procedures and controls into conformance with our operations;	
 
- 17 -

Table of Contents
 	•	 	coordinating our new product and process development;	
 
 	•	 	hiring additional management and other critical personnel;	
 
 	•	 	increasing the scope, geographic diversity and complexity of our operations;	
 
 	•	 	difficulties in consolidating facilities and transferring processes and know-how;	
 
 	•	 	difficulties in reducing costs of the acquired entity’s business;	
 
 	•	 	diversion of management’s attention from the management of our business; and	
 
 	•	 	adverse effects on existing business relationships with customers.	
We are subject to litigation risks, including securities class action litigation, which may be costly to defend and the outcome of which is uncertain and could adversely affect our business and financial condition.
All industries, including the semiconductor industry, are subject to legal claims, with and without merit, including securities class action litigation that may be particularly costly and which may divert the attention of our management and our resources in general. We are involved in a variety of legal matters, most of which we consider either routine matters that arise in the normal course of business or immaterial for our aggregate business operations. These routine matters typically fall into broad categories such as those involving suppliers and customers, employment and labor, and intellectual property. We believe it is unlikely that the final outcome of these legal claims will have a material adverse effect on our financial position, results of operations or cash flows. However, defense and settlement costs can be substantial, even with respect to claims that we believe have no merit. Due to the inherent uncertainty of the litigation process, the resolution of any particular legal claim or proceeding could have a material effect on our business, financial condition, results of operations or cash flows.
As mentioned above, from time to time, we have been, or may in the future be, involved in securities litigation or litigation arising from our acquisitions. We can provide no assurance as to the outcome of any such litigation matter in which we are a party. These types of matters are costly to defend and even if resolved in our favor, could have a material adverse effect on our business, financial condition, results of operations and cash flow. Such litigation could also substantially divert the attention of our management and our resources in general. Uncertainties resulting from the initiation and continuation of securities or other litigation could harm our ability to obtain credit and financing for our operations and to compete in the marketplace. Because the price of our Common Stock has been, and may continue to be, volatile, we can provide no assurance that securities litigation will not be filed against us in the future. In addition, we can provide no assurance that our past or future acquisitions will not subject us to additional litigation. See Part I, Item 3 “Legal Proceedings” of this Annual Report for more information on our legal proceedings.
We are subject to many environmental laws and regulations that could result in significant expenses and could adversely affect our business, results of operations and financial condition.
We are subject to a variety of U.S. federal, state, local and foreign governmental laws, rules and regulations related to the use, storage, handling, discharge or disposal of certain toxic, volatile or otherwise hazardous chemicals used in manufacturing our products throughout the world. Some of these regulations in the U.S. include the Federal Clean Water Act, Clean Air Act, Resource Conservation and Recovery Act, Comprehensive Environmental Response, Compensation, and Liability Act and similar state statutes and regulations. Any of these regulations could require us to acquire equipment or to incur substantial other expenses to comply with environmental regulations. If we were to incur such additional expenses, our product costs could significantly increase, materially affecting our business, financial condition and results of operations. Any failure to comply with present or future environmental laws, rules and regulations could result in fines, suspension of production or cessation of operations, any of which could have a material adverse effect on our business, results of operations and financial condition. Our operations affected by such requirements include, among others: the disposal of wastewater containing residues from our manufacturing operations through publicly operated treatment works or
 
- 18 -

Table of Contents
sewer systems, and which may be subject to volume and chemical discharge limits and may also require discharge permits; and the use, storage and disposal of materials that may be classified as toxic or hazardous. Any of these may result in, or may have resulted in, environmental conditions for which we could be liable.
Some environmental laws impose liability, sometimes without fault, for investigating or cleaning up contamination on, or emanating from, our currently or formerly owned, leased or operated properties, as well as for damages to property or natural resources and for personal injury arising out of such contamination. Such liability may also be joint and several, meaning that we could be held responsible for more than our share of the liability involved, or even the entire liability. In addition, the presence of environmental contamination could also interfere with ongoing operations or adversely affect our ability to sell or lease our properties. Environmental requirements may also limit our ability to identify suitable sites for new or expanded plants. Discovery of contamination for which we are responsible, the enactment of new laws and regulations, or changes in how existing requirements are enforced, could require us to incur additional costs for compliance or subject us to unexpected liabilities.
Our products may be found to be defective and, as a result, warranty claims and product liability claims may be asserted against us, which may harm our business, reputation with our customers, results of operations and financial condition.
Our products are typically sold at prices that are significantly lower than the cost of the equipment or other goods in which they are incorporated. For example, our products that are incorporated into a television may be sold for several cents, whereas the television maker might sell the television for several hundred dollars. Although we maintain rigorous quality control systems, we shipped approximately 41 billion, 32 billion and 29 billion individual semiconductor devices in years ending December 31, 2013, 2012 and 2011, respectively, to customers around the world, and in the ordinary course of our business, we receive warranty claims and product liability claims for some of these products that are defective, or that do not perform to published specifications. Since a defect or failure in our products could give rise to failures in the end-products that incorporate them (and consequential claims for damages against our customers from their customers), we may face claims for damages that are disproportionate to the revenues and profits we receive from the products involved. In addition, our ability to reduce such liabilities may be limited by the laws or the customary business practices of the countries where we do business. Even in cases where we do not believe we have legal liability for such claims, we may choose to pay for them to retain a customer’s business or goodwill or to settle claims to avoid protracted litigation. Our results of operations and business could be adversely affected as a result of a significant quality or performance issue in our products, if we are required or choose to pay for the damages that result. Although we currently have liability insurance, we may not have sufficient insurance coverage, and we may not have sufficient resources, to satisfy all possible warranty claims and product liability claims. In addition, any perception that our products are defective would likely result in reduced sales of our products, loss of customers and harm to our business, reputation, results of operations and financial condition.
We may fail to attract or retain the qualified technical, sales, marketing, finance and management personnel required to operate our business successfully, which could adversely affect our business, results of operations and financial condition.
Our future success depends, in part, upon our ability to attract and retain highly qualified technical, sales, marketing, finance and managerial personnel. Personnel with the necessary expertise are scarce and competition for personnel with these skills is intense. We may not be able to retain existing key technical, sales, marketing, finance and managerial employees or be successful in attracting, assimilating or retaining other highly qualified technical, sales, marketing, finance and managerial personnel in the future. For example, we have faced, and continue to face, intense competition for qualified technical and other personnel in China, where our assembly, test and packaging facilities are located. A number of U.S. and multi-national corporations, both in the semiconductor industry and in other industries, have recently established and are continuing to establish factories and plants in China, and the competition for qualified personnel has increased significantly as a result. If we are
 
- 19 -

Table of Contents
unable to retain existing key employees or are unsuccessful in attracting new highly qualified employees, our business, results of operations and financial condition could be materially and adversely affected.
We may not be able to achieve future growth, and any such growth may place a strain on our management and on our systems and resources, which could adversely affect our business, results of operations and financial condition.
Our ability to successfully grow our business within the semiconductor industry requires effective planning and management. Our past growth, and our targeted future growth, may place a significant strain on our management and on our systems and resources, including our financial and managerial controls, reporting systems and procedures. In addition, we will need to continue to train and manage our workforce worldwide. If we are unable to effectively plan and manage our growth effectively, our business and prospects will be harmed and we will not be able to maintain our profit growth or achieve future growth, which could adversely affect our business, results of operations and financial condition.
Obsolete inventories as a result of changes in demand for our products and change in life cycles of our products could adversely affect our business, results of operations and financial condition.
The life cycles of some of our products depend heavily upon the life cycles of the end-products into which our products are designed. End-market products with short life cycles require us to manage closely our production and inventory levels. Inventory may also become obsolete because of adverse changes in end-market demand. We may in the future be adversely affected by obsolete or excess inventories, which may result from unanticipated changes in the estimated total demand for our products or the estimated life cycles of the end-products into which our products are designed. In addition, some customers restrict how far back the date of manufacture for our products can be and certain customers may stop ordering products from us and go out of business due to adverse economic conditions; therefore, some of our product inventory may become obsolete and, thus, adversely affect our business, results of operations and financial condition.
If OEMs do not design our products into their applications, our net sales may be adversely affected.
We expect an increasingly significant portion of net sales will come from products we design specifically for our customers. However, we may be unable to achieve these design wins. In addition, a design win from a customer does not guarantee future sales to that customer. Without design wins from OEMs, we would only be able to sell our products to these OEMs as a second source, which usually means we are only able to sell a limited amount of product to them. Once an OEM designs another supplier’s semiconductors into one of its product platforms, it is more difficult for us to achieve future design wins with that OEM’s product platform because changing suppliers involves significant cost, time, effort and risk to an OEM. Achieving a design win with a customer does not ensure that we will receive significant revenues from that customer, and we may be unable to convert design wins into actual sales. Even after a design win, the customer is not obligated to purchase our products and can choose at any time to stop using our products, if, for example, its own products are not commercially successful.
We are subject to interest rate risk that could have an adverse effect on our cost of working capital and interest expenses, which could adversely affect our business, results of operations and financial condition.
We have credit facilities with financial institutions in the U.S., Asia and Europe, as well as other debt instruments, with interest rates equal to LIBOR or similar indices plus a negotiated margin. Our largest credit facility is our five-year $300 million revolving senior credit facility, which had $179 million outstanding as of December 31, 2013. A rise in interest rates could have an adverse impact upon our cost of working capital and our interest expense. As of December 31, 2013, an increase of 1% in interest rates on our credit facilities would increase our annual interest rate expense by less than $1 million.
 
- 20 -

Table of Contents
We may have a significant amount of debt with various financial institutions worldwide. Any indebtedness could adversely affect our business, results of operations, financial condition and our ability to meet our payment obligations under such debt.
We may have a significant amount of debt and substantial debt service requirements in our borrowings, including our credit facilities with various financial institutions worldwide. During 2013, we obtained a five-year $300 million revolving senior credit facility with Bank of America, N.A., which had $179 million outstanding as of December 31, 2013. In addition, as of December 31, 2013, we had an aggregate outstanding debt of $6 million on our lines of credit, which an additional $7 million was used for import and export guarantees under our credit facilities with various financial institutions worldwide. As of December 31, 2013 an aggregate amount of $99 million was available for future borrowings under our lines of credit and $121 million under our revolving senior credit facility. We are permitted under the terms of our debt agreements under various credit facilities to incur substantial additional debt.
A significant amount of debt could have significant consequences on our future operations, including:
 
 	•	 	making it more difficult for us to meet our payment and other obligations under our outstanding debt;	
 
 	•	 	resulting in an event of default if we fail to comply with the financial and other restrictive covenants contained in our debt agreements, which event of default could result in all of our debt becoming immediately due and payable and, in the case of an event of default under our secured debt could permit the lenders to foreclose on our assets securing that debt;	
 
 	•	 	reducing the availability of our cash flow to fund working capital, capital expenditures, acquisitions and other general corporate purposes, and limiting our ability to obtain additional financing for these purposes;	
 
 	•	 	subjecting us to the risk of increased sensitivity to interest rate increases on our indebtedness with variable interest rates;	
 
 	•	 	limiting our flexibility in planning for, or reacting to, and increasing our vulnerability to, changes in our business, the industry in which we operate and the general economy; and	
 
 	•	 	placing us at a competitive disadvantage compared to our competitors that have less debt or are less leveraged.	
Any of the above-listed factors could have an adverse effect on our business, results of operations, financial condition and our ability to meet our payment obligations under our debt.
Restrictions in our credit facilities may limit our business and financial activities, including our ability to obtain additional capital in the future.
During 2013, we entered into a Credit Agreement with Bank of America, N.A., as administrative agent for the lenders under the credit agreement, which provides for a five-year $300 million revolving senior credit facility, which includes $10 million swing line sublimit, a $10 million letter of credit sublimit, and $20 million alternative currency sublimit. In addition, we may from time to time request increases in the aggregate commitment under the Credit Agreement of up to $200 million, subject to the lenders electing to increase their commitments or by means of the addition of new lenders.
This Credit Agreement contains covenants imposing various restrictions on our business and financial activities. These restrictions may affect our ability to operate our business and undertake certain financial activities and may limit our ability to take advantage of potential business or financial opportunities as they arise. The restrictions these covenants place on us include limitations on our ability to incur liens, incur indebtedness, make investments, dissolve or merge or consolidate with or into another entity, dispose of certain property, make restricted payments, issue or sell equity interests, engage in other different material lines of business, conduct
 
- 21 -

Table of Contents
related party transactions, enter into certain burdensome contractual obligations and use proceeds from any credit facility to purchase or carry margin stock or to extend credit to others for the same purpose. The Credit Agreement also requires us to meet certain financial ratios, including a fixed charge coverage ratio and a consolidated leverage ratio.
Our ability to comply with the Credit Agreement may be affected by events beyond our control, including prevailing economic, financial and industry conditions, and are subject to the risks stated in this section of the Annual Report. The breach of any of these covenants or restrictions could result in a default under the Credit Agreement. An event of default under the Credit Agreement would permit Bank of America, N.A. to declare all amounts owed under such Credit Agreement to be immediately due and payable in full. Acceleration of our indebtedness may cause us to be unable to make interest payments for the credit facilities and repay the principal amount of the credit facilities. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations— Debt instruments ” in Part II, Item 7 of this Annual Report for additional information.
Our business benefits from certain Chinese government incentives. Expiration of, or changes to, these incentives could adversely affect our results of operations and financial condition.
The Chinese government has provided various incentives to technology companies, including our manufacturing facilities located in Shanghai, China, in order to encourage development of the high-tech industry. These incentives include reduced tax rates and other measures. As a result, we are entitled to a preferential enterprise income tax rate of 15% so long as our manufacturing facilities continue to maintain their High and New Technology Enterprise “HNTE” status. One of our Shanghai manufacturing facilities has been approved for its HNTE status for the tax years 2011-2013. For 2014 and future years, this facility no longer qualifies for the HNTE status and therefore all of its future and deferred income will be taxed at the statutory tax rate of 25%. Our other Shanghai manufacturing facility has been approved for its HNTE status for the tax years 2012-2014. In addition, one of our wafer fabrication facilities located in Shanghai has been approved for its HNTE status for the tax years 2011-2013. We expect this facility to be approved for its HNTE status for tax year 2014 . Any prior years that have already been approved are subject to audits to ensure all requirements are met. If we were to no longer meet the HNTE requirements, our statutory tax rate for our approved Shanghai manufacturing facility and wafer fabrication facility would increase to 25%, which could adversely affect our results of operations and financial condition.
During 2012, the China government began an audit of our largest Chinese subsidiary for our 2009-2011 HNTE status as part of an overall evaluation of the reduced tax rates provided to many high tech companies. In April 2013, we were notified by the China government that they had completed their tax audit and had concluded that we owed additional tax related to tax year 2011 in the amount of $5 million, which was paid during 2013.
In connection with our joint venture in Chengdu, China, we have qualified for tax incentives offered in the Go West Initiative (“Go West”), where companies are entitled to a preferential income tax rate of 15% for doing business in western China. If we were to no longer meet the Go West requirements, our statutory tax rate for this joint venture would increase to 25%, which could adversely affect our results of operations and financial condition.
The impact of our Go West and HNTE status, collectively called tax holidays, decreased our tax expense by approximately $2 million, $6 million and $7 million for the years ended December 31, 2013, 2012 and 2011, respectively. The benefit of the tax holidays on both basic and diluted earnings per share for the year ended December 31, 2013 was approximately $0.05. The benefit of the tax holidays on basic and diluted earnings per share for the year ended December 31, 2012 was approximately $0.14 and $0.13, respectively. The benefit of the tax holidays on both basic and diluted earnings per share for the year ended December 31, 2011 was approximately $0.15.
 
- 22 -

Table of Contents
We operate a global business through numerous foreign subsidiaries, and there is a risk that tax authorities will challenge our transfer pricing methodologies and/or legal entity structures, which could adversely affect our results of operations and financial condition.
We conduct operations worldwide through our foreign subsidiaries, and are therefore subject to complex transfer pricing regulations in the jurisdictions in which we operate. Transfer pricing regulations generally require that, for tax purposes, transactions between related parties be priced on a basis that would be comparable to an arm’s length transaction between unrelated parties. There is uncertainty and inherent subjectivity in complying with these rules. To the extent that any foreign tax authorities disagree with our transfer pricing policies, we could become subject to significant tax liabilities and penalties. Based on our current knowledge and probability assessment of potential outcomes, we believe that we have provided for all tax exposures. However, the ultimate outcome of a tax examination could differ materially from our provisions and could have a material adverse effect on our business, financial condition, results of operations or cash flows.
Our legal organizational structure could result in unanticipated unfavorable tax or other consequences which could have a material adverse effect on our financial condition and results of operations. In some countries, we maintain multiple entities for tax or other purposes. Changes in tax laws, regulations, future jurisdictional profitability of the Company and its subsidiaries, and related regulatory interpretations in the countries in which we operate may impact the taxes we pay or tax provision we record, which could have a material adverse effect on our results of operations. In addition, any challenges to how our entities are structured or realigned or their business purpose by taxing authorities could result in the Company becoming subject to significant tax liabilities and penalties which could have a material adverse effect on our business, financial condition, results of operations or cash flows.
The value of our benefit plan assets and liabilities is based on estimates and assumptions, which may prove inaccurate and the actual amount of expenses recorded in the consolidated financial statements could differ materially from the assumptions used.
Certain of our employees in the U.K. participate in a company-sponsored defined benefit, which is closed to new entrants and is frozen with respect to future benefit accruals. The retirement benefit is based on the final average compensation and service of each eligible employee. In accounting for these plans, we are required to make actuarial assumptions that are used to calculate the earning value of the related assets, where applicable, and liabilities and the amount of expenses to be recorded in our consolidated financial statements. Assumptions include the expected return on plan assets, discount rates, and mortality rates. While we believe the underlying assumptions under the projected unit credit method are appropriate, the carrying value of the related assets and liabilities and the actual amount of expenses recorded in the consolidated financial statements could differ materially from the assumptions used.
Changes in actuarial assumptions for our defined benefit plan could increase the volatility of the plan’s asset value, require us to increase cash contributions to the plan and have a negative impact on our cash flows, results of operations and financial condition.
The assets of our defined benefit plan (the “plan”) consist primarily of high quality, corporate bonds and stocks traded on the London Stock Exchange and are determined from time to time based on their fair value, requiring us to utilize certain actuarial assumptions for the plan’s fair value determination.
As of December 31, 2013, the benefit obligation of the plan was approximately $149 million and the total assets in such plan were approximately $117 million. Therefore, the plan was underfunded by approximately $33 million. The difference between plan obligations and assets, or the funded status of the plan, is a significant factor in determining the net periodic benefit costs of the plan and the ongoing funding requirements of the plan.
Any fluctuations in the United Kingdom’s equity markets and bond markets or changes in several key actuarial assumptions, including, but not limited to, changes in discount rate, estimated return on the plan and
 
- 23 -

Table of Contents
mortality rates, can (i) affect the level of plan funding; (ii) cause volatility in the net periodic pension cost; and (iii) increase our future funding requirements. In the event that actual results differ from the actuarial assumptions or actuarial assumptions are changed, the funding status of the plan may change. Any deficiency in the funding of the plan could result in additional charges to equity and an increase in future plan expense and cash contribution. A significant increase in our funding requirements could have a negative impact on our cash flows, results of operations and financial condition.
In 2012, we adopted a payment plan with the trustees of the defined benefit plan, in which we will pay approximately £2 million GBP (approximately $3 million based on a USD:GBP exchange rate of 1.6:1) every year from 2012 through 2019.
Certain of our customers and suppliers require us to comply with their codes of conduct, which may include certain restrictions that may substantially increase the cost of our business as well as have an adverse effect on our operating efficiencies, results of operations and financial condition.
Certain of our customers and suppliers require us to agree to comply with the Electronic Industry Code of Conduct (“EICC”) or their own codes of conduct, which may include detailed provisions on labor, human rights, health and safety, environment, corporate ethics and management systems. Certain of these provisions are not requirements under the laws of the countries in which we operate and may be burdensome to comply with on a regular basis. Moreover, new provisions may be added or material changes may be made to any these codes of conduct, and we may have to promptly implement such new provisions or changes, which may substantially further increase the cost of our business, be burdensome to implement and adversely affect our operational efficiencies and results of operations. If we violate any such codes of conduct, we may lose further business with the customer or supplier and, in addition, we may be subject to fines from the customer or supplier. While we believe that we are currently in compliance with our customers and suppliers’ codes of conduct, there can be no assurance that, from time to time, if any one of our customers and suppliers audits our compliance with such code of conduct, we would be found to be in full compliance. A loss of business from these customers or suppliers could have a material adverse effect on our business, results of operations and financial conditions.
Compliance with government regulations and customer demands regarding the use of “conflict minerals” may result in increased costs and may have a negative impact on our business, results of operations and financial condition.
The Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 imposes new disclosure requirements regarding the use of certain minerals, which are mined from the Democratic Republic of Congo and adjoining countries, known as conflict minerals. When these new requirements are implemented, they could affect the pricing, sourcing and availability of minerals used in the manufacture of semiconductor devices (including our products). There will be additional costs associated with complying with the disclosure requirements, such as costs related to determining the source of any conflict minerals used in our products. Our supply chain is complex and we may be unable to verify the origins for all metals used in our products. Customers may demand that the products they purchase be free of conflict minerals. Therefore, we may encounter challenges with our customers and stockholders if we are unable to certify that our products are conflict free. The implementation of this requirement could affect the sourcing and availability of products we purchase from suppliers. This may reduce the number of suppliers that may be able to provide conflict free products, and may affect our ability to obtain products in sufficient quantities to meet customer demand or at competitive prices. The disclosure rules will take effect for us in May 2014.
There are risks associated with previous and future acquisitions. We may ultimately not be successful in overcoming these risks or any other problems encountered in connection with acquisitions.
The risks commonly encountered in acquisitions of companies include, among other things, higher than anticipated acquisition costs and expenses, the difficulty and expense in integrating the operations and personnel of the companies, the difficulty of bringing standards, procedures and controls into conformance with our
 
- 24 -

Table of Contents
operations, the ability to coordinate our new products and process development, the ability to hire additional management and other critical personnel, the ability to increase the scope, geographic diversity and complexity of our operations, difficulties in consolidating facilities and transferring processes and know-how, difficulties in reducing costs, prolonged diversion of our management’s attention from the management of our business, the ability to clearly define our present and future strategies, the loss of key employees and customers as a result of changes in management and any geographic distances may make integration slower and more challenging. We may ultimately not be successful in overcoming these risks or any other problems encountered in connection with acquisitions.
In addition, any acquisition may cause large one-time expenses as well as create goodwill and other intangible assets that may result in significant asset impairment charges in the future.
If we fail to maintain an effective system of internal controls or discover material weaknesses in our internal control over financial reporting, we may not be able to report our financial results accurately or detect fraud, which could harm our business and the trading price of our Common Stock.
Effective internal controls are necessary for us to produce reliable financial reports and are important in our effort to prevent financial fraud. We are required to periodically evaluate the effectiveness of the design and operation of our internal controls. These evaluations may result in the conclusion that enhancements, modifications or changes to our internal controls are necessary or desirable. While management evaluates the effectiveness of our internal controls on a regular basis, these controls may not always be effective. There are inherent limitations on the effectiveness of internal controls, including collusion, management override, and failure of human judgment. Because of this, control procedures are designed to reduce rather than eliminate business risks. If we fail to maintain an effective system of internal controls or if management or our independent registered public accounting firm were to discover material weaknesses in our internal controls, we may be unable to produce reliable financial reports or prevent fraud, which could harm our financial condition and results of operations and result in loss of investor confidence and a decline in our stock price.
Terrorist attacks, or threats or occurrences of other terrorist activities, whether in the United States or internationally, may affect the markets in which our Common Stock trades, the markets in which we operate and our results of operations and financial condition.
Terrorist attacks, or threats or occurrences of other terrorist or related activities, whether in the United States or internationally, may affect the markets in which our Common Stock trades, the markets in which we operate and our profitability. Future terrorist or related activities could affect our domestic and international sales, disrupt our supply chains and impair our ability to produce and deliver our products. Such activities could affect our physical facilities or those of our suppliers or customers. Such terrorist attacks could cause seaports or airports, to or through which we ship, to be shut down, thereby preventing the delivery of raw materials and finished goods to or from our manufacturing facilities in China, Taiwan and Germany and our wafer fabrication facilities in China, Missouri and the U.K., or to our regional sales offices. Due to the broad and uncertain effects that terrorist attacks have had on financial and economic markets generally, we cannot provide any estimate of how these activities might affect our future results of operations and financial condition.
System security risks, data protection breaches, cyber-attacks and other related cybersecurity issues could disrupt our internal operations, and any such disruption could reduce our expected revenue, increase our expenses, damage our reputation and adversely affect our stock price.
Experienced computer programmers and hackers may be able to penetrate our security controls and misappropriate or compromise our confidential information or that of third parties, create system disruptions or cause shutdowns. Computer programmers and hackers also may be able to develop and deploy viruses, worms and other malicious software programs that attack our websites, products or otherwise exploit any security vulnerabilities of our websites and products. The costs to us to eliminate or alleviate cyber or other security
 
- 25 -

Table of Contents
problems, bugs, viruses, worms, malicious software programs and security vulnerabilities could be significant, and our efforts to address these problems may not be successful and could result in interruptions, delays, cessation of service and loss of existing or potential customers that may impede our sales, manufacturing, distribution or other critical functions.
We manage and store various proprietary information and sensitive or confidential data relating to our business and third party business. Breaches of our security measures or the accidental loss, inadvertent disclosure or unapproved dissemination of proprietary information or sensitive or confidential data about us or our partners or customers, including the potential loss or disclosure of such information or data as a result of fraud, trickery or other forms of deception, could expose us, our partners and customers or the individuals affected to a risk of loss or misuse of this information, result in litigation and potential liability for us, damage our brand and reputation or otherwise harm our business. In addition, the cost and operational consequences of implementing further data protection measures could be significant.
Delayed sales, significant costs or lost customers resulting from these system security risks, data protection breaches, cyber-attacks and other related cybersecurity issues could adversely affect our financial results, stock price and reputation.
RISKS RELATED TO OUR INTERNATIONAL OPERATIONS
Our international operations subject us to risks that could adversely affect our operations.
We expect net sales from foreign markets to continue to represent a significant portion of our total net sales. In addition, the majority of our manufacturing facilities are located overseas in China. In 2013, 2012 and 2011, our Asian and European subsidiaries represented 91%, 90% and 88%, respectively, of our net sales. There are risks inherent in doing business internationally, and any or all of the following factors could cause harm to our business:
 
 	•	 	changes in, or impositions of, legislative or regulatory requirements, including tax laws in the U.S. and in the countries in which we manufacture or sell our products;	
 
 	•	 	compliance with trade or other laws in a variety of jurisdictions;	
 
 	•	 	trade restrictions, transportation delays, work stoppages, and economic and political instability;	
 
 	•	 	changes in import/export regulations, tariffs and freight rates;	
 
 	•	 	difficulties in collecting receivables and enforcing contracts;	
 
 	•	 	currency exchange rate fluctuations;	
 
 	•	 	restrictions on the transfer of funds from foreign subsidiaries to the U.S.;	
 
 	•	 	the possibility of international conflict, particularly between or among China, the U.K., Germany, Taiwan and the U.S.;	
 
 	•	 	legal, regulatory, political and cultural differences among the countries in which we do business;	
 
 	•	 	longer customer payment terms; and	
 
 	•	 	changes in U.S. or foreign tax regulations.	
We have significant operations and assets in China, the United Kingdom, Germany, Hong Kong and Taiwan and, as a result, will be subject to risks inherent in doing business in those jurisdictions, which may adversely affect our financial performance and results of operations.
We have a significant portion of our assets in mainland China, United Kingdom, Germany, Hong Kong and Taiwan. Our ability to operate in these countries may be adversely affected by changes in those jurisdictions’ laws and regulations, including those relating to taxation, import and export tariffs, environmental regulations,
 
- 26 -

Table of Contents
land use rights, property and other matters. In addition, our results of operations and financial performance are subject to the economic and political situations. We believe that our operations are in compliance with all applicable legal and regulatory requirements. However, the central or local governments of these jurisdictions may impose new, stricter regulations or interpretations of existing regulations that would require additional expenditures and efforts on our part to ensure our compliance with such regulations or interpretations.
Changes in the political environment or government policies in those jurisdictions could result in revisions to laws or regulations or their interpretation and enforcement, increased taxation, restrictions on imports, import duties or currency revaluations. In addition, a significant destabilization of relations between or among China, the United Kingdom, Germany, Hong Kong, Taiwan and the U.S. could result in restrictions or prohibitions on our operations or the sale of our products or the forfeiture of our assets in these jurisdictions. There can be no certainty as to the application of the laws and regulations of these jurisdictions in particular instances. Enforcement of existing laws or agreements may be sporadic and implementation and interpretation of laws inconsistent. Moreover, there is a high degree of fragmentation among regulatory authorities, resulting in uncertainties as to which authorities have jurisdiction over particular parties or transactions. The possibility of political conflict between these countries or with the U.S. could have an adverse impact upon our ability to transact business in these jurisdictions and to generate profits.
A slowdown in the Chinese economy could limit the growth in demand for electronic devices containing our products, which would have a material adverse effect on our business, results of operations and prospects.
We believe that an increase in demand in China for electronic devices that include our products will be an important factor in our future growth. Although the Chinese economy has grown significantly in recent years, there can be no assurance that such growth will continue. Any weakness in the Chinese economy could result in a decrease in demand for electronic devices containing our products and, thereby, materially and adversely affect our business, results of operations and prospects.
Economic regulation in China could materially and adversely affect our business, results of operations and prospects.
We have a significant portion of our manufacturing capacity in China. In addition, in 2013 36% of our total sales were billed to customers in China. In recent years, the Chinese economy has experienced periods of rapid expansion and wide fluctuations in the rate of inflation. In response to these factors, the Chinese government has, from time to time, adopted measures to regulate growth and contain inflation, including measures designed to restrict credit or control prices. Such actions in the future could increase the cost of doing business in China or decrease the demand for our products in China and, thereby, have a material adverse effect on our business, results of operations and prospects.
We could be adversely affected by violations of the United States’ Foreign Corrupt Practices Act, the United Kingdom’s Bribery Act 2010 and similar worldwide anti-bribery laws.
The United States’ Foreign Corrupt Practices Act (“FCPA”), the United Kingdom’s Bribery Act 2010 (the “UK Bribery Act”) and similar anti-bribery laws in other jurisdictions generally prohibit companies and their intermediaries from making improper payments to government officials for the purpose of obtaining or retaining business. Our policies mandate compliance with these anti-bribery laws. We operate in many parts of the world that may have experienced governmental corruption to some degree and, in certain circumstances, strict compliance with anti-bribery laws may conflict with local customs and practices. We train our staff concerning FCPA, the UK Bribery Act and related anti-bribery laws. We have established procedures and controls to monitor internal and external compliance. There can be no assurance that our internal controls and procedures always will protect us from reckless or criminal acts committed by our employees or agents. If we are found to be liable for FCPA, the UK Bribery Act and other anti-bribery law violations (either due to our own acts or inadvertence, or due to the acts or inadvertence of others), we could incur criminal or civil penalties or other sanctions, which could have a material adverse effect on our business.
 
- 27 -

Table of Contents
We are subject to foreign currency risk as a result of our international operations.
We face exposure to adverse movements in foreign currency exchange rates, principally the Chinese Yuan, the Taiwanese dollar, the Euro and the British Pound Sterling and, to a lesser extent, the Japanese Yen and the Hong Kong dollar. Our income and expenses are based on a mix of currencies and a decline in one currency relative to the other currencies could adversely affect our results of operations. Furthermore, our results of operations are reported in U.S. dollars, which is our reporting currency. In the event the U.S. dollar weakens against a foreign currency, we will experience a currency transaction loss, which could adversely affect our results of operations. Also, fluctuations in foreign currency exchange rates may have an adverse impact and be increasingly influential to our overall sales, profits and results of operations as amounts that are measured in foreign currency are translated back to U.S. dollars for reporting purposes. Our foreign currency risk may change over time as the level of activity in foreign markets grows and could have an adverse impact upon our financial results, especially as the portion of our sales attributable to Europe increases. We do not usually employ hedging techniques designed to mitigate foreign currency exposures and, therefore, we could experience currency losses as these currencies fluctuate against the U.S. dollar.
China is experiencing rapid social, political and economic change, which has increased labor costs and other related costs that could make doing business in China less advantageous than in prior years. Increased labor costs in China could adversely affect our business, results of operations and financial condition.
Historically, labor in China has been readily available at a lower cost compared to other countries, and any increase in labor cost in China has been consistent with the projected annual increase in the inflation index and the amount of past labor cost increases. However, because China is experiencing rapid social, political and economic change, there can be no assurance that labor will continue to be available in China at costs consistent with historical levels. Any future increase in labor cost in China is likely to be higher than historical and projected amounts and may occur multiple times in any given year. As a result of experiencing such rapid social, political and economic change, China is also likely to enact new, and/or revise its existing, labor laws and regulations on employee compensation and benefits. These changes in Chinese labor laws and regulations will likely to have an adverse effect on product manufacturing costs in China. Furthermore, if China workers go on strike to demand higher wages, our operations could be disrupted. Many of our suppliers are currently dealing with labor shortages in China, which may result in future supply delays and disruptions and may drive a substantial increase in their labor costs that is likely to be shared by us in the form of price increases to us. New or revised government labor laws or regulations, strikes or labor shortages could cause our product costs to rise and/or could cause manufacturing partners on whom we rely to exit the business. These events could have a material adverse impact on our product availability and quality, which would affect our business, results of operations and financial condition.
We may not continue to receive preferential tax treatment in Asia, thereby increasing our income tax expense and reducing our net income.
As an incentive for establishing our manufacturing subsidiaries in China, we received preferential tax treatment. We also receive preferential tax treatment in Taiwan. Governmental changes in foreign tax law may cause us not to be able to continue receiving these preferential tax treatments in the future, which may cause an increase in our income tax expense, thereby reducing our net income.
The distribution of any earnings of our foreign subsidiaries to the United States may be subject to United States income taxes, thus reducing our net income.
With the establishment of our holding companies in 2007 and 2011, we intend to permanently reinvest overseas all earnings from foreign subsidiaries. Although we intend to permanently reinvest overseas all earnings, certain unusual circumstances may require us to repatriate funds. This was the case during the first quarter of 2009, in which we repatriated approximately $29 million of accumulated earnings from one of our Chinese subsidiaries, resulting in additional non-cash U.S. federal and state income tax expense of approximately $5 million.
 
- 28 -

Table of Contents
As of December 31, 2013, accumulated and undistributed earnings of our subsidiaries in China were approximately $354 million, which we consider as a permanent investment.
As of December 31, 2013, we have undistributed earnings from non-U.S. operations of approximately $430 million (including approximately $45 million of restricted earnings, which are not available for dividends). Additional U.S. federal and state income taxes of approximately $101 million would be required should such earnings be repatriated to the U.S.
We may, in the future, plan to distribute earnings of our foreign subsidiaries to the U.S. We may be required to pay U.S. income taxes on these earnings to the extent we have not previously recorded deferred U.S. taxes on such earnings. Any such taxes would reduce our net income in the period in which these earnings are distributed.
RISKS RELATED TO OUR COMMON STOCK
Variations in our quarterly operating results may cause our stock price to be volatile.
We have experienced substantial variations in net sales, gross profit margin and operating results from quarter to quarter. We believe that the factors that influence this variability of quarterly results include:
 
 	•	 	strength of the global economy and the stability of the financial markets;	
 
 	•	 	general economic conditions in the countries where we sell our products;	
 
 	•	 	seasonality and variability in the computing and communications market and our other end-markets;	
 
 	•	 	the timing of our and our competitors’ new product introductions;	
 
 	•	 	product obsolescence;	
 
 	•	 	the scheduling, rescheduling and cancellation of large orders by our customers;	
 
 	•	 	the cyclical nature of the demand for our customers’ products;	
 
 	•	 	our ability to develop new process technologies and achieve volume production at our fabrication facilities;	
 
 	•	 	changes in manufacturing yields;	
 
 	•	 	adverse movements in exchange rates, interest rates or tax rates; and	
 
 	•	 	the availability of adequate supply commitments from our outside suppliers or subcontractors.	
Accordingly, a comparison of our results of operations from period to period is not necessarily meaningful to investors and our results of operations for any period do not necessarily indicate future performance. Variations in our quarterly results may trigger volatile changes in our stock price.
General or industry specific market conditions or stock market performance or domestic or international macroeconomic and geopolitical factors unrelated to our performance also may affect the price of our stock. For these reasons, investors should not rely on recent or historical trends to predict future stock prices, financial condition, results of operations or cash flows. In addition, as discussed in Part I, Item 3 “Legal Proceedings” of this Annual Report, we are involved in several lawsuits. Additional volatility in the price of our securities could result in the filing of additional litigation, which could result in substantial costs and the diversion of management time and resources.
We may enter into future acquisitions and take certain actions in connection with such acquisitions that could adversely affect the price of our Common Stock.
As part of our growth strategy, we expect to review acquisition prospects that would implement our vertical integration strategy or offer other growth opportunities. From time to time, we may be in various stages of
 
- 29 -

Table of Contents
discussions and we may acquire businesses, products or technologies in the future. In the event of future acquisitions, we could:
 
 	•	 	use a significant portion of our available cash;	
 
 	•	 	issue equity securities, which would dilute current stockholders’ percentage ownership;	
 
 	•	 	incur substantial debt;	
 
 	•	 	incur or assume contingent liabilities, known or unknown;	
 
 	•	 	incur amortization expenses related to intangibles;	
 
 	•	 	incur large, immediate accounting write-offs; and	
 
 	•	 	create goodwill and other intangible assets that may require impairment charges in the future.	
Such actions by us could harm our results from operations and adversely affect the price of our Common Stock.
Our directors, executive officers and significant stockholders hold a substantial portion of our Common Stock, which may lead to conflicts with other stockholders over corporate transactions and other corporate matters.
Our directors, executive officers and our affiliate, LSC, beneficially own approximately 28% of our outstanding Common Stock, including options to purchase shares of our Common Stock that are exercisable within 60 days of December 31, 2013. These stockholders, acting together, will be able to influence significantly all matters requiring stockholder approval, including the election of directors and significant corporate transactions such as mergers or other business combinations. This control may delay, deter or prevent a third party from acquiring or merging with us, which could adversely affect the market price of our Common Stock.
LSC, our largest stockholder, owns approximately 18% (approximately 8 million shares) of our Common Stock. Some of our directors and executive officers may have potential conflicts of interest because of their positions with LSC or their ownership of LSC common stock. Raymond Soong, the Chairman of the Board of Directors, is the Chairman of LSC, and is the Chairman of Lite-On Technology Corporation, a significant shareholder of LSC. C.H. Chen, our former President and Chief Executive Officer and currently the Vice Chairman of the Board of Directors, is also Vice Chairman of LSC and Lite-On Technology Corporation. Dr. Keh-Shew Lu, our President and Chief Executive Officer and a member of our Board of Directors, is a member of the Board of Directors of Lite-On Technology Corporation. L.P. Hsu, a member of the Board of Directors since 2007, serves as a consultant to Lite-On Technology Corporation. Several of our directors and executive officers own LSC common stock and hold options to purchase LSC common stock. Service on our Board of Directors and as a director or officer of LSC, or ownership of LSC common stock by our directors and executive officers, could create, or appear to create, actual or potential conflicts of interest when directors and officers are faced with decisions that could have different implications for LSC and us. For example, potential conflicts could arise in connection with decisions involving the Common Stock owned by LSC, or under the other agreements we may enter into with LSC. In each of 2013, 2012 and 2011, LSC accounted for approximately 1% of our net sales. Also, in 2013, 2012 and 2011, approximately 2%, 3% and 5%, respectively, of our net sales were from products manufactured by LSC, making LSC one of our largest external suppliers of discrete semiconductor products.
We may have difficulty resolving any potential conflicts of interest with LSC, and even if we do, the resolution may be less favorable than if we were dealing with an unrelated third party.
We were formed in 1959, and our early corporate records are incomplete. As a result, we may have difficulty in assessing and defending against claims relating to rights to our Common Stock purporting to arise during periods for which our records are incomplete.
We were formed in 1959 under the laws of California and reincorporated in Delaware in 1968. We have had several transfer agents since being formed. In addition, our early corporate records, including our stock ledger,
 
- 30 -

Table of Contents
are incomplete. As a result, we may have difficulty in assessing and defending against claims relating to rights to our Common Stock purporting to arise during periods for which our records are incomplete.
Non-cash tender offers, debt equity swaps or equity exchanges to consummate our business activities are likely to have the effect of diluting the ownership interest of existing stockholders, including qualified stockholders who receive shares of our Common Stock in such business activities.
We, from time to time, may utilize non-cash tender offers, debt equity swaps or equity exchanges in accordance with the guidance and rules promulgated by the United States Securities and Exchange Commission to consummate our business activities. Such means to consummate our business activities will likely involve issuance of our Common Stock in large quantities and will subsequently dilute the ownership interest of existing stockholders, including stockholders who previously received shares of our Common Stock in such transactions. Any sales in the public market of the newly issued Common Stock could adversely affect prevailing market prices of our Common Stock. In addition, utilizing non-cash tender offers, debt equity swaps or equity exchanges may encourage short selling because such utilization could depress the price of our Common Stock.
Anti-takeover effects of certain provisions of Delaware law and our Certificate of Incorporation and Bylaws, may hinder a take-over attempt .
Some provisions of Delaware law, our certificate of incorporation and bylaws may be deemed to have an anti-takeover effect and may delay or prevent a tender offer or takeover attempt, including those attempts that might result in a premium over the market price for the shares held by stockholders.
Section 203 of Delaware General Corporation Law may deter a take-over attempt.
Section 203 of the Delaware General Corporation Law prohibits transactions between a Delaware corporation and an “interested stockholder,” which is defined as a person who, together with any affiliates or associates, beneficially owns, directly or indirectly, 15.0% or more of the outstanding voting shares of a Delaware corporation. This provision prohibits certain business combinations between an interested stockholder and a Delaware corporation for a period of three years after the date the stockholder becomes an interested stockholder, unless:
 
 	(i)	either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder is approved by the corporation’s board of directors prior to the date the interested stockholder becomes an interested stockholder;	
 
 	(ii)	the interested stockholder acquired at least 85.0% of the voting stock of the corporation (other than stock held by directors who are also officers or by certain employee stock plans) in the transaction in which the stockholder became an interested stockholder; or	
 
 	(iii)	the business combination is approved by a majority of the board of directors and by the affirmative vote of 66.66% of the outstanding voting stock that is not owned by the interested stockholder.	
For this purpose, business combinations include mergers, consolidations, sales or other dispositions of assets having an aggregate value in excess of 10.0% of the aggregate market value of the consolidated assets or outstanding stock of the corporation, and certain transactions that would increase the interested stockholder’s proportionate share ownership in the corporation.
Certificate of Incorporation and Bylaw Provisions may deter a take-over attempt.
Provisions of our certificate of incorporation and bylaws may have the effect of making it more difficult for a third party to acquire control of our Company. In particular, our certificate of incorporation authorizes our Board of Directors to issue, without further action by the stockholders, up to 1,000,000 shares of preferred stock with rights and preferences, including voting rights, designated from time to time by the Board of Directors.
 
- 31 -

Table of Contents
The existence of authorized but unissued shares of preferred stock enables our Board of Directors to render it more difficult or to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise.
 
Item 1B.	Unresolved Staff Comments.	
None
 
Item 2.	Properties.	
Our primary physical properties at December 31, 2013 were as follows:

Primary use	  	Location	  	Lease
Expiration	 	  	Year
Purchased	  	Sq. Ft.	 	
Regional sales office	  	Shanghai, China	  	 	 	 	  	2010	  	 	7,000	  	
Regional sales office	  	Shanghai, China	  	 	 	 	  	2013	  	 	10,000	  	
Regional sales office	  	Shenzhen, China	  	 	April 2014	  	  	 	  	 	5,000	  	
Manufacturing facility/Logistics	  	Shanghai, China	  	 	February 2017	  	  	 	  	 	723,000	  	
Manufacturing facility/Logistics	  	Shanghai, China	  	 	March 2017	  	  	 	  	 	230,000	  	
Headquarters/R&D center	  	Plano, Texas	  	 	 	 	  	2010	  	 	42,000	  	
Sales/Administrative office	  	Westlake Village, California	  	 	August 2014	  	  	 	  	 	2,000	  	
Sales office/R&D center	  	San Jose, California	  	 	July 2015	  	  	 	  	 	4,000	  	
Regional sales office	  	Amherst, New Hampshire	  	 	Monthly	  	  	 	  	 	1,000	  	
Regional sales office	  	Beauzelle, France	  	 	February 2015	  	  	 	  	 	1,000	  	
Manufacturing facility/R&D center	  	Lee’s Summit, Missouri	  	 	December 2017	  	  	 	  	 	70,000	  	
Regional sales office	  	Seongnam-si, South Korea	  	 	December 2014	  	  	 	  	 	2,000	  	
R&D center	  	Hsinchu, Taiwan	  	 	November 2015	  	  	 	  	 	26,000	  	
Warehouse	  	Taipei, Taiwan	  	 	 	 	  	1987	  	 	12,000	  	
Sales/Administrative/Logistics	  	Taipei, Taiwan	  	 	 	 	  	2006	  	 	35,500	  	
Regional sales office	  	Kaohsiung City, Taiwan	  	 	April 2014	  	  	 	  	 	1,000	  	
Regional sales office	  	Munich, Germany	  	 	July 2016	  	  	 	  	 	6,000	  	
Manufacturing facility/R&D center	  	Manchester, England	  	 	 	 	  	1998	  	 	75,000	  	
Administrative/Logistics	  	Manchester, England	  	 	 	 	  	2004	  	 	81,000	  	
Manufacturing facility	  	Neuhaus, Germany	  	 	 	 	  	1996	  	 	53,000	  	
Manufacturing facility	  	Chengdu, China	  	 	October 2014	  	  	 	  	 	25,000	  	
Vacant land	  	Plano, Texas	  	 	 	 	  	2008	  	 	16 acres	  	
Manufacturing facility/Logistics	  	Chengdu, China	  	 	May 2061	  	  	 	  	 	32 acres	  	
Manufacturing facility/Logistics	  	Shanghai, China	  	 	February 2056	  	  	 	  	 	17 acres	  	
Sales/Administrative office	  	Taipei, Taiwan	  	 	 	 	  	2000-2008	  	 	11,000	  	
Manufacturing facility	  	Taipei, Taiwan	  	 	June 2014	  	  	 	  	 	70,500	  	
R&D/Warehouse/Administrative office	  	Taipei, Taiwan	  	 	April 2014	  	  	 	  	 	44,000	  	
Manufacturing facility/R&D center	  	Shanghai, China	  	 	 	 	  	2007	  	 	567,000	  	
Manufacturing facility/R&D center	  	Shanghai, China	  	 	December 2020	  	  	 	  	 	60,000	  	
Warehouse	  	Shanghai, China	  	 	December 2015	  	  	 	  	 	5,800	  	
Sales/Administrative office	  	Shenzhen, China	  	 	February 2014	  	  	 	  	 	9,900	  	
Sales office/R&D center	  	Shanghai, China	  	 	May 2015	  	  	 	  	 	1,600	  	
Regional sales office	  	Xiamen, China	  	 	April 2014	  	  	 	  	 	1,000	  	
We believe our current facilities are adequate for the foreseeable future.
 
- 32 -

Table of Contents
Item 3.	Legal Proceedings.	
We are currently a party to a purported stockholder derivative action in the United States District Court for the District of Delaware, entitled  Scherer v. Keh-Shew Lu , Civil Action No. 1:13-cv-00358-UNA (D. Del. filed Mar. 5, 2013), on behalf of the Company against its directors, in which plaintiff alleges that (a) the Board approved awards of stock options to Dr. Keh-Shew Lu, our President and Chief Executive Officer, in 2009, 2010, 2011 and 2012 that exceeded the limitation on the number of shares of the Company’s Common Stock that may be purchased upon the exercise of options granted to any person in any given year under the Company’s 2001 Omnibus Equity Incentive Plan as amended by the stockholders on May 28, 2009; (b) the Company’s disclosures in its 2010, 2011 and 2012 proxy statements regarding the limitation on the number of shares of the Company’s Common Stock that may be purchased upon the exercise of options granted to any person in any given year under the Company’s 2001 Omnibus Equity Incentive Plan as amended by the stockholders on May 28, 2009 were inaccurate; and (c) the Company’s disclosures in its 2010, 2011 and 2012 proxy statements that the grants of stock options to Dr. Lu in 2009, 2010, 2011 and 2012 complied with the terms of the Company’s 2001 Omnibus Equity Incentive Plan as amended by the stockholders on May 28, 2009 were incorrect. The Compensation Committee reviewed the grants of stock options to Dr. Lu in 2009, 2010, 2011 and 2012 (each such annual grant, an “Option Grant”), and approved a Confirmation Agreement, dated April 1, 2013, in which the Company and Dr. Lu agreed and confirmed that Dr. Lu will assert no claim that any Option Grant in 2009, 2010, 2011 or 2012 provided for the purchase of more than 100,000 shares of the Company’s Common Stock, and that each Option Grant document be deemed amended to reflect the foregoing 100,000 share limitation. On April 3, 2013, defendants and the Company filed answers to the complaint. On May 8, 2013, defendants filed a motion for judgment on the pleadings dismissing the action on the ground that the claims are moot. On June 24, 2013, the Court approved the parties’ stipulation providing for the withdrawal of the motion for judgment on the pleadings and the dismissal of the action as moot upon the filing and adjudication of plaintiff’s motion for an award of attorney’s fees and costs. On July 29, 2013, plaintiff filed a motion for an award of attorneys’ fees and costs. On September 20, 2013, the Company filed its opposition to plaintiff’s motion. On October 11, 2013, plaintiff filed her reply in further support of her motion. The motion is now fully submitted. No hearing date has been set for this motion.
We are also currently a party to a putative securities class action in the United States District Court for the Eastern District of Texas, entitled  Local 731 I.B. of T. Excavators and Pavers Pension Trust Fund v. Diodes, Inc. , Civil Action No. 6:13-cv-00247 (E.D. Tex. filed Mar. 15, 2013), against the Company, Dr. Lu and Richard D. White. In this action, plaintiff purportedly on behalf of a class of investors who purchased the Company’s Common Stock between February 9, 2011 and June 9, 2011, alleges that defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Securities and Exchange Commission Rule 10b-5 promulgated thereunder by making allegedly misleading public statements during the class period regarding the labor market in China and its impact on the Company’s business and prospects. On June 14, 2013, the Court entered an order appointing Local 731 I.B. of T. Excavators and Pavers Pension Trust Fund as lead plaintiff and approved lead plaintiff’s selection of Robbins Geller Rudman & Dowd as lead plaintiff’s counsel and the Ward & Smith Law Firm as lead plaintiff’s liaison counsel. On August 1, 2013, lead plaintiff filed an amended complaint reiterating the same claims for relief against the same defendants as asserted in the original complaint. On September 16, 2013, defendants filed a motion to dismiss the amended complaint. Lead plaintiff filed its opposition to defendants’ motion to dismiss on October 31, 2013. Defendants filed their reply in further support of their motion to dismiss on December 3, 2013. Lead plaintiff filed its sur-reply in further opposition of defendant’s motion to dismiss on December 13, 2013. The motion is now fully submitted. No hearing date has been set for this motion. Pursuant to the Private Securities Litigation Reform Act of 1995, all discovery and other proceedings are stayed pending a ruling on any motion to dismiss. The defendants intend to defend this action vigorously.
On February 20, 2014, a purported “tag-along” stockholder derivative action was filed in the United States District Court for the Eastern District of Texas, entitled  Persson v. Keh-Shew Lu , Case No. 4:14-cv-00108-RC-ALM (E.D. Tex. filed Feb. 20, 2014), on behalf of the Company against its directors, in which plaintiff alleges that the Board breached their fiduciary duties by allowing the Company to make allegedly misleading public
 
- 33 -

Table of Contents
statements in 2011 regarding the labor market in China and its impact on the Company’s business and prospects, by failing to maintain internal controls and by selling shares of Diodes stock while allegedly in possession of material nonpublic information regarding the labor market in China and its impact on the Company’s business and prospects. The complaint has not yet been served. The complaint does not seek any damages or other relief against the Company. The defendants intend to defend this lawsuit vigorously.
While we intend to defend any lawsuit vigorously, we presently believe that the ultimate outcome of current pending legal proceeding will not have any material adverse effect on our financial position, cash flows or overall results of operations. Litigation is subject to inherent uncertainties, and unfavorable rulings could occur. An unfavorable ruling could include monetary damages. Were an unfavorable ruling to occur, there exists the possibility of a material adverse impact on our business or results of operations for the period in which the ruling occurs or future periods.
From time to time, the Company is involved in various routine legal proceedings incidental to the conduct of its business. The Company’s management does not believe that any of these legal proceedings will have a material adverse impact on the business, financial condition or results of operations of the Company.
 
Item 4.	Mine Safety Disclosures.	
Not Applicable.
 
- 34 -

Table of Contents
PART II
 
Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.	
Market Information
Our Common Stock is traded on the Nasdaq Global Select Market (“NasdaqGS”) under the symbol “DIOD.” In July 2000, November 2003, December 2005 and July 2007, we effected 50% stock dividends in the form of three-for-two stock splits. The following table shows the range of high and low closing sales prices per share for our Common Stock for each fiscal quarter from January 1, 2012 as reported by NasdaqGS.

Calendar Quarter
Ended	  	Closing Sales Price of
Common Stock	 	
 	  	High	 	  	Low	 	
First quarter 2014 (through February 21, 2014)	  	$	24.68	  	  	$	22.12	  	
 	  	 	 	 	  	 	 	 	
Fourth quarter 2013	  	 	25.31	  	  	 	19.41	  	
Third quarter 2013	  	 	28.02	  	  	 	24.10	  	
Second quarter 2013	  	 	26.04	  	  	 	18.31	  	
First quarter 2013	  	 	21.51	  	  	 	17.58	  	
 	  	 	 	 	  	 	 	 	
Fourth quarter 2012	  	 	17.35	  	  	 	13.29	  	
Third quarter 2012	  	 	19.54	  	  	 	17.01	  	
Second quarter 2012	  	 	23.32	  	  	 	17.60	  	
First quarter 2012	  	 	27.29	  	  	 	21.29	  	
 	  	 	 	 	  	 	 	 	
Holders and Recent Stock Price
On February 21, 2014, the closing sales price of our Common Stock as reported by NasdaqGS was $23.44, and there were approximately 360 holders of record of our Common Stock.
Dividends
We have never declared or paid cash dividends on our Common Stock, and currently do not intend to pay dividends in the foreseeable future as we intend to retain any earnings for use in our business. Our credit agreement with Bank of America N.A. and other lender parties permits us to pay dividends up to $1.5 million per fiscal year to our stockholders so long as we have not defaulted and are in continuing operation at the time of such dividend. The payment of dividends is within the discretion of our Board of Directors, and will depend upon, among other things, our earnings, financial condition, capital requirements, and general business conditions. We have never repurchased shares of our Common Stock.
Securities Authorized for Issuance Under Equity Compensation Plans
The information regarding the Company’s equity compensation plans required to be disclosed by Item 201(d) of Regulation S-K is incorporated by reference from the Company’s 2014 definitive proxy statement into Item 12 of Part III of this Annual report.
Performance Graph
Set forth below is a line graph comparing the yearly percentage change in the cumulative total stockholder return of our Common Stock against the cumulative total return of the Nasdaq Composite and the Nasdaq Industrial Index for the five calendar years ending December 31, 2013. The graph is not necessarily indicative of future price performance.
 
- 35 -

Table of Contents
The graph shall not be deemed incorporated by reference by any general statement incorporating by reference this Annual Report into any filing under the Securities Act of 1933 or under the Securities Exchange Act of 1934, except to the extent that the Company specifically incorporates this information by reference, and shall not otherwise be deemed filed under such Acts.

 
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
CUMULATIVE TOTAL RETURN SUMMARY	 	 	 	  	 	 	  	 	 	  	 	 	  	 	 	  	 	 	
December 2013	  	 	 	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
 	  	 	 	2008	 	  	2009	 	  	2010	 	  	2011	 	  	2012	 	  	2013	 	
Diodes Incorporated	  	Return%	 	 	 	 	  	 	236.80	  	  	 	32.24	  	  	 	-21.08	  	  	 	-18.54	  	  	 	35.79	  	
 	  	Cum $	 	 	100.00	  	  	 	336.80	  	  	 	445.38	  	  	 	351.49	  	  	 	286.30	  	  	 	388.78	  	
NASDAQ Industrials Index	  	Return%	 	 	 	 	  	 	-4.42	  	  	 	38.40	  	  	 	0.31	  	  	 	21.52	  	  	 	44.54	  	
 	  	Cum $	 	 	100.00	  	  	 	95.58	  	  	 	132.28	  	  	 	132.69	  	  	 	161.25	  	  	 	233.07	  	
NASDAQ Composite-Total Returns	  	Return%	 	 	 	 	  	 	45.34	  	  	 	18.13	  	  	 	-0.79	  	  	 	17.75	  	  	 	40.17	  	
 	  	Cum $	 	 	100.00	  	  	 	145.34	  	  	 	171.70	  	  	 	170.34	  	  	 	200.57	  	  	 	281.14	  	
Source: Data provided by Zacks Investment Research, Inc., copyright 2014. Used with permission. All rights reserved.
The graph assumes $100 invested on December 31, 2008 in our Common Stock, the stock of the companies in the Nasdaq Composite Index and the stock of companies in the Nasdaq Industrial Index, and that all dividends received within a quarter, if any, were reinvested in that quarter.
Issuer Purchases of Equity Securities
There have been no repurchases of our Common Stock during the fourth quarter of 2013.
 
- 36 -

Table of Contents
Item 6.	Selected Financial Data.	
The following selected consolidated financial data for the fiscal years ended December 31, 2013 through 2009 is qualified in its entirety by, and should be read in conjunction with, the other information and consolidated financial statements, including the notes thereto, appearing elsewhere herein. Certain amounts as presented in the accompanying consolidated financial statements have been reclassified to conform to 2013 financial statement presentation.

(In thousands, except per share data)	  	Years ended December 31,	 	
Statement of Income Data	  	2013	 	 	2012	 	 	2011	 	 	2010	 	 	2009	 	
Net sales	  	$	826,846	 	 	$	633,806	 	 	$	635,251	 	 	$	612,886	 	 	$	434,357	 	
Gross profit	  	 	237,836	 	 	 	161,586	 	 	 	193,697	 	 	 	224,869	 	 	 	121,207	 	
Selling, general and administrative	  	 	132,106	 	 	 	101,363	 	 	 	89,974	 	 	 	88,784	 	 	 	70,396	 	
Research and development	  	 	48,302	 	 	 	33,761	 	 	 	27,231	 	 	 	26,584	 	 	 	23,757	 	
Amortization of acquisition-related intangible assets	  	 	8,078	 	 	 	5,122	 	 	 	4,503	 	 	 	4,425	 	 	 	4,665	 	
Impairment of goodwill	  	 	5,318	 	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	—  	 	
Restructuring	  	 	1,535	 	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	(440	) 	
Loss (gain) on sale of assets	  	 	216	 	 	 	(3,556	) 	 	 	—  	 	 	 	—  	 	 	 	—  	 	
Other	  	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	144	 	 	 	—  	 	
Total operating expenses	  	 	195,555	 	 	 	136,690	 	 	 	121,708	 	 	 	119,937	 	 	 	98,378	 	
Income from operations	  	 	42,281	 	 	 	24,896	 	 	 	71,989	 	 	 	104,932	 	 	 	22,829	 	
Interest income	  	 	1,274	 	 	 	778	 	 	 	1,024	 	 	 	2,842	 	 	 	4,871	 	
Interest expense	  	 	(5,580	) 	 	 	(876	) 	 	 	(3,139	) 	 	 	(5,229	) 	 	 	(7,471	) 	
Amortization of debt discount	  	 	—  	 	 	 	—  	 	 	 	(6,032	) 	 	 	(7,656	) 	 	 	(8,302	) 	
Gain (loss) on securities carried at fair value	  	 	601	 	 	 	7,100	 	 	 	(1,039	) 	 	 	—  	 	 	 	—  	 	
Other income (expense)	  	 	9	 	 	 	(1,091	) 	 	 	861	 	 	 	3,214	 	 	 	(777	) 	
Income before income taxes and noncontrolling interest	  	 	38,585	 	 	 	30,807	 	 	 	63,664	 	 	 	98,103	 	 	 	11,150	 	
Income tax provision	  	 	14,481	 	 	 	4,825	 	 	 	10,157	 	 	 	17,839	 	 	 	1,302	 	
Net income	  	 	24,104	 	 	 	25,982	 	 	 	53,507	 	 	 	80,264	 	 	 	9,848	 	
Less: net (income) loss attributable to noncontrolling interest	  	 	2,428	 	 	 	(1,830	) 	 	 	(2,770	) 	 	 	(3,531	) 	 	 	(2,335	) 	
Net income attributable to common stockholders	  	 	26,532	 	 	 	24,152	 	 	 	50,737	 	 	 	76,733	 	 	 	7,513	 	
Earnings per share attributable to common stockholders:	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Basic	  	$	0.57	 	 	$	0.53	 	 	$	1.12	 	 	$	1.74	 	 	$	0.18	 	
Diluted	  	$	0.56	 	 	$	0.51	 	 	$	1.09	 	 	$	1.68	 	 	$	0.17	 	
Number of shares used in computation:	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Basic	  	 	46,363	 	 	 	45,780	 	 	 	45,202	 	 	 	44,146	 	 	 	42,237	 	
Diluted	  	 	47,658	 	 	 	46,899	 	 	 	46,713	 	 	 	45,546	 	 	 	43,449	 	
 	 	
 	  	As of December 31,	 	
Balance Sheet Data	  	2013	 	 	2012	 	 	2011	 	 	2010	 	 	2009	 	
Total assets	  	$	1,162,258	 	 	$	920,063	 	 	$	793,064	 	 	$	846,550	 	 	$	1,021,898	 	
Working capital	  	 	493,169	 	 	 	377,892	 	 	 	317,087	 	 	 	289,387	 	 	 	354,309	 	
Long-term debt, net of current portion	  	 	182,799	 	 	 	44,131	 	 	 	2,857	 	 	 	3,393	 	 	 	124,797	 	
Total Diodes Incorporated stockholders’ equity	  	 	702,742	 	 	 	677,185	 	 	 	633,760	 	 	 	541,444	 	 	 	440,634	 	
 
- 37 -

Table of Contents
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	
The following section discusses management’s view of the financial condition, results of operations and cash flows of Diodes Incorporated and its subsidiaries (collectively, “the Company,” “our Company,” “we,” “our,” “ours,” or “us”) and should be read together with the consolidated financial statements and the notes to consolidated financial statements included elsewhere in this Form 10-K.
The following discussion contains forward-looking statements and information relating to our Company. We generally identify forward-looking statements by the use of terminology such as “may,” “will,” “could,” “should,” “potential,” “continue,” “expect,” “intend,” “plan,” “estimate,” “anticipate,” “believe,” “project,” or similar phrases or the negatives of such terms. We base these statements on our beliefs as well as assumptions we made using information currently available to us. Such statements are subject to risks, uncertainties and assumptions, including those identified in Part I, Item 1A.“Risk Factors,” as well as other matters not yet known to us or not currently considered material by us. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on such forward-looking statements. Forward-looking statements do not guarantee future performance and should not be considered as statements of fact.
You should not unduly rely on these forward-looking statements, which speak only as of the date of this Annual Report on Form 10-K. Unless required by law, we undertake no obligation to publicly update or revise any forward-looking statements to reflect new information or future events or otherwise. The Private Securities Litigation Reform Act of 1995 (the “Act”) provides certain “safe harbor” provisions for forward-looking statements. All forward-looking statements made in this Annual Report on Form 10-K are made pursuant to the Act.
Summary of the Year Ended December 31, 2013
 
 	•	 	Net sales for 2013 was $827 million, compared to $634 million in 2012;	
 
 	•	 	Gross profit for 2013 was $238 million, or 29% of net sales, an increase of 47% from the $162 million, or 25% of net sales, in 2012;	
 
 	•	 	Net income attributable to common stockholders for 2013 was $27 million, or $0.56 per diluted share, an increase of 10% from the $24 million, or $0.51 per diluted share, in 2012;	
 
 	•	 	Cash flow from operations for 2013 was $110 million, an increase of 71% from the $64 million in 2012;	
 
 	•	 	Obtained a $300 million revolving senior credit facility; and	
 
 	•	 	Completed the acquisition of BCD Semiconductor Manufacturing Limited (“BCD”) during the first quarter of 2013 as part of our strategy to purse selective strategic acquisitions.	
Overview of 2013
For the first quarter of 2013, we achieved record quarterly revenue despite the typical seasonal softness in the quarter and the slowdown at certain key original equipment manufacturer (“OEM”) customers. Our sequential revenue growth was due to our continued design win momentum, as well as one month of revenue contribution from our acquisition of BCD. In addition, gross profit margin improved sequentially due to revenue increases in the higher margin regions of North America and Europe, but the improvements were offset by acquisition accounting adjustments in connection with the acquisition of BCD. Margins also benefited from a better than expected manufacturing recovery following the Chinese New Year holiday, lower gold prices and a more favorable product mix. Also during the quarter, we finalized our acquisition of BCD and this transaction, excluding acquisition accounting adjustments, was immediately accretive to earnings. The industrial and
 
- 38 -

Table of Contents
communication end-markets improved in both North America and Europe, while computing was slightly better than expected with some expansion in WiFi modules. Although the consumer end-market was softer, we continued to execute our strategy and capitalize on our strong position in smartphones and tablets with new products and design wins in both devices and chargers.
For the second quarter of 2013, our past design win momentum and new product initiatives, combined with our first full quarter of revenue contribution from BCD, contributed to the achievement of record quarterly revenue and increased market share despite the slowdown at certain major OEM customers and continued weakness in the PC market. During the quarter we were also able to improve our gross margin, which included the BCD inventory valuation adjustment, due to improved product mix, lower gold prices, copper wire conversion, as well as our cost reduction efforts. Furthermore, the integration of BCD progressed as we moved ahead of schedule in transferring BCD products into our Shanghai packaging facilities. As a result of these collective factors, we reported solid earnings growth and generated strong cash flow for the quarter. North America and Europe combined revenue was up slightly after a very strong first quarter. We continued to increase share as well as new design win revenue at Asia smartphone manufacturers, while LED TV also showed strength. The growth in both of these markets offset the continued softness in PCs. Generally speaking, the industrial and automotive end-markets remained relatively consistent in both North America and Europe.
For the third quarter of 2013, we achieved record quarterly revenue, increased market share gains and solid operational performance across our business. Our past design win momentum and strength in the TV market and at certain major OEM customers were able to offset the continued weakness in the PC market. We also further improved our gross margin through our cost reduction efforts and improved BCD wafer fabrication facility loadings. Additionally, we reduced our operating expenses on a dollar basis and as a percentage of revenue, demonstrating further progress towards achieving our target model of 20% of revenue. These achievements are even more notable when considering the weakness of the U.S. dollar relative to most of the currencies where we have operations, in particular the British Pound and the Euro. Our improved operational efficiencies and cost reductions were able to mostly offset this currency impact and allowed us to exceed our operational expectations for the quarter. Our record third quarter revenue was driven by growth in all regions with strong increases in North America and Europe after a relatively flat second quarter in these regions. We also achieved record sales in the China local market. In the communications end-market, our solid position with smartphone manufacturers continued to be a key driver of sales as a result of our growing new design win revenue. Computing grew slightly in the quarter, primarily due to increased sales for our products used in tablets, partially offset by weakness in notebooks and motherboards. The automobile and industrial end-markets were also up in the quarter on the strength in both North America and Europe.
During the fourth quarter of 2013, revenue reflected greater than normal seasonality due to weakness in the PC market as well as cautious inventory management at distributors. In addition, revenue in the quarter was down sequentially primarily due to a global reduction in distributor point of purchase, which was down for North America and Europe was impacted to an even greater extent. Distributors in all regions focused on inventory management as inventory declined sequentially. OEM sales were down and distributor point of sale was up. Global channel inventory remained in line and under three months. Despite the prolonged weakness in the PC market, we have been able to gain market share across our business due to past design win momentum and new product initiatives. Also during the quarter, we improved our balance sheet by reducing our long-term debt and inventory and generated positive cash flows from operations. All end-markets were down with industrial being down the greatest percentage due to declines in North America and Europe followed by computing. The consumer and communications end-markets were the strongest performers in the fourth quarter compared to the third quarter.
Business Acquisitions
On March 5, 2013, we completed the acquisition of BCD for an aggregate consideration of approximately $155 million, excluding acquisition costs, fees and expenses. In addition, a $5 million retention plan for employees of BCD, payable at the 12, 18 and 24 month anniversaries of the acquisition, has been established.
 
- 39 -

Table of Contents
The acquisition was funded by drawings on our bank credit facilities. The results of operations of BCD have been included in the consolidated financial statements from March 1, 2013. The purpose of this acquisition is to further our strategy of expanding our market and growth opportunities through select strategic acquisitions. This acquisition enhanced our analog product portfolio by expanding our standard linear and power management offerings, including AC/DC and DC/DC solutions for power adapters and chargers, as well as other electronic products. BCD’s established presence in Asia, with a particularly strong local market position in China, offers us even greater penetration of the consumer, computing and communications end-markets. Likewise, we believe we can achieve increased market penetration for BCD’s products by leveraging our global customer base and sales channels. In addition, BCD has in-house manufacturing capabilities in China, as well as a cost-effective development team, that can be deployed across multiple product families. We also believe we will be able to apply our packaging capabilities and expertise to BCD’s products in order to improve cost efficiencies, utilization and product mix. See Note 17 of the “Notes to Consolidated Financial Statements” of this Annual Report for additional information regarding the acquisition of BCD.
Business Outlook
Looking forward, we remain focused on achieving our goal of $1 billion in annual revenue with model profitability. The BCD acquisition has brought us one step closer toward achieving that goal. We have a solid pipeline of designs and expanded customer relationships across all regions and product lines. The success of our business depends, among other factors, on the strength of the global economy and the stability of the financial markets, our customers’ demand for our products, the ability of our customers to meet their payment obligations, the likelihood of customers canceling or deferring existing orders and end-user consumers’ demand for items containing our products in the end-markets we serve. We believe the long-term outlook for our business remains generally favorable despite the recent volatility in the global economy and the equity and credit markets as we continue to execute on the strategy that has proven successful for us over the years. See “Risk Factors –  The success of our business depends on the strength of the global economy and the stability of the financial markets, and any weaknesses in these areas may have a material adverse effect on our revenues, results of operations and financial condition.”  in Part I, Item 1A of this Annual Report for additional information.
Factors Relevant to Our Results of Operations
In 2013, the following factors affected, and, we believe, will continue to affect, our results of operations:
 
 	•	 	We have experienced pressure from our customers and competitors to reduce the selling price for our standard products, and we expect future improvements in net income to result primarily from increases in sales volume and improvements in product mix as well as manufacturing cost reductions in order to offset any reduced average selling prices (“ASP”) of our products. See “Risk Factors –  We are and will continue to be under continuous pressure from our customers and competitors to reduce the price of our products, which could adversely affect our growth and profit margins ” in Part I, Item 1A of this Annual Report for additional information.	
 
 	•	 	For the years ended December 31, 2013, 2012 and 2011, our original equipment manufacturer (“OEM”) and electronic manufacturing services (“EMS”) customers together accounted for 35%, 47% and 47% of net sales, respectively, while our global network of distributors accounted for 65%, 53% and 53% of net sales, respectively. The percentage of net sales to our global network of distributors has increased in 2013 primarily due to the fact that the majority of BCD net sales are to distributors.	
 
 	•	 	Our gross profit margin was 29% in 2013, compared to 25% in 2012 and 30% in 2011. Our gross profit margin increased in 2013 primarily due to lower gold prices, improved product mix, stable pricing, copper wire conversion and cost reduction efforts. Future gross profit margins will depend primarily on market prices, our product mix, manufacturing cost savings, and the demand for our products.	
 
 	•	 	For 2013, the percentage of our net sales derived from our Asian subsidiaries was 82%, compared to 79% in 2012 and 75% in 2011. The 2013 increase in sales in Asia was primarily due to the acquisition of BCD. Europe accounted for approximately 9%, 11% and 13% of our net sales in 2013, 2012 and	
 
- 40 -

Table of Contents
 	2011, respectively. The 2013 decrease in Europe was primarily due to sales remaining relatively flat compared to 2012, while Asia sales increased. In addition, North America accounted for approximately 9%, 10% and 12% of our net sales in 2013, 2012 and 2011, respectively. The 2013 decrease in North America was primarily due to sales remaining relatively flat compared to 2012, while Asia sales increased.	
 
 	•	 	As of December 31, 2013, we had invested approximately $529 million in our manufacturing and wafer fabrication facilities in China. During 2013, we invested approximately $32 million in these facilities, and we expect to continue to invest in our facilities, although the amount to be invested will depend on product demand and new product developments.	
 
 	•	 	For 2013, our capital expenditures, excluding capital expenditures related to our manufacturing facilities in Chengdu, China, were approximately 5% of our net sales, which is lower than our historical 10% to 12% of net sales model. During 2013, we reduced our capital spending target range. Therefore, for 2014, based on current market conditions and excluding Chengdu building expenditures, we expect capital expenditures to be 5% to 8% of net sales.	
 
 	•	 	Our investment in research and development for 2013 increased to $48 million, or 6% of net sales, compared to $34 million, or 5% of net sales, in 2012. The 2013 increase in research and development was primarily due to the acquisition of BCD. We expect research and development costs to continue to increase as we look to invest in developing new products.	
Description of Sales and Expenses
Net sales
The principal factors that have affected or could affect our net sales from period to period are:
 
 	•	 	The condition of the economy in general and of the semiconductor industry in particular,	
 
 	•	 	Our customers’ adjustments in their order levels,	
 
 	•	 	Changes in our pricing policies or the pricing policies of our competitors or suppliers,	
 
 	•	 	The addition or termination of key supplier relationships,	
 
 	•	 	The rate of introduction and acceptance by our customers of new products,	
 
 	•	 	Our ability to compete effectively with our current and future competitors,	
 
 	•	 	Our ability to enter into and renew key corporate and strategic relationships with our customers, vendors and strategic alliances,	
 
 	•	 	Changes in foreign currency exchange rates,	
 
 	•	 	A major disruption of our information technology infrastructure,	
 
 	•	 	Unforeseen catastrophic events, such as armed conflict, terrorism, fires, typhoons and earthquakes, and	
 
 	•	 	Any other disruptions, such as labor shortages, unplanned maintenance or other manufacturing problems.	
Cost of goods sold
Cost of goods sold includes manufacturing costs for our semiconductors and our wafers. These costs include raw materials used in our manufacturing processes as well as labor costs and overhead expenses. Cost of goods sold is also impacted by yield improvements, capacity utilization and manufacturing efficiencies. In addition, cost of goods sold includes the cost of products that we purchase from other manufacturers and sell to our customers. Cost of goods sold is also affected by inventory obsolescence if our inventory management is not efficient.
 
- 41 -

Table of Contents
Selling, general and administrative expenses
Selling, general and administrative expenses relate primarily to compensation and associated expenses for personnel in general management, sales and marketing, information technology, engineering, human resources, procurement, planning and finance, and sales commissions, as well as outside legal, accounting and consulting expenses, and other operating expenses.
Research and development expenses
Research and development expenses consist of compensation and associated costs of employees engaged in research and development projects, as well as materials and equipment used for these projects. Research and development expenses are primarily associated with our wafer facilities in China, Kansas City, Missouri and Manchester, United Kingdom (“U.K.”) and our manufacturing facilities in China, as well as with our engineers in the U.S. and Taiwan. All research and development expenses are expensed as incurred.
Amortization of acquisition-related intangible assets
Amortization of acquisition-related intangible assets consists of amortization of acquisition-related intangible assets, such as developed technologies and customer relationships.
Impairment of goodwill
Impairment of goodwill consists of the impairment amount recognized as a result of a reporting unit’s goodwill exceeding its implied fair value.
Restructuring
Restructuring consists of charges to reduce our cost structure to enhance operating effectiveness and improve profitability.
Gain on sale of assets
Gain on sale of assets consists of the sale of certain assets such as intangibles or buildings.
Interest income / expense
Interest income consists of interest earned on our cash and investment balances. Interest expense consists of interest payable on our outstanding credit facilities and other debt instruments.
Gain (loss) on securities carried at fair value
From time to time we may hold investments in the form of common stock or some other similar equivalent and have elected fair value accounting treatment.
Income tax provision
Our global presence requires us to pay income taxes in a number of jurisdictions. See Note11 of “Notes to Consolidated Financial Statements” for additional information.
Net income attributable to noncontrolling interest
Noncontrolling interest represents the minority investors’ share of earnings of our subsidiaries.
Net income attributable to common stockholders
Net income attributable to common stockholders is net income less net income attributable to noncontrolling interest.
 
- 42 -

Table of Contents
Results of Operations
The following table sets forth, for the periods indicated, the percentage that certain items in the statement of income bear to net sales and the percentage dollar increase (decrease) of such items from period to period.

 	  	Percent of Net Sales
Year Ended December 31,	 	 	Percentage Dollar
Increase (Decrease)
Year Ended December 31,	 	
 	  	2013	 	 	2012	 	 	2011	 	 	‘12 to ‘13	 	 	‘11 to ‘12	 	
Net sales	  	 	100 	% 	 	 	100 	% 	 	 	100 	% 	 	 	31 	% 	 	 	—  	% 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Cost of goods sold	  	 	(71	) 	 	 	(75	) 	 	 	(70	) 	 	 	25	 	 	 	7	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Gross profit	  	 	29	 	 	 	25	 	 	 	30	 	 	 	47	 	 	 	(17	) 	
Operating expenses	  	 	(23	) 	 	 	(21	) 	 	 	(19	) 	 	 	43	 	 	 	12	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Income from operations	  	 	6	 	 	 	4	 	 	 	11	 	 	 	70	 	 	 	(65	) 	
Interest income	  	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	64	 	 	 	(24	) 	
Interest expense and amortization of debt discount	  	 	(1	) 	 	 	—  	 	 	 	(1	) 	 	 	537	 	 	 	(138	) 	
Gain (loss) on securities carried at fair value	  	 	—  	 	 	 	1	 	 	 	—  	 	 	 	(92	) 	 	 	783	 	
Other income (expenses)	  	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	(101	) 	 	 	(227	) 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Income before income
taxes and noncontrolling interest	  	 	5	 	 	 	5	 	 	 	10	 	 	 	25	 	 	 	(52	) 	
Income tax provision	  	 	2	 	 	 	1	 	 	 	2	 	 	 	200	 	 	 	(52	) 	
Net income	  	 	3	 	 	 	4	 	 	 	8	 	 	 	(7	) 	 	 	(52	) 	
Net (income) loss attributable to noncontrolling interest	  	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	(233	) 	 	 	(34	) 	
Net income attributable to common stockholders	  	 	3	 	 	 	4	 	 	 	8	 	 	 	10	 	 	 	(53	) 	
The following discussion explains in greater detail our consolidated operating results and financial condition. This discussion should be read in conjunction with the consolidated financial statements and notes thereto appearing elsewhere in this Annual Report  (in thousands) .

Year 2013 Compared to Year 2012	 	
 	  	2013	 	  	2012	 	
Net sales	  	$	826,846	 	  	$	633,806	 	
Net sales for 2013 increased $193 million to $827 million from $634 million for 2012. The 31% increase in net sales represented an approximately 25% increase in units sold and a 5% increase in ASP. The net sales increase for 2013 was primarily attributable to our past design win momentum and new product initiatives, combined with the inclusion of ten months of BCD net sales.

 	  	2013	 	 	2012	 	
Cost of goods sold	  	$	589,010	 	 	$	472,220	 	
Gross profit	  	$	237,836	 	 	$	161,586	 	
Gross profit margin	  	 	29	% 	 	 	25	% 	
Cost of goods sold increased $117 million, or 25%, for 2013 to $589 million, compared to $472 million for 2012. As a percent of sales, cost of goods sold decreased from 75% for 2012 to 71% for 2013. Our average unit cost (“AUP”) was relatively flat.
Gross profit for 2013 increased 47% to $238 million from $162 million for 2012. Gross profit as a percentage of net sales was 29% for 2013, compared to 25% for 2012. The increase in gross margin was primarily due to lower gold prices, improved product mix, stable pricing, copper wire conversion and cost reduction efforts.

 	  	2013	 	  	2012	 	
Selling, general and administrative (“SG&A”)	  	$	132,106	 	  	$	101,363	 	
 
- 43 -

Table of Contents
SG&A for 2013 increased $31 million, or 30%, to $132 million, compared to $101 million for 2012. SG&A, as a percentage of net sales, was 16% in 2013 and 2012. The dollar amount increase in SG&A included increases in wages, including BCD retention costs, freight and professional fees, which was primarily due to the acquisition of BCD.

 	  	2013	 	  	2012	 	
Research and development (“R&D”)	  	$	48,302	 	  	$	33,761	 	
R&D for 2013 increased to $48 million, or 6% of net sales, compared to $34 million, or 5% of net sales, for 2012. The increase in R&D included increases in wages, including BCD retention costs, which was primarily due to the acquisition of BCD.

 	  	2013	 	  	2012	 	
Amortization of acquisition-related intangible assets	  	$	8,078	 	  	$	5,122	 	
Amortization of acquisition-related intangibles was $8 million for 2013, compared to $5 million for 2012. The $3 million increase was primarily due to the amortization expense on the acquired intangibles as part of the acquisition of BCD.

 	  	2013	 	  	2012	 	
Impairment of goodwill	  	$	5,318	 	  	$	—  	 	
Impairment of goodwill was $5 million for 2013. The carrying amount of a reporting unit’s (Eris Technology Corporation) goodwill exceeded its implied fair value, and therefore an impairment loss was recognized.

 	  	2013	 	  	2012	 	
Restructuring	  	$	1,535	 	  	$	—  	 	
Restructuring was $2 million for 2013. In the second quarter of 2013, we initiated restructuring plans primarily relating to our U.K. development team and the closure of our New York sales office. The amounts recorded primarily relate to termination and severance costs. All restructuring was completed in the third quarter of 2013.

 	  	2013	 	  	2012	 	
Loss (gain) on sale of assets	  	$	216	 	  	$	(3,556	) 	
Gain on sale of assets was $4 million for 2012, which was mainly from the sale of an intangible asset located in Europe and a sale of a building located in Taiwan.

 	  	2013	 	  	2012	 	
Interest income	  	$	1,274	 	  	$	778	 	
Interest income for 2013 and 2012 was $1 million, which was mainly from interest earned on bank accounts.

 	  	2013	 	  	2012	 	
Interest expense	  	$	5,580	 	  	$	876	 	
Interest expense for 2013 was $6 million, compared to $1 million for 2012. The $5 million increase is primarily due to the amounts borrowed under the $300 million revolving senior credit facility in connection with acquiring BCD.

 	  	2013	 	  	2012	 	
Gain on securities carried at fair value	  	$	601	 	  	$	7,100	 	
 
- 44 -

Table of Contents
Gain on securities carried at fair value for 2013 was $1 million compared to $7 million for 2012. For 2013, the gain was from unrealized and realized gains in trading securities. For 2012, the gain was from a $4 million unrealized gain on the shares of common stock of BCD held as an investment and a $3 million realized gain on the shares of common stock of Eris prior to obtaining a controlling interest.

 	  	2013	 	  	2012	 	
Other income (expense)	  	$	9	 	  	$	(1,091	) 	
Other income for 2013 was negligible, compared to other expense of $1 million for 2012. Included in other income for 2013 were foreign currency gains and miscellaneous income. Included in other expense for 2012 were foreign currency losses, partially offset by miscellaneous income.

 	  	2013	 	  	2012	 	
Income tax provision	  	$	14,481	 	  	$	4,825	 	
We recognized income tax expense of $15 million for 2013, resulting in an effective tax rate of 38%, as compared to 16% for 2012. Income tax expense for 2013 was impacted by $5 million additional tax expense in regard to a tax audit by the China tax authorities. In addition, the mix of pretax earnings among foreign and domestic subsidiaries changed from 2012 to 2013, resulting in an increased effective tax rate.

 	  	2013	 	  	2012	 	
Net (income) loss attributable to noncontrolling interest	  	$	2,428	 	  	$	(1,830	) 	
Net (income) loss attributable to noncontrolling interest primarily represents the minority investors’ share of the earnings of certain China subsidiaries and Eris. During 2012, the Company acquired approximately 51% of the outstanding common stock of Eris, and the income or loss attributable to the 49% noncontrolling interest is included in this account. The joint venture investments were eliminated in the consolidations of our financial statements, and the activities of our subsidiaries were included therein. The noncontrolling interest in the subsidiaries and their equity balances are reported separately in the consolidation of our financial statements. The loss attributable to noncontrolling interest for 2013 was impacted by the impairment of goodwill of approximately $5 million (attributable to Eris), of which 49% was recognized in noncontrolling interest.

 	  	2013	 	  	2012	 	
Net income attributable to common stockholders	  	$	26,532	 	  	$	24,152	 	
Net income attributable to common stockholders increased 10% to $27 million (or $0.57 basic earnings per share and $0.56 diluted earnings per share) for 2013, compared to $24 million (or $0.53 basic earnings per share and $0.51 diluted earnings per share) for 2012. Net income attributable to common stockholders for 2013 was impacted by impairment of goodwill, acquisition accounting expenses related to acquisition of BCD and increased interest expense due to borrowings under our $300 million revolving senior credit facility.

Year 2012 Compared to Year 2011	 	
 	  	2012	 	  	2011	 	
Net sales	  	$	633,806	 	  	$	635,251	 	
Net sales for 2012 decreased $1 million to $634 million from $635 million for 2011. The small decrease in net sales represented an approximately 10% increase in units sold, which was offset by a 10% decrease in ASP. ASP was impacted by pricing pressure and product mix.

 	  	2012	 	 	2011	 	
Cost of goods sold	  	$	472,220	 	 	$	441,554	 	
Gross profit	  	$	161,586	 	 	$	193,697	 	
Gross profit margin	  	 	25	% 	 	 	30	% 	
 
- 45 -

Table of Contents
Cost of goods sold increased $31 million, or 7%, for 2012 to $472 million, compared to $442 million for 2011. As a percent of sales, cost of goods sold increased from 70% for 2011 to 75% for 2012. Our average unit cost (“AUP”) decreased approximately 3%. Although AUP decreased, it was not enough to offset the reduction in ASP.
Gross profit for 2012 decreased 17% to $162 million from $194 million for 2011. Gross profit as a percentage of net sales was 25% for 2012, compared to 30% for 2011. The decrease in gross margin was primarily due to a weaker pricing environment and product mix coupled with increased manufacturing costs due mainly to raw material cost increases, particularly gold, and lower equipment utilization.

 	  	2012	 	  	2011	 	
SG&A	  	$	101,363	 	  	$	89,974	 	
SG&A for 2012 increased $11 million, or 13%, to $101 million, compared to $90 million for 2011. SG&A, as a percentage of net sales, was 16% in 2012, compared to 14% in 2011. The increase in SG&A was primarily due to increases in wages and benefits, freight and professional fees.

 	  	2012	 	  	2011	 	
R&D	  	$	33,761	 	  	$	27,231	 	
R&D for 2012 increased to $34 million, or 5% of net sales, compared to $27 million, or 4% of net sales, for 2011. The increase in R&D was due to increase in engineering supplies, material purchases, development services and wages and benefits.

 	  	2012	 	  	2011	 	
Amortization of acquisition-related intangible assets	  	$	5,122	 	  	$	4,503	 	
Amortization of acquisition-related intangibles was approximately $5 million for 2012 and 2011.

 	  	2012	 	  	2011	 	
Gain on sale of assets	  	$	3,556	 	  	$	—  	 	
Gain on sale of assets was approximately $4 million for 2012, which was mainly from the sale of an intangible asset located in Europe and a sale of a building located in Taiwan.

 	  	2012	 	  	2011	 	
Interest income	  	$	778	 	  	$	1,024	 	
Interest income for 2012 and 2011 was $1 million, which was mainly from interest earned on bank accounts.

 	  	2012	 	  	2011	 	
Interest expense	  	$	876	 	  	$	3,139	 	
Interest expense for 2012 was $1 million, compared to $3 million for 2011. The $2 million decrease is due primarily to the reduced interest paid on our convertible senior notes, which were repurchased in 2011.

 	  	2012	 	  	2011	 	
Amortization of debt discount	  	$	—  	 	  	$	6,032	 	
Amortization of debt discount for 2012 was $0 as the amortization period on our convertible senior notes ended as of September 30, 2011.

 	  	2012	 	  	2011	 	
Gain (loss) on securities carried at fair value	  	$	7,100	 	  	$	(1,039	) 	
 
- 46 -

Table of Contents
Gain on securities carried at fair value for 2012 was $7 million compared to loss on securities carried at fair value of $1 million for 2011. For 2012, the gain was from a $4 million gain on the shares of common stock of BCD held as an investment and a $3 million gain on the shares of common stock of Eris prior to obtaining a controlling interest. For 2011, the loss was from the shares of common stock of Eris that would have otherwise been accounted for under the equity method of accounting.

 	  	2012	 	 	2011	 	
Other income (expense)	  	$	(1,091	) 	 	$	861	 	
Other expense for 2012 was $1 million, compared to other income of $1 million for 2011. Included in other expense for 2012 were foreign currency losses, partially offset by miscellaneous income. Included in other income for 2011 were foreign currency gains and miscellaneous income.

 	  	2012	 	  	2011	 	
Income tax provision	  	$	4,825	 	  	$	10,157	 	
We recognized income tax expense of $5 million for 2012, resulting in an effective tax rate of 16%, which is the same effective tax rate as 2011.

 	  	2012	 	  	2011	 	
Net income attributable to noncontrolling interest	  	$	1,830	 	  	$	2,770	 	
Net income attributable to noncontrolling interest primarily represents the minority investor’s share of the earnings of certain China subsidiaries for 2012 and 2011 and Eris for part of 2012. During 2012, the Company acquired approximately 51% of the outstanding common stock of Eris, and the income or loss attributable to the 49% noncontrolling interest is included in this account. The joint venture investments were eliminated in the consolidations of our financial statements, and the activities of our subsidiaries were included therein. The noncontrolling interest in the subsidiaries and their equity balances are reported separately in the consolidation of our financial statements.

 	  	2012	 	  	2011	 	
Net income attributable to common stockholders	  	$	24,152	 	  	$	50,737	 	
Net income attributable to common stockholders decreased 53% to $24 million (or $0.53 basic earnings per share and $0.51 diluted earnings per share) for 2012, compared to $51 million (or $1.12 basic earnings per share and $1.09 diluted earnings per share) for 2011, due primarily to increased cost of goods sold and operating expenses.
Financial Condition
Liquidity and Capital Resources
Our primary sources of liquidity are cash and cash equivalents, funds from operations and, if necessary, borrowings under our credit facilities. As of December 31, 2013, we have a U.S. credit agreement consisting of a $300 million revolving senior credit facility (the “Revolver”), which includes a $10 million swing line sublimit, a $10 million letter of credit sublimit, and a $20 million alternative currency sublimit. The Revolver matures on January 8, 2018, and as of December 31, 2013, $179 million was outstanding. In addition, we have foreign credit facilities with borrowing capacity of approximately $112 million of which $6 million was outstanding and $7 million was used for import and export guarantees and bank acceptance notes as of December 31, 2013. Our primary liquidity requirements have been to meet our inventory and capital expenditure needs and to fund on-going operations. For 2013, 2012 and 2011, our working capital was $493 million, $378 million, and $317 million, respectively. Our working capital increased in 2013 mainly due to the consolidation of BCD’s net assets as a result of the acquisition. Our working capital increased in 2012 primarily due to the increase in cash and cash equivalents, mainly due to a draw down on our previous term loan, and an increase in accounts receivable
 
- 47 -

Table of Contents
and inventories, which were partially offset by the increase in accrued liabilities and other current liabilities. We expect cash generated by our operations together with existing cash, cash equivalents, short-term investments and available credit facilities to be sufficient to cover cash needs for working capital and capital expenditures for at least the next 12 months.
In 2013, 2012 and 2011, our capital expenditures were $44 million, $60 million and $83 million, respectively, which includes $7 million, $14 million and $18 million of capital expenditures related to the investment agreement with the Management Committee of the Chengdu Hi-Tech Industrial Development Zone (the “CDHT”) for 2013, 2012 and 2011, respectively. Our capital expenditures for these periods were primarily related to manufacturing expansion in our facilities in China and, to a lesser extent, our wafer fabrication facility in the U.S. and office buildings in the U.S. and China. Capital expenditures, excluding capital expenditures related to the investment agreement, for 2013 were approximately 5% of our net sales, which was lower than our historical 10% to 12% of net sales model. During 2013, we reduced our capital spending target range. Therefore, for 2014, we expect capital expenditures, excluding capital expenditures related to the investment agreement, to be 5% to 8% of net sales.
During 2010, we announced an investment agreement with the Management Committee of the CDHT. Under this agreement, we have agreed to form a joint venture with a Chinese partner, Chengdu Ya Guang Electronic Company Limited, to establish a semiconductor manufacturing facility for surface-mounted component production, assembly and test in Chengdu, China. We initially will own at least 95% of the joint venture. The manufacturing facility will be developed in phases over a ten year period, and in order to qualify for certain financial incentives, we were obligated to contribute at least $48 million to the joint venture by December 31, 2013. The CDHT will grant the joint venture a fifty year land lease, provides temporary facilities for up to three years at a subsidized rent while the joint venture builds the manufacturing facility and provides corporate and employee tax incentives, tax refunds, subsidies and other financial support to the joint venture and its qualified employees. This is a long-term, multi-year project that will provide us additional capacity as needed. As of December 31, 2013, we have invested $48 million, primarily for capital expenditures.
On March 5, 2013 we completed the acquisition of BCD for an aggregate consideration of approximately $155 million, excluding acquisition costs, fees and expenses. In addition, a $5 million retention plan for employees of BCD, payable at the 12, 18 and 24 month anniversaries of the acquisition, has been established. The acquisition was funded by drawings on our bank credit facility. As part of our strategy to expand our semiconductor product offerings and to maximize our market opportunities, we may acquire product lines or companies in order to enhance our portfolio and accelerate our new offerings, which could have a material impact on liquidity and require us to draw down on our credit facilities or increase our borrowings and limits. See Note 17 of the “Notes to Consolidated Financial Statements” of this Annual Report for additional information about BCD and Part I, Item 1 of this Annual Report for additional information about our strategy.
Restricted cash is pledged as collateral when we enter into agreements with banks for certain banking facilities. As of December 31, 2013, restricted cash of $5 million was pledged as collateral for issuance of bank acceptance notes and letters of credit.
As of December 31, 2013, we had short-term investments totaling $23 million. These investments are highly liquid with maturity dates greater than three months at the date of purchase. We generally can access these investments in a relatively short amount of time but in doing so we generally forfeit all earned and future interest income.
Discussion of Cash Flows
Cash and cash equivalents have increased from $130 million at December 31, 2011, to $157 million at December 31, 2012, then increased to $192 million at December 31, 2013. The increase from 2011 to 2012 was primarily due to the draw down on a previous term loan. The increase during 2013 was primarily due to cash acquired in connection with the acquisition of BCD.
 
- 48 -

Table of Contents
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	  	Year Ended December 31,	 	
 	  	2013	 	 	2012	 	 	Change	 	 	2012	 	 	2011	 	 	Change	 	
Net cash provided by operating activities	  	$	109,891	 	 	$	64,221	 	 	$	45,670	 	 	$	64,221	 	 	$	61,650	 	 	$	2,571	 	
Net cash used by investing activities	  	 	(186,402	) 	 	 	(77,419	) 	 	 	(108,983	) 	 	 	(77,419	) 	 	 	(98,312	) 	 	 	20,893	 	
Net cash provided by (used by) financing activities	  	 	112,361	 	 	 	38,542	 	 	 	73,819	 	 	 	38,542	 	 	 	(107,713	) 	 	 	146,255	 	
Effect of exchange rates on cash and cash equivalents	  	 	3,664	 	 	 	2,267	 	 	 	1,397	 	 	 	2,267	 	 	 	2,984	 	 	 	(717	) 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Net increase (decrease) in cash and cash equivalents	  	$	39,514	 	 	$	27,611	 	 	$	11,903	 	 	$	27,611	 	 	$	(141,391	) 	 	$	169,002	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Operating Activities
Net cash provided by operating activities during 2013 was $110 million, resulting primarily from $24 million of net income in the period, $74 million of depreciation and amortization and $14 million from non-cash share-based compensation, partially offset by changes in operating assets and liabilities. Net cash provided by operating activities was $64 million for 2012 and $62 million for 2011.
Net cash provided by operating activities increased by $46 million from 2012 to 2013. This increase resulted primarily from an increase in non-cash related items such as depreciation, amortization, impairment of goodwill, and changes in operating assets and liabilities.
Net cash provided by operating activities increased by $3 million from 2011 to 2012. This increase resulted primarily from the treatment of certain tax items relating to the retirement of our convertible senior notes in 2011 that did not occur in 2012, partially offset by the decrease in net income (from $54 million in 2011 to $26 million in 2012).
Investing Activities
Net cash used by investing activities for 2013 was $186 million, resulting primarily from $125 million used for acquisitions, net of cash acquired, $47 million in capital expenditures and $23 million used in purchases of short-term investments, partially offset by other investing items.
Net cash used by investing activities for 2012 was $77 million, resulting primarily from $20 million used for acquisitions, net of cash acquired and $58 million in capital expenditures.
Net cash used by investing activities for 2011 was $98 million, resulting primarily from $14 million in purchases of securities and $81 million in capital expenditures.
Financing Activities
Net cash provided by financing activities for 2013 was $112 million, resulting primarily from a $181 million draw down on our Revolver, partially offset by repayments of debt.
Net cash provided by financing activities for 2012 was $39 million, resulting primarily from a $40 million draw down on our previous term loan.
Net cash used by financing activities for 2011 was $108 million, resulting primarily from $135 million in repayments of short-term debt, which was mainly the retirement of our convertible senior notes.
 
- 49 -

Table of Contents
Debt instruments
On January 8, 2013, we and Diodes International B.V. (the “BV Entity”) (collectively with us, the “Borrowers”) and certain subsidiaries of ours as guarantors, entered into a Credit Agreement (the “Credit Agreement”) with Bank of America and other participating lenders (collectively, the “Lenders”). Certain capitalized terms used in this description of the Credit Agreement have the meanings given to them in the Credit Agreement.
The Credit Agreement provides for a five-year, $300 million revolving senior credit facility (the “Revolver”), which includes $10 million swing line sublimit, a $10 million letter of credit sublimit, and $20 million alternative currency sublimit. The Borrowers may from time to time request increases in the aggregate commitment under the Credit Agreement of up to $200 million, subject to the lenders electing to increase their commitments or by means of the addition of new Lenders, and subject to at least half of each increase in aggregate commitment being in the form of term loans (“Incremental Term Loans”), with the remaining amount of each being an increase the amount of the Revolver.
The Revolver matures on January 8, 2018 (the “Revolver Maturity Date”). Incremental Term Loans mature no earlier than the Revolver Maturity Date. The proceeds under the Revolver and the Incremental Term Loans may be used for the purposes of refinancing certain existing debt, for working capital and capital expenditures, and for general corporate purposes, including financing permitted acquisitions.
The B.V. Entity’s obligations under the Credit Agreement are guaranteed by us. Each Borrower’s obligations under the Credit Agreement are guaranteed by certain of that Borrower’s subsidiaries. The Borrower’s obligations under the Credit Agreement are secured by substantially all assets of the Borrowers and certain of their subsidiaries.
Under the Revolver, the Borrowers may borrow through Base Rate Loans (as defined) in United States Dollars (“USD”) or through Eurocurrency Rate Loans (as defined) in USD, Euros, British Pounds Sterling or another currencies approved by the Lenders subject, as to all currencies other than USD, to the Alternative Currency sublimit. Base Rate Loans bear interest at a fluctuating rate per annum equal to the sum of (a) the highest of (i) the Federal Funds Rate plus  1 ⁄ 2  of 1.00%, (ii) the rate of interest in effect for such day as publicly announced from time to time by Bank of America as its “prime rate,” and (iii) the Eurocurrency Rate plus 1.00%, plus (b) an amount between 0.50% per annum and 1.25% per annum, based upon the Borrowers’ and their subsidiaries’ Consolidated Leverage Ratio. Eurocurrency Rate Loans bear interest at LIBOR plus an amount between 1.50% and 2.25% per annum, based upon the Borrowers’ and their subsidiaries’ Consolidated Leverage Ratio.
Incremental Term Loans will be on pricing and amortization terms to be agreed upon.
The Credit Agreement contains certain financial and non-financial covenants, including, but not limited to, a maximum Consolidated Leverage Ratio, a minimum Consolidated Fixed Charge Coverage Ratio, and restrictions on liens, indebtedness, investments, fundamental changes, dispositions, and restricted payments (including dividends).
As of December 31, 2013, our U.S., Asia and Europe subsidiaries had available lines of credit of up to an aggregate of approximately $112 million, with several financial institutions. These lines of credit are unsecured, uncommitted and, in some instances, may be repayable on demand, except for two Taiwanese credit facilities that are collateralized by assets. Loans under these lines of credit bear interest at LIBOR or similar indices plus a specified margin. At December 31, 2013, there was $6 million outstanding on these lines of credit, and the interest rates ranged from 1.4% to 3.3%. See Note 7 of “Notes to Consolidated Financial Statements” of this Annual Report for additional information.
During 2013, we entered into a net settlement agreement with China Construction Bank (“CCB”) whereby CCB loaned us $20 million and we in turn invested the same $20 million with CCB. The principal of the $20
 
- 50 -

Table of Contents
million investment is guaranteed by CCB and is collateral for the $20 million loan. The net interest income realized by the investment was immaterial as of December 31, 2013. The investment and the offsetting loan are non-cancelable, will mature in June 2014 and are shown net of each other on the balance sheet.
Off-Balance Sheet Arrangements
We do not have any transactions, arrangements and other relationships with unconsolidated entities that will affect our liquidity or capital resources. We have no special purpose entities that provided off-balance sheet financing, liquidity or market or credit risk support, nor do we engage in leasing, hedging or research and development services, that could expose us to liability that is not reflected on the face of our financial statements. During 2013, we entered into a net settlement agreement with CCB whereby CCB loaned us $20 million and we in turn invested the same $20 million with CCB. The principal of the $20 million investment is guaranteed by CCB and is collateral for the $20 million loan. The net interest income realized by the investment was immaterial as of December 31, 2013. The investment and the offsetting loan are non-cancelable, will mature in June 2014 and are shown net of each other on the balance sheet as the Company believes the arrangement qualifies for the offsetting provisions in GAAP.
Contractual Obligations
The following table represents our contractual obligations as of December 31, 2013:

 	  	Payments due by period (in thousands)	 	
 	  	Total	  	Less than
1 year	 	  	1-3 years	 	  	3-5 years	 	  	More than
5 years	 	
Long-term debt	  	$183,926	  	$	1,127	  	  	$	1,699	  	  	$	180,116	  	  	$	984	  	
Capital leases	  	704	  	 	305	 	  	 	380	 	  	 	19	 	  	 	—  	 	
Operating leases	  	29,489	  	 	8,247	 	  	 	12,628	 	  	 	8,614	 	  	 	—  	 	
Defined benefit obligations	  	19,200	  	 	3,200	 	  	 	6,400	 	  	 	6,400	 	  	 	3,200	 	
Purchase obligations	  	8,622	  	 	8,622	 	  	 	—  	 	  	 	—  	 	  	 	—  	 	
 	  	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total obligations	  	$241,941	  	$	21,501	  	  	$	21,107	  	  	$	195,149	  	  	$	4,184	  	
 	  	 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Tax liabilities are not included in the above contractual obligations as we cannot make reasonable estimates of the amount and period in which those tax liabilities would be paid. See “ Accounting for income taxes ” below and Note 11 of “Notes to Consolidated Financial Statements” of this Annual Report for additional information.
Critical Accounting Policies and Estimates
The preparation of financial statements in conformity with U.S. GAAP requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an on-going basis, we evaluate our estimates, which are based upon historical experiences, market trends and financial forecasts and projections, and upon various other assumptions that management believes to be reasonable under the circumstances at that certain point in time. Actual results may differ, significantly at times, from these estimates under different assumptions or conditions.
We believe the following critical accounting policies and estimates affect the significant estimates and judgments we use in the preparation of our consolidated financial statements, and may involve a higher degree of judgment and complexity than others.
Revenue recognition
Revenue is recognized when there is persuasive evidence that an arrangement exists, when delivery has occurred, when the price to the buyer is fixed or determinable and when collectability of the receivable is
 
- 51 -

Table of Contents
reasonably assured. These elements are met when title to the products is passed to the buyers, which is generally when product is shipped to the customer or when product is delivered to the customer. Generally, we recognize revenue upon shipment to manufacturers (direct ship) as well as upon sales to distributors using the “sell in” model, which is when product is shipped to the distributors (point of purchase).
Certain customers have limited rights of return and/or are entitled to price adjustments on products held in their inventory or upon sale to their end customers. We reduce net sales in the period of sale for estimates of product returns, distributor price adjustments and other allowances. Our reserve estimates are based upon historical data as well as projections of sales, distributor inventories, price adjustments, average selling prices and market conditions. Actual returns and adjustments could be significantly different from our estimates and provisions, resulting in an adjustment to net sales.
We record allowances/reserves for the following items: (i) ship and debit, which arise when we, from time to time based on market conditions, issue credit to certain distributors upon their shipments to their end customers, (ii) stock rotation, which are contractual obligations that permit certain distributors, up to four times a year, to return a portion of their inventory based on historical shipments to them in exchange for an equal and offsetting order, and (iii) price protection, which arise when market conditions cause average selling prices to decrease and we issue credit to certain distributors on their inventory.
Ship and debit reserves are recorded as a reduction to net sales with a corresponding reduction to accounts receivable. Stock rotation reserves are recorded as a reduction to net sales with a corresponding reduction to cost of goods sold for the estimated cost of inventory that is expected to be returned. Price protection reserves are recorded as a reduction to net sales with a corresponding increase in accrued liabilities.
Inventories
Inventories are stated at the lower of cost or market value. Cost is determined principally by the first-in, first-out method. On an on-going basis, we evaluate our inventory for obsolescence and slow-moving items. This evaluation includes analysis of sales levels, sales projections, and purchases by item, as well as raw material usage related to our manufacturing facilities. If our review indicates a reduction in utility below carrying value, we reduce our inventory to a new cost basis. If future demand or market conditions are different than our current estimates, an inventory adjustment may be required, and would be reflected in cost of goods sold in the period the revision is made.
Accounting for income taxes
As part of the process of preparing our consolidated financial statements, we are required to estimate our income taxes in each of the tax jurisdictions in which we operate. This process involves using an asset and liability approach whereby deferred tax assets and liabilities are recorded for differences in the financial reporting bases and tax bases of our assets and liabilities. Deferred tax accounting requires that we evaluate net deferred tax assets by jurisdiction to determine if these assets will more likely than not be realized. This analysis requires considerable judgment and is subject to change to reflect future events and changes in the tax laws.
A tax position is recognized as a benefit only if it is more likely than not that the tax position would be sustained based on its technical merits in a tax examination, using the presumption the tax authority has full knowledge of all relevant facts regarding the position. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on ultimate settlement with the tax authority. For tax positions not meeting the more likely than not test, no tax benefit is recorded.
Goodwill and other indefinite lived intangible assets
Goodwill is tested for impairment on an annual basis, on October 1, and between annual tests if indicators of potential impairment exist. We use the simplified goodwill impairment test, which allows us to first assess
 
- 52 -

Table of Contents
qualitatively whether it is necessary to perform step one of the two-step annual goodwill impairment test. We are required to perform step one and calculate the fair value of our reporting units only if we conclude that it is more likely than not that a reporting unit’s fair value is less than its carrying value (that is, a likelihood of more than 50%). The qualitative analysis, which is referred to as step zero is performed, and the Company considers all relevant factors specific to its reporting units. Some factors considered in step zero are macroeconomic conditions, industry and market considerations, cost factors, overall financial performance, events affecting a reporting unit and other relevant entity-specific events. If any reporting unit fails step zero, its goodwill and other indefinite lived intangible assets will be tested using the two-step process. The first step requires a comparison of the fair value of the reporting unit to the respective carrying value. If the reporting unit fails step one, meaning that its carrying value exceeds its fair value, then the second step must be performed. The second step computes the amount of impairment, if any, by comparing the implied fair value of the reporting unit’s goodwill with the carrying amount of that goodwill. If the carrying amount of the reporting unit’s goodwill exceeds its implied fair value, an impairment loss will be recognized.
Share-based compensation
We use the Black-Scholes-Merton model to determine the fair value of stock options on the date of grant. The amount of compensation expense recognized using the Black-Scholes-Merton model requires us to exercise judgment and make assumptions relating to the factors that determine the fair value of our stock option grants. The fair value calculated by this model is a function of several factors, including the grant price, the expected future volatility, the expected term of the option and the risk-free interest rate of the option. The expected term and expected future volatility of the options require our judgment. In addition, we are required to estimate the expected forfeiture rate and only recognize expense for those stock options expected to vest. We estimate the forfeiture rate based on historical experience and to the extent our actual forfeiture rate is different from our estimate, share-based compensation expense is adjusted accordingly. Restricted stock grants are measured based on the fair market value of the underlying stock on the date of grant.
Fair value measurements
Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on the assumptions that market participants would use in pricing an assets or liability. Fair value is based on a hierarchy of valuation techniques, which is determined on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. These two types of inputs create a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

Level 1:	  	Quoted prices for identical instruments in active markets.
 	
Level 2:	  	Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets.
 	
Level 3:	  	Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.	
Our defined benefit plan assets are valued under methods of fair value. All of the securities held by the plan are publicly traded and highly liquid. Therefore, the majority of the securities are valued under Level 1 and one security is valued under Level 2 using quoted prices for identical or similar securities.
Defined benefit plan
We maintain a pension plan covering certain of our employees in the U.K. For financial reporting purposes, the net pension and supplemental retirement benefit obligations and the related periodic pension costs are
 
- 53 -

Table of Contents
calculated based upon, among other things, assumptions of the discount rate for plan obligations, estimated return on pension plan assets and mortality rates. These obligations and related periodic costs are measured using actuarial techniques and assumptions. The projected unit credit method is the actuarial cost method used to compute the pension liabilities and related expenses. See “Fair value measurements”  above in regard to pension plan assets.
Contingencies
From time to time, we are involved in a variety of legal matters that arise in the normal course of business. Based on information available, we evaluate the likelihood of potential outcomes. We record the appropriate liability when the amount is deemed probable and reasonably estimable. In addition, we do not accrue for estimated legal fees and other directly related costs as they are expensed as incurred.
Recently Issued Accounting Pronouncements
See Note 1 of “Notes to Consolidated Financial Statements” of this Annual Report for additional information regarding the status of recently issued accounting pronouncements.
 
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk.	
Foreign Currency Risk
We face exposure to adverse movements in foreign currency exchange rates, primarily in Asia and Europe. Our foreign currency risk may change over time as the level of activity in foreign markets grows and could have a material adverse impact upon our financial results. Certain of our assets, including certain bank accounts and accounts receivable, and liabilities exist in non-U.S. dollar denominated currencies, which are sensitive to foreign currency exchange fluctuations. These currencies are principally the Chinese Yuan, the Taiwanese dollar and the British Pound Sterling and, to a lesser extent, the Japanese Yen, the Euro and the Hong Kong dollar. In the future, we may enter into hedging arrangements designed to mitigate foreign currency fluctuations. See “Risk Factors –  We are subject to foreign currency risk as a result of our international operations.”  in Part I, Item 1A of this Annual Report for additional information.
Effect on Reporting Income
Certain of our subsidiaries have a functional currency that differs from the currencies in which some of their expenses are denominated. Our income and expenses are based on a mix of currencies and a decline in one currency relative to the other currencies could adversely affect our results of operations. Furthermore, our results of operations are reported in U.S. dollars, which is our reporting currency. In the event the U.S. dollar weakens against a foreign currency, we will experience a currency transaction loss, which could adversely affect our results of operations. If a foreign currency were to weaken (or strengthen) by 1.0% against the U.S. dollar, we would experience currency transaction gain (or loss) of less than $1 million per quarter.
Foreign Currency Transaction Risk
We also are subject to foreign currency risk arising from intercompany transactions that are expected to be settled in cash in the near term where the cash balances are held in denominations other than our subsidiaries’ functional currency. If exchange rates weaken against the functional currency, we would incur a remeasurement gain in the value of the cash balances, and if the exchange rates strengthen against the functional currency, we would incur a remeasurement loss in the value of the cash balances, assuming the net monetary asset balances remained constant. Our ultimate realized gain or loss with respect to currency fluctuations will generally depend on the size and type of transaction, the size and currencies of the net monetary assets and the changes in the exchange rates associated with these currencies. If the Chinese Yuan, the Taiwanese dollar, the Euro and the British Pound Sterling were to weaken (or strengthen) by 1.0% against the U.S. dollar, we would experience currency transaction gain (or loss) of less than $1 million. Net foreign exchange transaction gains (or losses) are included in other income and expense.
 
- 54 -

Table of Contents
Foreign Currency Translation Risk
When our foreign subsidiaries’ books are maintained in their functional currency, fluctuations in foreign currencies impact the amount of total assets and liabilities that we report for our foreign subsidiaries upon the translation of these amounts into U.S. dollars for reporting purposes. All elements of the subsidiaries’ financial statements, except for stockholders’ equity accounts, are translated using a currency exchange rate. Assets and liabilities denominated in foreign currencies are translated at the exchange rate on the balance sheet date. Income and expense accounts denominated in foreign currencies are translated at the weighted-average exchange rate during the period presented. Resulting translation adjustments are recorded as a separate component of accumulated other comprehensive income or loss within stockholders’ equity in the consolidated balance sheets, which are accumulated in this account until sale or liquidation of the foreign entity investment, at which time they are reported as adjustments to the gain or loss on sale of investment.
Foreign Currency Denominated Defined Benefit Plans
We have a contributory defined benefit plan that covers certain employees in the U.K., which is closed to new entrants and frozen with respect to future benefit accruals. The retirement benefit is based on the final average compensation and service of each eligible employee. December 31 is our annual measurement date and on the measurement date, defined benefit plan assets are determined based on fair value. Defined benefit plan assets consist primarily of high quality corporate bonds and stocks that are denominated in the currency in which the benefits will be paid and that have terms to maturity approximating to the terms of the related pension liability. The net pension and supplemental retirement benefit obligations and the related periodic costs are based on, among other things, assumptions of the discount rate, estimated return on plan assets and mortality rates. These obligations and related periodic costs are measured using actuarial techniques and assumptions. The projected unit credit method is the actuarial cost method used to compute the pension liabilities and related expenses.
As of December 31, 2013, the plan was underfunded and a liability of approximately $33 million was reflected in our consolidated financial statements as a noncurrent liability. The amount recognized in accumulated other comprehensive income was a net loss of $28 million. If the British Pound Sterling were to (weaken) or strengthen by 1.0% against the U.S. dollar, we would experience currency translation liability (decrease) or increase of less than $1 million. The weighted-average discount rate assumption used to determine benefit obligations as of December 31, 2013 was 4.6%. A 0.2% increase/(decrease) in the discount rate used to calculate the net period benefit cost for the year would reduce/increase annual benefit cost by less than $1 million. A 0.2% increase/(decrease) in the discount rate used to calculate the year-end projected benefit obligation would increase/(decrease) the year-end projected benefit obligation by approximately $5 million. The expected return on plan assets is determined based on historical and expected future returns of the various assets classes and as such, each 1.0% increase/(decrease) in the expected rate of return assumption would increase/(decrease) the net period benefit cost by approximately $1 million. The asset value of the defined benefit plan has been volatile in recent years due primarily to wide fluctuations in the U.K. equity markets and bond markets. See “Risk Factors— Due to the recent fluctuations in the United Kingdom’s equity markets and bond markets, changes in actuarial assumptions for our defined benefit plan could increase the volatility of the plan’s asset value, require us to increase cash contributions to the plan and have a negative impact on our results of operations and financial condition. ” in Part I, Item 1A of this Annual Report for additional information.
Interest Rate Risk
We have credit facilities with financial institutions in the U.S., Asia and Europe as well as other debt instruments with interest rates equal to LIBOR or similar indices plus a negotiated margin. A rise in interest rates could have an adverse impact upon our cost of working capital and our interest expense. As a matter of policy, we do not enter into derivative transactions for speculative purposes. As of December 31, 2013, our outstanding principal debt included $179 million outstanding under our revolving senior credit facility, $6 million outstanding under foreign lines of credit and $7 million used for import and export guarantees and bank
 
- 55 -

Table of Contents
acceptance notes. Based on an increase or decrease in interest rates by 1.0% for the year on our credit facilities, our annual interest rate expense would increase or decrease by less than $1 million.
Political Risk
We have a significant portion of our assets in mainland China, Taiwan and the U.K. The possibility of political conflict between the any of these countries or with the U.S. could have a material adverse impact upon our ability to transact business through these important business channels and to generate profits. See “Risk Factors” –  Risks Related to our International Operations”  in Part I, Item 1A of this Annual Report for additional information.
Inflation Risk
Inflation did not have a material effect on net sales or net income in fiscal year 2013. A significant increase in inflation could affect future performance.
Credit Risk
The success of our business depends, among other factors, on the strength of the global economy and the stability of the financial markets, which in turn affect our customers’ demand for our products, the ability of our customers to meet their payment obligations, the likelihood of customers canceling or deferring existing orders and end-user consumers’ demand for items containing our products in the end-markets we serve. We provide credit to customers in the ordinary course of business and perform ongoing credit evaluations, while at times providing extended terms. We believe that our exposure to concentrations of credit risk with respect to trade receivables is largely mitigated by dispersion of our customers over various geographic areas, operating primarily in electronics manufacturing and distribution. We believe our allowance for doubtful accounts is sufficient to cover customer credit risks.
 
Item 8.	Financial Statements and Supplementary Data.	
See Part IV, Item 15 “Exhibits and Financial Statement Schedules” for the Company’s Consolidated Financial Statements and the notes and schedules thereto filed as part of this Annual Report.
 
Item 9.	Changes In and Disagreements With Accountants on Accounting and Financial Disclosure.	
Not Applicable.
 
Item 9A.	Controls and Procedures.	
Disclosure Controls and Procedures
Our Chief Executive Officer, Keh-Shew Lu, and Chief Financial Officer, Richard D. White, with the participation of the Company’s management, carried out an evaluation of the effectiveness of our disclosure controls and procedures pursuant to Exchange Act Rule 13a-15(e). Based upon that evaluation, the Chief Executive Officer and the Chief Financial Officer believe that, as of the end of the period covered by this report, our disclosure controls and procedures are effective at the reasonable assurance level to ensure that information required to be included in this report is:
 
 	•	 	recorded, processed, summarized and reported within the time period specified in the Commission’s rules and forms; and	
 
 	•	 	accumulated and communicated to our management, including the Chief Executive Officer and the Chief Financial Officer, to allow timely decisions required disclosure.	
Disclosure controls and procedures, no matter how well designed and implemented, can provide only reasonable assurance of achieving an entity’s disclosure objectives. The likelihood of achieving such objectives
 
- 56 -

Table of Contents
is affected by limitations inherent in disclosure controls and procedures. These include the fact that human judgment in decision-making can be faulty and that breakdowns in internal control can occur because of human failures such as simple errors, mistakes or intentional circumvention of the established processes.
Management’s Annual Report on Internal Control Over Financial Reporting
Management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed by, or under the supervision of, the Company’s Chief Executive Officer and the Chief Financial Officer and implemented by the Company’s Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America.
The Company’s internal control over financial reporting includes those policies and procedures that: (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles in the United States of America, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Under the supervision and with the participation of management, including our Chief Executive Officer and the Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework and criteria established in  Internal Control—Integrated Framework (1992)  issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). This evaluation included review of the documentation of controls, testing of operating effectiveness of controls and a conclusion on this evaluation. Based on this evaluation, management concluded that the Company’s internal control over financial reporting was effective as of December 31, 2013.
Moss Adams LLP, an independent registered public accounting firm, has audited and reported on the consolidated financial statements of Diodes Incorporated and on the effectiveness of our internal control over financial reporting. The report of Moss Adams LLP is contained in this Annual Report.
Changes in Controls over Financial Reporting
There was no change in our internal control over financial reporting, known to the Chief Executive Officer or the Chief Financial Officer, that occurred during the last fiscal quarter covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
 
Item 9B.	Other Information.	
None.
 
- 57 -

Table of Contents
PART III
 
Item 10.	Directors, Executive Officers and Corporate Governance.	
The information concerning the directors, executive officers and corporate governance of the Company is incorporated herein by reference from the section entitled “Proposal One – Election of Directors” contained in the definitive proxy statement of the Company to be filed pursuant to Section 14(a) of the Securities Exchange Act of 1934 within 120 days after the Company’s fiscal year end of December 31, 2013, for its annual stockholders’ meeting for 2014 (the “Proxy Statement”).
We have adopted a code of ethics that applies to our Chief Executive Officer and senior financial officers. The code of ethics has been posted on our website under the Corporate Governance portion of the Investor Relations section at www.diodes.com. We intend to satisfy disclosure requirements regarding amendments to, or waivers from, any provisions of our code of ethics on our website.
 
Item 11.	Executive Compensation.	
The information concerning executive compensation is incorporated herein by reference from the section entitled “Proposal One – Election of Directors” contained in the Proxy Statement.
 
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.	
The information concerning the security ownership of certain beneficial owners and management and related stockholder matters is incorporated herein by reference from the section entitled “General Information – Security Ownership of Certain Beneficial Owners and Management” and “Proposal One—Election of Directors” contained in the Proxy Statement.
 
Item 13.	Certain Relationships, Related Transactions and Director Independence.	
The information concerning certain relationships, related transactions and director independence is incorporated herein by reference from the section entitled “Proposal One – Election of Directors – Certain Relationships, Related Transactions and Director Independence” and “Proposal One – Elections of Directors” contained in the Proxy Statement.
 
Item 14.	Principal Accounting Fees and Services.	
The information concerning the Company’s principal accountant’s fees and services is incorporated herein by reference from the section entitled “Ratification of the Appointment of Independent Registered Public Accounting Firm” contained in the Proxy Statement.
 
- 58 -

Table of Contents
PART IV
 
Item 15.	Exhibits, Financial Statement Schedules.	
 
 	(a)	Financial Statements and Schedules	
Our consolidated financial statements are as set forth under Item 8 of this report on Form 10-K.
 
 	(1)	Financial statements:	

 	  	Page	
Report of Independent Registered Public Accounting Firm	  	60	
 	 	
Consolidated Balance Sheets at December 31, 2013, and 2012	  	61 to 62	
 	 	
Consolidated Statements of Income for the Years Ended December  31, 2013, 2012 and 2011	  	63	
 	 	
Consolidated Statements of Comprehensive Income for the Years Ended December  31, 2013, 2012 and 2011	  	64	
 	 	
Consolidated Statements of Equity for the Years Ended December  31, 2013, 2012 and 2011	  	65	
 	 	
Consolidated Statements of Cash Flows for the Years Ended December  31, 2013, 2012 and 2011	  	66 to 67	
 	 	
Notes to Consolidated Financial Statements	  	68 to 103	
 
 	(2)	Schedules:	
None
Schedules not listed above have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements and note thereto.
 
 	(b)	Exhibits	
The exhibits listed on the Index to Exhibits are filed as exhibits or incorporated by reference to this Annual Report.
 
 	(c)	Financial Statements of Unconsolidated Subsidiaries and Affiliates	
Not Applicable.
 
- 59 -

Table of Contents
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders
Diodes Incorporated and Subsidiaries
We have audited the accompanying consolidated balance sheets of Diodes Incorporated and Subsidiaries (the “Company”) as of December 31, 2013 and 2012, and the related consolidated statements of income, comprehensive income, stockholders’ equity and cash flows for each of the three years in the period ended December 31, 2013. We also have audited the Company’s internal control over financial reporting as of December 31, 2013, based on criteria established in  Internal Control – Integrated Framework (1992)  issued by the Committee of Sponsoring Organizations of the Treadway Commission. The Company’s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Control Over Financial Reporting appearing under Item 9A. Our responsibility is to express an opinion on these consolidated financial statements and an opinion on the Company’s internal control over financial reporting based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement and whether effective internal control over financial reporting was maintained in all material respects. Our audits of the consolidated financial statements included examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall consolidated financial statement presentation. Our audits of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also include performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the consolidated financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of Diodes Incorporated and Subsidiaries as of December 31, 2013 and 2012, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2013, in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, Diodes Incorporated and Subsidiaries, maintained, in all material respects, effective internal control over financial reporting as of December 31, 2013, based on criteria established in Internal Control – Integrated Framework (1992)  issued by the Committee of Sponsoring Organizations of the Treadway Commission.
/s/ Moss Adams, LLP
Los Angeles, California
February 27, 2014
 
- 60 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS

(Amounts in thousands)
December 31,	  	2013	 	  	2012	 	
ASSETS	  	
CURRENT ASSETS	  	 	 	 	  	 	 	 	
Cash and cash equivalents	  	$	196,635	 	  	$	157,121	 	
Short-term investments	  	 	22,922	 	  	 	—  	 	
Accounts receivable, net	  	 	192,267	 	  	 	152,073	 	
Inventories	  	 	180,396	 	  	 	153,293	 	
Deferred income taxes, current	  	 	10,513	 	  	 	9,995	 	
Prepaid expenses and other	  	 	47,352	 	  	 	18,928	 	
 	  	 	 	 	  	 	 	 	
Total current assets	  	 	650,085	 	  	 	491,410	 	
 	  	 	 	 	  	 	 	 	
PROPERTY, PLANT AND EQUIPMENT, net	  	 	322,013	 	  	 	243,296	 	
DEFERRED INCOME TAXES, non-current	  	 	28,237	 	  	 	36,819	 	
OTHER ASSETS	  	 	 	 	  	 	 	 	
Goodwill	  	 	84,714	 	  	 	87,359	 	
Intangible assets, net	  	 	53,571	 	  	 	44,337	 	
Other	  	 	23,638	 	  	 	16,842	 	
 	  	 	 	 	  	 	 	 	
Total assets	  	$	1,162,258	 	  	$	920,063	 	

The accompanying notes are an integral part of these financial statements.
 
- 61 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS (Continued)

(Amounts in thousands, except share data)
December 31,	  	2013	 	 	2012	 	
LIABILITIES AND EQUITY	  	 	 	 	 	 	 	 	
CURRENT LIABILITIES	  	 	 	 	 	 	 	 	
Lines of credit and short-term debt	  	$	5,814	 	 	$	7,629	 	
Accounts payable	  	 	89,212	 	 	 	64,072	 	
Accrued liabilities	  	 	60,684	 	 	 	41,139	 	
Income tax payable	  	 	1,206	 	 	 	678	 	
 	  	 	 	 	 	 	 	 	
Total current liabilities	  	 	156,916	 	 	 	113,518	 	
 	  	 	 	 	 	 	 	 	
LONG-TERM DEBT, net of current portion	  	 	182,799	 	 	 	44,131	 	
OTHER LONG-TERM LIABILITIES	  	 	78,866	 	 	 	41,974	 	
 	  	 	 	 	 	 	 	 	
Total liabilities	  	 	418,581	 	 	 	199,623	 	
 	  	 	 	 	 	 	 	 	
COMMITMENTS AND CONTINGENCIES (see note 16)	  	 	 	 	 	 	 	 	
EQUITY	  	 	 	 	 	 	 	 	
Diodes Incorporated stockholders’ equity	  	 	 	 	 	 	 	 	
Preferred stock—par value $1.00 per share; 1,000,000 shares authorized; no shares issued or outstanding	  	 	—  	 	 	 	—  	 	
Common stock—par value $0.66 2/3 per share; 70,000,000 shares authorized; 46,680,973 and 46,010,815 issued and outstanding at December 31, 2013 and 2012, respectively	  	 	31,120	 	 	 	30,674	 	
Additional paid-in capital	  	 	289,668	 	 	 	280,571	 	
Retained earnings	  	 	426,328	 	 	 	399,796	 	
Accumulated other comprehensive loss	  	 	(44,374	) 	 	 	(33,856	) 	
 	  	 	 	 	 	 	 	 	
Total Diodes Incorporated stockholders’ equity	  	 	702,742	 	 	 	677,185	 	
Noncontrolling interest	  	 	40,935	 	 	 	43,255	 	
 	  	 	 	 	 	 	 	 	
Total equity	  	 	743,677	 	 	 	720,440	 	
 	  	 	 	 	 	 	 	 	
Total liabilities and equity	  	$	1,162,258	 	 	$	920,063	 	
 	  	 	 	 	 	 	 	 	
The accompanying notes are an integral part of these financial statements.
 
- 62 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME

(Amounts in thousands, except per share data)
Years ended December 31,	  	2013	 	 	2012	 	 	2011	 	
NET SALES	  	$	826,846	 	 	$	633,806	 	 	$	635,251	 	
COST OF GOODS SOLD	  	 	589,010	 	 	 	472,220	 	 	 	441,554	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
Gross profit	  	 	237,836	 	 	 	161,586	 	 	 	193,697	 	
OPERATING EXPENSES	  	 	 	 	 	 	 	 	 	 	 	 	
Selling, general and administrative	  	 	132,106	 	 	 	101,363	 	 	 	89,974	 	
Research and development	  	 	48,302	 	 	 	33,761	 	 	 	27,231	 	
Amortization of acquisition related intangible assets	  	 	8,078	 	 	 	5,122	 	 	 	4,503	 	
Impairment of goodwill	  	 	5,318	 	 	 	—  	 	 	 	—  	 	
Restructuring	  	 	1,535	 	 	 	—  	 	 	 	—  	 	
Loss (gain) on sale of assets	  	 	216	 	 	 	(3,556	) 	 	 	—  	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
Total operating expenses	  	 	195,555	 	 	 	136,690	 	 	 	121,708	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
Income from operations	  	 	42,281	 	 	 	24,896	 	 	 	71,989	 	
OTHER INCOME (EXPENSES)	  	 	 	 	 	 	 	 	 	 	 	 	
Interest income	  	 	1,274	 	 	 	778	 	 	 	1,024	 	
Interest expense	  	 	(5,580	) 	 	 	(876	) 	 	 	(3,139	) 	
Amortization of debt discount	  	 	—  	 	 	 	—  	 	 	 	(6,032	) 	
Gain (loss) on securities carried at fair value	  	 	601	 	 	 	7,100	 	 	 	(1,039	) 	
Other	  	 	9	 	 	 	(1,091	) 	 	 	861	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
Total other income (expenses)	  	 	(3,696	) 	 	 	5,911	 	 	 	(8,325	) 	
Income before income taxes and noncontrolling interest	  	 	38,585	 	 	 	30,807	 	 	 	63,664	 	
INCOME TAX PROVISION	  	 	14,481	 	 	 	4,825	 	 	 	10,157	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
NET INCOME	  	 	24,104	 	 	 	25,982	 	 	 	53,507	 	
Less: NET (INCOME) LOSS attributable to noncontrolling interest	  	 	2,428	 	 	 	(1,830	) 	 	 	(2,770	) 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
NET INCOME attributable to common stockholders	  	$	26,532	 	 	$	24,152	 	 	$	50,737	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
EARNINGS PER SHARE attributable to common stockholders	  	 	 	 	 	 	 	 	 	 	 	 	
Basic	  	$	0.57	 	 	$	0.53	 	 	$	1.12	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
Diluted	  	$	0.56	 	 	$	0.51	 	 	$	1.09	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
Number of shares used in computation	  	 	 	 	 	 	 	 	 	 	 	 	
Basic	  	 	46,363	 	 	 	45,780	 	 	 	45,202	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
Diluted	  	 	47,658	 	 	 	46,899	 	 	 	46,713	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
The accompanying notes are an integral part of these financial statements.
 
- 63 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

 	  	Twelve Months Ended December 31,	 	
 	  	2013	 	 	2012	 	 	2011	 	
Net income	  	$	24,104	  	 	$	25,982	  	 	$	53,507	  	
Translation adjustment	  	 	6,453	 	 	 	7,317	 	 	 	(690	) 	
Unrealized gain (loss) on defined benefit plan, net of tax	  	 	(16,971	) 	 	 	(5,411	) 	 	 	10,008	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
Comprehensive income	  	 	13,586	 	 	 	27,888	 	 	 	62,825	 	
Less: Comprehensive (income) loss attributable to noncontrolling interest	  	 	2,428	 	 	 	(1,830	) 	 	 	(2,770	) 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
Total comprehensive income attributable to common stockholders	  	$	16,014	  	 	$	26,058	  	 	$	60,055	  	
 	  	 	 	 	 	 	 	 	 	 	 	 	
The accompanying notes are an integral part of these financial statements.
 
- 64 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EQUITY

(Amounts in thousands)
Years ended December 31, 2011, 2012 and 2013	 	 	
 	 	Common stock	 	 	Additional
paid-in
capital	 	 	Retained
earnings	 	 	Accumulated
other
comprehensive
loss	 	 	Total Diodes
Incorporated
Stockholders’
equity	 	 	Noncontrolling
interest	 	 	Total equity	 	 	
 	 	Shares	 	 	Amount	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
BALANCE, December 31, 2010	 	 	44,663	 	 	$	29,775	  	 	$	231,842	  	 	$	324,907	  	 	$	(45,080	) 	 	$	541,444	  	 	$	11,448	  	 	$	552,892	  	 	 	 	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Total comprehensive income	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	50,737	 	 	 	9,318	 	 	 	60,055	 	 	 	2,770	 	 	 	62,825	 	 	 	 	 	
Dividend to noncontrolling interest	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	737	 	 	 	737	 	 	 	 	 	
Common stock issued for share-based plans	 	 	769	 	 	 	648	 	 	 	2,886	 	 	 	—  	 	 	 	—  	 	 	 	3,534	 	 	 	—  	 	 	 	3,534	 	 	 	 	 	
Excess tax benefit from share-based compensation	 	 	—  	 	 	 	—  	 	 	 	15,024	 	 	 	—  	 	 	 	—  	 	 	 	15,024	 	 	 	—  	 	 	 	15,024	 	 	 	 	 	
Share-based compensation	 	 	—  	 	 	 	—  	 	 	 	13,703	 	 	 	—  	 	 	 	—  	 	 	 	13,703	 	 	 	—  	 	 	 	13,703	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
BALANCE, December 31, 2011	 	 	45,432	 	 	$	30,423	  	 	$	263,455	  	 	$	375,644	  	 	$	(35,762	) 	 	$	633,760	  	 	$	14,955	  	 	$	648,715	  	 	 	 	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Total comprehensive income	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	24,152	 	 	 	1,906	 	 	 	26,058	 	 	 	1,830	 	 	 	27,888	 	 	 	 	 	
Acquisition of noncontrolling interest	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	26,470	 	 	 	26,470	 	 	 	 	 	
Common stock issued for share-based plans	 	 	579	 	 	 	251	 	 	 	1,074	 	 	 	—  	 	 	 	—  	 	 	 	1,325	 	 	 	—  	 	 	 	1,325	 	 	 	 	 	
Excess tax benefit from share-based compensation	 	 	—  	 	 	 	—  	 	 	 	1,644	 	 	 	—  	 	 	 	—  	 	 	 	1,644	 	 	 	—  	 	 	 	1,644	 	 	 	 	 	
Share-based compensation	 	 	—  	 	 	 	—  	 	 	 	14,398	 	 	 	—  	 	 	 	—  	 	 	 	14,398	 	 	 	—  	 	 	 	14,398	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
BALANCE, December 31, 2012	 	 	46,011	 	 	$	30,674	  	 	$	280,571	  	 	$	399,796	  	 	$	(33,856	) 	 	$	677,185	  	 	$	43,255	  	 	$	720,440	  	 	 	 	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Total comprehensive income	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	26,532	 	 	 	(10,518	)	 	 	16,014	 	 	 	(2,428	) 	 	 	13,586	 	 	 	 	 	
Acquisition of noncontrolling interest	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	108	 	 	 	108	 	 	 	 	 	
Common stock issued for share-based plans	 	 	670	 	 	 	446	 	 	 	2,189	 	 	 	—  	 	 	 	—  	 	 	 	2,635	 	 	 	—  	 	 	 	2,635	 	 	 	 	 	
Excess tax benefit from share-based compensation	 	 	—  	 	 	 	—  	 	 	 	(6,643	) 	 	 	—  	 	 	 	—  	 	 	 	(6,643	) 	 	 	—  	 	 	 	(6,643	) 	 	 	 	 	
Share-based compensation	 	 	—  	 	 	 	 	 	 	 	13,551	 	 	 	—  	 	 	 	—  	 	 	 	13,551	 	 	 	—  	 	 	 	13,551	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
BALANCE, December 31, 2013	 	 	46,681	 	 	$	31,120	  	 	$	289,668	  	 	$	426,328	  	 	$	(44,374	) 	 	$	702,742	  	 	$	40,935	  	 	$	743,677	  	 	 	 	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
The accompanying notes are an integral part of these financial statements.
 
- 65 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS

(Amounts in thousands)
Years ended December 31,	  	2013	 	 	2012	 	 	2011	 	
CASH FLOWS FROM OPERATING ACTIVITIES	  	 	 	 	 	 	 	 	 	 	 	 	
Net income	  	$	24,104	  	 	$	25,982	  	 	$	53,507	  	
Adjustments to reconcile net income to net cash provided by operating activities, net of effects of acquisitions:	  	 	 	 	 	 	 	 	 	 	 	 	
Depreciation	  	 	65,529	 	 	 	59,063	 	 	 	56,927	 	
Amortization of intangibles	  	 	8,078	 	 	 	5,130	 	 	 	4,511	 	
Impairment of goodwill	  	 	5,318	 	 	 	—  	 	 	 	—  	 	
Amortization of convertible senior notes issuance costs	  	 	—  	 	 	 	—  	 	 	 	412	 	
Amortization of discount on convertible senior notes	  	 	—  	 	 	 	—  	 	 	 	6,032	 	
Share-based compensation	  	 	13,551	 	 	 	14,398	 	 	 	13,703	 	
Excess tax benefit from share-based compensation	  	 	6,643	 	 	 	(1,644	) 	 	 	(15,024	) 	
Loss (gain) on disposal of property, plant and equipment	  	 	270	 	 	 	(3,554	) 	 	 	31	 	
Loss (gain) on securities carried at fair value	  	 	(601	) 	 	 	(7,100	) 	 	 	1,039	 	
Deferred income taxes	  	 	(1,959	) 	 	 	(13,051	) 	 	 	(21,916	) 	
Other	  	 	3,069	 	 	 	(334	) 	 	 	(297	) 	
Changes in operating assets:	  	 	 	 	 	 	 	 	 	 	 	 	
Accounts receivable	  	 	(18,241	) 	 	 	(6,360	) 	 	 	(4,406	) 	
Inventories	  	 	14,860	 	 	 	(5,492	) 	 	 	(20,187	) 	
Prepaid expenses and other current assets	  	 	(3,803	) 	 	 	3,162	 	 	 	(7,483	) 	
Changes in operating liabilities:	  	 	 	 	 	 	 	 	 	 	 	 	
Accounts payable	  	 	(8,594	) 	 	 	(7,440	) 	 	 	(3,584	) 	
Accrued liabilities	  	 	171	 	 	 	2,257	 	 	 	(8,513	) 	
Other liabilities	  	 	1,957	 	 	 	(4,179	) 	 	 	3,069	 	
Income taxes payable	  	 	(461	) 	 	 	3,378	 	 	 	3,829	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
Net cash provided by operating activities	  	 	109,891	 	 	 	64,216	 	 	 	61,650	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
CASH FLOWS FROM INVESTING ACTIVITIES	  	 	 	 	 	 	 	 	 	 	 	 	
Acquisitions, net of cash acquired	  	 	(124,916	) 	 	 	(20,048	) 	 	 	—  	 	
Decrease in restricted cash	  	 	6,886	 	 	 	—  	 	 	 	—  	 	
Purchase of short-term investments	  	 	(22,922	) 	 	 	—  	 	 	 	—  	 	
Purchases of equity securities	  	 	(5,393	) 	 	 	(3,413	) 	 	 	(14,117	) 	
Proceeds from sale of equity securities	  	 	7,458	 	 	 	—  	 	 	 	—  	 	
Purchases of property, plant and equipment	  	 	(47,054	) 	 	 	(58,166	) 	 	 	(80,941	) 	
Proceeds from sales of property, plant and equipment	  	 	59	 	 	 	1,969	 	 	 	40	 	
Proceeds from sales of intangibles	  	 	—  	 	 	 	2,122	 	 	 	—  	 	
Other	  	 	(520	) 	 	 	117	 	 	 	(3,294	) 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
Net cash used by investing activities	  	 	(186,402	) 	 	 	(77,419	) 	 	 	(98,312	) 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
CASH FLOWS FROM FINANCING ACTIVITIES	  	 	 	 	 	 	 	 	 	 	 	 	
Advance on lines of credit and short term debt	  	 	15,101	 	 	 	3,659	 	 	 	8,000	 	
Repayments on lines of credit and short-term debt	  	 	(34,573	) 	 	 	(9,556	) 	 	 	—  	 	
Net proceeds from the issuance of common stock	  	 	2,635	 	 	 	1,318	 	 	 	3,526	 	
Excess tax benefit from share-based compensation	  	 	(6,643	) 	 	 	1,644	 	 	 	15,024	 	
Proceeds from long-term debt	  	 	181,000	 	 	 	71,720	 	 	 	—  	 	
Repayments of long-term debt	  	 	(42,145	) 	 	 	(30,445	) 	 	 	(134,706	) 	
Repayments of capital lease obligations	  	 	(627	) 	 	 	(295	) 	 	 	(285	) 	
Other	  	 	(2,387	) 	 	 	502	 	 	 	728	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
Net cash provided by (used by) financing activities	  	 	112,361	 	 	 	38,547	 	 	 	(107,713	) 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS	  	 	3,664	 	 	 	2,267	 	 	 	2,984	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	  	 	39,514	 	 	 	27,611	 	 	 	(141,391	) 	
CASH AND CASH EQUIVALENTS, beginning of year	  	 	157,121	 	 	 	129,510	 	 	 	270,901	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
CASH AND CASH EQUIVALENTS, end of year	  	$	196,635	  	 	$	157,121	  	 	$	129,510	  	

The accompanying notes are an integral part of these financial statements.
 
- 66 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)

(Amounts in thousands)
Years ended December 31,	  	2013	 	 	2012	 	 	2011	 	
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION	  	 	 	 	 	 	 	 	 	 	 	 	
Cash paid during the year for:	  	 	 	 	 	 	 	 	 	 	 	 	
Interest	  	$	4,373	 	 	$	914	 	 	$	3,322	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
Income taxes	  	$	10,396	 	 	$	17,086	 	 	$	12,118	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
Non-cash activities:	  	 	 	 	 	 	 	 	 	 	 	 	
Property, plant and equipment purchased on accounts payable	  	$	2,714	 	 	$	(1,957	) 	 	$	(1,934	) 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
Acquisition:	  	 	 	 	 	 	 	 	 	 	 	 	
Fair value of assets acquired	  	$	247,012	 	 	$	76,438	 	 	$	—  	 	
Liabilities assumed	  	 	(92,277	) 	 	 	(13,924	) 	 	 	—  	 	
Cash acquired	  	 	(29,819	) 	 	 	6,108	 	 	 	—  	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
Net assets acquired	  	$	124,916	 	 	$	68,622	 	 	$	—  	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
The accompanying notes are an integral part of these financial statements.
 
- 67 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
NOTE 1 – SUMMARY OF OPERATIONS AND SIGNIFICANT ACCOUNTING POLICIES
Nature of operations – Diodes Incorporated and its subsidiaries (collectively, the “Company”) is a leading global manufacturer and supplier of high-quality, application specific standard products within the broad discrete, logic and analog semiconductor markets, serving the consumer electronics, computing, communications, industrial and automotive markets. These products include diodes, rectifiers, transistors, MOSFETs, protection devices, functional specific arrays, single gate logic, amplifiers and comparators, Hall-effect and temperature sensors, power management devices including LED drivers, DC-DC switching and linear voltage regulators and voltage references along with special function devices including USB power switches, load switches, voltage supervisors and motor controllers. The products are sold primarily throughout Asia, North America and Europe.
Principles of consolidation – The consolidated financial statements include the accounts of Diodes Incorporated, its wholly-owned subsidiaries and its controlled majority-owned subsidiaries. The Company accounts for equity investments in companies over which it has the ability to exercise significant influence, but does not hold a controlling interest, under the equity method, and it records its proportionate share of income or losses in interest and other, net in the consolidated statements of income. All significant intercompany balances and transactions have been eliminated.
Revenue recognition – Revenue is recognized when there is persuasive evidence that an arrangement exists, when delivery has occurred, when the price to the buyer is fixed or determinable and when collectability of the receivable is reasonably assured. These elements are met when title to the products is passed to the buyers, which is generally when product is shipped to the customers. Generally, the Company recognizes revenue upon shipment to manufacturers (direct ship) as well as upon sales to distributors using the “sell in” model, which is when product is shipped to the distributors (point of purchase).
Certain customers have limited rights of return and/or are entitled to price adjustments on products held in their inventory or upon sale to their end customers. The Company reduces net sales in the period of sale for estimates of product returns, distributor price adjustments and other allowances. The Company’s reserve estimates are based upon historical data as well as projections of sales, distributor inventories, price adjustments, average selling prices and market conditions.
The Company records allowances/reserves for the following items: (i) ship and debit, which arise when the Company, from time to time based on market conditions, issues credit to certain distributors upon their shipments to their end customers, (ii) stock rotation, which are contractual obligations that permit certain distributors, up to four times a year, to return a portion of their inventory based on historical shipments to them in exchange for an equal and offsetting order, and (iii) price protection, which arise when market conditions cause average selling prices to decrease and the Company issues credit to certain distributors on their inventory.
Ship and debit reserves are recorded as a reduction to net sales with a corresponding reduction to accounts receivable. Stock rotation reserves are recorded as a reduction to net sales with a corresponding reduction to cost of goods sold for the estimated cost of inventory that is expected to be returned. Price protection reserves are recorded as a reduction to net sales with a corresponding increase in accrued liabilities. Revenue is reduced in the period of sale for estimates of product returns and other allowances including distributor adjustments, which were approximately $68 million, $48 million and $41 million in 2013, 2012 and 2011, respectively.
Product warranty – The Company generally warrants its products for a period of one year from the date of sale. Historically, warranty expense has not been material.
 
- 68 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
Cash and cash equivalents – The Company considers all highly liquid investments with maturity of three months or less at the date of purchase to be cash equivalents. The Company currently maintains substantially all of its day-to-day operating cash balances with major financial institutions.
Allowance for doubtful accounts – The Company evaluates the collectability of its accounts receivable based upon a combination of factors, including the current business environment and historical experience. If the Company is aware of a customer’s inability to meet its financial obligations, it records an allowance to reduce the receivable to the amount it reasonably believes will be collected from the customer. For all other customers, the Company records an allowance based upon the amount of time the receivables are past due. If actual accounts receivable collections differ from these estimates, an adjustment to the allowance may be necessary with a resulting effect on operating expense. Accounts receivable are presented net of valuation allowance, which were approximately $2 million in 2013, 2012 and 2011.
Inventories – Inventories are stated at the lower of cost or market value. Cost is determined principally by the first-in, first-out method. Cost includes materials, labor, and manufacturing overhead related to the purchase and production of inventories. Any write-down of inventory to the lower of cost or market at the close of a fiscal period creates a new cost basis that subsequently would not be marked up based on changes in underlying facts and circumstances. On an on-going basis, the Company evaluates inventory for obsolescence and slow-moving items. This evaluation includes analysis of sales levels, sales projections, and purchases by item, as well as raw material usage related to the Company’s manufacturing facilities. If the Company’s review indicates a reduction in utility below carrying value, it reduces inventory to a new cost basis. If future demand or market conditions are different than the Company’s current estimates, an inventory adjustment to write down inventory may be required, and would be reflected in cost of goods sold in the period the revision is made.
Property, plant and equipment – Purchased property, plant and equipment is recorded at historical cost and acquired property, plant and equipment is recorded at fair value on the date of acquisition. Property, plant and equipment is depreciated using straight-line methods over the estimated useful lives, which range from 20 to 55 years for buildings and 3 to 10 years for machinery and equipment. The estimated lives of leasehold improvements range from 3 to 5 years, and are amortized over the shorter of the remaining lease term or their estimated useful lives.
Goodwill and other indefinite lived intangible assets – Goodwill is tested for impairment on an annual basis, on October 1, and between annual tests if indicators of potential impairment exist. For 2013 and 2012, the Company used the simplified goodwill impairment test, which allows the Company to first assess qualitatively whether it is necessary to perform step one of the two-step annual goodwill impairment test. The Company is required to perform step one and calculate the fair value of its reporting units only if the Company concludes that it is more likely than not (that is, a likelihood of more than 50%) that a reporting unit’s fair value is less than its carrying value. The qualitative analysis, which is referred to as step zero, was performed and the Company considered all relevant factors specific to its reporting units. Some factors considered in step zero were macroeconomic conditions, industry and market considerations, cost factors, overall financial performance, events affecting a reporting unit and other relevant entity-specific events.
For 2013, the Company’s step zero conclusion was that goodwill is more likely than not to be not impaired and no further testing is required until the next annual test date (or sooner if conditions or events before that date raise concerns of potential impairment in the business) for all reporting units except for one. The reporting unit for Eris Technology Corporation failed the step zero test. Therefore, its goodwill and other indefinite lived intangible assets were tested using the two-step process. The first step required comparison of the fair value of the reporting unit to the respective carrying value. The reporting unit failed step one as the fair value of the
 
- 69 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
reporting unit was less than the carrying value. The second step was then performed to compute the amount of impairment, if any. In the second step, the impairment was computed by comparing the implied fair value of the reporting unit goodwill with the carrying amount of that goodwill. In this case, the carrying amount of the reporting unit’s goodwill exceeded its implied fair value, and therefore an impairment loss was recognized for the excess in the amount of $5 million. In addition, all the other indefinite lived assets, such as trade name for Eris were not impaired.
For 2012, the Company’s conclusion of step zero was that goodwill is deemed to be not impaired and no further testing was required until the next annual test date.
Impairment of long-lived assets – The Company’s long-lived assets are reviewed whenever events or changes in circumstances indicate that the carrying value may not be recoverable .  The Company considers assets to be impaired if the carrying value exceeds the undiscounted projected cash flows from operations. If impairment exists, the assets are written down to fair value or to the projected discounted cash flows from related operations. As of December 31, 2013, the Company expects the remaining carrying value of assets to be recoverable. No impairment of long-lived assets has been identified during any of the periods presented. The weighted average amortization period for amortizable intangible assets is approximately 8 years.
Business combinations – The Company recognizes all (and only) the assets acquired and liabilities assumed in the transaction and establishes the acquisition-date fair value as the measurement objective for all assets acquired and liabilities assumed in a business combination. Certain provisions prescribe, among other things, the determination of acquisition-date fair value of consideration paid in a business combination (including contingent consideration) and the exclusion of transaction and acquisition-related restructuring costs from acquisition accounting.
Income taxes – Income taxes are accounted for using an asset and liability approach whereby deferred tax assets and liabilities are recorded for differences in the financial reporting bases and tax bases of the Company’s assets and liabilities. If it is more likely than not that some portion of deferred tax assets will not be realized, a valuation allowance is recorded.
Generally accepted accounting principles in the United States of America (“GAAP”) prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Tax positions shall initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions shall initially and subsequently be measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and all relevant facts.
Research and development costs – Internally-developed research and development costs are expensed as incurred. Acquired in-process research and development (“IPR&D”) is capitalized as an indefinite-lived intangible asset and evaluated periodically for impairment. When the project is completed, an expected life is determined and the IPR&D is amortized as an expense over the expected life.
Shipping and handling costs – Shipping and handling costs for products shipped to customers, which are included in selling, general and administrative expenses, were $10 million, $6 million and $5 million for the years ended December 31, 2013, 2012 and 2011, respectively.
 
- 70 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
Concentration of credit risk – Financial instruments, which potentially subject the Company to concentrations of credit risk, include trade accounts receivable. Credit risk is limited by the dispersion of the Company’s customers over various geographic areas, operating primarily in electronics manufacturing and distribution. The Company performs on-going credit evaluations of its customers, and generally requires no collateral. Historically, credit losses have not been significant.
The Company currently maintains substantially all of its day-to-day cash balances and short-term investments with major financial institutions. Cash balances are usually in excess of Federal and/or foreign deposit insurance limits.
Valuation of financial instruments – The carrying value of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, working capital line of credit, and long-term debt approximate fair value due to their current market conditions, maturity dates and other factors.
Use of estimates – The preparation of financial statements in conformity with GAAP requires that management make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The level of uncertainty in estimates and assumptions increases with the length of time until the underlying transactions are completed. Actual results may differ from these estimates in amounts that may be material to the consolidated financial statements and accompanying notes.
Earnings per share – Basic earnings per share is calculated by dividing net earnings attributable to common stockholders by the weighted-average number of shares of Common Stock outstanding during the period. Diluted earnings per share is calculated similarly but includes potential dilution from the exercise of stock options and stock awards, except when the effect would be anti-dilutive. Earnings per share are computed using the “treasury stock method.”
For the three years ended December 31, 2013, 2012 and 2011, options and share grants outstanding for 2 million shares, of common stock have been excluded from the computation of diluted earnings per share because their effect was anti-dilutive.
 
- 71 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)

 	  	Year Ended December 31,	 	
 	  	2013	 	  	2012	 	  	2011	 	
Basic	  	 	 	 	  	 	 	 	  	 	 	 	
Weighted average number of common shares outstanding used in computing basic earnings per share	  	 	46,363	 	  	 	45,780	 	  	 	45,202	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	
Net income attributable to common stockholders	  	$	26,532	 	  	$	24,152	 	  	$	50,737	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	
Basic earnings per share attributable to common stockholders	  	$	0.57	 	  	$	0.53	 	  	$	1.12	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	
Diluted	  	 	 	 	  	 	 	 	  	 	 	 	
Weighted average number of common shares outstanding used in computing basic earnings per share	  	 	46,363	 	  	 	45,780	 	  	 	45,202	 	
Add: Assumed exercise of stock options and stock awards	  	 	1,295	 	  	 	1,119	 	  	 	1,511	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	
Weighted average number of common shares outstanding used in computing diluted earnings per share	  	 	47,658	 	  	 	46,899	 	  	 	46,713	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	
Net income attributable to common stockholders	  	$	26,532	 	  	$	24,152	 	  	$	50,737	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	
Diluted earnings per share attributable to common stockholders	  	$	0.56	 	  	$	0.51	 	  	$	1.09	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	
Share-based compensation – The Company uses the Black-Scholes-Merton model to determine the fair value of stock options on the date of grant and recognizes compensation expense for stock options on a straight-line basis. Restricted stock grants are measured based on the fair market value of the underlying stock on the date of grant and compensation expense for restricted stock grants is recognized on a straight-line basis over the requisite service period.
The amount of compensation expense recognized using the Black-Scholes-Merton model requires the Company to exercise judgment and make assumptions relating to the factors that determine the fair value of its stock option grants. The fair value calculated by this model is a function of several factors, including the grant price, the expected future volatility, the expected term of the option and the risk-free interest rate of the option. The expected term and expected future volatility of the options require judgment. In addition, the Company is required to estimate the expected forfeiture rate and only recognize expense for those stock options expected to vest. The Company estimates the forfeiture rate based on historical experience, and to the extent its actual forfeiture rate is different from its estimate, share-based compensation expense is adjusted accordingly.
Functional currencies and foreign currency translation – The functional currency for most of the Company’s international operations is the U.S. dollar. In some cases, the Company enters into transactions involving foreign currencies. Some subsidiaries functional currency is their local currency, as the Company believes it is the appropriate currency. The Company believes the New Taiwan (“NT”) dollar is the functional currency for its Taiwan based entities and the British Pound Sterling (“GBP”) is the functional currency for its U.K. based entities, which most appropriately reflects the current economic facts and circumstances of their operations. Assets and liabilities denominated in foreign currencies are translated at the exchange rate on the balance sheet date. Income and expense accounts denominated in foreign currencies are translated at the
 
- 72 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
weighted-average exchange rate during the period presented. Resulting translation adjustments are recorded as a separate component of accumulated other comprehensive income or loss within stockholders’ equity in the consolidated balance sheets. Included in other income are foreign exchange losses of $1 million, $2 million and $1 million for the years ended December 31, 2013, 2012 and 2011, respectively.
The Company uses the U.S. dollar as the functional currency for its Hong Kong based entities and the majority of its mainland China entities as substantially all monetary transactions are made in U.S. dollars, and other significant economic facts and circumstances currently support that position. Some of the Company’s mainland China entities use the Chinese Yuan. As these factors may change in the future, the Company periodically assesses its position with respect to the functional currency of its foreign subsidiaries.
Defined benefit plan – The Company maintains pension plans covering certain of its employees in the U.K. The overfunded or underfunded status of pension and postretirement benefit plans are recognized on the balance sheet. Actuarial gains and losses, prior service costs or credits, are recognized in other comprehensive income (loss), net of tax effects, until they are amortized as a component of net periodic benefit cost. For financial reporting purposes, the net pension and supplemental retirement benefit obligations and the related periodic pension costs are calculated based upon, among other things, assumptions of the discount rate for plan obligations, estimated return on pension plan assets and mortality rates. These obligations and related periodic costs are measured using actuarial techniques and assumptions. The projected unit credit method is the actuarial cost method used to compute the pension liabilities and related expenses.
Investment in joint ventures – Investment in joint ventures over which the Company does have the ability to exercise significant influence and that, in general, are at least 20 percent owned are stated at cost plus equity in undistributed net income (loss) of the joint venture. These investments are evaluated for impairment, in which an impairment loss would be recorded whenever a decline in the value of an equity investment below its carrying amount is determined to be “other than temporary.” In judging “other than temporary,” the Company would consider the length of time and extent to which the fair value of the investment has been less than the carrying amount of the investment, the near-term and longer-term operating and financial prospects of the investee, and the Company’s longer-term intent of retaining the investment in the investee.
Noncontrolling interest – Noncontrolling interest (previously referred to as minority interest) primarily relates to the minority investors’ share of the earnings of certain China and Taiwan subsidiaries. Noncontrolling interests are a separate component of equity and not a liability, the amount of which increases or decreases with changes in the Company’s ownership interest of the subsidiaries, that leave control intact, be treated as equity transactions, rather than step acquisitions or diluted gain or losses. The noncontrolling interest in the Company’s subsidiaries and their equity balances are reported separately in the consolidated financial statements, and activities of these subsidiaries are included therein.
Contingencies – From time to time, the Company may be involved in a variety of legal matters that arise in the normal course of business. Based on information available, the Company evaluates the likelihood of potential outcomes. The Company records the appropriate liability when the amount is deemed probable and reasonably estimable. In addition, the Company does not accrue for estimated legal fees and other directly related costs as they are expensed as incurred.
Comprehensive income (loss) – GAAP generally requires that recognized revenue, expenses, gains and losses be included in net income. Although certain changes in assets and liabilities are reported as separate components of the equity section of the consolidated balance sheet, such items, along with net income, are components of comprehensive income or loss. The components of accumulated other comprehensive income or
 
- 73 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
loss include foreign currency translation adjustments and unrealized gain or loss on defined benefit plan. Accumulated other comprehensive loss was $(44) million, $(34) million and $(36) million at December 31, 2013, 2012 and 2011, respectively.
There is no income tax expense or benefit associated with each component of comprehensive income. As of December 31, 2013, the accumulated balance for each component of comprehensive income are as follows:

 	  	2013	 	 	2012	 	
Translation adjustment	  	$	(16,210	) 	 	$	(22,663	) 	
Unrealized loss on defined benefit plan	  	$	(28,164	) 	 	$	(11,193	) 	
Reclassifications – Certain amounts from prior periods have been reclassified to conform to the current years’ presentation such as schedules included in the notes to consolidated financial statements.
Recently issued accounting pronouncements – In March 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2013-05,  Foreign Currency Matters (Topic 830): Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity . ASU No. 2013-05 provides additional guidance with respect to the reclassification into income of the cumulative translation adjustment (“CTA”) recorded in accumulated other comprehensive income associated with a foreign entity of a parent company. This ASU differentiates between transactions occurring within a foreign entity and transactions affecting an investment in a foreign entity. For transactions within a foreign entity, the full CTA associated with the foreign entity would be reclassified into income only when the sale of a subsidiary or group of net assets within the foreign entity represents the substantially complete liquidation of that foreign entity. For transactions affecting an investment in a foreign entity (for example, control or ownership of shares in a foreign entity), the full CTA associated with the foreign entity would be reclassified into income only if the parent no longer has a controlling interest in that foreign entity as a result of the transaction. In addition, acquisitions of a foreign entity completed in stages (also known as step acquisitions) could trigger the release of CTA associated with an equity method investment in that entity at the point a controlling interest in the foreign entity is obtained. This ASU is effective prospectively beginning January 1, 2014, with early adoption permitted. This ASU could impact the Company’s consolidated financial results in the event of a transaction as described above.
In July 2013, the FASB, issued ASU No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists . ASU No. 2013-11 provides that an entity is required to present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. If a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. ASU No. 2013-11 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. The adoption of this guidance affects presentation only and, therefore, it is not expected to have a material impact on the Company’s consolidated financial results.
NOTE 2 – FAIR VALUE MEASUREMENTS
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A fair value measurement assumes that the transaction to sell the asset or transfer the liability occurs in the principal market for the asset or liability or, in
 
- 74 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
the absence of a principal market, the most advantageous market for the asset or liability. The price in the principal (or most advantageous) market used to measure the fair value of the asset or liability shall not be adjusted for transaction costs. An orderly transaction is a transaction that assumes exposure to the market for a period prior to the measurement date to allow for marketing activities that are usual and customary for transactions involving such assets and liabilities; it is not a forced transaction. Market participants are buyers and sellers in the principal market that are (i) independent, (ii) knowledgeable, (iii) able to transact and (iv) willing to transact.
The Company uses valuation techniques that are consistent with the market approach, the income approach and/or the cost approach. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets and liabilities. The income approach uses valuation techniques to convert future amounts, such as cash flows or earnings, to a single present amount on a discounted basis. The cost approach is based on the amount that currently would be required to replace the service capacity of an asset (replacement costs). Valuation techniques should be consistently applied. Inputs to valuation techniques refer to the assumptions that market participants would use in pricing the asset or liability. Inputs may be observable, meaning those that reflect the assumptions market participants would use in pricing the asset or liability developed based on market data obtained from independent sources, or unobservable, meaning those that reflect the reporting entity’s own assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. These two types of inputs create a three-tier fair value hierarchy that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows:
Level 1 Inputs—Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.
Level 2 Inputs—Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (for example, interest rates, volatilities, prepayment speeds, loss severities, credit risks and default rates) or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
Level 3 Inputs—Significant unobservable inputs that reflect an entity’s own assumptions that market participants would use in pricing the assets or liabilities.
As of December 31, 2013, the Company had investments in trading securities and short-term investments. Trading securities were purchased on the open market and unrealized gains and losses are included in other income (expense). The trading securities are valued under the fair value hierarchy using Level 1 Inputs. Short-term investments of $22 million consist of investments such as time deposits, which are highly liquid with maturity dates greater than three months at the date of purchase. Generally, the Company can access these investments in a relatively short amount of time but in doing so it generally forfeits all earned and future interest income. The short-term investments are valued under the fair value hierarchy using Level 2 Inputs.
 
- 75 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
Financial assets and liabilities carried at fair value as of December 31, 2013 are classified in the following table:

Description	  	Fair
Market
Value	 	  	Quoted
Prices in
Active
Markets
for
Identical
Assets
(Level 1)	 	  	Significant
Other
Observable
Inputs
(Level 2)	 	  	Significant
Unobservable
Inputs
(Level 3)	 	  	Total
Changes
in Fair
Values
Included
in
Current
Period
Earnings	 	
Trading securities	  	$	5,634	 	  	$	5,634	 	  	$	—  	 	  	$	—  	 	  	$	235	 	
Short-term investments	  	 	22,922	 	  	 	—  	 	  	 	22,922	 	  	 	—  	 	  	 	—  	 	
During 2013, the Company entered into a net settlement agreement with China Construction Bank (“CCB”) whereby CCB loaned the Company $20 million and the Company in turn invested the same $20 million with CCB. The principal of the $20 million investment is guaranteed by CCB and is collateral for the $20 million loan. The Company believes that the $20 million investment and loan approximate fair value. The net interest income, which is guaranteed by CCB, realized by the investment was immaterial as of December 31, 2013. The investment and the offsetting loan are non-cancelable, will mature in June 2014 and are shown net of each other on the balance sheet as the Company believes the arrangement qualifies for the offsetting provisions in GAAP.
As of December 31, 2012, the Company had investments in shares of common stock of BCD Semiconductor Manufacturing Limited (“BCD”), which were purchased on the open market and records unrealized gains and losses in other income (expense). The shares of common stock are valued under the fair value hierarchy using Level 1 Inputs. See Note 17 for further information about BCD.
Financial assets and liabilities carried at fair value as of December 31, 2012 are classified in the following table:

Trading Securities	  	Fair
Market
Value	 	  	Quoted
Prices in
Active
Markets
for
Identical
Assets
(Level 1)	 	  	Significant
Other
Observable
Inputs
(Level 2)	 	  	Significant
Unobservable
Inputs
(Level 3)	 	  	Total
Changes
in Fair
Values
Included
in
Current
Period
Earnings	 	
BCD common stock	  	$	7,092	 	  	$	7,092	 	  	$	—  	 	  	$	—  	 	  	$	3,679	 	
Certain financial assets and financial liabilities are measured at fair value on a non-recurring basis; that is, the instruments are not measured at fair value on an ongoing basis but are subject to fair value adjustments in certain circumstances (for example, when there is evidence of impairment). The Company believes its long-term debt under its revolving credit facility approximates fair value and is valued under the fair value hierarchy using Level 2 Inputs and a discounted cash flow model. Financial assets and financial liabilities measured at fair value on a non-recurring basis were not significant at December 31, 2013 and 2012. Certain non-financial assets and non-financial liabilities are measured at fair value on a recurring and non-recurring basis include goodwill, other intangible assets and other non-financial long-lived assets.
 
- 76 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
NOTE 3 – INVENTORIES
Inventories, stated at the lower of cost or market value, at December 31 were:

 	  	2013	 	  	2012	 	
Finished goods	  	$	67,487	 	  	$	59,319	 	
Work-in-progress	  	 	43,031	 	  	 	30,564	 	
Raw materials	  	 	69,878	 	  	 	63,410	 	
 	  	 	 	 	  	 	 	 	
 	  	$	180,396	 	  	$	153,293	 	
 	  	 	 	 	  	 	 	 	
NOTE 4 – PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment at December 31 were:

 	  	2013	 	 	2012	 	
Buildings and leasehold improvements	  	$	107,342	 	 	$	53,068	 	
Machinery and equipment	  	 	549,971	 	 	 	465,106	 	
 	  	 	 	 	 	 	 	 	
 	  	 	657,313	 	 	 	518,174	 	
Less: Accumulated depreciation and amortization	  	 	(386,455	) 	 	 	(322,403	) 	
 	  	 	 	 	 	 	 	 	
 	  	 	270,858	 	 	 	195,771	 	
Construction in-progress	  	 	34,922	 	 	 	31,227	 	
Land	  	 	16,233	 	 	 	16,298	 	
 	  	 	 	 	 	 	 	 	
 	  	$	322,013	 	 	$	243,296	 	
 	  	 	 	 	 	 	 	 	
Depreciation and amortization of property, plant and equipment was $66 million, $59 million and $57 million for the years ended December 31, 2013, 2012 and 2011, respectively.
NOTE 5 – INTANGIBLE ASSETS
Intangible assets subject to amortization at December 31 were as follows:

December 31, 2013	 	
Intangible Assets	  	Useful life	 	  	Gross
Carrying
Amount	 	  	Accumulated
Amortization	 	 	Currency
Exchange	 	 	Net	 	
Amortized intangible assets:	  	 	 	 	  	 	 	 	  	 	 	 	 	 	 	 	 	 	 	 	
Patents	  	 	5-15 years	  	  	$	11,812	 	  	$	(6,274	) 	 	$	(228	) 	 	$	5,310	 	
Software license	  	 	3 years	  	  	 	1,212	 	  	 	(1,149	) 	 	 	(63	) 	 	 	—  	 	
Developed product technology	  	 	2-10 years	  	  	 	53,508	 	  	 	(20,654	) 	 	 	(5,516	) 	 	 	27,338	 	
Customer relationships	  	 	12 years	  	  	 	20,393	 	  	 	(4,168	) 	 	 	(1,193	) 	 	 	15,032	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	 	 	 	 	 	 	 	 	
Total amortized intangible assets:	  	 	 	 	  	$	86,925	 	  	$	(32,245	) 	 	$	(7,000	) 	 	$	47,680	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	 	 	 	 	 	 	 	 	
Intangible assets with indefinite lives:	  	 	 	 	  	 	 	 	  	 	 	 	 	 	 	 	 	 	 	 	
Trademarks and trade names	  	 	Indefinite	  	  	$	6,403	 	  	$	—  	 	 	$	(512	) 	 	$	5,891	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	 	 	 	 	 	 	 	 	
Total Intangible assets with indefinite lives:	  	 	 	 	  	$	6,403	 	  	$	—  	 	 	$	(512	) 	 	$	5,891	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	 	 	 	 	 	 	 	 	
Total intangible assets:	  	 	 	 	  	$	93,328	 	  	$	(32,245	) 	 	$	(7,512	) 	 	$	53,571	 	

- 77 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)

 	
December 31, 2012	 	
Intangible Assets	  	Useful life	 	  	Gross
Carrying
Amount	 	  	Accumulated
Amortization	 	 	Currency
Exchange
and
Other	 	 	Net	 	
Amortized intangible assets:	  	 	 	 	  	 	 	 	  	 	 	 	 	 	 	 	 	 	 	 	
Patents	  	 	5-15 years	  	  	$	11,795	 	  	$	(5,393	) 	 	$	(273	) 	 	$	6,129	 	
Software license	  	 	3 years	  	  	 	1,212	 	  	 	(1,149	) 	 	 	(63	) 	 	 	—  	 	
Developed product technology	  	 	2-10 years	  	  	 	42,408	 	  	 	(15,316	) 	 	 	(5,481	) 	 	 	21,611	 	
Customer relationships	  	 	12 years	  	  	 	14,292	 	  	 	(2,303	) 	 	 	(1,234	) 	 	 	10,755	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	 	 	 	 	 	 	 	 	
Total amortized intangible assets:	  	 	 	 	  	$	69,707	 	  	$	(24,161	) 	 	$	(7,051	) 	 	$	38,495	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	 	 	 	 	 	 	 	 	
Intangible assets with indefinite lives:	  	 	 	 	  	 	 	 	  	 	 	 	 	 	 	 	 	 	 	 	
Trademarks and trade names	  	 	Indefinite	  	  	$	6,403	 	  	$	—  	 	 	$	(561	) 	 	$	5,842	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	 	 	 	 	 	 	 	 	
Total Intangible assets with indefinite lives:	  	 	 	 	  	$	6,403	 	  	$	—  	 	 	$	(561	) 	 	$	5,842	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	 	 	 	 	 	 	 	 	
Total intangible assets:	  	 	 	 	  	$	76,110	 	  	$	(24,161	) 	 	$	(7,612	) 	 	$	44,337	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	 	 	 	 	 	 	 	 	
Amortization expense related to intangible assets subject to amortization was $8 million, $5 million and $5 million for the years ended December 31, 2013, 2012 and 2011, respectively.
Amortization of intangible assets through 2018 is as follows:

Years	  	 	 	
2014	  	$	    7,973	 	
2015	  	 	7,513	 	
2016	  	 	7,121	 	
2017	  	 	6,466	 	
2018	  	 	5,402	 	
NOTE 6 – GOODWILL
Changes in goodwill for the years ended December 31 were as follows:

Balance at December 31, 2011	  	$	67,818	 	
Acquisitions	  	 	16,913	 	
Currency exchange	  	 	2,628	 	
 	  	 	 	 	
Balance at December 31, 2012	  	$	87,359	 	
 	  	 	 	 	
Acquisitions	  	 	2,518	 	
Impairment	  	 	(5,318	) 	
Currency exchange	  	 	155	 	
 	  	 	 	 	
Balance at December 31, 2013	  	$	84,714	 	

- 78 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
NOTE 7 – BANK CREDIT AGREEMENTS AND OTHER SHORT-TERM AND LONG-TERM DEBT
Lines of Credit – The Company maintains lines of credit with several financial institutions through its entities worldwide totaling $112 million. These lines of credit, are collateralized by each subsidiary’s premises, are unsecured, uncommitted and, in some instances, may be repayable on demand.
Revolving Senior Credit Facility – On January 8, 2013, the Company and Diodes International B.V. (the “Foreign Borrower” and collectively with the Company, the “Borrowers”) and certain subsidiaries of the Company as guarantors, entered into a Credit Agreement (the “Credit Agreement”) with Bank of America, N.A. (“Bank of America”) and other participating lenders (collectively, the “Lenders”).
The Credit Agreement provides for a five-year, $300 million revolving senior credit facility (the “Revolver”), which includes $10 million swing line sublimit, a $10 million letter of credit sublimit, and $20 million alternative currency sublimit. The Borrowers may from time to time request increases in the aggregate commitment under the Credit Agreement of up to $200 million, subject to the Lenders electing to increase their commitments or by means of the addition of new Lenders, and subject to at least half of each increase in aggregate commitment being in the form of term loans (“Incremental Term Loans”), with the remaining amount of each being an increase the amount of the Revolver.
The Revolver matures on January 8, 2018 (the “Revolver Maturity Date”). Incremental Term Loans mature no earlier than the Revolver Maturity Date. The proceeds under the Revolver and the Incremental Term Loans may be used for the purposes of refinancing certain existing debt, for working capital and capital expenditures, and for general corporate purposes, including financing permitted acquisitions.
The Foreign Borrower’s obligations under the New Credit Agreement are guaranteed by the Company. Each Borrower’s obligations under the New Credit Agreement are guaranteed by certain of that Borrower’s subsidiaries. The Borrower’s obligations under the New Credit Agreement are secured by substantially all assets of the Borrowers and certain of their subsidiaries.
Under the Revolver, the Borrowers may borrow in United States Dollars (“USD”), Euros, British Pounds Sterling or another currency approved by the Lenders. Borrowed amounts bear interest at a rate per annum equal to the sum of (a) the highest of (i) the Federal Funds Rate plus  1 ⁄ 2  of 1.00%, (ii) the rate of interest in effect for such day as publicly announced from time to time by Bank of America as its “prime rate,” and (iii) the Eurocurrency Rate plus 1.00%, plus (b) an amount between 0.50% per annum and 1.25% per annum, based upon the Borrowers’ and their subsidiaries’ Consolidated Leverage Ratio. Eurocurrency loans bear interest at LIBOR plus an amount between 1.50% and 2.25% per annum, based upon the Borrowers’ and their subsidiaries’ Consolidated Leverage Ratio.
Incremental Term Loans will be on pricing and amortization terms to be agreed upon.
The Credit Agreement contains certain financial and non-financial covenants, including, but not limited to, a maximum Consolidated Leverage Ratio, a minimum Consolidated Fixed Charge Coverage Ratio, and restrictions on liens, indebtedness, investments, fundamental changes, dispositions, and restrictive payments (including dividends).
In connection with the acquisition of BCD, the Company drew down on the Revolver to fund the acquisition and pay for costs associated with the acquisition. See Note 17 for further information about the acquisition of BCD.
 
- 79 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
Term Loan – On November 25, 2009 the Company entered into a credit agreement with Bank of America, as modified by a certain amendments, including the Sixth Amendment to Credit Agreement dated as of April 30, 2012. The Fifth Amendment added an additional borrower, the Foreign Borrower, and provided for an additional term loan in the amount of $40 million (the “Term Loan”). The Term Loan bore interest at a rate per annum equal to the Eurocurrency Rate (as defined) plus 1.25% per annum. On February 1, 2012, the Foreign Borrower drew down the full $40 million.
As part of the Credit agreement, the Company’s Term Loan was terminated with no penalties and on January 8, 2013, the Company drew down $45 million on the Revolver to retire the Term Loan and pay fees and expenses in connection with entering into the Credit Agreement.
The credit unused and available under the various facilities as of December 31, 2013, was $220 million (net of $7 million credit used for import and export guarantee), as follows:

2013
Lines of Credit	 	  	 	  	  Outstanding at December 31,  	 	 	
 	 	  	Terms	  	2013	 	  	2012	 	 	 	 	
$	112,023	 	  	Unsecured, interest at LIBOR plus margin, due quarterly	  	$	5,814	 	  	$	5,629	 	 	 	 	
 	—  	 	  	Secured, interest at LIBOR plus margin, due monthly	  	 	—  	 	  	 	2,000	 	 	 	 	
 	 	 	  	 	  	 	 	 	  	 	 	 	 	 	 	
$	112,023	 	  	 	  	$	5,814	 	  	$	7,629	 	 	 	 	
 	 	 	  	 	  	 	 	 	  	 	 	 	 	 	 	
Long-term debt – The balances as of December 31, consist of the following:

 	  	2013	 	 	2012	 	
Notes payable to Taiwan bank, principal amount of TWD 158 million, variable interest (approximately 2.1% and 3.3% as of December 31, 2013 and 2012, respectively), of which TWD 132 million matures on July 6, 2021, and TWD 26 million matured July 6, 2013, secured by land and building.	  	 	2,500	 	 	 	2,979	 	
Notes payable to Taiwan banks, variable interest between 1.8% and 2.5% as of December 31, 2013, maturity dates range from 2013 to 2023, secured by land, building and equipment.	  	 	2,426	 	 	 	2,215	 	
Revolver	  	 	179,000	 	 	 	—  	 	
Term Loan	  	 	—  	 	 	 	40,000	 	
 	  	 	 	 	 	 	 	 	
Total long-term debt	  	 	183,926	 	 	 	45,194	 	
Less: Current portion	  	 	(1,127	) 	 	 	(1,063	) 	
 	  	 	 	 	 	 	 	 	
Long-term debt, net of current portion	  	$	182,799	 	 	$	44,131	 	

- 80 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
The annual contractual maturities of long-term debt at December 31, 2013 are as follows:

2014	  	 	1,127	 	
2015	  	 	1,132	 	
2016	  	 	567	 	
2017	  	 	555	 	
2018	  	 	179,561	 	
Thereafter	  	 	984	 	
 	  	 	 	 	
Total long-term debt	  	$	183,926	  	
 	  	 	 	 	
During 2013, the Company entered into a net settlement agreement with CCB whereby CCB loaned the Company $20 million and the Company in turn invested the same $20 million with CCB. The principal of the $20 million investment is guaranteed by CCB and is collateral for the $20 million loan. The net interest income realized by the investment was immaterial as of December 31, 2013. The investment and the offsetting loan are non-cancelable, will mature in June 2014 and are shown net of each other on the balance sheet as the Company believes the arrangement qualifies for the offsetting provisions in GAAP.
Convertible senior notes – In October 2006, the Company issued and sold Notes with an aggregate principal amount of $230 million due 2026. On September 30, 2011, substantially all of the note holders surrendered their Notes for purchase. On December 1, 2011, the Company elected to purchase the remaining outstanding principal amount plus accrued and unpaid interest to, but excluding, December 1, 2011, the redemption date. The Company has delivered the aggregate purchase price for the accepted Notes, which includes accrued and unpaid interest, to the Paying Agent for distribution to the note holders. As of December 31, 2011, all Notes have been redeemed.
The amount of interest expense, including amortization of debt discount for the liability component and debt issuance costs, for the year ended December 31, 2011 is as follows:

 	  	2011	 	
Notes contractual interest expense	  	$	2,267	 	
Amortization of debt discount	  	 	6,032	 	
Amortization of debt issuance costs	  	 	412	 	
 	  	 	 	 	
Total	  	$	8,711	 	
 	  	 	 	 	
NOTE 8 – CAPITAL LEASE OBLIGATIONS
Future minimum lease payments under capital lease agreements are summarized as follows:

For years ending December 31,	  	 	 	
2014	  	$	305	  	
2015	  	 	195	 	
2016	  	 	185	 	
2017	  	 	19	 	
 	  	 	704	 	
Less: Interest	  	 	(40	) 	
 	  	 	 	 	
Present value of minimum lease payments	  	 	664	 	
Less: Current portion	  	 	(280	) 	
 	  	 	 	 	
Long-term portion	  	$	384	  	

- 81 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
At December 31, 2013, property under capital leases had a cost of $3 million, and the related accumulated depreciation was $2 million. Depreciation of assets held under capital lease is included in depreciation expense.
NOTE 9 – ACCRUED LIABILITIES AND OTHER LONG-TERM LIABILITIES
Accrued liabilities and other current liabilities at December 31 were:

 	  	2013	 	  	2012	 	
Compensation and payroll taxes	  	$	22,414	 	  	$	12,837	 	
Accrued expenses	  	 	23,159	 	  	 	12,338	 	
Accrued pricing adjustments	  	 	2,891	 	  	 	1,304	 	
Equipment purchases	  	 	7,395	 	  	 	7,081	 	
Accrued professional services	  	 	2,215	 	  	 	2,512	 	
Other	  	 	2,610	 	  	 	5,067	 	
 	  	 	 	 	  	 	 	 	
 	  	$	60,684	 	  	$	41,139	 	
 	  	 	 	 	  	 	 	 	
Other long-term liabilities at December 31 were:

 	  	2013	 	  	2012	 	
Accrued defined benefit plan	  	$	32,749	 	  	$	17,853	 	
Unrecognized tax benefits	  	 	20,710	 	  	 	14,591	 	
Income tax contingencies	  	 	9,829	 	  	 	—  	 	
Deferred compensation	  	 	3,535	 	  	 	2,213	 	
Other	  	 	12,043	 	  	 	7,317	 	
 	  	 	 	 	  	 	 	 	
 	  	$	78,866	 	  	$	41,974	 	
 	  	 	 	 	  	 	 	 	
NOTE 10 – STOCKHOLDERS’ EQUITY
The Company has never declared or paid cash dividends on its Common Stock. The Company’s credit agreement, dated January 8, 2013, with Bank of America N.A. and other lenders parties permits the Company to pay dividends up to $1.5 million per fiscal year to its stockholders so long as it has not defaulted and is in continuing operation at the time of such dividend. The payment of dividends is within the discretion of the Company’s Board of Directors. See Note 7 for additional information regarding the Company’s credit agreements.
NOTE 11 – INCOME TAXES

Income before income taxes	  	2013	 	 	2012	 	 	2011	 	
U.S.	  	$	(12,936	) 	 	$	(24,411	) 	 	$	(28,238	) 	
Foreign	  	 	51,521	 	 	 	55,218	 	 	 	91,902	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
Total	  	$	38,585	 	 	$	30,807	 	 	$	63,664	 	

- 82 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
The components of the income tax provision (benefit) are as follows for the years ended December 31:

 	  	2013	 	 	2012	 	 	2011	 	
Current tax provision (benefit)	  	 	 	 	 	 	 	 	 	 	 	 	
Federal	  	$	1,315	 	 	$	1,424	 	 	$	14,049	 	
Foreign	  	 	9,270	 	 	 	10,756	 	 	 	18,324	 	
State	  	 	(187	) 	 	 	142	 	 	 	214	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
 	  	 	10,398	 	 	 	12,322	 	 	 	32,587	 	
Deferred tax provision (benefit)	  	 	 	 	 	 	 	 	 	 	 	 	
Federal	  	 	(1,531	) 	 	 	(8,784	) 	 	 	(20,906	) 	
Foreign	  	 	(2,197	) 	 	 	(3,247	) 	 	 	(1,165	) 	
State	  	 	9	 	 	 	317	 	 	 	(466	) 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
 	  	 	(3,719	) 	 	 	(11,714	) 	 	 	(22,537	) 	
Liability for unrecognized tax benefits	  	 	7,802	 	 	 	4,217	 	 	 	107	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
Total income tax provision	  	$	14,481	 	 	$	4,825	 	 	$	10,157	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	
Effective Tax Rate Reconciliation
Reconciliation between the effective tax rate and the statutory tax rates for the years ended December 31, 2013, 2012 and 2011 is as follows:

 	  	2013	 	 	2012	 	 	2011	 	
 	  	Amount	 	 	Percent
of pretax
earnings	 	 	Amount	 	 	Percent
of pretax
earnings	 	 	Amount	 	 	Percent
of pretax
earnings	 	
Federal tax	  	$	13,505	 	 	 	35.0	 	 	$	10,783	 	 	 	35.0	 	 	$	22,282	 	 	 	35.0	 	
State income taxes, net of federal tax provision (benefit)	  	 	29	 	 	 	0.1	 	 	 	213	 	 	 	0.7	 	 	 	(366	) 	 	 	(0.6	) 	
Foreign income taxed at lower tax rates (1)	  	 	(8,363	) 	 	 	(21.7	) 	 	 	(15,515	) 	 	 	(50.4	) 	 	 	(6,356	) 	 	 	(10.0	) 	
U.S. tax impact of foreign operations	  	 	911	 	 	 	2.4	 	 	 	496	 	 	 	1.6	 	 	 	1,115	 	 	 	1.8	 	
Foreign tax credits, net of valuation allowance (2)	  	 	—  	 	 	 	—  	 	 	 	3,135	 	 	 	10.2	 	 	 	(5,843	) 	 	 	(9.2	) 	
Goodwill impairment	  	 	904	 	 	 	2.3	 	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	—  	 	
Research and development	  	 	(2,294	) 	 	 	(5.9	) 	 	 	—  	 	 	 	—  	 	 	 	—  	 	 	 	—  	 	
Liability for unrecognized tax benefits	  	 	7,802	 	 	 	20.2	 	 	 	4,217	 	 	 	13.7	 	 	 	107	 	 	 	0.2	 	
U.S. provision-to-return adjustments	  	 	554	 	 	 	1.4	 	 	 	(102	) 	 	 	(0.3	) 	 	 	(167	) 	 	 	(0.3	) 	
Other	  	 	1,433	 	 	 	3.7	 	 	 	1,598	 	 	 	5.2	 	 	 	(615	) 	 	 	(1.0	) 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Income tax provision	  	$	14,481	 	 	 	37.5	 	 	$	4,825	 	 	 	15.7	 	 	$	10,157	 	 	 	15.9	 	

(1)	The decrease in 2013 compared to 2012 in foreign income taxed at lower tax rates was primarily due to increased earnings in the U.S.	
(2)	The change in 2013 was due to the Company not claiming a foreign tax credit in 2013.	
Uncertain Tax Positions
In accordance with the provisions related to accounting for uncertainty in income taxes, the Company recognizes the benefit of a tax position if the position is “more likely than not” to prevail upon examination by the relevant tax authority. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
 
- 83 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)

 	  	2013	 	 	2012	 	
Balance at January 1,	  	$	14,591	  	 	$	10,177	  	
Additions based on tax positions related to the current year	  	 	3,659	 	 	 	1,593	 	
Additions for prior years tax positions	  	 	10,206	 	 	 	3,945	 	
Reductions for prior years tax positions	  	 	(7,746	) 	 	 	(1,124	) 	
 	  	 	 	 	 	 	 	 	
Balance at December 31,	  	$	20,710	  	 	$	14,591	  	
 	  	 	 	 	 	 	 	 	
It is reasonably possible that the amount of the unrecognized benefit with respect to certain of the Company’s unrecognized tax positions will significantly increase or decrease within the next 12 months. These changes may be the result of settlements of ongoing audits or competent authority proceedings. At this time, an estimate of the range of the reasonably possible outcomes cannot be made.
The Company files income tax returns in the U.S. federal jurisdiction and in various state and foreign jurisdictions. The Company is no longer subject to U.S. federal income tax examinations by tax authorities for tax years before 2007. During the second quarter of 2013, the Internal Revenue Service (“IRS”) commenced an examination of the Company’s U.S. federal income tax return for the 2010 tax year. The examination is ongoing, and the IRS has not proposed adjustments to any tax positions at this time. With respect to state and local jurisdictions and countries outside of the U.S., with limited exceptions, the Company is no longer subject to income tax audits for years before 2006. Although the outcome of tax audits is always uncertain, the Company believes that adequate amounts of tax, interest and penalties, if any, have been provided for in the Company’s reserve for any adjustments that may result from future tax audits. The Company recognizes accrued interest and penalties, if any, related to unrecognized tax benefits in interest expense. The Company had an insignificant amount of accrued interest and penalties at December 31, 2013, 2012 and 2011.
Deferred Taxes
At December 31, 2013 and 2012, the Company’s deferred tax assets and liabilities are comprised of the following items:

 	  	2013	 	 	2012	 	
Deferred tax assets, current	  	 	 	 	 	 	 	 	
Inventory cost	  	$	6,113	 	 	$	6,158	 	
Accrued expenses and accounts receivable	  	 	2,422	 	 	 	2,047	 	
Share based compensation and others	  	 	1,978	 	 	 	1,790	 	
 	  	 	 	 	 	 	 	 	
Total deferred tax assets, current	  	$	10,513	 	 	$	9,995	 	
 	  	 	 	 	 	 	 	 	
Deferred tax assets, non-current	  	 	 	 	 	 	 	 	
Foreign tax credits	  	$	20,911	 	 	$	20,537	 	
Research and development tax credits	  	 	5,460	 	 	 	4,331	 	
Net operating loss carryforwards	  	 	13,130	 	 	 	13,977	 	
Accrued pension	  	 	17,110	 	 	 	10,089	 	
Share based compensation and others	  	 	18,371	 	 	 	21,811	 	
 	  	 	 	 	 	 	 	 	
 	  	 	74,982	 	 	 	70,745	 	
Valuation allowances	  	 	(35,908	) 	 	 	(27,022	) 	
 	  	 	 	 	 	 	 	 	
Total deferred tax assets, non-current	  	 	39,074	 	 	 	43,723	 	
Deferred tax liabilities, non-current	  	 	 	 	 	 	 	 	
Plant, equipment and intangible assets	  	 	(10,837	) 	 	 	(6,904	) 	
 	  	 	 	 	 	 	 	 	
Total deferred tax liabilities, non-current	  	 	(10,837	) 	 	 	(6,904	) 	
 	  	 	 	 	 	 	 	 	
Net deferred tax assets, non-current	  	$	28,237	 	 	$	36,819	 	

- 84 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
At December 31, 2013, the Company had federal and state tax credit carryforwards of approximately $27 million and $1 million, respectively which are available to offset future income tax liabilities. The federal tax credit carryforwards begin to expire in 2014 and the state tax credit carryforwards will begin to expire in 2020. The Company determined that it is more likely than not that a portion of its federal foreign tax credit and research credit carryforwards will expire before they are utilized. Accordingly, the Company recorded valuation allowances of $1 million, $4 million and $1 million during the years ended December 31, 2013, 2012 and 2011, respectively.
At December 31, 2013, the Company had federal and state net operating loss (“NOL”) carryforwards of approximately $33 million and $17 million, respectively, which are available to offset future taxable income. The federal NOL carryforwards will begin to expire in 2018. The Company determined that it is more likely than not that the federal NOL carryforwards will be utilized; thus, no valuation allowance has been recorded. The state NOL carryforwards will begin to expire in 2014. The Company determined that it is more likely than not that the state NOL carryforwards will expire before they are fully utilized and recorded a full valuation allowance on the state NOL carryforwards in prior years. The Company maintained this full valuation allowance for the year ended December 31, 2013.
Supplemental Information
Funds repatriated from foreign subsidiaries to the U.S. may be subject to federal and state income taxes. The Company intends to permanently reinvest overseas all of its earnings from its foreign subsidiaries; accordingly, U.S. taxes are not being recorded on undistributed foreign earnings. As of December 31, 2013, the Company has undistributed earnings from its non-U.S. operations of approximately $430 million (including approximately $45 million of restricted earnings which are not available for dividends). Additional federal and state income taxes of approximately $101 million would be required should such earnings be repatriated to the U.S.
The impact of tax holidays decreased the Company’s tax expense by approximately $2 million, $6 million and $7 million for the years ended December 31, 2013, 2012 and 2011, respectively. The benefit of the tax holidays on both basic and diluted earnings per share for the year ended December 31, 2013 was approximately $0.05. The benefit of the tax holidays on basic and diluted earnings per share for the year ended December 31, 2012 was approximately $0.14 and $0.13, respectively. The benefit of the tax holidays on both basic and diluted earnings per share for the year ended December 31, 2011 was approximately $0.15. During 2012, the China government began an audit of the Company’s High and New Technology Enterprise status for its largest Chinese subsidiary for 2009-2011 as part of an overall evaluation of the reduced tax rates provided to many high tech companies. This subsidiary has a reduced tax rate of 15%. In April 2013, the Company was notified by the China government that they had completed their tax audit and had concluded that the Company owed additional tax related to tax year 2011 in the amount of $5 million, which was paid during 2013. This subsidiary has been approved for its HNTE status for the tax years 2012-2014. The Company’s other China manufacturing facility has been approved for its HNTE status for the tax years 2011-2013. For 2014 and future years, this facility no longer qualifies for the HNTE status and therefore all of its future and deferred income will be taxed at the statutory tax rate of 25%.
NOTE 12 – EMPLOYEE BENEFIT PLANS
Defined Benefit Plan
The Company has adopted a contributory defined benefit plan that covers certain employees in the U.K. The defined benefit plan is closed to new entrants and frozen with respect to future benefit accruals. The retirement benefit is based on the final average compensation and service of each eligible employee. The Company
 
- 85 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
determined the fair value of the defined benefit plan assets and utilizes an annual measurement date of December 31. At subsequent measurement dates, defined benefit plan assets will be determined based on fair value. Defined benefit plan assets consist primarily of high quality corporate bonds that are denominated in the currency in which the benefits will be paid and that have terms to maturity approximating the terms of the related pension liability. The net pension and supplemental retirement benefit obligations and the related periodic costs are based on, among other things, assumptions of the discount rate, estimated return on plan assets and mortality rates. These obligations and related periodic costs are measured using actuarial techniques and assumptions. The projected unit credit method is the actuarial cost method used to compute the pension liabilities and related expenses.
Net period benefit costs associated with the defined benefit were less than $1 million for both the years ended December 31, 2013 and 2012, respectively. All unrecognized actuarial gains and losses, prior service costs and accumulated other comprehensive income are eliminated and the balance sheet liability is set equal to the funded status of the defined benefit plan at acquisition date.
The following table summarizes the net periodic benefit costs of the Company’s plan for the years ended December 31, 2013 and 2012:

 	  	Defined Benefit Plan	 	
Components of net periodic benefit cost:	  	2013	 	 	2012	 	
Service cost	  	$	313	 	 	$	317	 	
Interest cost	  	 	5,384	 	 	 	5,638	 	
Recognized actuarial loss	  	 	239	 	 	 	(70	) 	
Expected return on plan assets	  	 	(5,556	) 	 	 	(5,446	) 	
 	  	 	 	 	 	 	 	 	
Net periodic benefit cost	  	$	380	 	 	$	439	 	
 	  	 	 	 	 	 	 	 	
The following tables set forth the benefit obligation, the fair value of plan assets, and the funded status as of December 31:

 	  	Defined Benefit Plan	 	
 	  	2013	 	 	2012	 	
Change in benefit obligation:	  	 	 	 	 	 	 	 	
Beginning balance	  	$	124,751	 	 	$	109,877	 	
Service cost	  	 	313	 	 	 	317	 	
Interest cost	  	 	5,384	 	 	 	5,638	 	
Actuarial gain (loss)	  	 	21,765	 	 	 	7,134	 	
Benefits paid	  	 	(6,719	) 	 	 	(3,506	) 	
Settlements	  	 	240	 	 	 	—  	 	
Currency changes	  	 	3,582	 	 	 	5,291	 	
 	  	 	 	 	 	 	 	 	
Benefit obligation at December 31	  	$	149,316	 	 	$	124,751	 	
 	  	 	 	 	 	 	 	 	
Change in plan assets:	  	 	 	 	 	 	 	 	
Beginning balance—fair value	  	$	106,898	 	 	$	96,384	 	
Employer contribution	  	 	2,960	 	 	 	1,904	 	
Actual return on plan assets	  	 	10,987	 	 	 	7,536	 	
Benefits paid	  	 	(6,719	) 	 	 	(3,506	) 	
Currency changes	  	 	2,441	 	 	 	4,580	 	
 	  	 	 	 	 	 	 	 	
Fair value of plan assets at December 31	  	$	116,567	 	 	$	106,898	 	
 	  	 	 	 	 	 	 	 	
Underfunded status at December 31	  	$	(32,749	) 	 	$	(17,853	) 	

- 86 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
Based on an actuarial study performed as of December 31, 2013, the plan is underfunded by approximately $33 million and the liability is reflected in the Company’s consolidated balance sheets as a noncurrent liability and the amount recognized in accumulated other comprehensive income was approximately $28 million. The majority of the increase of the underfunded status in 2013 was caused by the change in mortality rates.
The Company applies the “10% corridor” approach to amortize unrecognized actuarial gains (losses). Under this approach, only actuarial gains (losses) that exceed 10% of the greater of the projected benefit obligation or the market-related value of the plan assets are amortized. For the year ended December 31, 2013, the plan’s total recognized loss increased by $15 million. The variance between the actual and expected return to plan assets during 2013 increased the total unrecognized net loss by $6 million. The total unrecognized net loss is more than 10% of the projected benefit obligation and 10% of the plan assets. Therefore, the excess amount will be amortized over the average term to retirement of plan participants not yet in receipt of pension, which as of December 31, 2013 the average term was 14 years.
The following weighted-average assumptions were used to determine net periodic benefit costs for the year ended December 31:

 	  	    2013    	 	 	    2012    	 	
Discount rate	  	 	4.6	% 	 	 	5.1	% 	
Expected long-term return on plan assets	  	 	5.9	% 	 	 	5.6	% 	
The following weighted-average assumption was used to determine the benefit obligations for the year ended December 31:

 	  	    2013    	 	 	    2012    	 	
Discount rate	  	 	4.6	% 	 	 	5.1	% 	
The expected long-term return on plan assets was determined based on historical and expected future returns of the various asset classes. The plan’s investment policy includes a mandate to diversify assets and invest in a variety of asset classes to achieve its expected long-term return and is currently invested in a variety of funds representing most standard equity and debt security classes. Trustees of the plan may make changes at any time. The following summarizes the plan asset allocations of the assets in the plan and expected long-term return by asset category:

Asset category	  	Expected long-term return	 	 	Assets allocation	 	
Cash	  	 	0.5	% 	 	 	2	% 	
Equity securities	  	 	7.3	% 	 	 	47	% 	
Debt securities	  	 	4.1	% 	 	 	39	% 	
Target return funds	  	 	7.3	% 	 	 	12	% 	
 	  	 	 	 	 	 	 	 	
Total	  	 	5.9	% 	 	 	100	% 	
Benefit plan payments are primarily made from funded benefit plan trusts and current assets. The following summarizes the expected future benefit payments, including future benefit accrual, as of December 31, 2013:

Year	  	 	 	
2014	  	$	3,975	  	
2015	  	 	3,975	 	
2016	  	 	4,571	 	
2017	  	 	4,621	 	
2018	  	 	4,803	 	
2019-2023	  	 	30,921	 	
 
- 87 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
The Company adopted a payment plan with the trustees of the defined benefit plan, in which the Company will pay approximately £2 million GBP (approximately $3 million based on a USD:GBP exchange rate of 1.6:1) every year from 2012 through 2019.
The Company’s overall defined benefit plan investment strategy is to achieve a mix of investments for long-term growth and for near-term benefit payments with a wide diversification of asset types and fund strategies. The target allocations for plan assets are 48% equity securities, 40% corporate bonds and government securities, and 12% to absolute return funds. Equity securities primarily include investments in large-cap and mid-cap companies primarily located in the U.K. Fixed income securities include corporate bonds of companies from diversified industries, and U.K. government bonds. The absolute return fund is mainly invested in a mixture of equities and bonds.
The plan’s trustees appoint fund managers to carry out all the day-to-day functions relating to the management of the fund and its administration. The fund managers must invest their portion of the plan’s assets in accordance with their investment manager agreement agreed by the trustees. The trustees are responsible for agreeing these investment manager agreements and for deciding on the portion of the plan’s assets that will be invested with each fund manager. When making decisions, the trustees take advice from experts including the plan’s actuary and also consult with the Company.
The following table summarizes the major categories of the plan assets:

December 31, 2013	 	
Assets Category	  	Level 1	 	  	Level 2	 	  	Level 3	 	  	Total	 	
Cash	  	$	2,173	 	  	$	—  	 	  	$	—  	 	  	$	2,173	 	
Equity securities:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
U.K.	  	 	27,370	 	  	 	—  	 	  	 	—  	 	  	 	27,370	 	
North America	  	 	9,480	 	  	 	—  	 	  	 	—  	 	  	 	9,480	 	
Europe (excluding U.K.)	  	 	9,160	 	  	 	—  	 	  	 	—  	 	  	 	9,160	 	
Japan	  	 	4,003	 	  	 	—  	 	  	 	—  	 	  	 	4,003	 	
Pacific Basin (excluding Japan)	  	 	3,296	 	  	 	—  	 	  	 	—  	 	  	 	3,296	 	
Emerging markets	  	 	936	 	  	 	—  	 	  	 	—  	 	  	 	936	 	
Fixed income securities:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Corporate bonds	  	 	—  	 	  	 	25,808	 	  	 	—  	 	  	 	25,808	 	
Index linked securities:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
U.K. Treasuries	  	 	20,094	 	  	 	—  	 	  	 	—  	 	  	 	20,094	 	
Other types of investments:	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Absolute return funds	  	 	14,247	 	  	 	—  	 	  	 	—  	 	  	 	14,247	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Total	  	$	90,759	 	  	$	25,808	 	  	$	—  	 	  	$	116,567	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	  	 	 	 	
Fair value is taken to mean the bid value of securities, as supplied by the fund managers. All the plan’s securities are publically traded and highly liquid. Therefore, the majority of the securities are valued using Level 1 Inputs and one security is valued using Level 2 Inputs using quoted prices for identical or similar securities. The plan does not hold any Level 3 securities. See Note 2 for additional information regarding fair value and Levels 1, 2 and 3.
The investment manager agreements require the fund managers to invest in a diverse range of stocks and bonds across each particular asset class. The stocks held by the plan in a particular asset class should therefore
 
- 88 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
match closely the underlying stocks in the relevant index. The Company believes that this leads to minimal concentration of risk within each asset class; although it recognizes that some asset classes are inherently more risky than others.
The Company also has pension plans in Asia for which the benefit obligation, fair value of the plan assets and the funded status amounts are deemed immaterial and therefore, not included in the amounts or assumptions above.
401(k) Retirement Plan
The Company maintains a 401(k) retirement plan (“the Plan”) for the benefit of qualified employees at its U.S. locations. Employees who participate may elect to make salary deferral contributions to the Plan up to 100% of the employees’ eligible payroll subject to annual Internal Revenue Code maximum limitations. The Company currently makes a matching contribution of $1 for every $2 contributed by the participant up to 6% (3% maximum matching) of the participant’s eligible payroll, which vests over four years. In addition, the Company may make a discretionary contribution to the entire qualified employee pool, in accordance with the Plan.
As stipulated by the regulations of China, the Company maintains a retirement plan pursuant to the local municipal government for the employees in China. The Company is required to make contributions to the retirement plan at a rate between 10% and 22% of the employee’s eligible payroll. Pursuant to the Taiwan Labor Standard Law and Factory Law, the Company maintains a retirement plan for the employees in Taiwan, whereby the Company makes contributions at a rate of 6% of the employee’s eligible payroll.
For the years ended December 31, 2013, 2012 and 2011, total amounts expensed under these plans were approximately $6 million, $5 million and $4 million, respectively.
Deferred Compensation Plan
The Company maintains a Non-Qualified Deferred Compensation Plan (the “Deferred Compensation Plan”) for executive officers, key employees and members of the Board of Directors (the “Board”). The Deferred Compensation Plan allows eligible participants to defer the receipt of eligible compensation, including equity awards, until designated future dates. The Company offsets its obligations under the Deferred Compensation Plan by investing in the actual underlying investments. These investments are classified as trading securities and are carried at fair value. At December 31, 2013, these investments totaled approximately $3 million. All gains and losses in these investments are materially offset by corresponding gains and losses in the deferred compensation plan liabilities.
Share-Based Plans
The Company maintains share-based compensation plans for its Board, officers and key employees, which provide for stock options and stock awards under its 2013 Equity Incentive Plan.
 
- 89 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
NOTE 13 – SHARE-BASED COMPENSATION
The following table shows the total compensation cost charged as an expense for share-based compensation plans, including stock options and share grants, recognized in the statements of income for the years ended December 31, 2013, 2012 and 2011:

 	  	2013	 	  	2012	 	  	2011	 	
Cost of goods sold	  	$	522	 	  	$	458	 	  	$	394	 	
Selling, general and administrative expense	  	 	11,645	 	  	 	12,715	 	  	 	12,266	 	
Research and development expense	  	 	1,384	 	  	 	1,225	 	  	 	1,043	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	
Total share-based compensation expense	  	$	13,551	 	  	$	14,398	 	  	$	13,703	 	
 	  	 	 	 	  	 	 	 	  	 	 	 	
Stock Options – Stock options under the Company’s 2001 Omnibus Equity Incentive Plan (“2001 Plan”) generally vest in equal annual installments over a four-year period and expire ten years after the grant date.
In May 2013, the Company’s stockholders approved the Company’s 2013 Equity Incentive Plan (“2013 Plan”). Since the approval of the 2013 Plan, all stock options have been granted under the 2013 Plan, and the Company will not grant any further stock options under its 2001 Plan. Stock options under the 2013 Plan generally vest in equal annual installments over a four-year period and expire eight years after the grant date. For additional information on the 2013 Plan, see the Company’s definitive Proxy Statement filed with the SEC on April 19, 2013.
Share-based compensation expense for stock options granted during 2013, 2012 and 2011 was calculated on the date of grant using the Black-Scholes-Merton option-pricing model with the following weighted-average assumptions:

 	  	2013	 	 	2012	 	 	2011	 	
Expected volatility	  	 	53.36	% 	 	 	53.86	% 	 	 	52.53	% 	
Expected term (years)	  	 	7.2	 	 	 	7.5	 	 	 	7.5	 	
Risk free interest rate	  	 	1.49	% 	 	 	1.16	% 	 	 	2.37	% 	
Forfeiture rate	  	 	0.78	% 	 	 	0.76	% 	 	 	0.47	% 	
Expected volatility – The Company estimates expected volatility using historical volatility. Public trading volume on options in the Company’s stock is not material. As a result, the Company determined that utilizing an implied volatility factor would not be appropriate. The Company calculates historical volatility for the period that is commensurate with the option’s expected term assumption. For 2013, the expected volatility for grants to officers and the Board is 53.36%, while the expected volatility for grants to all other employees is 56.91%.
Expected term – The Company has evaluated expected term based on history and exercise patterns across its demographic population. The Company believes that this historical data is the best estimate of the expected term of a new option. For 2013, the expected term for grants to officers and the Board is 7 years, while the expected term for grants to all other employees is 5 years.
Risk free interest rate – The Company estimate the risk-free interest rate based on zero-coupon U.S. treasury securities for a period that is commensurate with the expected term assumption.
Forfeiture rate—The amount of stock-based compensation recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest as forfeitures are estimated at the time of grant
 
- 90 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The term “forfeitures” is distinguished from “cancellations” or “expirations” and represents only the unvested portion of the surrendered option. This analysis will be re-evaluated at least annually, and the forfeiture rate for all grants will be adjusted as necessary.
Dividend yield – The Company historically has not paid a cash dividend on its common stock; therefore this input is zero.
The weighted-average grant-date fair value of options granted during 2013, 2012 and 2011 was $12.88, $10.60, and $16.55, respectively. The total cash received from option exercises was $3 million, $1 million and $4 million during 2013, 2012 and 2011, respectively.
For the years ended December 31, 2013, 2012 and 2011, stock option expense was $4 million, $5 million and $5, respectively.
At December 31, 2013, unamortized compensation expense related to unvested options, net of estimated forfeitures, was approximately $6 million. The weighted average period over which share-based compensation expense related to these options will be recognized is approximately 2 years.
A summary of the Company’s stock option plans is as follows:

Stock Options	  	Shares	 	 	Weighted
Average
Exercise
Price	 	  	Weighted
Average
Remaining
Contractual
Term (years)	 	  	Aggregate
Intrinsic
Value	 	
Outstanding at January 1, 2011	  	 	3,707	 	 	$	14.14	 	  	 	5.2	 	  	$	47,891	 	
Granted	  	 	385	 	 	 	29.07	 	  	 	 	 	  	 	 	 	
Exercised	  	 	(496	) 	 	 	7.17	 	  	 	 	 	  	 	11,120	 	
Forfeited or expired	  	 	(9	) 	 	 	20.80	 	  	 	 	 	  	 	 	 	
 	  	 	 	 	 	 	 	 	  	 	 	 	  	 	 	 	
Outstanding at January 1, 2011	  	 	3,587	 	 	 	16.69	 	  	 	5.1	 	  	 	22,299	 	
Exercisable at December 31, 2011	  	 	2,622	 	 	 	14.51	 	  	 	3.9	 	  	 	20,201	 	
Outstanding at January 1, 2012	  	 	3,587	 	 	 	16.69	 	  	 	 	 	  	 	 	 	
Granted	  	 	402	 	 	 	19.31	 	  	 	 	 	  	 	 	 	
Exercised	  	 	(274	) 	 	 	4.81	 	  	 	 	 	  	 	4,249	 	
Forfeited or expired	  	 	(2	) 	 	 	20.10	 	  	 	 	 	  	 	 	 	
 	  	 	 	 	 	 	 	 	  	 	 	 	  	 	 	 	
Outstanding at December 31, 2012	  	 	3,713	 	 	 	17.85	 	  	 	5.0	 	  	 	9,744	 	
Exercisable at December 31, 2012	  	 	2,715	 	 	 	16.48	 	  	 	3.7	 	  	 	9,472	 	
Outstanding at January 1, 2013	  	 	3,713	 	 	 	17.85	 	  	 	 	 	  	 	 	 	
Granted	  	 	186	 	 	 	23.35	 	  	 	 	 	  	 	 	 	
Exercised	  	 	(341	) 	 	 	7.70	 	  	 	 	 	  	 	5,722	 	
Forfeited or expired(1)	  	 	(432	) 	 	 	20.34	 	  	 	 	 	  	 	 	 	
 	  	 	 	 	 	 	 	 	  	 	 	 	  	 	 	 	
Outstanding at December 31, 2013	  	 	3,126	 	 	 	18.93	 	  	 	4.2	 	  	 	17,461	 	
Exercisable at December 31, 2013	  	 	2,509	 	 	 	18.01	 	  	 	3.3	 	  	 	16,144	 	
 
(1) 	The Compensation Committee of the Board of Directors reviewed the grants of stock options to the Company’s Chief Executive Officer in 2009, 2010, 2011 and 2012 (each such annual grant, an “Option Grant”), and approved a Confirmation Agreement, dated April 1, 2013, in which the Company and the	
 
- 91 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
 	Company’s Chief Executive Officer agreed and confirmed that the Company’s Chief Executive Officer will assert no claim that any Option Grant in 2009, 2010, 2011 or 2012 provided for the purchase of more than 100,000 shares of the Company’s Common Stock, and that each Option Grant document be deemed amended to reflect the foregoing 100,000 share limitation.	
The following table summarizes information about stock options outstanding at December 31, 2013:

Plan	  	Range of exercise
prices	 	  	Number
outstanding	 	  	Weighted
average
remaining
contractual
life (years)	 	  	Weighted
average
exercise price	 	
2001 Plan	  	$	8.14-29.21	  	  	 	2,944	 	  	 	4.0	 	  	$	18.67	 	
2013 Plan	  	$	23.35	 	  	 	182	 	  	 	7.4	 	  	$	23.35	 	
The following summarizes information about stock options exercisable at December 31, 2013:

Plan	  	Range of exercise
prices	 	  	Number
exercisable	 	  	Weighted
average
remaining
contractual
life (years)	 	  	Weighted
average
exercise price	 	
2001 Plan	  	$	8.14-29.21	  	  	 	2,509	 	  	 	3.3	 	  	$	18.03	 	
2013 Plan	  	$	23.35	 	  	 	—  	 	  	 	7.4	 	  	$	23.35	 	
Share Grants – Restricted stock awards and restricted stock units generally vest in equal annual installments over a four-year period.
Since the approval of the 2013 Plan, all share grants have been granted under the 2013 Plan, and the Company will not grant any further share grants under its 2001 Plan.
A summary of the Company’s non-vested share grants in 2013, 2012 and 2011 are presented below:

Restricted Stock Grants	  	Shares	 	 	Weighted
Average
Grant Date
Fair Value	 	  	Aggregate
Intrinsic
Value	 	
Nonvested at January 1, 2011	  	 	871	 	 	$	18.66	 	  	 	 	 	
Granted	  	 	472	 	 	 	25.78	 	  	 	 	 	
Vested	  	 	(274	) 	 	 	20.23	 	  	 	 	 	
Forfeited	  	 	(45	) 	 	 	19.68	 	  	 	 	 	
 	  	 	 	 	 	 	 	 	  	 	 	 	
Nonvested at December 31, 2011	  	 	1024	 	 	$	21.48	 	  	$	—  	 	
Nonvested at January 1, 2012	  	 	1024	 	 	$	21.48	 	  	 	 	 	
Granted	  	 	482	 	 	 	18.95	 	  	 	 	 	
Vested	  	 	(305	) 	 	 	21.48	 	  	 	 	 	
Forfeited	  	 	(37	) 	 	 	21.67	 	  	 	 	 	
 	  	 	 	 	 	 	 	 	  	 	 	 	
Nonvested at December 31, 2012	  	 	1,164	 	 	$	20.42	 	  	$	—  	 	
Nonvested at January 1, 2013	  	 	1,164	 	 	$	20.42	 	  	 	 	 	
Granted	  	 	453	 	 	 	24.66	 	  	 	 	 	
Vested	  	 	(428	) 	 	 	19.9	 	  	$	8,512	 	
Forfeited	  	 	(58	) 	 	 	21.66	 	  	 	 	 	
 	  	 	 	 	 	 	 	 	  	 	 	 	
Nonvested at December 31, 2013	  	 	1,131	 	 	$	22.35	 	  	$	26,656	 	
 
- 92 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
For each of the years ended December 31 of 2013, 2012 and 2011, there was approximately $9 million of total recognized share-based compensation expense related to restricted stock arrangements granted under the plans. The total unrecognized share-based compensation expense as of December 31, 2013 was approximately $20 million, which is expected to be recognized over a weighted average period of approximately 2 years.
On September 22, 2009, the Company entered into an employment agreement (the “Agreement”) with Dr. Keh-Shew Lu, President and Chief Executive Officer of the Company (the “Employee”), pursuant to which he will continue to be employed by the Company in such positions for an additional six-year term. As part of the Agreement, the Company and the Employee entered into a Stock Award Agreement that provides that: (i) the Company shall grant to the Employee 100,000 shares of Common Stock in the form of restricted stock awards on each of April 14, 2010, 2011, 2012, 2013, 2014 and 2015; (ii) each such installment would vest only if the Company achieved $1 billion net sales; (iii) upon the termination of the Employee’s employment, the Company’s obligation to grant any subsequent installment would terminate; and (iv) any granted shares would be automatically forfeited and returned to the Company if the Employee’s employment with the Company is terminated before the Company achieves the specified target amount of net sales, except in the case of death or disability (as defined) in which case the granted shares would become fully vested on the date of death or disability. The estimated fair value of this grant is approximately $12 million and is being expensed on a straight line basis through April 14, 2015. As of December 31, 2013, four annual installments have been granted and are included in the above table as granted but not vested. As of December 31, 2013, no installments have vested.
NOTE 14 – RELATED PARTY TRANSACTIONS
The Company conducts business with a related party company, Lite-On Semiconductor Corporation, and its subsidiaries and affiliates (“LSC”). LSC is the Company’s largest stockholder, owning 18% of the Company’s outstanding Common Stock as of December 31, 2013, and is a member of the Lite-On Group of companies. C.H. Chen, the Company’s former President and Chief Executive Officer and currently the Vice Chairman of the Board of Directors, is also Vice Chairman of LSC and Lite-On Technology Corporation. Raymond Soong, the Chairman of the Board of Directors, is the Chairman of LSC, and is the Chairman of Lite-On Technology Corporation, a significant shareholder of LSC. Dr. Keh-Shew Lu, the Company’s President and Chief Executive Officer and a member of its Board of Directors, is a member of the Board of Directors of Lite-On Technology Corporation. L.P. Hsu, a member of the Board of Directors since May 2007 serves as a consultant to Lite-On Technology Corporation. The Company considers its relationship with LSC, a member of the Lite-On Group of companies, to be mutually beneficial and the Company plans to continue its strategic alliance with LSC.
The Company also conducts business with a significant company, Keylink International (B.V.I.) Inc. and its subsidiaries and affiliates (“Keylink”). Keylink is the Company’s 5% joint venture partner in the Company’s Shanghai manufacturing facilities.
The Audit Committee of the Company’s Board reviews all related party transactions for potential conflict of interest situations on an ongoing basis, all in accordance with such procedures as the Audit Committee may adopt from time to time.
Lite-On Semiconductor Corporation (LSC) – The Company sold products to LSC totaling approximately 1% of its net sales for the years ended December 31, 2013, 2012 and 2011, respectively. Also for the years ended December 31, 2013, 2012 and 2011, 2%, 3% and 5%, respectively, of the Company’s net sales were from semiconductor products purchased from LSC for subsequent sale, making LSC one of the Company’s largest suppliers. The Company also rented warehouse space in Hong Kong, which the lease term ended March 2011 from a member of the Lite-On Group.
 
- 93 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
Net sales to, and purchases from, LSC were as follows for years ended December 31:

 	  	2013	 	  	2012	 	  	2011	 	
Net sales	  	$	770	  	  	$	1,054	  	  	$	1,980	  	
Purchases	  	$	35,329	  	  	$	33,928	  	  	$	37,879	  	
Keylink International (B.V.I.) Inc. – The Company sells products to, and purchases inventory from, companies owned by Keylink. The Company sold products to companies owned by Keylink, totaling 1%, 3% and 2% of net sales for the years ended December 31, 2013, 2012 and 2011, respectively. Also for the years ended December 31, 2013, 2012 and 2011, 1% of the Company’s net sales were from semiconductor products purchased from companies owned by Keylink. In addition, the Company’s subsidiaries in China lease their manufacturing facilities in Shanghai from, and subcontract a portion of their manufacturing process (metal plating and environmental services) to, Keylink. The Company also pays a consulting fee to Keylink. The aggregate amounts for these services for the years ended December 31, 2013, 2012 and 2011 were $17 million, $16 million and $17 million, respectively.
Net sales to, and purchases from, companies owned by Keylink were as follows for years ended December 31:

 	  	2013	 	  	2012	 	  	2011	 	
Net sales	  	$	10,559	  	  	$	19,336	  	  	$	11,965	  	
Purchases	  	$	8,030	  	  	$	7,826	  	  	$	11,168	  	
Accounts receivable from, and accounts payable to, LSC and Keylink were as follows as of December 31:

 	  	 	  	2013	 	  	2012	 	
Accounts receivable	  	 	  	 	 	 	  	 	 	 	
 	  	LSC	  	$	140	 	  	$	204	 	
 	  	Keylink	  	 	4,927	 	  	 	10,457	 	
 	  	 	  	 	 	 	  	 	 	 	
 	  	 	  	$	5,067	 	  	$	10,661	 	
 	  	 	  	 	 	 	  	 	 	 	
Accounts payable	  	 	  	 	 	 	  	 	 	 	
 	  	LSC	  	$	5,670	 	  	$	5,308	 	
 	  	Keylink	  	 	6,505	 	  	 	5,095	 	
 	  	 	  	 	 	 	  	 	 	 	
 	  	 	  	$	12,175	  	  	 	$10,403	 	
 	  	 	  	 	 	 	  	 	 	 	
Eris Technology Corporation – Prior to the Company obtaining a controlling financial interest in Eris on August 31, 2012, Eris was a related party due to significant, but noncontrolling, equity investment. The Company subcontracted to Eris some of its wafers for assembly and test and also purchased finished goods not sourced from the Company’s wafers. With respect to assembly and test fees and the finished goods purchases, the Company paid Eris approximately $10 million and $16 million for the years ended December 31, 2012 and 2011, respectively. See Note 17 for further information about business combinations.
 
- 94 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
NOTE 15 – SEGMENT INFORMATION AND ENTERPRISE-WIDE DISCLOSURES
An operating segment is defined as a component of an enterprise about which separate financial information is available that is evaluated regularly by the chief decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company’s chief decision-making group consists of the President and Chief Executive Officer, Chief Financial Officer, Senior Vice President of Operations and Senior Vice President of Sales and Marketing. For financial reporting purposes, the Company operates in a single segment, standard semiconductor products, through its various manufacturing and distribution facilities. The Company aggregates its products in a single segment because the products have similar economic characteristics, are similar in production process and manufacture flow, and share the same customers and target end-equipment markets.
The Company’s primary operations include the operations in Asia, North America and Europe. Revenues are attributed to geographic areas based on the location of subsidiaries producing the revenues:

2013	  	Asia	 	 	North
America	 	 	Europe	 	 	Consolidated	 	
Total sales	  	$	750,339	 	 	$	143,251	 	 	$	165,179	 	 	$	1,058,769	 	
Inter-company sales	  	 	(75,731	) 	 	 	(65,947	) 	 	 	(90,245	) 	 	 	(231,923	) 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Net sales	  	$	674,608	 	 	$	77,304	 	 	$	74,934	 	 	$	826,846	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Property, plant and equipment	  	$	268,196	 	 	$	30,040	 	 	$	23,777	 	 	$	322,013	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Assets	  	$	858,114	 	 	$	120,104	 	 	$	184,040	 	 	$	1,162,258	 	

2012	  	Asia	 	 	North
America	 	 	Europe	 	 	Consolidated	 	
Total sales	  	$	573,085	 	 	$	133,973	 	 	$	154,955	 	 	$	862,013	 	
Inter-company sales	  	 	(75,230	) 	 	 	(66,626	) 	 	 	(86,351	) 	 	 	(228,207	) 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Net sales	  	$	497,855	 	 	$	67,347	 	 	$	68,604	 	 	$	633,806	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Property, plant and equipment	  	$	186,563	 	 	$	31,309	 	 	$	25,424	 	 	$	243,296	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Assets	  	$	554,603	 	 	$	136,261	 	 	$	229,199	 	 	$	920,063	 	

2011	  	Asia	 	 	North
America	 	 	Europe	 	 	Consolidated	 	
Total sales	  	$	559,109	 	 	$	137,789	 	 	$	194,455	 	 	$	891,353	 	
Inter-company sales	  	 	(82,958	) 	 	 	(61,907	) 	 	 	(111,237	) 	 	 	(256,102	) 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Net sales	  	$	476,151	 	 	$	75,882	 	 	$	83,218	 	 	$	635,251	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Property, plant and equipment	  	$	162,022	 	 	$	33,684	 	 	$	29,687	 	 	$	225,393	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Assets	  	$	494,375	 	 	$	112,863	 	 	$	185,826	 	 	$	793,064	 	
 	  	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
The accounting policies of the operating entities are the same as those described in the summary of significant accounting policies. Sales are attributed to geographic areas based on the location of the subsidiaries producing the sales.
 
- 95 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
Geographic Information—Historically, the Company reported revenues “billed to” customers located in various countries. In 2013, the Company changed to revenues “shipped to” customer locations as it believes the change better represents where the Company’s customers business activities occur. All years presented reflect this change.
Revenues were derived from (shipped to) customers located in the following countries. “All others” represents countries with less than 3% of total revenues each:

2013	  	Revenue	 	  	% of Total
Revenue	 	
China	  	$	522,587	 	  	 	63	% 	
U.S.	  	 	72,232	 	  	 	9	% 	
Korea	  	 	68,693	 	  	 	8	% 	
Germany	  	 	45,631	 	  	 	6	% 	
Singapore	  	 	43,066	 	  	 	5	% 	
Taiwan	  	 	30,233	 	  	 	4	% 	
All others	  	 	44,404	 	  	 	5	% 	
 	  	 	 	 	  	 	 	 	
Total	  	$	826,846	 	  	 	100	% 	

2012	  	Revenue	 	  	% of Total
Revenue	 	
China	  	$	381,307	 	  	 	60	% 	
U.S.	  	 	62,862	 	  	 	10	% 	
Korea	  	 	52,670	 	  	 	8	% 	
Germany	  	 	41,037	 	  	 	6	% 	
Singapore	  	 	26,877	 	  	 	4	% 	
Taiwan	  	 	20,973	 	  	 	3	% 	
All others	  	 	48,080	 	  	 	9	% 	
 	  	 	 	 	  	 	 	 	
Total	  	$	633,806	 	  	 	100	% 	

2011	  	Revenue	 	  	% of Total
Revenue	 	
China	  	$	359,647	 	  	 	57	% 	
U.S.	  	 	71,796	 	  	 	11	% 	
Germany	  	 	48,264	 	  	 	8	% 	
Korea	  	 	39,051	 	  	 	6	% 	
Taiwan	  	 	33,437	 	  	 	5	% 	
Singapore	  	 	24,036	 	  	 	4	% 	
All others	  	 	59,020	 	  	 	9	% 	
 	  	 	 	 	  	 	 	 	
Total	  	$	635,251	 	  	 	100	% 	
 	  	 	 	 	  	 	 	 	
Major customers – No customer accounted for 10% or greater of the Company’s total net sales in 2013, 2012 and 2011.
 
- 96 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
NOTE 16 – COMMITMENTS AND CONTINGENCIES
Operating leases – The Company leases offices, manufacturing plants and warehouses under operating lease agreements expiring through December 2020. Rental expense amounted to approximately $9 million, $7 million and $7 million for the years ended December 31, 2013, 2012 and 2011, respectively.
Future minimum lease payments under non-cancelable operating leases at December 31, 2013 are:

2014	  	$	8,247	 	
2015	  	 	6,709	 	
2016	  	 	5,919	 	
2017	  	 	5,482	 	
2018 and thereafter	  	 	3,132	 	
 	  	 	 	 	
 	  	$	29,489	 	
 	  	 	 	 	
In addition, the Company has two fifty year land right leases: one in Chengdu, China, on which the Company does not pay rent and which expires in 2061; and one in Shanghai, China, on which the Company does not pay rent and which expires in 2056.
Purchase commitments – The Company has entered into non-cancelable purchase contracts for capital expenditures, primarily for manufacturing equipment in China, for approximately $9 million at December 31, 2013.
Contingencies—From time to time, the Company may be involved in a variety of legal matters that arise in the normal course of business. Based on information available, the Company evaluates the likelihood of potential outcomes. The Company records the appropriate liability when the amount is deemed probable and reasonably estimable. In addition, the Company does not accrue for estimated legal fees and other directly related costs as they are expensed as incurred.
The Company is currently a party to a purported stockholder derivative action in the United States District Court for the District of Delaware, entitled  Scherer v. Keh-Shew Lu , Civil Action No. 1:13-cv-00358-UNA (D. Del. filed Mar. 5, 2013), on behalf of the Company against its directors, in which plaintiff alleges that (a) the Board approved awards of stock options to Dr. Keh-Shew Lu, our President and Chief Executive Officer, in 2009, 2010, 2011 and 2012 that exceeded the limitation on the number of shares of the Company’s Common Stock that may be purchased upon the exercise of options granted to any person in any given year under the Company’s 2001 Omnibus Equity Incentive Plan as amended by the stockholders on May 28, 2009; (b) the Company’s disclosures in its 2010, 2011 and 2012 proxy statements regarding the limitation on the number of shares of the Company’s Common Stock that may be purchased upon the exercise of options granted to any person in any given year under the Company’s 2001 Omnibus Equity Incentive Plan as amended by the stockholders on May 28, 2009 were inaccurate; and (c) the Company’s disclosures in its 2010, 2011 and 2012 proxy statements that the grants of stock options to Dr. Lu in 2009, 2010, 2011 and 2012 complied with the terms of the Company’s 2001 Omnibus Equity Incentive Plan as amended by the stockholders on May 28, 2009 were incorrect. The Compensation Committee reviewed the grants of stock options to Dr. Lu in 2009, 2010, 2011 and 2012 (each such annual grant, an “Option Grant”), and approved a Confirmation Agreement, dated April 1, 2013, in which the Company and Dr. Lu agreed and confirmed that Dr. Lu will assert no claim that any Option Grant in 2009, 2010, 2011 or 2012 provided for the purchase of more than 100,000 shares of the Company’s Common Stock, and that each Option Grant document be deemed amended to reflect the foregoing 100,000 share limitation. On April 3, 2013, defendants and the Company filed answers to the complaint. On May 8, 2013,
 
- 97 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
defendants filed a motion for judgment on the pleadings dismissing the action on the ground that the claims are moot. On June 24, 2013, the Court approved the parties’ stipulation providing for the withdrawal of the motion for judgment on the pleadings and the dismissal of the action as moot upon the filing and adjudication of plaintiff’s motion for an award of attorney’s fees and costs. On July 29, 2013, plaintiff filed a motion for an award of attorneys’ fees and costs. On September 20, 2013, the Company filed its opposition to plaintiff’s motion. On October 11, 2013, plaintiff filed her reply in further support of her motion. The motion is now fully submitted. No hearing date has been set for this motion.
The Company is also currently a party to a putative securities class action in the United States District Court for the Eastern District of Texas, entitled  Local 731 I.B. of T. Excavators and Pavers Pension Trust Fund v. Diodes, Inc. , Civil Action No. 6:13-cv-00247 (E.D. Tex. filed Mar. 15, 2013), against the Company, Dr. Lu and Richard D. White. In this action, plaintiff purportedly on behalf of a class of investors who purchased the Company’s Common Stock between February 9, 2011 and June 9, 2011, alleges that defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Securities and Exchange Commission Rule 10b-5 promulgated thereunder by making allegedly misleading public statements during the class period regarding the labor market in China and its impact on the Company’s business and prospects. On June 14, 2013, the Court entered an order appointing Local 731 I.B. of T. Excavators and Pavers Pension Trust Fund as lead plaintiff and approved lead plaintiff’s selection of Robbins Geller Rudman & Dowd as lead plaintiff’s counsel and the Ward & Smith Law Firm as lead plaintiff’s liaison counsel. On August 1, 2013, lead plaintiff filed an amended complaint reiterating the same claims for relief against the same defendants as asserted in the original complaint. On September 16, 2013, defendants filed a motion to dismiss the amended complaint. Lead plaintiff filed its opposition to defendants’ motion to dismiss on October 31, 2013. Defendants filed their reply in further support of their motion to dismiss on December 3, 2013. Lead plaintiff filed its sur-reply in further opposition of defendant’s motion to dismiss on December 13, 2013. The motion is now fully submitted. No hearing date has been set for this motion. Pursuant to the Private Securities Litigation Reform Act of 1995, all discovery and other proceedings are stayed pending a ruling on any motion to dismiss. The defendants intend to defend this action vigorously.
On February 20, 2014, a purported “tag-along” stockholder derivative action was filed in the United States District Court for the Eastern District of Texas, entitled  Persson v. Keh-Shew Lu , Case No. 4:14-cv-00108-RC-ALM (E.D. Tex. filed Feb. 20, 2014), on behalf of the Company against its directors, in which plaintiff alleges that the Board breached their fiduciary duties by allowing the Company to make allegedly misleading public statements in 2011 regarding the labor market in China and its impact on the Company’s business and prospects, by failing to maintain internal controls and by selling shares of Diodes stock while allegedly in possession of material nonpublic information regarding the labor market in China and its impact on the Company’s business and prospects. The complaint has not yet been served. The complaint does not seek any damages or other relief against the Company. The defendants intend to defend this lawsuit vigorously.
NOTE 17 – BUSINESS COMBINATION
BCD Semiconductor Manufacturing Limited
On March 5, 2013, the Company completed the acquisition of all the outstanding ordinary shares, par value $0.001 per share, of BCD (the “Shares”), including Shares represented by American Depository Shares (“ADSs”), which were cancelled in exchange for the right to receive $1.33-1/3 in cash per Share, without interest. Each ADS represented six Shares and was converted into the right to receive $8.00 in cash, without interest. The aggregate consideration was approximately $155 million, excluding acquisition costs, fees and expenses. In addition, a $5 million retention plan for employees of BCD, payable at the 12, 18 and 24 month
 
- 98 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
anniversaries of the acquisition, has been established. The employee retention plan is intended to benefit the Company and not the selling shareholders, and therefore has been excluded from the determination of the purchase price. The acquisition was funded by drawings on the Company’s revolving senior credit facility. See Note 7 for additional information regarding the Company’s credit facility.
The Company’s purchase price for BCD and related costs are estimated as follows:

Purchase price (cost of shares)	  	$	154,735	 	
Acquisition related costs (included in selling, general and administrative expenses)	  	 	2,075	 	
 	  	 	 	 	
Total purchase price	  	$	156,810	 	
 	  	 	 	 	
The results of operations of BCD have been included in the consolidated financial statements from March 1, 2013. The consolidated revenue and earnings of BCD included in the Company’s consolidated financial statements for the year ended December 31, 2013 were approximately $155 million and $6 million, respectively, which include acquisition accounting adjustments. The Company’s purpose in making this acquisition is to further its strategy of expanding its market and growth opportunities through select strategic acquisitions. This acquisition is expected to enhance the Company’s analog product portfolio by expanding its standard linear and power management offerings, including AC/DC and DC/DC solutions for power adapters and chargers, as well as other electronic products. BCD’s established presence in Asia, with a particularly strong local market position in China, offers the Company even greater penetration of the consumer, computing and communications markets. Likewise, the Company believes it can achieve increased market penetration for BCD’s products by leveraging the Company’s own global customer base and sales channels. In addition, BCD has in-house manufacturing capabilities in China, as well as a cost-effective development team that can be deployed across multiple product families. The Company also believes it will be able to apply its packaging capabilities and expertise to BCD’s products in order to improve cost efficiencies, utilization and product mix.
Under the accounting guidance for step acquisitions, the Company is required to record all assets acquired and liabilities assumed at fair value, and recognize goodwill of the acquired business. The step acquisition guidelines also require that the Company remeasure its preexisting investment in BCD at fair value, and recognize any gains or losses from such remeasurement. The fair value of the Company’s interest immediately before the closing date was $7 million, which resulted in the Company recognizing a non-cash gain of approximately $4 million within other income (expense) for the year ended December 31, 2013. The shares of BCD common stock were valued under the fair value hierarchy as a Level 1 Input.
 
- 99 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
The following summarizes the allocation of the purchase price to the fair value of the assets acquired and liabilities assumed at the date of acquisition:

 	  	March 1, 2013
Acquisition
Method	 	
Assets acquired:	  	 	 	 	
Cash and cash equivalents	  	$	29,819	 	
Accounts receivable, net	  	 	20,862	 	
Inventory	  	 	42,909	 	
Prepaid expenses and other current assets	  	 	27,205	 	
Property, plant and equipment, net	  	 	99,390	 	
Deferred tax assets	  	 	1,612	 	
Other long-term assets	  	 	5,497	 	
Other intangible assets	  	 	17,200	 	
Goodwill	  	 	2,518	 	
 	  	 	 	 	
Total assets acquired	  	$	247,012	 	
 	  	 	 	 	
Liabilities assumed:	  	 	 	 	
Lines of credit	  	$	17,336	 	
Accounts payable	  	 	34,758	 	
Accrued liabilities and other	  	 	16,703	 	
Deferred tax liability	  	 	5,055	 	
Other liabilities	  	 	18,425	 	
 	  	 	 	 	
Total liabilities assumed	  	 	92,277	 	
 	  	 	 	 	
Total net assets acquired, net of cash acquired	  	$	154,735	 	
 	  	 	 	 	
The fair value of the significant identified intangible assets was estimated by using the market approach, income approach and cost approach valuation methodologies. Inputs used in the methodologies primarily included projected future cash flows, discounted at a rate commensurate with the risk involved. The total amount of intangible assets acquired subject to amortization expense is $17 million, which has a residual value of zero and weighted-average amortization period of 6 years. Goodwill arising from the acquisition is attributable to future income from new customer contracts, synergy of combined operations, the acquired workforce and future technology that has yet to be designed or even conceived. In addition, goodwill will be deductible for income tax purposes.
The Company estimated the fair value of acquired receivables to be $21 million with a gross contractual amount of $21million. The Company expects to collect substantially all of the acquired receivables. The Company evaluated and adjusted the acquired inventory for a reasonable profit allowance, which is intended to permit the Company to report only the profits normally associated with its activities following the acquisition as it relates to the work-in-progress and finished goods inventory. As such, the Company increased the inventory acquired from BCD by approximately $5 million, and recorded that increase into cost of goods sold, of which approximately $2 million was recorded in the first quarter of 2013 and $3 million was recorded in the second quarter of 2013 as the acquired work-in-progress and finished goods inventory was sold.
 
- 100 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
The following unaudited pro forma consolidated results of operations for the years ended December 31, 2013 and 2012 have been prepared as if the acquisition of BCD had occurred at January 1, 2012, for each year:

 	  	Twelve Months Ended
December 31,	 	
 	  	2013	 	  	2012	 	
Net revenues	  	$	847,947	 	  	$	776,650	 	
Net income attributable to common stockholders	  	$	25,513	 	  	$	19,233	 	
Earnings per share—Basic	  	$	0.55	 	  	$	0.42	 	
Earnings per share—Diluted	  	$	0.54	 	  	$	0.41	 	
The unaudited pro forma consolidated results of operations do not purport to be indicative of the results that would have been obtained if the above acquisition had actually occurred as of the dates indicated or of those results that may be obtained in the future. These unaudited pro forma consolidated results of operations were derived, in part, from the historical consolidated financial statements of BCD and other available information and assumptions believed to be reasonable under the circumstances.
Eris Technology Corporation
Prior to August 31, 2012, the Company owned less than 50% of the outstanding common stock of Eris, a publicly traded company listed on Taiwan’s GreTai Securities Market that provides design, manufacturing and after-market services for diode products. The Company elected the fair value option to account for its less than 50% ownership that otherwise would have been accounted for under the equity method of accounting. See Note 2 for further information about the fair value option.
On August 31, 2012, the Company acquired additional shares to bring its ownership to approximately 51% of the outstanding common stock of Eris. The Company has accounted for the additional purchase of shares as a business combination achieved in stages under the accounting guidance for step acquisitions and consolidated Eris beginning September 1, 2012. The consolidated revenue for Eris for the period ended December 31, 2012 was approximately $3 million. The Company may from time to time seek to purchase additional shares of Eris common stock in the open market, in privately negotiated transactions or otherwise. Such purchases, if any, will depend on prevailing market conditions, the Company’s liquidity requirements, and other factors. The amounts involved may be material.
The Company’s purpose for obtaining a controlling interest in Eris was to expand its semiconductor product offerings and to maximize its market opportunities. In addition, the Company’s main interest in Eris is for its automatic manufacturing capabilities in test and assembly for various diode products. The business scope for Eris comprises Schottky Diodes, TVS Diodes, Zener Diodes, Bridge Diodes, Wafers, LEDs and the relevant devices.
Under the accounting guidance for step acquisitions, the Company is required to record all assets acquired, liabilities assumed, and noncontrolling interests at fair value, and recognize the entire goodwill of the acquired business. The step acquisition guidelines also require that the Company remeasure its preexisting investment in Eris at fair value, and recognize any gains or losses from such remeasurement. The fair value of the Company’s interest immediately before the closing date was $27 million, which resulted in the Company recognizing a non-cash gain of approximately $2 million within other income (expense) for the year ended December 31, 2012. The shares of Eris common stock were valued under the fair value hierarchy as a Level 1 Input. In addition, Level 1 Input fair value measurements were used to measure both the fair value of the Company’s preexisting investment and the fair value of the noncontrolling interest, which was $26 million.
 
- 101 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
The Company recorded $8 million of goodwill (which is not deductible for tax purposes) and $18 million of intangible assets associated with this acquisition. The intangible assets associated with this acquisition consist primarily of finite-lived intangibles of $15 million for developed technology and customer relationships to be amortized on a straight-line basis over a period of 12 years and 10 years, respectively. In addition, an indefinite-lived trade name in the amount of $3 million was also recorded. The fair value of the significant identified intangible assets was estimated by using the market approach, income approach and cost approach valuation methodologies. Inputs used in the methodologies primarily included projected future cash flows, discounted at a rate commensurate with the risk involved.
During the 2013 annual impairment of goodwill test, the Company recognized a $5 million impairment loss as the carrying amount of Eris’s goodwill exceeded its implied fair value. See Note 1 for additional information regarding the Company’s annual impairment of goodwill testing.
Unaudited pro forma results of operations assuming this acquisition had taken place at the beginning of each period are not provided as this acquisition does not meet the definition of a material business combination.
Power Analog Microelectronics, Inc.
On October 29, 2012, the Company acquired Power Analog Microelectronics, Inc. (“PAM”) for $16 million, $3 million of which was held back and will be paid over the next two years subject to the satisfaction of certain terms and conditions. PAM is a provider of advanced analog and high-voltage power ICs, and its product portfolio includes Class D audio amplifiers, DC-DC converters and LED backlighting drivers. PAM was founded in Silicon Valley in 2004 and has technical and business centers in Shanghai, Shenzhen, Taipei and Tokyo.
The Company acquired PAM as it believes PAM will strengthen its position as a global provider of high-quality analog products by expanding Diodes’ product portfolio with innovative ‘filter-less’ digital audio amplifiers, application-specific power management ICs, as well as high-performance LED drivers and DC-DC converters.
The Company recorded $9 million of goodwill (which is not deductible for tax purposes) and $6 million of intangible assets associated with this acquisition. The intangible assets associated with this acquisition consist of finite-lived intangibles for developed technology and customer relationships to be amortized on a straight-line basis over a period of 3 to 12 years. The fair value of the significant identified intangible assets was estimated by using the market approach, income approach and cost approach valuation methodologies. Inputs used in the methodologies primarily included projected future cash flows, discounted at a rate commensurate with the risk involved.
The consolidated revenue for PAM for the year ended December 31, 2012 was approximately $1 million. Unaudited pro forma results of operations assuming this acquisition had taken place at the beginning of each period are not provided as this acquisition does not meet the definition of a material business combination.
 
- 102 -

Table of Contents
DIODES INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Table amounts in thousands except per share data)
 
NOTE 18 – SELECTED QUARTERLY FINANCIAL DATA (Unaudited)

 	  	Quarter Ended	 	
 	  	March 31	 	 	June 30	 	  	Sept. 30	 	  	Dec. 31	 	
Fiscal 2013	  	 	 	 	 	 	 	 	  	 	 	 	  	 	 	 	
Net sales	  	$	176,964	 	 	$	214,379	 	  	$	224,510	 	  	$	210,993	 	
Gross profit	  	 	46,183	 	 	 	61,293	 	  	 	69,559	 	  	 	60,801	 	
Net income (loss) attributable to common shareholders	  	 	(1,926	) 	 	 	8,635	 	  	 	13,619	 	  	 	6,204	 	
Earnings (loss) per share attributable to common shareholders	  	 	 	 	 	 	 	 	  	 	 	 	  	 	 	 	
Basic	  	$	(0.04	) 	 	$	0.19	 	  	$	0.29	 	  	$	0.13	 	
Diluted	  	 	(0.04	) 	 	 	0.18	 	  	 	0.28	 	  	 	0.13	 	
 	 	
 	  	Quarter Ended	 	
 	  	March 31	 	 	June 30	 	  	Sept. 30	 	  	Dec. 31 (i)	 	
Fiscal 2012	  	 	 	 	 	 	 	 	  	 	 	 	  	 	 	 	
Net sales	  	$	144,663	 	 	$	159,239	 	  	$	166,617	 	  	$	163,287	 	
Gross profit	  	 	33,706	 	 	 	41,028	 	  	 	43,605	 	  	 	43,247	 	
Net income attributable to common shareholders	  	 	4,871	 	 	 	6,653	 	  	 	8,553	 	  	 	4,075	 	
Earnings per share attributable to common shareholders	  	 	 	 	 	 	 	 	  	 	 	 	  	 	 	 	
Basic	  	$	0.11	 	 	$	0.15	 	  	$	0.19	 	  	$	0.09	 	
Diluted	  	 	0.10	 	 	 	0.14	 	  	 	0.18	 	  	 	0.09	 	
Note: The sum of the quarterly earnings per share may not equal the full year amount, as the computations of the weighted average number of common shares outstanding for each quarter and for the full year are performed independently.
 
(i)	In the fourth quarter of 2012, a correction of the 2011 foreign tax credits valuation allowance was recorded.	
 
- 103 -

Table of Contents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

DIODES INCORPORATED (Registrant)	 	 	 	 	
 	 	 	
By: /s/ Keh-Shew Lu	 	 	 	February 27, 2014	
KEH-SHEW LU
President and Chief Executive Officer
(Principal Executive Officer)	 	 	 	 	

By: /s/ Richard D. White	 	 	 	February 27, 2014	
RICHARD D. WHITE
Chief Financial Officer, Secretary, and Treasurer
(Principal Financial and Accounting Officer)	 	 	 	 	
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Dr. Keh-Shew Lu, President and Chief Executive Officer, and Richard D. White, Chief Financial Officer, Secretary, and Treasurer, his true and lawful attorneys-in-fact and agents, with full power of substitution, to sign and execute on behalf of the undersigned and any and all amendments to this report, and to perform any acts necessary in order to file the same, with all exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requested and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agents, or their or his or her substitutes, shall do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on February 27, 2014.

/s/ Keh-Shew Lu	 	 	 	 	
KEH-SHEW LU
President and Chief Executive Officer
(Principal Executive Officer)	 	 	 	 	

/s/ Richard D. White	 	 	 	 	
RICHARD D. WHITE
Chief Financial Officer, Secretary, and Treasurer
(Principal Financial and Accounting Officer)	 	 	 	 	

/s/ Raymond Soong	 	 	 	/s/ C.H. Chen	
RAYMOND SOONG
Chairman of the Board of Directors	 	 	 	C.H. CHEN
Director	

/s/ Michael R. Giordano	 	 	 	/s/ L.P. Hsu	
MICHAEL R. GIORDANO
Director	 	 	 	L.P. HSU
Director	

/s/ Keh-Shew Lu	 	 	 	/s/ John M. Stich	
KEH-SHEW LU
Director	 	 	 	JOHN M. STICH
Director	

/s/ Michael K.C. Tsai	 	 	 	 	
MICHAEL K.C. TSAI
Director	 	 	 	 	
 
- 104 -

Table of Contents
INDEX TO EXHIBITS

Number	 	Description	 	Form	 	Date of First Filing	 	Exhibit
Number	 	Filed
Herewith	
 	 	 	 	 	 	
  3.1	 	Certificate of Incorporation, as amended.	 	S-3	 	September 8, 2005	 	3.1	 	 	
 	 	 	 	 	 	
  3.2	 	Amended By-laws of the Company dated May 21, 2012	 	8-K	 	May 24, 2012	 	3.1	 	 	
 	 	 	 	 	 	
  4.1	 	Form of Certificate for Common Stock, par value $0.66 2/3 per share	 	S-3	 	August 25, 2005	 	4.1	 	 	
 	 	 	 	 	 	
  4.2	 	Form of Convertible Senior Notes due 2026	 	S-3	 	October 4, 2006	 	4.1	 	 	
 	 	 	 	 	 	
  4.3	 	Form of Indenture for the Convertible Senior Notes due 2026	 	S-3	 	October 4, 2006	 	4.3	 	 	
 	 	 	 	 	 	
10.1 *	 	Company’s 1993 Non-Qualified Stock Option Plan	 	S-8	 	May 9, 1994	 	 	 	 	
 	 	 	 	 	 	
10.2 *	 	Company’s 1993 Incentive Stock Option Plan	 	10-K	 	March 31, 1995	 	 	 	 	
 	 	 	 	 	 	
10.3	 	Loan Agreement between the Company and FabTech Incorporated	 	10-K	 	April 1, 1996	 	10.16	 	 	
 	 	 	 	 	 	
10.4	 	KaiHong Joint Venture Agreement between the Company and Mrs. J.H. Xing	 	10-K	 	April 1, 1996	 	10.17	 	 	
 	 	 	 	 	 	
10.5*	 	2001 Omnibus Equity Incentive Plan	 	DEF14A	 	April 27, 2001	 	B	 	 	
 	 	 	 	 	 	
10.6	 	Sale and Leaseback Agreement between Shanghai Kaihong Electronic Co., Ltd. and Shanghai Ding Hong Company, Ltd.	 	10-Q	 	May 15, 2002	 	10.46	 	 	
 	 	 	 	 	 	
10.7	 	Lease Agreement between Shanghai Kaihong Electronic Co., Ltd. and Shanghai Ding Hong Company, Ltd.	 	10-Q	 	May 15, 2002	 	10.47	 	 	
 	 	 	 	 	 	
10.8	 	Lease Agreement for Plant #2 between Shanghai Kaihong Electronic Co., Ltd. and Shanghai Ding Hong Electronic Equipment Limited	 	10-Q	 	August 9, 2004	 	10.52	 	 	
 	 	 	 	 	 	
10.9	 	Amendment to The Sale and Lease Agreement dated as January 31, 2002 with Shanghai Ding Hong Electronic Co., Ltd.	 	10-Q	 	August 9, 2004	 	10.56	 	 	
 	 	 	 	 	 	
10.10	 	Lease Agreement between Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology) and Shanghai Yuan Hao Electronic Co., Ltd.	 	10-Q	 	August 9, 2004	 	10.57	 	 	
 	 	 	 	 	 	
10.11	 	Supplementary to the Lease agreement dated as September 30, 2003 with Shanghai Ding Hong Electronic Co., Ltd.	 	10-Q	 	August 9, 2004	 	10.58	 	 	
 	 	 	 	 	 	
10.12*	 	Employment agreement between the Company and Mark King, dated August 29, 2005	 	8-K	 	September 2, 2005	 	10.2	 	 	
 	 	 	 	 	 	
10.13*	 	Employment agreement between the Company and Joseph Liu, dated August 29, 2005	 	8-K	 	September 2, 2005	 	10.3	 	 	
 
- 105 -

Table of Contents
INDEX TO EXHIBITS (continued)

Number	 	Description	 	Form	 	Date of First Filing	 	Exhibit
Number	 	Filed
Herewith	
 	 	 	 	 	 	
10.14*	 	Form of Indemnification Agreement between the Company and its directors and executive officers.	 	8-K	 	September 2, 2005	 	10.5	 	 	
 	 	 	 	 	 	
10.15	 	Wafer purchase Agreement dated January 10, 2006 between Diodes Taiwan Inc. and Lite-On Semiconductor Corporation	 	8-K	 	January 12, 2006	 	2.1	 	 	
 	 	 	 	 	 	
10.16	 	Supplementary to the Lease Agreement dated on September 5, 2004 with Shanghai Ding Hong Electronic Co., Ltd.	 	10-Q	 	May 10, 2006	 	10.14	 	 	
 	 	 	 	 	 	
10.17	 	Supplementary to the Lease Agreement dated on June 28, 2004 with Shanghai Yuan Hao Electronic Co., Ltd.	 	10-Q	 	May 10, 2006	 	10.15	 	 	
 	 	 	 	 	 	
10.18	 	Agreement on Application, Construction and Transfer of Power Facilities, dated as of March 15, 2006, between the Company and Shanghai Yahong Electronic Co., Ltd	 	10-Q	 	May 10, 2006	 	10.16	 	 	
 	 	 	 	 	 	
10.19	 	Amended and Restated Lease Agreement dated as of September 1, 2006, between Diodes FabTech Inc. with Townsend Summit, LLC	 	8-K	 	October 11, 2006	 	10.1	 	 	
 	 	 	 	 	 	
10.20*	 	Deferred Compensation Plan effective January 1, 2007	 	8-K	 	January 8, 2007	 	99.1	 	 	
 	 	 	 	 	 	
10.21	 	A Supplement dated January 1, 2007 to the Lease Agreement on Disposal of Waste and Scraps between Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology) and Shanghai Yuan Hao Electronic Co., Ltd.	 	10-K	 	February 29, 2008	 	10.50	 	 	
 	 	 	 	 	 	
10.22	 	A Supplement dated January 1, 2007 to the Lease Agreement on Disposal of Waste and Scraps between Shanghai Kaihong Electronic Co., Ltd. and Shanghai Ding Hong Electronic Co., Ltd	 	10-K	 	February 29, 2008	 	10.51	 	 	
 	 	 	 	 	 	
10.23	 	Supplementary Agreement dated December 31, 2007 to the Lease Agreement dated June, 28, 2004 for Leasing Diodes Shanghai New Building’s Fourth and Fifth Floor between Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology) and Shanghai Yuan Hao Electronic Co., Ltd.	 	10-K	 	February 29, 2008	 	10.53	 	 	
 	 	 	 	 	 	
10.24	 	Accommodation Building Fourth and Fifth Floor Lease Agreement dated December 31, 2007 between Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology) and Shanghai Ding Hong Electronic Co., Ltd.	 	10-K	 	February 29, 2008	 	10.54	 	 	
 	 	 	 	 	 	
10.25	 	Consulting Agreement between the Company and Mr. M.K. Lu.	 	10-K	 	February 29, 2008	 	10.55	 	 	
 
- 106 -

Table of Contents
INDEX TO EXHIBITS (continued)

Number	 	Description	 	Form	 	Date of First Filing	 	Exhibit
Number	 	Filed
Herewith	
 	 	 	 	 	 	
10.26	 	Service Agreement between Diodes Zetex Limited and Colin Keith Greene, dated June 30, 2008.	 	10-Q	 	August 11, 2008	 	10.2	 	 	
 	 	 	 	 	 	
10.27	 	Fourth Floor of the Accommodation Building Lease Agreement dated January 1, 2008, between Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology) and Shanghai Ding Hong Electronic Co., Ltd.	 	10-Q	 	August 11, 2008	 	10.5	 	 	
 	 	 	 	 	 	
10.28	 	Factory Building Lease Agreement dated March 1, 2008 between Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology) and Shanghai Yuan Hao Electronic Co. Ltd.	 	10-Q	 	August 11, 2008	 	10.6	 	 	
 	 	 	 	 	 	
10.29	 	Supplemental Agreement to the Factory Building Lease Agreement dated as of August 11, 2008 between Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology) and Shanghai Yuan Hao Electronic Co., Ltd.	 	10-Q	 	November 7, 2008	 	10.2	 	 	
 	 	 	 	 	 	
10.30	 	Distributorship Agreement dated November 1, 2008 between Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology) and Shanghai Keylink Logistic Co., Ltd.	 	10-K	 	February 26, 2009	 	10.83	 	 	
 	 	 	 	 	 	
10.31	 	Lease Facility Safety Management Agreement dated December 31, 2008 between Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology) and Shanghai Yuan Howe Electronic Co., Ltd.	 	10-K	 	February 26, 2009	 	10.84	 	 	
 	 	 	 	 	 	
10.32	 	Company’s 2001 Omnibus Equity Incentive Plan, as amended December 22, 2008	 	10-K	 	February 26, 2009	 	10.87	 	 	
 	 	 	 	 	 	
10.33	 	Company’s Deferred Compensation Plan Effective January 1, 2007, as amended December 22, 2008	 	10-K	 	February 26, 2009	 	10.88	 	 	
 	 	 	 	 	 	
10.34	 	Second Supplemental Agreement to the Factory Building Lease Agreement dated August 19, 2009 between Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology) and Shanghai Yuan Hao Electronic Co., Ltd.	 	10-Q	 	November 16, 2009	 	10.1	 	 	
 	 	 	 	 	 	
10.35	 	Employment Agreement dated as of September 22, 2009, between the Company and Keh-Shew Lu	 	8-K	 	September 28, 2009	 	99.1	 	 	
 	 	 	 	 	 	
10.36***	 	Stock Award Agreement dated as of September 22, 2009, between the Company and Keh-Shew Lu	 	8-K	 	September 28, 2009	 	99.3	 	 	
 
- 107 -

Table of Contents
INDEX TO EXHIBITS (continued)

Number	 	Description	 	Form	 	Date of First Filing	 	Exhibit
Number	 	Filed
Herewith	
 	 	 	 	 	 	
10.37	 	Consulting Agreement dated January 1, 2009, between Diodes Incorporated and Keylink International (B.V.I.) Co., Ltd.	 	10-Q	 	May 8, 2009	 	10.1	 	 	
 	 	 	 	 	 	
10.38	 	Power Facility Construction Agreement dated October 29, 2009 between Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology) and Shanghai Yuan Hao Electronic Co., Ltd.	 	10-K	 	March 1, 2010	 	10.97	 	 	
 	 	 	 	 	 	
10.39	 	First Amendment to the DSH #2 Building Lease Agreement dated December 31, 2009 between Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology) and Shanghai Yuan Howe Electronics Co., Ltd.	 	10-K	 	March 1, 2010	 	10.98	 	 	
 	 	 	 	 	 	
10.40	 	Amendment, dated March 31, 2010, to the Credit Agreement among the Company, Diodes Zetex Limited and Bank of America, N.A.	 	10-Q	 	May 7, 2010	 	10.1	 	 	
 	 	 	 	 	 	
10.41	 	Construction Project Contract between Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology) and Shanghai Yuan Howe Electronic Co., Ltd.	 	10-Q	 	May 7, 2010	 	10.2	 	 	
 	 	 	 	 	 	
10.42	 	Third Floor of the Accommodation Building Lease Agreement, dated April 12, 2010, between Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology) and Shanghai Ding Hong Electronic Co., Ltd.	 	10-Q	 	May 7, 2010	 	10.3	 	 	
 	 	 	 	 	 	
10.43	 	First Amendment to Credit Agreement, dated July 16, 2010, among the Company, Diodes Zetex Limited and Bank of America, N.A.	 	10-Q	 	August 6, 2010	 	10.1	 	 	
 	 	 	 	 	 	
10.44*****	 	Credit Agreement, dated November 25, 2009, by and among the Company, Diodes Zetex Limited and Bank of America, N.A.	 	10-Q	 	August 6, 2010	 	10.2	 	 	
 	 	 	 	 	 	
10.45	 	Second Floor of the Accommodation Building Lease Agreement, dated September 1, 2010, between Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology) and Shanghai Ding Hong Electronic Company Limited.	 	10-Q	 	November 9, 2010	 	10.1	 	 	
 	 	 	 	 	 	
10.46	 	Security Guards Transfer Memorandum of Understanding, dated September 1, 2010, between Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology) and Shanghai Yuan Hao Electronic Company Limited.	 	10-Q	 	November 9, 2010	 	10.2	 	 	
 
- 108 -

Table of Contents
INDEX TO EXHIBITS (continued)

Number	 	Description	 	Form	 	Date of First Filing	 	Exhibit
Number	 	Filed
Herewith	
 	 	 	 	 	 	
10.47***	 	Investment Cooperation Agreement effective as of September 10, 2010, between Diodes Hong Kong Holding Company Limited and the Management Committee of the Chengdu Hi-Tech Industrial Development Zone.	 	8-K	 	September 16, 2010	 	99.1	 	 	
 	 	 	 	 	 	
10.48***	 	Supplementary Agreement to the Investment Cooperation Agreement effective as of September 10, 2010, between Diodes Hong Kong Holding Company Limited and the Management Committee of the Chengdu Hi-Tech Industrial Development Zone.	 	8-K	 	September 16, 2010	 	99.2	 	 	
 	 	 	 	 	 	
10.49***	 	Joint Venture Agreement effective as of November 5, 2010 between Diodes Hong Kong Holding Company Limited and Chengdu Ya Guang Electronic Company Limited.	 	8-K	 	November 12, 2010	 	99.1	 	 	
 	 	 	 	 	 	
10.50	 	Joint Venture Agreement Supplement Concerning the Establishment of Diodes Technology (Chengdu) Company Limited effective as of November 5, 2010, between Diodes Hong Kong Holding Company Limited and Chengdu Ya Guang Electronic Company Limited.	 	8-K	 	November 12, 2010	 	99.2	 	 	
 	 	 	 	 	 	
10.51	 	Second Amendment to Credit Agreement, dated November 24, 2010, among the Company, Diodes Zetex Limited and Bank of America, N.A.	 	8-K	 	December 1, 2010	 	10.1	 	 	
 	 	 	 	 	 	
10.52	 	Third Amendment to Credit Agreement, dated February 9, 2011, among the Company, Diodes Zetex Limited and Bank of America, N.A.	 	8-K	 	February 15, 2011	 	10.1	 	 	
 	 	 	 	 	 	
10.53	 	Second Amendment to the DSH #2 Building Lease Agreement, dated November 15, 2010, between Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology) and Shanghai Yuan Howe Electronics Company Limited.	 	10-K	 	February 28, 2012	 	10.112	 	 	
 	 	 	 	 	 	
10.54	 	Power Facility Expansion Construction Contract, dated January 24, 2011, between Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology) and Shanghai Yuan Howe Electronics Company Limited.	 	10-K	 	February 28, 2011	 	10.113	 	 	
 	 	 	 	 	 	
10.55	 	First Floor of the Accommodation Building Agreement, dated June 1, 2011, between Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology) and Shanghai Ding Hong Electronic Company Limited.	 	10-Q	 	November 9, 2011	 	10.1	 	 	
 
- 109 -

Table of Contents
INDEX TO EXHIBITS (continued)

Number	 	Description	 	Form	 	Date of First Filing	 	Exhibit
Number	 	Filed
Herewith	
 	 	 	 	 	 	
10.56	 	Third Floor of the Dormitory Building Lease Agreement, dated July 1, 2011, between Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology) and Shanghai Ding Hong Electronic Company Limited.	 	10-Q	 	November 9, 2011	 	10.2	 	 	
 	 	 	 	 	 	
10.57	 	Third Supplemental Agreement to the Factor Building Lease Agreement, dated May 16, 2011, between Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology) and Shanghai Yuan Hao Electronic Company Limited.	 	10-Q	 	November 9, 2011	 	10.3	 	 	
 	 	 	 	 	 	
10.58	 	Supplemental Agreement to the Power Facility Construction Agreement, dated March 21, 2011, between Shanghai Kai Hong Technology Company Limited and Shanghai Yuan Hao Electronic Company Limited.	 	10-Q	 	August 9, 2011	 	10.1	 	 	
 	 	 	 	 	 	
10.59	 	Credit Agreement, dated March 21, 2011, between Mega International Commercial Bank and Diodes Taiwan Inc.	 	10-Q	 	August 9, 2011	 	10.2	 	 	
 	 	 	 	 	 	
10.60******	 	Exchange Agreement dated September 28, 2009, between the Company and Raymond James & Associates, Inc.	 	10-K	 	February 28, 2012	 	10.61	 	 	
 	 	 	 	 	 	
10.61	 	Fourth Amendment to Credit Agreement, dated November 23, 2011, by and among Diodes Incorporated, Diodes Zetex Limited and Bank of America, N.A.	 	10-K	 	February 28, 2012	 	10.62	 	 	
 	 	 	 	 	 	
10.62	 	Fifth Amendment to Credit Agreement, dated February 1, 2012, by and among Diodes Incorporated, Diodes Zetex Limited, Diodes International B.V. and Bank of America, N.A.	 	8-K	 	February 7, 2012	 	10.1	 	 	
 	 	 	 	 	 	
10.63	 	Notice to Trustee of Optional Redemption dated October 12, 2011	 	8-K	 	October 13, 2011	 	99.1	 	 	
 	 	 	 	 	 	
10.64	 	Plating Process Agreement made and entered into among Shanghai Kaihong Electronic Co., Ltd., Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology), Diodes Shanghai, Shanghai Ding Hong Electronic Co., Ltd. and Shanghai Micro-Surface Co., Ltd.	 	10-K	 	February 29, 2008	 	10.52	 	 	
 	 	 	 	 	 	
10.65	 	Construction Design Consulting Agreement between Diodes Technology (Chengdu) Company Limited and Lite-On Technology Corporation.	 	10-Q	 	August 9, 2012	 	10.1	 	 	
 
- 110 -

Table of Contents
INDEX TO EXHIBITS (continued)

Number	 	Description	 	Form	 	Date of First Filing	 	Exhibit
Number	 	Filed
Herewith	
 	 	 	 	 	 	
10.66	 	Diodes Zetex Pension Scheme Recovery plan, dated February 28, 2012, between Trustees of the Diodes Zetex Pension Scheme and Diodes Zetex Limited	 	10-Q	 	August 9, 2012	 	10.2	 	 	
 	 	 	 	 	 	
10.67	 	Diodes Zetex Pension Scheme Schedule of contributions, dated March 28, 2012, between Trustees of the Diodes Zetex Pension Scheme and Diodes Zetex Limited	 	10-Q	 	August 9, 2012	 	10.3	 	 	
 	 	 	 	 	 	
10.68	 	Framework Agreement, dated March 26, 2012, among Diodes Zetex Limited, Diodes Zetex Semiconductors Limited, Diodes Incorporated, HR Trustees Limited, and Trustees	 	10-Q	 	August 9, 2012	 	10.4	 	 	
 	 	 	 	 	 	
10.69	 	Guarantee, dated March 26, 2012, among Diodes Zetex Semiconductors Limited, Diodes Zetex Limited, HR Trustees Limited, and Trustees	 	10-Q	 	August 9, 2012	 	10.5	 	 	
 	 	 	 	 	 	
10.70	 	Diodes Zetex Pension Scheme Information Protocol, dated April 10, 2012, among Diodes Zetex Limited, Diodes Zetex Semiconductors Limited, the Company, HR Trustees Limited and Trustees	 	10-Q	 	August 9, 2012	 	10.6	 	 	
 	 	 	 	 	 	
10.71	 	Legal Charge, dated March 26, 2012, among Zetex Semiconductors Limited, HR Trustees Limited, and Trustees	 	10-Q	 	August 9, 2012	 	10.7	 	 	
 	 	 	 	 	 	
10.72	 	Sixth Amendment to Credit Agreement, dated April 30, 2012, by and among the Company, Diodes Zetex Limited, Diodes International B.V., and Bank of America, N.A.	 	10-Q	 	November 9, 2012	 	10.1	 	 	
 	 	 	 	 	 	
10.73***	 	Credit Agreement, dated January 8, 2013, by and among the Company, Diodes International B.V., Diodes Investment Company, Diodes FabTech Inc., Diodes Holdings UK Limited, Diodes Zetex Limited, Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, and the other Lenders party thereto.	 	8-K	 	January 11, 2013	 	99.1	 	 	
 	 	 	 	 	 	
10.74	 	Agreement and Plan of Merger by and among the Company, Diodes Cayman Islands Company Limited and BCD Semiconductor Manufacturing Limited, dated as of December 26, 2012.	 	10-K	 	February 27, 2013	 	10.74	 	 	
 
- 111 -

Table of Contents
INDEX TO EXHIBITS (continued)

Number	 	Description	 	Form	 	Date of First Filing	 	Exhibit
Number	 	Filed
Herewith	
 	 	 	 	 	 	
10.75	 	Second Supplementary Agreement, dated as of January 23, 2013, to the Investment Cooperation Agreement effective as of September 10, 2010, by and among Diodes Hong Kong Holding Company Limited, Diodes (Shanghai) Investment Company Limited, Diodes Technology (Chengdu) Company Limited, and the Management Committee of the Chengdu Hi-Tech Industrial Development Zone	 	10-K	 	February 27, 2013	 	10.75	 	 	
 	 	 	 	 	 	
10.76	 	DSH #2 Building Lease Agreement dated as of January 28, 2013 between Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology) and Shanghai Yuan Howe Electronics Co., Ltd.	 	10-K	 	February 27, 2013	 	10.76	 	 	
 	 	 	 	 	 	
10.77*	 	Diodes Incorporated 2013 Equity Incentive Plan	 	S-8	 	June 13, 2013	 	99.1	 	 	
 	 	 	 	 	 	
10.78*	 	Form of Incentive Stock Option Agreement for the Diodes Incorporated 2013 Equity Incentive Plan	 	S-8	 	June 13, 2013	 	99.2	 	 	
 	 	 	 	 	 	
10.79*	 	Form of Stock Unit Agreement for the Diodes Incorporated 2013 Equity Incentive Plan	 	S-8	 	June 13, 2013	 	99.4	 	 	
 	 	 	 	 	 	
10.80*	 	Form of Nonstatutory Stock Option Agreement for the Diodes Incorporated 2013 Equity Incentive Plan, as amended (Domestic Version)	 	 	 	 	 	 	 	X	
 	 	 	 	 	 	
10.81*	 	Form of Nonstatutory Stock Option Agreement for the Diodes Incorporated 2013 Equity Incentive Plan (International Version)	 	 	 	 	 	 	 	X	
 	 	 	 	 	 	
10.82*	 	Form of Restricted Stock Agreement for the Diodes Incorporated 2013 Equity Incentive Plan, as amended (Domestic Version)	 	 	 	 	 	 	 	X	
 	 	 	 	 	 	
10.83*	 	Form of Restricted Stock Agreement for the Diodes Incorporated 2013 Equity Incentive Plan (International Version)	 	 	 	 	 	 	 	X	
 	 	 	 	 	 	
10.84	 	Supplement Agreement to Lease Agreement dated September 2013 between Shanghai Kaihong Electronic Co., Ltd and Shanghai Ding Hong Electronic Co., Ltd.	 	10-Q	 	November 12, 2013	 	10.6	 	 	
 	 	 	 	 	 	
10.85	 	Construction Design Consulting Assignment Agreement Supplemental Agreement between Diodes Technology (Chengdu) Company Limited and Lite-On Technology Corporation	 	10-Q	 	August 8, 2013	 	10.1	 	 	
 	 	 	 	 	 	
10.86	 	Procurement Agreement, dated May 3, 2013, between Diodes Taiwan Inc. and Lite-On Technology Corporation	 	10-Q	 	August 8, 2013	 	10.2	 	 	
 
- 112 -

Table of Contents
INDEX TO EXHIBITS (continued)

Number	 	Description	 	Form	 	Date of First Filing	 	Exhibit
Number	 	Filed
Herewith	
 	 	 	 	 	 	
10.87	 	Share Transfer Memorandum of Understanding, date June 18, 2013, among Diodes Incorporated, Chengdu Ya Guang Electronic Engineering Factory, and Zetex Chengdu Electronics Limited	 	10-Q	 	August 8, 2013	 	10.3	 	 	
 	 	 	 	 	 	
10.88*	 	Confirmation Agreement, dated April 1, 2013, by and between Diodes Incorporated and Dr. Keh-Shew Lu	 	8-K	 	April 3, 2013	 	99.1	 	 	
 	 	 	 	 	 	
10.89	 	Plating Process Agreement between Zetex (Chengdu) Electronic Company Limited and Diodes Technology (Chengdu) Company Limited, dated February 8, 2013	 	10-Q	 	May 10, 2013	 	10.1	 	 	
 	 	 	 	 	 	
14**	 	Code of Ethics for Chief Executive Officer and Senior Financial Officers	 	 	 	 	 	 	 	 	
 	 	 	 	 	 	
21	 	Subsidiaries of the Registrant	 	 	 	 	 	 	 	X	
 	 	 	 	 	 	
23.1	 	Consent of Independent Registered Public Accounting Firm	 	 	 	 	 	 	 	X	
 	 	 	 	 	 	
31.1	 	Certification Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002	 	 	 	 	 	 	 	X	
 	 	 	 	 	 	
31.2	 	Certification Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002	 	 	 	 	 	 	 	X	
 	 	 	 	 	 	
32.1****	 	Certification Pursuant to 18 U.S.C. adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	 	 	 	 	 	 	 	X	
 	 	 	 	 	 	
32.2****	 	Certification Pursuant to 18 U.S.C. adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	 	 	 	 	 	 	 	X	
 	 	 	 	 	 	
101.INS	 	XBRL Instance Document	 	 	 	 	 	 	 	X	
 	 	 	 	 	 	
101.SCH	 	XBRL Taxonomy Extension Schema	 	 	 	 	 	 	 	X	
 	 	 	 	 	 	
101.CAL	 	XBRL Taxonomy Extension Calculation Linkbase	 	 	 	 	 	 	 	X	
 	 	 	 	 	 	
101.LAB	 	XBRL Taxonomy Extension Labels Linkbase	 	 	 	 	 	 	 	X	
 	 	 	 	 	 	
101.DEF	 	XBRL Taxonomy Extension Definition Linkbase	 	 	 	 	 	 	 	X	
 	 	 	 	 	 	
101.PRE	 	XBRL Taxonomy Extension Presentation Linkbase	 	 	 	 	 	 	 	X	
 
- 113 -

Table of Contents
INDEX TO EXHIBITS (continued)
 
*	Constitute management contracts, or compensatory plans or arrangements, which are required to be filed pursuant to Item 601 of Regulation S-K.	
**	Provided in the Corporate Governance portion of the Investor Relations section of the Company’s website at http://www.diodes.com.	
***	Confidential treatment has been requested with respect to the omitted portions of these exhibits, which portions have been filed separately with the Securities and Exchange Commission.	
****	A certification furnished pursuant to Item 601 of the Regulation S-K will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.	
*****	This exhibit supersedes Exhibit 10.1 to the Form 8-K that was filed on December 2, 2009.	
******	This document was refiled pursuant to the expiration of the order granting confidential treatment on November 20, 2009 under the Securities Exchange Act of 1934.	
PLEASE NOTE: It is inappropriate for investors to assume the accuracy of any covenants, representations or warranties that may be contained in agreements or other documents filed as exhibits to this Annual Report on Form 10-K. In certain instances the disclosure schedules to such agreements or documents contain information that modifies, qualifies and creates exceptions to the representations, warranties and covenants. Moreover, some of the representations and warranties may not be complete or accurate as of a particular date because they are subject to a contractual standard of materiality that is different from those generally applicable to stockholders and/or were used for the purpose of allocating risk among the parties rather than establishing certain matters as facts. Accordingly, you should not rely on the representations and warranties as characterizations of the actual state of facts at the time they were made or otherwise.
 
- 114 -

Exhibit 10.80
DIODES INCORPORATED
2013 EQUITY INCENTIVE PLAN
NONSTATUTORY STOCK OPTION AGREEMENT
Diodes Incorporated, a Delaware corporation, (the “Company”), hereby grants an Option to purchase Shares to the Optionee named below. The terms and conditions of the Option are set forth in this cover sheet and the attached Nonstatutory Stock Option Agreement (together, this “Agreement”) and in the Diodes Incorporated 2013 Equity Incentive Plan as it may be amended from time to time.
Date of Option Grant:                            , [YEAR]
Name of Optionee:                                                                                                      
Number of Shares Covered by Option:                    
Exercise Price per Share: $            .        
Fair Market Value of a Share on Date of Option Grant: $            .        
Expiration Date:                    , [YEAR] [DO NOT EXCEED TEN YEARS FROM GRANT] This Option will expire earlier as a result of certain events, including your Separation From Service, as provided in this Agreement.
Vesting Commencement Date:                    , [YEAR]
Vesting Schedule:
Subject to all the terms of this Agreement and your continuous Service through the applicable dates of vesting, your right to purchase Shares under this Option shall incrementally vest as to 25% of the total number of Shares covered by this Option, as shown above, on the date that is 12 months after the Vesting Commencement Date (the “First Vesting Date”) and on each of the subsequent three anniversaries of the First Vesting Date. Upon termination of your Service at any time and for any reason or no reason (other than termination due to your death or Disability), all of the then outstanding unvested portion of this Option shall be forfeited to the Company without consideration as of your Termination Date. No partial vesting credit will be provided no matter when your Termination Date occurs.
By signing this cover sheet, you agree to all of the terms and conditions described in this Agreement and in the Plan. You are also acknowledging receipt of this Agreement and a copy of the Plan, the Plan’s prospectus, a copy of Proxy Materials and other required documents, all of which are made available to you without charge. The Proxy Materials, which include the proxy statement and the annual report to stockholders, can be accessed at http://investor.diodes.com/phoenix.zhtml?c=62202&p=proxy or alternatively, can be requested from the Company’s legal department, Diodes Incorporated, 4949 Hedgcoxe Road, Suite 200, Plano, Texas 75024 with telephone number (972) 987-3900. Any inconsistency between this Agreement and the Plan shall be resolved by reference to the Plan.

Optionee:	  	 	  	 	
 	  	(Signature)	  	 	
 	 	 	
Company:	  	 	  	 	
 	  	(Signature)	  	 	
Attachment

DIODES INCORPORATED
2013 EQUITY INCENTIVE PLAN
NONSTATUTORY STOCK OPTION AGREEMENT

1.	  	The Plan and
Other Agreements	  	The text of the Plan is incorporated in this Agreement by reference. You and the Company agree to execute such further instruments and to take such further action as may reasonably be necessary to carry out the intent of this Agreement. Unless otherwise defined in this Agreement, certain capitalized terms used in this Agreement are defined in the Plan.
 
This Agreement and the Plan constitute the entire understanding between you and the Company regarding this Option. Any prior agreements, commitments or negotiations concerning this Option are superseded.	
 	 	 	
2.	  	Award of
Nonstatutory Stock
Option	  	The Company awards you a Nonstatutory Stock Option as shown on the cover sheet to this Agreement. This Option is not intended to be an Incentive Stock Option under section 422 of the Code and will be interpreted accordingly.
 
This Option is not intended to be deferred compensation under section 409A of the Code and will be interpreted accordingly.	
 	 	 	
3.	  	Vesting	  	This Option is only exercisable before it expires and only with respect to the vested portion of the Option. This Option will vest according to the Vesting Schedule described in the cover sheet of this Agreement.	
 	 	 	
4.	  	Term	  	Your Option will expire in all cases no later than the close of business at Company headquarters on the Expiration Date, as shown on the cover sheet. Your Option may expire earlier if your Service terminates, as described in Sections 5, 6 and 7 below or on the date on which the Option is cancelled (and not substituted or assumed) pursuant to a Change in Control or merger or acquisition or reorganization or similar transaction involving the Company. You are solely responsible for determining whether and when to exercise any vested portion of this Option and also for keeping track of when your Option expires and when it therefore can no longer be exercised. The Company has no obligation (and does not intend) to provide you with any further notice of your Option’s expiration dates. The Company will have no liability to you or to any other person if all or any portion of your Option is not exercised before it expires for any reason.	
 	 	 	
5.	  	Termination of Service - General	  	If, while the Option is outstanding, your Service terminates for any reason, other than being terminated by the Company for Cause or due to your death or Disability, then the unvested portion of your Option shall be forfeited without consideration and shall	

 	 	 	 	 	
 	  	 	  	immediately expire on your Termination Date and the vested portion of your Option will expire at the earlier of (i) the close of business at Company headquarters on the date that is three (3) months after your Termination Date, (ii) the Expiration Date set forth in the attached cover sheet and further described in Section 4 above, or (iii) the date on which the Option is cancelled (and not substituted or assumed) pursuant to a Change in Control or merger or acquisition or reorganization or similar transaction involving the Company. In no event is the Option exercisable after the Expiration Date.	
 	 	 	
6.	  	Termination of
Service for
Cause	  	If your Service is terminated by the Company for Cause or if you commit an act(s) of Cause while this Option is outstanding, as determined by the Committee in its sole discretion, then you shall immediately forfeit all rights to your Option without consideration, including any vested portion of the Option, and the entire Option shall immediately expire, and any rights, payments and benefits with respect to the Option shall be subject to reduction or recoupment in accordance with applicable Company policies and the Plan. For avoidance of doubt, your Service shall also be deemed to have been terminated for Cause by the Company if, after your Service has otherwise terminated, facts and circumstances are discovered that would have justified a termination for Cause, including, without limitation, your violation of Company policies or breach of confidentiality or other restrictive covenants or conditions that may apply to you prior to or after your Termination Date.	
 	 	 	
7.	  	Termination of
Service due to Death
or Disability; Death
after Termination of
Service	  	If your Service terminates because of your death or Disability, then the unvested portion of your Option shall continue to vest as provided on the cover sheet to this Agreement and the vested portion of your Option will expire at the earlier of (i) the close of business at Company headquarters on the Expiration Date set forth in the attached cover sheet and further described in Section 4 above, or (ii) the date on which the Option is cancelled (and not substituted or assumed) pursuant to a Change in Control or merger or acquisition or similar transaction involving the Company. In no event is the Option exercisable after the Expiration Date.
 
If your death occurs within 3 (three) months after your Termination Date and if there is a vested unexercised portion of this Option outstanding at the time of your death, then your estate may exercise the vested portion of your Option until the earlier of (i) one year after your death, (ii) the close of business on the Expiration Date set forth in the attached cover sheet and further described in Section 4 above, or (iii) the date on which the Option is cancelled (and not substituted or assumed) pursuant to a Change in Control or merger or acquisition or reorganization or similar transaction involving the Company.	

 	 	 	 	 	
8.	  	Notice of Exercise	  	When you wish to exercise this Option, you must notify the Company by filing a “Notice of Exercise” form at the address given on the form. Your notice must specify how many Shares you wish to purchase. The notice can only become effective after it is received by the Company.
 
If someone else wants to exercise this Option after your death, that person must prove to the Company’s satisfaction that he or she is entitled to do so.	
 	 	 	
9.	  	Form of Payment	  	When you submit your notice of exercise, you must include payment of the aggregate Exercise Price for the Shares you are purchasing. Payment may be made in one (or a combination) of the following forms:
 
•   Cash received directly from Optionee’s brokerage account.
 
•   To the extent a public market for the Shares exists as determined by the Company, by Cashless Exercise through delivery (on a form prescribed by the Company) of an irrevocable direction to a securities broker to sell Shares and to deliver all or part of the sale proceeds to the Company in payment of the aggregate Exercise Price.
 
•   By Net Exercise as provided in Section 2(z) of the Plan.
 
•   To the extent approved by the Committee in its discretion and with all terms and conditions determined by the Committee, payment may be made in another form of legal consideration acceptable to the Committee.	
 	 	 	
10.	  	Transfer of Award	  	Prior to your death, only you may exercise this Option. You cannot gift, transfer, assign, alienate, pledge, hypothecate, attach, sell, or encumber this Option. If you attempt to do any of these things, this Option will immediately become invalid. You may, however, dispose of this Option in your will or it may be transferred by the laws of descent and distribution. Regardless of any marital property settlement agreement, the Company is not obligated to honor a notice of exercise from your spouse, nor is the Company obligated to recognize your spouse’s interest in your Option in any other way	
 	 	 	
11.	  	Leaves of Absence	  	For purposes of this Option, your Service does not terminate when you go on a bona fide leave of absence that was approved by the Company in writing, if the terms of the leave of absence provide for Service crediting, or when Service crediting is required by applicable law. Your Service terminates in any event when the approved leave of absence ends unless you immediately return to active work.	

 	 	 	 	 	
 	  	 	  	The Company determines which leaves of absence count for this purpose (along with determining the effect of a leave of absence on vesting of the Option), and when your Service terminates for all purposes under the Plan.	
 	 	 	
12.	  	Stockholder Rights	  	You, or your estate, shall have no rights as a stockholder of the Company with regard to the Option until you have been issued the applicable Shares by the Company and have satisfied all other conditions specified in the Plan. No adjustment shall be made for cash or stock dividends or other rights for which the record date is prior to the date when such applicable Shares are issued, except as provided in the Plan.	
 	 	 	
13.	  	Taxes and
Withholding	  	You will be solely responsible for payment of any and all applicable taxes, including without limitation any penalties or interest based upon such tax obligations, associated with this Award.
 
You will not be allowed to exercise this Option unless you make acceptable arrangements to pay any withholding or other taxes that may be due as a result of the Option exercise or sale of Shares acquired under this Option.
 
To the extent a public market for the Shares exists as determined by the Company, such withholding taxes may be settled by Cashless Exercise through delivery (on a form prescribed by the Company) of an irrevocable direction to a securities broker to sell Shares and to deliver all or part of the sale proceeds to the Company in payment of the withholding taxes.
 
To the extent approved by the Committee in its discretion and with all terms and conditions determined by the Committee, payment of withholding taxes may be made in another form of legal consideration acceptable to the Committee.
 
In accordance with Plan Section 2(z) and 16(b), you may elect to utilize Net Exercise to have Shares withheld from Option exercises at a per Share Fair Market Value on the date of Option exercise in order to satisfy the applicable tax withholding due in connection with exercises of this Option. As provided in Plan Section 16(b), no amount may be withheld under Net Exercise that would be in excess of minimum statutory withholding rates.	
 	 	 	
14.	  	Code Section 409A	  	This Award will be administered and interpreted to comply with Code Section 409A. The provisions of the Plan concerning Code Section 409A will apply to this Award to the extent needed.	

 	 	 	 	 	
15.	  	Restrictions on Exercise and Resale	  	By signing this Agreement, you agree not to (i) exercise this Option (“Exercise Prohibition”), or (ii) sell, transfer, dispose of, pledge, hypothecate, make any short sale of, or otherwise effect a similar transaction of any Shares acquired under this Option (each a “Sale Prohibition”) at a time when applicable laws, regulations or Company or underwriter trading policies prohibit the exercise or disposition of Shares. The Company will not permit you to exercise this Option if the issuance of Shares at that time would violate any law or regulation. The Company shall have the right to designate one or more periods of time, each of which generally will not exceed one hundred eighty (180) days in length (provided however, that such period may be extended in connection with the Company’s release (or announcement of release) of earnings results or other material news or events), and to impose an Exercise Prohibition and/or Sale Prohibition, if the Company determines (in its sole discretion) that such limitation(s) is needed in connection with a public offering of Shares or to comply with an underwriter’s request or trading policy, or could in any way facilitate a lessening of any restriction on transfer pursuant to the Securities Act or any state securities laws with respect to any issuance of securities by the Company, facilitate the registration or qualification of any securities by the Company under the Securities Act or any state securities laws, or facilitate the perfection of any exemption from the registration or qualification requirements of the Securities Act or any applicable state securities laws for the issuance or transfer of any securities. The Company may issue stop/transfer instructions and/or appropriately legend any stock certificates issued pursuant to this Option in order to ensure compliance with the foregoing. Any such Exercise Prohibition shall not alter the Vesting Schedule set forth in this Agreement other than to limit the periods during which this Option shall be exercisable.
 
If the sale of Shares acquired under this Award is not registered under the Securities Act, but an exemption is available which requires an investment representation or other representation and warranty, you shall represent and agree that the Shares being acquired are being acquired for investment, and not with a view to the sale or distribution thereof, and shall make such other representations and warranties as are deemed necessary or appropriate by the Company and its counsel.
 
You may also be required, as a condition of exercise of this Option, to enter into any Company stockholder agreement or other agreements that are applicable to stockholders.	
 	 	 	
16.	  	Clawback Policy	  	You expressly acknowledge and agree to be bound by Section 15(e) of the Plan, which contains provisions addressing the Company’s policy on recoupment of equity or other compensation.	

 	 	 	 	 	
17.	  	No Retention Rights	  	Your Option or this Agreement does not give you the right to be retained by the Company (or any Parent or any Subsidiaries or Affiliates) in any capacity. The Company (or any Parent and any Subsidiaries or Affiliates) reserves the right to terminate your Service at any time and for any reason.	
 	 	 	
18.	  	Extraordinary Compensation	  	This Option and the Shares subject to the Option are not intended to constitute or replace any pension rights or compensation and are not to be considered compensation of a continuing or recurring nature, or part of your normal or expected compensation, and in no way represent any portion of your salary, compensation or other remuneration for any purpose, including but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments.	
 	 	 	
19.	  	Adjustments	  	In the event of a stock split, a stock dividend or a similar change in the Company stock, the number of Shares covered by this Option (rounded down to the nearest whole number) and the Exercise Price per Share shall be adjusted pursuant to the Plan. Your Option shall be subject to the terms of the agreement of merger, liquidation or reorganization in the event the Company is subject to such corporate activity.	
 	 	 	
20.	  	Legends	  	All certificates or book entries representing the Common Stock issued under this Award may, where applicable, have endorsed thereon the following notations or legends and any other notation or legend the Company determines appropriate:	
 	 	 	
 	  	 	  	“THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER AND OPTIONS TO PURCHASE SUCH SHARES SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE REGISTERED HOLDER, OR HIS OR HER PREDECESSOR IN INTEREST. A COPY OF SUCH AGREEMENT IS ON FILE AT THE PRINCIPAL OFFICE OF THE COMPANY AND WILL BE FURNISHED UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY BY THE HOLDER OF RECORD OF THE SHARES REPRESENTED BY THIS CERTIFICATE.”	
 	 	 	
 	  	 	  	“THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR QUALIFIED UNDER THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR QUALIFICATION UNDER	

 	 	 	 	 	
 	  	 	  	APPLICABLE STATE LAWS OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION OR QUALIFICATION IS NOT REQUIRED.”	
 	 	 	
21.	  	Applicable Law	  	This Agreement will be interpreted and enforced under the laws of the State of Delaware without reference to the conflicts of law provisions thereof.	
 	 	 	
22.	  	Regulatory Compliance	  	The issuance of Common Stock pursuant to this Agreement shall be subject to full compliance with all applicable requirements of law and the requirements of any stock exchange or interdealer quotation system upon which the Common Stock may be listed or traded.	
 	 	 	
23.	  	Binding Effect; No Third Party Beneficiaries	  	This Agreement shall be binding upon and inure to the benefit of the Company and you and any respective heirs, representatives, successors and permitted assigns. This Agreement shall not confer any rights or remedies upon any person other than the Company and you and any respective heirs, representatives, successors and permitted assigns. The parties agree that this Agreement shall survive the settlement or termination of the Award.	
 	 	 	
24.	  	Notice	  	Any notice to be given or delivered to the Company relating to this Agreement shall be in writing and addressed to the Company at its principal corporate offices. All notices shall be deemed effective upon personal delivery or upon deposit in the postal mail, postage prepaid and properly addressed to the Company. Any notice to be given or delivered to you relating to this Agreement may be delivered by electronic form including without limitation by email (including prospectuses required by the SEC) as well as all other documents that the Company is required to deliver to its security holders (including annual reports and proxy statements). The Company may also deliver these documents by posting them on a web site maintained by the Company or by a third party under contract with the Company.	
 	 	 	
25.	  	Voluntary Participant	  	You acknowledge that you are voluntarily participating in the Plan.	
 	 	 	
26.	  	No Rights to Future Awards	  	Your rights, if any, in respect of or in connection with this Option or any other Awards are derived solely from the discretionary decision of the Company to permit you to participate in the Plan and to benefit from a discretionary future Award. By accepting this Option, you expressly acknowledge that there is no obligation on the part of the Company to continue the Plan and/or grant any additional Awards to you or benefits in lieu of Options or any other Awards even if Awards have been granted repeatedly in the past. All decisions with respect to future Awards, if any, will be at the sole discretion of the Committee.	

 	 	 	 	 	
27.	  	Future Value	  	The future value of the underlying Shares is unknown and cannot be predicted with certainty. If the underlying Shares do not increase in value after the Date of Option Grant, the Option will have little or no value. If you exercise the Option and obtain Shares, the value of the Shares acquired upon exercise may increase or decrease in value, even below the Exercise Price.	
 	 	 	
28.	  	No Advice Regarding Award	  	The Company has not provided any tax, legal or financial advice, nor has the Company made any recommendations regarding your participation in the Plan, or your acquisition or sale of the underlying Shares. You are hereby advised to consult with your own personal tax, legal and financial advisors regarding your participation in the Plan before taking any action related to the Plan.	
 	 	 	
29.	  	No Right to Damages	  	You will have no right to bring a claim or to receive damages if any portion of the Option is cancelled or expires unexercised. The loss of existing or potential profit in the Option will not constitute an element of damages in the event of the termination of your Service for any reason, even if the termination is in violation of an obligation of the Company or a Parent or a Subsidiary or an Affiliate to you.	
 	 	 	
30.	  	Data Privacy	  	You hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this document by the Company for the exclusive purpose of implementing, administering and managing your participation in the Plan. You understand that the Company holds certain personal information about you, including, but not limited to, name, home address and telephone number, date of birth, gender, social security or insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all Awards or any other entitlement to Shares awarded, cancelled, purchased, exercised, vested, unvested or outstanding in your favor for the purpose of implementing, managing and administering the Plan (“Data”). You understand that the Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in your country or elsewhere and that the recipient country may have different data privacy laws and protections than your country. You authorize the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing your participation in the Plan, including any requisite transfer of such Data, as may be required to a broker or other third party with whom you may elect to deposit any Shares acquired under the Plan.	

 	 	 	 	 	
31.	  	Other Information	  	You agree to receive stockholder information, including copies of any annual report, proxy statement and periodic report, from the Company’s website, if the Company wishes to provide such information through its website. You acknowledge that copies of the Plan, Plan prospectus, Plan information and stockholder information are also available upon written or telephonic request to the Plan’s administrator.	
 	 	 	
32.	  	Further Assistance	  	You agree to provide assistance reasonably requested by the Company in connection with actions taken by you while providing services to the Company, including but not limited to assistance in connection with any lawsuits or other claims against the Company arising from events during the period in which you rendered service to the Company.	
 	 	 	
33.	  	Legal Compliance	  	The Company (or any Parent or any Subsidiaries or Affiliates) is not responsible for your legal compliance requirements relating to this Award, including, but not limited to, tax reporting.	
 	 	 	
34.	  	Additional Conditions	  	If the Company shall determine, in its sole discretion, that the consent or approval of any governmental authority is necessary or desirable as a condition to the payment of benefits to you pursuant to the Plan, such payment shall not occur until such registration, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Company.	
 	 	 	
35.	  	Enforcement	  	The Company will be entitled to enforce its rights under this Agreement specifically, to recover damages by reason of any breach of any provision of this Agreement and to exercise all other rights to which it may be entitled. You agree and acknowledge that money damages may not be an adequate remedy for breach of the provisions of this Agreement and that the Company may in its sole discretion apply to any court of law or equity of competent jurisdiction for specific performance and/or injunctive relief in order to enforce or prevent any violations of the provisions of this Agreement.	
 	 	 	
36.	  	Nondisclosure of Confidential Information	  	You acknowledge that the businesses of the Company is highly competitive and that the Company’s strategies, methods, books, records, and documents, technical information concerning their products, equipment, services, and processes, procurement procedures and pricing techniques, the names of and other information (such as credit and financial data) concerning former, present or prospective customers and business affiliates, all comprise confidential business information and trade secrets which are valuable, special, and unique assets which the Company uses in their business to obtain a competitive advantage over competitors. You further acknowledge that protection of such confidential business information and trade secrets against unauthorized disclosure and use is of critical importance to the Company in maintaining its competitive position. You acknowledge that by reason of your duties to and association with	

 	 	 	 	 	
 	  	 	  	the Company, you have had and will have access to and have and will become informed of confidential business information which is a competitive asset of the Company. You hereby agree that you will not, at any time during or after employment, make any unauthorized disclosure of any confidential business information or trade secrets of the Company, or make any use thereof, except in the carrying out of services responsibilities. You shall take all necessary and appropriate steps to safeguard confidential business information and protect it against disclosure, misappropriation, misuse, loss and theft. Confidential business information shall not include information in the public domain (but only if the same becomes part of the public domain through a means other than a disclosure prohibited hereunder). The above notwithstanding, a disclosure shall not be unauthorized if (i) it is required by law or by a court of competent jurisdiction or (ii) it is in connection with any judicial, arbitration, dispute resolution or other legal proceeding in which your legal rights and obligations as a service provider or under this Agreement are at issue; provided, however, that you shall, to the extent practicable and lawful in any such events, give prior notice to the Company of your intent to disclose any such confidential business information in such context so as to allow the Company an opportunity (which you will not oppose) to obtain such protective orders or similar relief with respect thereto as may be deemed appropriate. Any information not specifically related to the Company would not be considered confidential to the Company. In the event of any conflict in terms between this Section 36 and the terms of any Company confidentiality or proprietary information agreement you have executed, the terms of such other confidentiality or proprietary information agreement shall prevail and govern.	

Exhibit 10.81
For Use in China, Germany, South Korea, Taiwan and the United Kingdom
DIODES INCORPORATED
2013 EQUITY INCENTIVE PLAN
NONSTATUTORY STOCK OPTION AGREEMENT
Diodes Incorporated, a Delaware corporation, (the “Company”), hereby grants an Option to purchase Shares to the Optionee named below. The terms and conditions of the Option are set forth in this cover sheet and the attached Nonstatutory Stock Option Agreement (together, this “Agreement”) and in the Diodes Incorporated 2013 Equity Incentive Plan as it may be amended from time to time.
Date of Option Grant:                            , [YEAR]
Name of Optionee:                                                                                                      
Number of Shares Covered by Option:                    
Exercise Price per Share: $            .            
Fair Market Value of a Share on Date of Option Grant: $            .            
Expiration Date:                    , [YEAR] [DO NOT EXCEED TEN YEARS FROM GRANT] This Option will expire earlier as a result of certain events, including your Separation From Service, as provided in this Agreement.
Vesting Commencement Date:                    , [YEAR]
Vesting Schedule:
Subject to all the terms of this Agreement and your continuous Service through the applicable dates of vesting, your right to purchase Shares under this Option shall incrementally vest as to 25% of the total number of Shares covered by this Option, as shown above, on the date that is 12 months after the Vesting Commencement Date (the “First Vesting Date”) and on each of the subsequent three anniversaries of the First Vesting Date. Upon termination of your Service at any time and for any reason or no reason (other than termination due to your death or Disability), all of the then outstanding unvested portion of this Option shall be forfeited to the Company without consideration as of your Termination Date. No partial vesting credit will be provided no matter when your Termination Date occurs.
By signing this cover sheet, you agree to all of the terms and conditions described in this Agreement and in the Plan. You are also acknowledging receipt of this Agreement and a copy of the Plan, the Plan’s prospectus, a copy of Proxy Materials and other required documents, all of which are made available to you without charge. The Proxy Materials, which include the proxy statement and the annual report to stockholders, can be accessed at http://investor.diodes.com/phoenix.zhtml?c=62202&p=proxy or alternatively, can be requested from the Company’s legal department, Diodes Incorporated, 4949 Hedgcoxe Road, Suite 200, Plano, Texas 75024 with telephone number (972) 987-3900. Any inconsistency between this Agreement and the Plan shall be resolved by reference to the Plan.

Optionee:	  	 	  	 	
 	  	(Signature)	  	 	
 	 	 	
Company:	  	 	  	 	
 	  	(Signature)	  	 	
Attachment

DIODES INCORPORATED
2013 EQUITY INCENTIVE PLAN
NONSTATUTORY STOCK OPTION AGREEMENT

 	 	 	
1.	  	The Plan and Other Agreements	  	The text of the Plan is incorporated in this Agreement by reference. You and the Company agree to execute such further instruments and to take such further action as may reasonably be necessary to carry out the intent of this Agreement. Unless otherwise defined in this Agreement, certain capitalized terms used in this Agreement are defined in the Plan.
 
This Agreement and the Plan constitute the entire understanding between you and the Company regarding this Option. Any prior agreements, commitments or negotiations concerning this Option are superseded.	
 	 	 	
2.	  	Award of Nonstatutory Stock Option	  	The Company awards you a Nonstatutory Stock Option as shown on the cover sheet to this Agreement. This Option is not intended to be an Incentive Stock Option under section 422 of the Code and will be interpreted accordingly.
 
This Option is not intended to be deferred compensation under section 409A of the Code and will be interpreted accordingly.	
 	 	 	
3.	  	Vesting	  	This Option is only exercisable before it expires and only with respect to the vested portion of the Option. This Option will vest according to the Vesting Schedule described in the cover sheet of this Agreement.	
 	 	 	
4.	  	Term	  	Your Option will expire in all cases no later than the close of business at Company headquarters on the Expiration Date, as shown on the cover sheet. Your Option may expire earlier if your Service terminates, as described in Sections 5, 6 and 7 below or on the date on which the Option is cancelled (and not substituted or assumed) pursuant to a Change in Control or merger or acquisition or reorganization or similar transaction involving the Company. You are solely responsible for determining whether and when to exercise any vested portion of this Option and also for keeping track of when your Option expires and when it therefore can no longer be exercised. The Company has no obligation (and does not intend) to provide you with any further notice of your Option’s expiration dates. The Company will have no liability to you or to any other person if all or any portion of your Option is not exercised before it expires for any reason.	
 	 	 	
5.	  	Termination of Service - General	  	If, while the Option is outstanding, your Service terminates for any reason, other than being terminated by the Company for Cause or due to your death or Disability, then the unvested portion of your Option shall be forfeited without consideration and shall	

 	 	 	 	 	
 	 	 	
 	  	 	  	immediately expire on your Termination Date and the vested portion of your Option will expire at the earlier of (i) the close of business at Company headquarters on the date that is three (3) months after your Termination Date, (ii) the Expiration Date set forth in the attached cover sheet and further described in Section 4 above, or (iii) the date on which the Option is cancelled (and not substituted or assumed) pursuant to a Change in Control or merger or acquisition or reorganization or similar transaction involving the Company. In no event is the Option exercisable after the Expiration Date. Except as otherwise provided in the Plan, this Agreement or such other applicable agreement, your eligibility to participate in the Plan ceases if your Service terminates for any reason.	
 	 	 	
6.	  	Termination of Service for Cause	  	If your Service is terminated by the Company for Cause or if you commit an act(s) of Cause while this Option is outstanding, as determined by the Committee in its sole discretion, then you shall immediately forfeit all rights to your Option without consideration, including any vested portion of the Option, and the entire Option shall immediately expire, and any rights, payments and benefits with respect to the Option shall be subject to reduction or recoupment in accordance with applicable Company policies and the Plan. For avoidance of doubt, your Service shall also be deemed to have been terminated for Cause by the Company if, after your Service has otherwise terminated, facts and circumstances are discovered that would have justified a termination for Cause, including, without limitation, your violation of Company policies or breach of confidentiality or other restrictive covenants or conditions that may apply to you prior to or after your Termination Date.	
 	 	 	
7.	  	Termination of Service due to Death or Disability; Death after Termination of Service	  	If your Service terminates because of your death or Disability, then the unvested portion of your Option shall continue to vest as provided on the cover sheet to this Agreement and the vested portion of your Option will expire at the earlier of (i) the close of business at Company headquarters on the Expiration Date set forth in the attached cover sheet and further described in Section 4 above, or (ii) the date on which the Option is cancelled (and not substituted or assumed) pursuant to a Change in Control or merger or acquisition or similar transaction involving the Company. In no event is the Option exercisable after the Expiration Date.
 
If your death occurs within 3 (three) months after your Termination Date and if there is a vested unexercised portion of this Option outstanding at the time of your death, then your estate may exercise the vested portion of your Option until the earlier of (i) one year after your death, (ii) the close of business on the Expiration Date set forth in the attached cover sheet and further described in Section 4 above, or (iii) the date on which the Option is cancelled (and not substituted or assumed) pursuant to a Change in Control or merger or acquisition or reorganization or similar transaction involving the Company.	

 	 	 	 	 	
 	 	 	
8.	  	Notice of Exercise	  	When you wish to exercise this Option, you must notify the Company by filing a “Notice of Exercise” form at the address given on the form. Your notice must specify how many Shares you wish to purchase. Your Shares will be registered in your name only. The notice can only become effective after it is received by the Company.
 
If someone else wants to exercise this Option after your death, that person must prove to the Company’s satisfaction that he or she is entitled to do so.	
 	 	 	
9.	  	Form of Payment	  	When you submit your notice of exercise, you must include payment of the aggregate Exercise Price for the Shares you are purchasing. Payment may be made in one (or a combination) of the following forms:
 
•     Cash received directly from Optionee’s brokerage account.
 
•     By Net Exercise as provided in Section 2(z) of the Plan.
 
•     To the extent a public market for the Shares exists as determined by the Company, by Cashless Exercise through delivery (on a form prescribed by the Company) of an irrevocable direction to a securities broker to sell Shares and to deliver all or part of the sale proceeds to the Company in payment of the aggregate Exercise Price.	
 	 	 	
10.	  	Transfer of Award	  	Prior to your death, only you may exercise this Option. You cannot gift, transfer, assign, alienate, pledge, hypothecate, attach, sell, or encumber this Option. If you attempt to do any of these things, this Option will immediately become invalid. You may, however, dispose of this Option in your will or it may be transferred by the laws of descent and distribution. Regardless of any marital property settlement agreement, the Company is not obligated to honor a notice of exercise from your spouse, nor is the Company obligated to recognize your spouse’s interest in your Option in any other way	
 	 	 	
11.	  	Leaves of Absence	  	For purposes of this Option, your Service does not terminate when you go on a bona fide leave of absence that was approved by the Company in writing, if the terms of the leave of absence provide for Service crediting, or when Service crediting is required by applicable law. Your Service terminates in any event when the approved leave of absence ends unless you immediately return to active work.	

 	 	 	 	 	
 	 	 	
 	  	 	  	The Company determines which leaves of absence count for this purpose (along with determining the effect of a leave of absence on vesting of the Option), and when your Service terminates for all purposes under the Plan.	
 	 	 	
12.	  	Stockholder Rights	  	You, or your estate, shall have no rights as a stockholder of the Company with regard to the Option until you have been issued the applicable Shares by the Company and have satisfied all other conditions specified in the Plan. No adjustment shall be made for cash or stock dividends or other rights for which the record date is prior to the date when such applicable Shares are issued, except as provided in the Plan.	
 	 	 	
13.	  	Taxes and Withholding	  	You will be solely responsible for payment of any and all applicable taxes, including without limitation any penalties or interest based upon such tax obligations, associated with this Award.
 
You will not be allowed to exercise this Option unless you make acceptable arrangements to pay any withholding or other taxes that may be due as a result of the Option exercise or sale of Shares acquired under this Option.
 
To the extent a public market for the Shares exists as determined by the Company, such withholding taxes may be settled by Cashless Exercise through delivery (on a form prescribed by the Company) of an irrevocable direction to a securities broker to sell Shares and to deliver all or part of the sale proceeds to the Company in payment of the withholding taxes.
 
To the extent approved by the Committee in its discretion and with all terms and conditions determined by the Committee, payment of withholding taxes may be made in another form of legal consideration acceptable to the Committee.
 
In accordance with Plan Section 2(z) and 16(b), you may elect to utilize Net Exercise to have Shares withheld from Option exercises at a per Share Fair Market Value on the date of Option exercise in order to satisfy the applicable tax withholding due in connection with exercises of this Option. As provided in Plan Section 16(b), no amount may be withheld under Net Exercise that would be in excess of minimum statutory withholding rates.	
 	 	 	
14.	  	Code Section 409A	  	This Award will be administered and interpreted to comply with Code Section 409A. The provisions of the Plan concerning Code Section 409A will apply to this Award to the extent needed.	

 	 	 	 	 	
15.	  	Restrictions on Exercise and Resale	  	By signing this Agreement, you agree not to (i) exercise this Option (“Exercise Prohibition”), or (ii) sell, transfer, dispose of, pledge, hypothecate, make any short sale of, or otherwise effect a similar transaction of any Shares acquired under this Option (each a “Sale Prohibition”) at a time when applicable laws, regulations or Company or underwriter trading policies prohibit the exercise or disposition of Shares. The Company will not permit you to exercise this Option if the issuance of Shares at that time would violate any law or regulation. The Company shall have the right to designate one or more periods of time, each of which generally will not exceed one hundred eighty (180) days in length (provided however, that such period may be extended in connection with the Company’s release (or announcement of release) of earnings results or other material news or events), and to impose an Exercise Prohibition and/or Sale Prohibition, if the Company determines (in its sole discretion) that such limitation(s) is needed in connection with a public offering of Shares or to comply with an underwriter’s request or trading policy, or could in any way facilitate a lessening of any restriction on transfer pursuant to the Securities Act or any state securities laws with respect to any issuance of securities by the Company, facilitate the registration or qualification of any securities by the Company under the Securities Act or any state securities laws, or facilitate the perfection of any exemption from the registration or qualification requirements of the Securities Act or any applicable state securities laws for the issuance or transfer of any securities. The Company may issue stop/transfer instructions and/or appropriately legend any stock certificates issued pursuant to this Option in order to ensure compliance with the foregoing. Any such Exercise Prohibition shall not alter the vesting schedule set forth in this Agreement other than to limit the periods during which this Option shall be exercisable.
 
If the sale of Shares acquired under this Award is not registered under the Securities Act, but an exemption is available which requires an investment representation or other representation and warranty, you shall represent and agree that the Shares being acquired are being acquired for investment, and not with a view to the sale or distribution thereof, and shall make such other representations and warranties as are deemed necessary or appropriate by the Company and its counsel.
 
You may also be required, as a condition of exercise of this Option, to enter into any Company stockholder agreement or other agreements that are applicable to stockholders.	
 	 	 	
16.	  	Clawback Policy	  	You expressly acknowledge and agree to be bound by Section 15(e) of the Plan, which contains provisions addressing the Company’s policy on recoupment of equity or other compensation.	
 	 	 	
17.	  	No Retention Rights	  	Your Option or this Agreement does not give you the right to be retained by the Company (or any Parent or any Subsidiaries or Affiliates) in any capacity. The Company (or any Parent or any Subsidiaries or Affiliates) reserves the right to terminate your Service at any time and for any reason.	

 	 	 	 	 	
 	  	 	  	In the event you are not an employee of the Company, the grant of the Option will not be interpreted to form an employment contract or relationship with the Company; and furthermore, the grant of the Option will not be interpreted to form an employment contract with your employer (or any Parent or any Subsidiaries or Affiliates).	
 	 	 	
18.	  	Extraordinary Compensation	  	This Option and the Shares subject to the Option are not intended to constitute or replace any pension rights or compensation and are not to be considered compensation of a continuing or recurring nature, or part of your normal or expected compensation, and in no way represent any portion of your salary, compensation or other remuneration for any purpose, including but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments.	
 	 	 	
19.	  	Adjustments	  	In the event of a stock split, a stock dividend or a similar change in the Company stock, the number of Shares covered by this Option (rounded down to the nearest whole number) and the Exercise Price per Share shall be adjusted pursuant to the Plan. Your Option shall be subject to the terms of the agreement of merger, liquidation or reorganization in the event the Company is subject to such corporate activity.	
 	 	 	
20.	  	Legends	  	All certificates or book entries representing the Common Stock issued under this Award may, where applicable, have endorsed thereon the following notations or legends and any other notation or legend the Company determines appropriate:	
 	 	 	
 	  	 	  	“THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER AND OPTIONS TO PURCHASE SUCH SHARES SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE REGISTERED HOLDER, OR HIS OR HER PREDECESSOR IN INTEREST. A COPY OF SUCH AGREEMENT IS ON FILE AT THE PRINCIPAL OFFICE OF THE COMPANY AND WILL BE FURNISHED UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY BY THE HOLDER OF RECORD OF THE SHARES REPRESENTED BY THIS CERTIFICATE.”	
 	 	 	
 	  	 	  	“THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR QUALIFIED UNDER THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE	

 	 	 	 	 	
 	  	 	  	SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR QUALIFICATION UNDER APPLICABLE STATE LAWS OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION OR QUALIFICATION IS NOT REQUIRED.”	
 	 	 	
21.	  	Applicable Law	  	This Agreement will be interpreted and enforced under the laws of the State of Delaware, United States of America without reference to the conflicts of law provisions thereof.	
 	 	 	
22.	  	Regulatory Compliance	  	The issuance of Common Stock pursuant to this Agreement shall be subject to full compliance with all applicable requirements of law and the requirements of any stock exchange or interdealer quotation system upon which the Common Stock may be listed or traded.	
 	 	 	
23.	  	Binding Effect; No Third Party Beneficiaries	  	This Agreement shall be binding upon and inure to the benefit of the Company and you and any respective heirs, representatives, successors and permitted assigns. This Agreement shall not confer any rights or remedies upon any person other than the Company and you and any respective heirs, representatives, successors and permitted assigns. The parties agree that this Agreement shall survive the settlement or termination of the Award.	
 	 	 	
24.	  	Notice	  	Any notice to be given or delivered to the Company relating to this Agreement shall be in writing and addressed to the Company at its principal corporate offices. All notices shall be deemed effective upon personal delivery or upon deposit in the postal mail, postage prepaid and properly addressed to the Company. Any notice to be given or delivered to you relating to this Agreement may be delivered by electronic form including without limitation by email (including prospectuses required by the SEC) as well as all other documents that the Company is required to deliver to its security holders (including annual reports and proxy statements). The Company may also deliver these documents by posting them on a web site maintained by the Company or by a third party under contract with the Company.	
 	 	 	
25.	  	Voluntary Participant	  	You acknowledge that you are voluntarily participating in the Plan.	
 	 	 	
26.	  	No Rights to Future Awards	  	Your rights, if any, in respect of or in connection with this Option or any other Awards are derived solely from the discretionary decision of the Company to permit you to participate in the Plan and to benefit from a discretionary future Award. By accepting this Option, you expressly acknowledge that there is no obligation on the part of the Company to continue the Plan and/or grant any additional Awards to you or benefits in lieu of Options or any other Awards even if Awards have been granted repeatedly in the past. All decisions with respect to future Awards, if any, will be at the sole discretion of the Committee.	

 	 	 	 	 	
 	 	 	
27.	  	Future Value	  	The future value of the underlying Shares is unknown and cannot be predicted with certainty. If the underlying Shares do not increase in value after the Date of Option Grant, the Option will have little or no value. If you exercise the Option and obtain Shares, the value of the Shares acquired upon exercise may increase or decrease in value, even below the Exercise Price.	
 	 	 	
28.	  	No Advice Regarding Award	  	The Company has not provided any tax, legal or financial advice, nor has the Company made any recommendations regarding your participation in the Plan, or your acquisition or sale of the underlying Shares. You are hereby advised to consult with your own personal tax, legal and financial advisors regarding your participation in the Plan before taking any action related to the Plan.	
 	 	 	
29.	  	No Right to Damages	  	You will have no right to bring a claim or to receive damages if any portion of the Option is cancelled or expires unexercised. The loss of existing or potential profit in the Option will not constitute an element of damages in the event of the termination of your Service for any reason, even if the termination is in violation of an obligation of the Company or a Parent or a Subsidiary or an Affiliate to you.	
 	 	 	
30.	  	Data Privacy	  	You hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this document by the Company (or any Parent or any Subsidiaries or Affiliates) for the exclusive purpose of implementing, administering and managing your participation in the Plan. You understand that the Company (or any Parent or any Subsidiaries or Affiliates) holds certain personal information about you, including, but not limited to, name, home address and telephone number, date of birth, gender, social security or insurance number or other identification number, salary, nationality, job title, any Shares or directorships held in the Company (or any Parent or any Subsidiaries or Affiliates), details of all Awards or any other entitlement to Shares awarded, cancelled, purchased, exercised, vested, unvested or outstanding in your favor for the purpose of implementing, managing and administering the Plan (“Data”). You understand that the Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in your country or elsewhere and that the recipient country may have different data privacy laws and protections than your country. You authorize the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the	

 	 	 	 	 	
 	 	 	
 	  	 	  	purposes of implementing, administering and managing your participation in the Plan, including any requisite transfer of such Data, as may be required to a broker or other third party with whom you may elect to deposit any Shares acquired under the Plan. You understand that you may view your Data, request additional information about the storage and processing of the Data, require any necessary amendments to the Data or refuse or withdraw the consents herein, in any case without cost, by contacting the Chief Financial Officer in writing. You understand that refusing or withdrawing consent may affect your ability to participate in the Plan. For more information on the consequences of refusing to consent or withdrawing consent, you may contact the Chief Financial Officer	
 	 	 	
31.	  	Legal Compliance	  	The Company (or any Parent or any Subsidiaries or Affiliates) is not responsible for your legal compliance requirements relating to the Option, including, but not limited to, tax reporting and the exchange of local currency into or from U.S. dollars.	
 	 	 	
32.	  	Additional Conditions	  	If the Company shall determine, in its sole discretion, that the consent or approval of any governmental authority is necessary or desirable as a condition to the payment of benefits to you pursuant to the Plan, such payment shall not occur until such registration, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Company.	
 	 	 	
33.	  	Currency Exchange Risk	  	You agree and acknowledge that you will bear any and all risk associated with the exchange or fluctuation of currency associated with the Option (the “Currency Exchange Risk”). You waive and release the Company (or any Parent or any Subsidiaries or Affiliates) from any potential claims arising out of the Currency Exchange Risk.	
 	 	 	
34.	  	Exchange Control Requirements	  	You agree and acknowledge that you will comply with any and all exchange control requirements applicable to the Option and any resulting funds including, without limitation, reporting or repatriation requirements.	
 	 	 	
35.	  	English Language	  	You agree to receive the terms and conditions of this Agreement and any other related communications in English. If you receive this Agreement or any other document related to the Plan translated into a language other than English and if the translated version is different than the English version, the English version will control.	
 	 	 	
36.	  	Electronic Delivery	  	You agree to provide assistance reasonably requested by the Company in connection with actions taken by you while providing services to the Company, including but not limited to assistance in connection with any lawsuits or other claims against the Company arising from events during the period in which you rendered service to the Company.	

 	 	 	 	 	
 	 	 	
37.	  	Other Information	  	You agree to receive stockholder information, including copies of any annual report, proxy statement and periodic report, from the Company’s website, if the Company wishes to provide such information through its website. You acknowledge that copies of the Plan, Plan prospectus, Plan information and stockholder information are also available upon written or telephonic request to the Plan’s administrator.	
 	 	 	
38.	  	Special Terms for Employees in China	  	Notwithstanding any contrary provision of the Agreement, if you are employed in China, then you acknowledge and agree that:
 
(a) You will not acquire Shares pursuant to this Option, or transfer, assign, sell or otherwise deal with those Shares, except in compliance with applicable laws and the terms of this Agreement.
 
(b) You will not be able to exercise your Option if the Company (i) determines in its sole discretion that compliance with applicable laws in China will impose an excessive burden on the Company or (ii) it has not set up any procedures it determines in its sole discretion are necessary or desirable to enable it comply with applicable laws in China. The Company will not extend the time during which you can exercise this Option if it determines in accordance with the preceding sentence that you may not exercise this Option.
 
(c) The Company may require you to exercise your Option by a Cashless Exercise in which you instruct the Company’s designated broker to exercise the Option and use a portion of the sale proceeds to pay the exercise price and any applicable taxes, commissions and fees.
 
(d) If the Company does not require you to exercise your Option by a Cashless Exercise, the Company may require that you retain the Shares you obtain from the exercise of your Option in your account at the Company’s designated brokerage firm until you sell the Shares, even if you stop working for the Company (or any Parent or any Subsidiary or an Affiliate). Following your termination of employment, the Company may restrict your ability to sell or transfer those Shares in your account. Within a specified period of time ( e.g.,  90 days) following your termination of employment the Company may sell any Shares in your account that you received from your Option.
 
(e) When the Shares resulting from the exercise of your Option are sold, the proceeds of such sale, after deduction of applicable commissions and fees, may be transferred to China and made available to you through an account maintained by an Affiliate in China.	

 	 	 	 	 	
 	 	 	
39.	  	Further Assistance	  	You agree to provide assistance reasonably requested by the Company in connection with actions taken by you while providing services to the Company, including but not limited to assistance in connection with any lawsuits or other claims against the Company arising from events during the period in which you rendered service to the Company.	
 	 	 	
40.	  	Legal Compliance	  	The Company (or any Parent or any Subsidiaries or Affiliates) is not responsible for your legal compliance requirements relating to this Award, including, but not limited to, tax reporting.	
 	 	 	
41.	  	Additional Conditions	  	If the Company shall determine, in its sole discretion, that the consent or approval of any governmental authority is necessary or desirable as a condition to the payment of benefits to you pursuant to the Plan, such payment shall not occur until such registration, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Company.	
 	 	 	
42.	  	Enforcement	  	The Company will be entitled to enforce its rights under this Agreement specifically, to recover damages by reason of any breach of any provision of this Agreement and to exercise all other rights to which it may be entitled. You agree and acknowledge that money damages may not be an adequate remedy for breach of the provisions of this Agreement and that the Company may in its sole discretion apply to any court of law or equity of competent jurisdiction for specific performance and/or injunctive relief in order to enforce or prevent any violations of the provisions of this Agreement.	
 	 	 	
43.	  	Nondisclosure of Confidential Information	  	You acknowledge that the businesses of the Company is highly competitive and that the Company’s strategies, methods, books, records, and documents, technical information concerning their products, equipment, services, and processes, procurement procedures and pricing techniques, the names of and other information (such as credit and financial data) concerning former, present or prospective customers and business affiliates, all comprise confidential business information and trade secrets which are valuable, special, and unique assets which the Company uses in their business to obtain a competitive advantage over competitors. You further acknowledge that protection of such confidential business information and trade secrets against unauthorized disclosure and use is of critical importance to the Company in maintaining its competitive position. You acknowledge that by reason of your duties to and association with the Company, you have had and will have access to and have and will become informed of confidential business information which is a competitive asset of the Company. You hereby agree that you will not, at any time during or after employment, make any unauthorized disclosure of any confidential business information or trade secrets of the Company, or make any use thereof, except	

 	 	 	 	 	
 	  	 	  	in the carrying out of services responsibilities. You shall take all necessary and appropriate steps to safeguard confidential business information and protect it against disclosure, misappropriation, misuse, loss and theft. Confidential business information shall not include information in the public domain (but only if the same becomes part of the public domain through a means other than a disclosure prohibited hereunder). The above notwithstanding, a disclosure shall not be unauthorized if (i) it is required by law or by a court of competent jurisdiction or (ii) it is in connection with any judicial, arbitration, dispute resolution or other legal proceeding in which your legal rights and obligations as a service provider or under this Agreement are at issue; provided, however, that you shall, to the extent practicable and lawful in any such events, give prior notice to the Company of your intent to disclose any such confidential business information in such context so as to allow the Company an opportunity (which you will not oppose) to obtain such protective orders or similar relief with respect thereto as may be deemed appropriate. Any information not specifically related to the Company would not be considered confidential to the Company. In the event of any conflict in terms between this Section 36 and the terms of any Company confidentiality or proprietary information agreement you have executed, the terms of such other confidentiality or proprietary information agreement shall prevail and govern.	

Exhibit 10.82
DIODES INCORPORATED
2013 EQUITY INCENTIVE PLAN
STOCK UNIT AGREEMENT
Diodes Incorporated, a Delaware corporation, (the “Company”), hereby awards Stock Units to the Participant named below. The terms and conditions of the Award are set forth in this cover sheet and in the attached Stock Unit Agreement (together, this “Agreement”) and in the Diodes Incorporated 2013 Equity Incentive Plan as it may be amended from time to time (the “Plan”).
Date of Award:
Name of Participant:
Number of Stock Units Awarded:
Fair Market Value of a Share on Date of Stock Unit Grant: $            .            
Vesting Commencement Date:                             , [YEAR]
Vesting Schedule:
Subject to all the terms of this Agreement and your continuous Service through the applicable dates of vesting, you will become incrementally vested as to 25% of the total Number of Stock Units Awarded, as shown above, on the date that is 12 months after the Vesting Commencement Date (the “First Vesting Date”) and on each of the subsequent three anniversaries of the First Vesting Date. Upon termination of your Service at any time and for any reason or no reason (other than termination due to your death or Disability), all of the then outstanding unvested Stock Units shall be forfeited to the Company without consideration as of your Termination Date. No partial vesting credit will be provided no matter when your Termination Date occurs.
By signing this cover sheet, you agree to all of the terms and conditions described in this Agreement and in the Plan. You are also acknowledging receipt of this Agreement and a copy of the Plan, the Plan’s prospectus, a copy of Proxy Materials and other required documents, all of which are made available to you without charge. The Proxy Materials, which include the proxy statement and the annual report to stockholders, can be accessed at http://investor.diodes.com/phoenix.zhtml?c=62202&p=proxy or alternatively, can be requested from the Company’s legal department, Diodes Incorporated, 4949 Hedgcoxe Road, Suite 200, Plano, Texas 75024 with telephone number (972) 987-3900. Any inconsistency between this Agreement and the Plan shall be resolved by reference to the Plan.

Participant:	 	 	
 	 	(Signature)	
 	 	
Company:	 	 	
 	 	(Signature)	
Attachment
 
-1-

DIODES INCORPORATED
2013 EQUITY INCENTIVE PLAN
STOCK UNIT AGREEMENT

1.	  	The Plan and
Other Agreements	  	The text of the Plan is incorporated in this Agreement by reference. You and the Company agree to execute such further instruments and to take such further action as may reasonably be necessary to carry out the intent of this Agreement. Unless otherwise defined in this Agreement, certain capitalized terms used in this Agreement are defined in the Plan.
 
This Agreement and the Plan constitute the entire understanding between you and the Company regarding this Award of Stock Units. Any prior agreements, commitments or negotiations concerning this Award are superseded.	
 	 	 	
2.	  	Award of Stock Units	  	The Company awards you the number of Stock Units shown on the cover sheet of this Agreement. The Award is subject to the terms and conditions of this Agreement and the Plan. The Company will not issue any Shares if the issuance of such Shares at that time would violate any law or regulation.	
 	 	 	
3.	  	Vesting and Settlement	  	This Award will vest according to the Vesting Schedule described in the cover sheet of this Agreement. To the extent a Stock Unit becomes vested and subject to your satisfaction of any tax withholding obligations as discussed below, each vested Stock Unit will entitle you to receive one Share which will be distributed to you on the earliest of (i) a Change in Control, or (ii) the applicable scheduled vesting date set forth in the first sentence of the Vesting Schedule section in the cover sheet to this Agreement. Issuance of such Shares shall be in complete satisfaction of such vested Stock Units. Such settled Stock Units shall be immediately cancelled and no longer outstanding and you shall have no further rights or entitlements related to those settled Stock Units.	
 	 	 	
4.	  	Transfer of Award	  	You cannot gift, transfer, assign, alienate, pledge, hypothecate, attach, sell, or encumber this Award. If you attempt to do any of these things, this Award will immediately become invalid. You may, however, dispose of this Award in your will or it may be transferred by the laws of descent and distribution. Regardless of any marital property settlement agreement, the Company is not obligated to recognize your spouse’s interest in your Award in any other way.	
 
-2-

 	 	 	 	 	
5.	  	Termination of
Service – General	  	If, while the unvested Stock Units are outstanding, your Service terminates for any reason, other than being terminated by the Company for Cause or due to your death or Disability, then the unvested portion of your Stock Units shall be forfeited without consideration and shall immediately expire on your Termination Date.	
 	 	 	
6.	  	Termination of
Service for Cause	  	If your Service is terminated by the Company for Cause or if you commit an act(s) of Cause while the unvested Stock Units are outstanding, as determined by the Committee in its sole discretion, then you shall immediately forfeit all rights to your unvested Stock Units without consideration, and the entire unvested Stock Units shall immediately expire, and any rights, payments and benefits with respect to the unvested Stock Units shall be subject to reduction or recoupment in accordance with applicable Company policies and the Plan. For avoidance of doubt, your Service shall also be deemed to have been terminated for Cause by the Company if, after your Service has otherwise terminated, facts and circumstances are discovered that would have justified a termination for Cause, including, without limitation, your violation of Company policies or breach of confidentiality or other restrictive covenants or conditions that may apply prior to or after your Termination Date.	
 	 	 	
7.	  	Termination of
Service due to Death
or Disability	  	If your Service terminates because of your death or Disability, then the unvested portion of your Stock Units shall continue to vest as provided on the cover sheet of this Agreement.	
 	 	 	
8.	  	Leaves of Absence	  	For purposes of this Award, your Service does not terminate when you go on a bona fide leave of absence that was approved by the Company in writing, if the terms of the leave of absence provide for Service crediting, or when Service crediting is required by applicable law. Your Service terminates in any event when the approved leave of absence ends unless you immediately return to active work.
 
The Company determines which leaves of absence count for this purpose (along with determining the effect of a leave of absence on vesting of the Award), and when your Service terminates for all purposes under the Plan.	
 
-3-

 	 	 	 	 	
9.	  	Stockholder Rights	  	As a holder of Stock Units, you shall have no rights other than those of a general creditor of the Company. Subject to the terms of this Agreement, a holder of outstanding Stock Units has none of the rights and privileges of a stockholder of the Company. Without limiting the generality of the foregoing, a holder of outstanding Stock Units has no right to vote or to receive dividends (if any) on the shares represented by such Stock Units. Subject to the terms and conditions of this Agreement, Stock Units create no fiduciary duty of the Company to you and only represent an unfunded and unsecured contractual obligation of the Company. The Stock Units shall not be treated as property or as a trust fund of any kind.
 
You, or your estate, shall have no rights as a stockholder of the Company with regard to the Award until you have been issued the applicable Shares by the Company and have satisfied all other conditions specified in the Plan. No adjustment shall be made for cash or stock dividends or other rights for which the record date is prior to the date when such applicable Shares are issued, except as provided in the Plan.	
 	 	 	
10.	  	Taxes and
Withholding	  	You will be solely responsible for payment of any and all applicable taxes, including without limitation any penalties or interest based upon such tax obligations, associated with this Award.
 
The delivery to you of any Shares underlying vested Stock Units will not be permitted unless and until you have satisfied any withholding or other taxes that may be due. Any such tax withholding obligations may be settled in the Company’s discretion by the Company withholding and retaining a portion of the Shares from the Shares that would otherwise be deliverable to you under the vesting Stock Units as provided in the next two sentences. Such withheld Shares will be applied to pay the withholding obligation by using the aggregate fair market value of the withheld Shares as of the date of settlement. You will be delivered the net amount of vested Shares after the Share withholding has been effected and you will not receive the withheld Shares. The Company will not deliver any fractional number of Shares.	
 	 	 	
11.	  	Code Section 409A	  	This Award will be administered and interpreted to comply with Code Section 409A. The provisions of the Plan concerning Code Section 409A will apply to this Award to the extent needed.	
 
-4-

 	 	 	 	 	
 	 	 	
12.	  	Restrictions on Resale	  	By signing this Agreement, you agree not to sell, transfer, dispose of, pledge, hypothecate, make any short sale of, or otherwise effect a similar transaction of any Shares acquired under this Award (each a “Sale Prohibition”) at a time when applicable laws, regulations or Company or underwriter trading policies prohibit the sale or disposition of Shares.
 
The Company shall have the right to designate one or more periods of time, each of which generally will not exceed one hundred eighty (180) days in length (provided however, that such period may be extended in connection with the Company’s release (or announcement of release) of earnings results or other material news or events), and to impose a Sale Prohibition, if the Company determines (in its sole discretion) that such limitation(s) is/are needed in connection with a public offering of Shares or to comply with an underwriter’s request or trading policy, or could in any way facilitate a lessening of any restriction on transfer pursuant to the Securities Act or any state securities laws with respect to any issuance of securities by the Company, facilitate the registration or qualification of any securities by the Company under the Securities Act or any state securities laws, or facilitate the perfection of any exemption from the registration or qualification requirements of the Securities Act or any applicable state securities laws for the issuance or transfer of any securities. The Company may issue stop/transfer instructions and/or appropriately legend any stock certificates issued pursuant to this Award in order to ensure compliance with the foregoing.
 
If the sale of Shares acquired under this Award is not registered under the Securities Act, but an exemption is available which requires an investment representation or other representation and warranty, you shall represent and agree that the Shares being acquired are being acquired for investment, and not with a view to the sale or distribution thereof, and shall make such other representations and warranties as are deemed necessary or appropriate by the Company and its counsel.
 
You may also be required, as a condition of this Award, to enter into any Company stockholder agreement or other agreements that are applicable to stockholders.	
 	 	 	
13.	  	Clawback Policy	  	You expressly acknowledge and agree to be bound by Section 15(e) of the Plan, which contains provisions addressing the Company’s policy on recoupment of equity or other compensation.	
 
-5-

 	 	 	 	 	
 	 	 	
14.	  	No Retention Rights	  	Your Award or this Agreement does not give you the right to be retained by the Company (or any Parent or any Subsidiaries or Affiliates) in any capacity. The Company (or any Parent and any Subsidiaries or Affiliates) reserves the right to terminate your Service at any time and for any reason.	
 	 	 	
15.	  	Extraordinary Compensation	  	This Award and the Shares subject to the Award are not intended to constitute or replace any pension rights or compensation and are not to be considered compensation of a continuing or recurring nature, or part of your normal or expected compensation, and in no way represent any portion of your salary, compensation or other remuneration for any purpose, including but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments.	
 	 	 	
16.	  	Adjustments	  	In the event of a stock split, a stock dividend or a similar change in the Company stock, the number of outstanding Stock Units covered by this Award shall be adjusted (and rounded down to the nearest whole number) pursuant to the Plan. Your Stock Units shall be subject to the terms of the agreement of merger, liquidation or reorganization in the event the Company is subject to such corporate activity.	
 	 	 	
17.	  	Legends	  	All certificates or book entries representing the Common Stock issued under this Award may, where applicable, have endorsed thereon the following notations or legends and any other notation or legend the Company determines appropriate:
 
“THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER AND OPTIONS TO PURCHASE SUCH SHARES SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE REGISTERED HOLDER, OR HIS OR HER PREDECESSOR IN INTEREST. A COPY OF SUCH AGREEMENT IS ON FILE AT THE PRINCIPAL OFFICE OF THE COMPANY AND WILL BE FURNISHED UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY BY THE HOLDER OF RECORD OF THE SHARES REPRESENTED BY THIS CERTIFICATE.”

-6-

 	 	 	 	 	
 	  	 	  	“THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR QUALIFIED UNDER THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR QUALIFICATION UNDER APPLICABLE STATE LAWS OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION OR QUALIFICATION IS NOT REQUIRED.”	
 	 	 	
18.	  	Applicable Law	  	This Agreement will be interpreted and enforced under the laws of the State of Delaware without reference to the conflicts of law provisions thereof.	
 	 	 	
19.	  	Regulatory Compliance	  	The issuance of Common Stock pursuant to this Agreement shall be subject to full compliance with all applicable requirements of law and the requirements of any stock exchange or interdealer quotation system upon which the Common Stock may be listed or traded.	
 	 	 	
20.	  	Binding Effect; No Third Party Beneficiaries	  	This Agreement shall be binding upon and inure to the benefit of the Company and you and any respective heirs, representatives, successors and permitted assigns. This Agreement shall not confer any rights or remedies upon any person other than the Company and you and any respective heirs, representatives, successors and permitted assigns. The parties agree that this Agreement shall survive the settlement or termination of the Award.	
 	 	 	
21.	  	Notice	  	Any notice to be given or delivered to the Company relating to this Agreement shall be in writing and addressed to the Company at its principal corporate offices. All notices shall be deemed effective upon personal delivery or upon deposit in the postal mail, postage prepaid and properly addressed to the Company. Any notice to be given or delivered to you relating to this Agreement may be delivered by electronic form including without limitation by email (including prospectuses required by the SEC) as well as all other documents that the Company is required to deliver to its security holders (including annual reports and proxy statements). The Company may also deliver these documents by posting them on a web site maintained by the Company or by a third party under contract with the Company.	
 
-7-

 	 	 	 	 	
 	 	 	
22.	  	Voluntary
Participant	  	You acknowledge that you are voluntarily participating in the Plan.	
 	 	 	
23.	  	No Rights to Future Awards	  	Your rights, if any, in respect of or in connection with this Award or any other Awards are derived solely from the discretionary decision of the Company to permit you to participate in the Plan and to benefit from a discretionary future Award. By accepting this Award, you expressly acknowledge that there is no obligation on the part of the Company to continue the Plan and/or grant any additional Awards to you or benefits in lieu of other Awards even if Awards have been granted repeatedly in the past. All decisions with respect to future Awards, if any, will be at the sole discretion of the Committee.	
 	 	 	
24.	  	Future Value	  	The future value of the underlying Shares is unknown and cannot be predicted with certainty. If the underlying Shares do not maintain or increase their value after the Date of Award, the Award could have little or no value. If you obtain Shares under this Award, the value of the Shares acquired upon settlement may subsequently increase or decrease in value, and could decrease to a value less than the taxes payable upon settlement.	
 	 	 	
25.	  	No Advice Regarding Award	  	The Company has not provided any tax, legal or financial advice, nor has the Company made any recommendations regarding your participation in the Plan, or your acquisition or sale of the underlying Shares. You are hereby advised to consult with your own personal tax, legal and financial advisors regarding your participation in the Plan before taking any action related to the Plan.	
 	 	 	
26.	  	No Right to Damages	  	You will have no right to bring a claim or to receive damages if any portion of the Award is cancelled or expires. The loss of existing or potential profit in the Award will not constitute an element of damages in the event of the termination of your Service for any reason, even if the termination is in violation of an obligation of the Company or a Parent or a Subsidiary or an Affiliate to you.	
 	 	 	
27.	  	Data Privacy	  	You hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this document by the Company for the exclusive purpose of implementing, administering and managing your participation in the Plan. You understand that the Company holds certain personal information about you, including, but not limited to, name,	
 
-8-

 	 	 	 	 	
 	 	 	
 	  	 	  	home address and telephone number, date of birth, gender, social security or insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all Awards or any other entitlement to Shares awarded, cancelled, purchased, exercised, vested, unvested or outstanding in your favor for the purpose of implementing, managing and administering the Plan (“Data”). You understand that the Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in your country or elsewhere and that the recipient country may have different data privacy laws and protections than your country. You authorize the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing your participation in the Plan, including any requisite transfer of such Data, as may be required to a broker or other third party with whom you may elect to deposit any Shares acquired under the Plan.	
 	 	 	
28.	  	Other Information	  	You agree to receive stockholder information, including copies of any annual report, proxy statement and periodic report, from the Company’s website, if the Company wishes to provide such information through its website. You acknowledge that copies of the Plan, Plan prospectus, Plan information and stockholder information are also available upon written or telephonic request to the Plan’s administrator.	
 	 	 	
29.	  	Further Assistance	  	You agree to provide assistance reasonably requested by the Company in connection with actions taken by you while providing services to the Company, including but not limited to assistance in connection with any lawsuits or other claims against the Company arising from events during the period in which you rendered service to the Company.	
 	 	 	
30.	  	Legal Compliance	  	The Company (or any Parent or any Subsidiaries or Affiliates) is not responsible for your legal compliance requirements relating to this Award, including, but not limited to, tax reporting.	
 	 	 	
31.	  	Additional
Conditions	  	If the Company shall determine, in its sole discretion, that the consent or approval of any governmental authority is necessary or desirable as a condition to the payment of benefits to you pursuant to the Plan, such payment shall not occur until such registration, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Company.	
 
-9-

 	 	 	 	 	
 	 	 	
32.	  	Enforcement	  	The Company will be entitled to enforce its rights under this Agreement specifically, to recover damages by reason of any breach of any provision of this Agreement and to exercise all other rights to which it may be entitled. You agree and acknowledge that money damages may not be an adequate remedy for breach of the provisions of this Agreement and that the Company may in its sole discretion apply to any court of law or equity of competent jurisdiction for specific performance and/or injunctive relief in order to enforce or prevent any violations of the provisions of this Agreement.	
 	 	 	
33.	  	Nondisclosure of Confidential Information	  	You acknowledge that the businesses of the Company is highly competitive and that the Company’s strategies, methods, books, records, and documents, technical information concerning their products, equipment, services, and processes, procurement procedures and pricing techniques, the names of and other information (such as credit and financial data) concerning former, present or prospective customers and business affiliates, all comprise confidential business information and trade secrets which are valuable, special, and unique assets which the Company uses in their business to obtain a competitive advantage over competitors. You further acknowledge that protection of such confidential business information and trade secrets against unauthorized disclosure and use is of critical importance to the Company in maintaining its competitive position. You acknowledge that by reason of your duties to and association with the Company, you have had and will have access to and have and will become informed of confidential business information which is a competitive asset of the Company. You hereby agree that you will not, at any time during or after employment, make any unauthorized disclosure of any confidential business information or trade secrets of the Company, or make any use thereof, except in the carrying out of services responsibilities. You shall take all necessary and appropriate steps to safeguard confidential business information and protect it against disclosure, misappropriation, misuse, loss and theft. Confidential business information shall not include information in the public domain (but only if the same becomes part of the public domain through a means other than a disclosure prohibited hereunder). The above notwithstanding, a disclosure shall not be unauthorized if (i) it is required by law or by a court of competent jurisdiction or (ii) it is in connection with any judicial, arbitration, dispute resolution or other legal proceeding in which your legal rights	
 
-10-

 	 	 	 	 	
 	 	 	
 	  	 	  	and obligations as a service provider or under this Agreement are at issue; provided, however, that you shall, to the extent practicable and lawful in any such events, give prior notice to the Company of your intent to disclose any such confidential business information in such context so as to allow the Company an opportunity (which you will not oppose) to obtain such protective orders or similar relief with respect thereto as may be deemed appropriate. Any information not specifically related to the Company would not be considered confidential to the Company. In the event of any conflict in terms between this Section 30 and the terms of any Company confidentiality or proprietary information agreement you have executed, the terms of such other confidentiality or proprietary information agreement shall prevail and govern.	
 
-11-

For Use in China, Germany, South Korea, Taiwan and the United Kingdom
 
Exhibit 10.83
DIODES INCORPORATED
2013 EQUITY INCENTIVE PLAN
STOCK UNIT AGREEMENT
Diodes Incorporated, a Delaware corporation, (the “Company”), hereby awards Stock Units to the Participant named below. The terms and conditions of the Award are set forth in this cover sheet and in the attached Stock Unit Agreement (together, this “Agreement”) and in the Diodes Incorporated 2013 Equity Incentive Plan as it may be amended from time to time (the “Plan”).
Date of Award:
Name of Participant:
Number of Stock Units Awarded:
Fair Market Value of a Share on Date of Stock Unit Grant: $            .            
Vesting Commencement Date:                                , [YEAR]
Vesting Schedule:
Subject to all the terms of this Agreement and your continuous Service through the applicable dates of vesting, you will become incrementally vested as to 25% of the total Number of Stock Units Awarded, as shown above, on the date that is 12 months after the Vesting Commencement Date (the “First Vesting Date”) and on each of the subsequent three anniversaries of the First Vesting Date. Upon termination of your Service at any time and for any reason or no reason (other than termination due to your death or Disability), all of the then outstanding unvested Stock Units shall be forfeited to the Company without consideration as of your Termination Date. No partial vesting credit will be provided no matter when your Termination Date occurs.
By signing this cover sheet, you agree to all of the terms and conditions described in this Agreement and in the Plan. You are also acknowledging receipt of this Agreement and a copy of the Plan, the Plan’s prospectus, a copy of Proxy Materials and other required documents, all of which are made available to you without charge. The Proxy Materials, which include the proxy statement and the annual report to stockholders, can be accessed at http://investor.diodes.com/phoenix.zhtml?c=62202&p=proxy or alternatively, can be requested from the Company’s legal department, Diodes Incorporated, 4949 Hedgcoxe Road, Suite 200, Plano, Texas 75024 with telephone number (972) 987-3900. Any inconsistency between this Agreement and the Plan shall be resolved by reference to the Plan.

Participant:	 	 	
 	 	(Signature)	
 	 	
Company:	 	 	
 	 	(Signature)	
Attachment
 
-1-

For Use in China, Germany, South Korea, Taiwan and the United Kingdom
 
DIODES INCORPORATED
2013 EQUITY INCENTIVE PLAN
STOCK UNIT AGREEMENT

1.	  	The Plan and
Other Agreements	  	The text of the Plan is incorporated in this Agreement by reference. You and the Company agree to execute such further instruments and to take such further action as may reasonably be necessary to carry out the intent of this Agreement. Unless otherwise defined in this Agreement, certain capitalized terms used in this Agreement are defined in the Plan.
 
This Agreement and the Plan constitute the entire understanding between you and the Company regarding this Award of Stock Units. Any prior agreements, commitments or negotiations concerning this Award are superseded.	
 	 	 	
2.	  	Award of Stock Units	  	The Company awards you the number of Stock Units shown on the cover sheet of this Agreement. The Award is subject to the terms and conditions of this Agreement and the Plan. The Company will not issue any Shares if the issuance of such Shares at that time would violate any law or regulation.	
 	 	 	
3.	  	Vesting and Settlement	  	This Award will vest according to the Vesting Schedule described in the cover sheet of this Agreement. To the extent a Stock Unit becomes vested and subject to your satisfaction of any tax withholding obligations as discussed below, each vested Stock Unit will entitle you to receive one Share which will be distributed to you on the earliest of (i) a Change in Control, or (ii) the applicable scheduled vesting date set forth in the first sentence of the Vesting Schedule section in the cover sheet to this Agreement. Issuance of such Shares shall be in complete satisfaction of such vested Stock Units. Such settled Stock Units shall be immediately cancelled and no longer outstanding and you shall have no further rights or entitlements related to those settled Stock Units.	
 	 	 	
4.
.	  	Transfer of Award	  	You cannot gift, transfer, assign, alienate, pledge, hypothecate, attach, sell, or encumber this Award. If you attempt to do any of these things, this Award will immediately become invalid. You may, however, dispose of this Award in your will or it may be transferred by the laws of descent and distribution. Regardless of any marital property settlement agreement, the Company is not obligated to recognize your spouse’s interest in your Award in any other way.	
 
-2-

For Use in China, Germany, South Korea, Taiwan and the United Kingdom

 	 	 	
5.	  	Termination of            
Service – General	  	If, while the unvested Stock Units are outstanding, your Service terminates for any reason, other than being terminated by the Company for Cause or due to your death or Disability, then the unvested portion of your Stock Units shall be forfeited without consideration and shall immediately expire on your Termination Date.	
 	 	 	
6.	  	Termination of
Service for Cause	  	If your Service is terminated by the Company for Cause or if you commit an act(s) of Cause while the unvested Stock Units are outstanding, as determined by the Committee in its sole discretion, then you shall immediately forfeit all rights to your unvested Stock Units without consideration, and the entire unvested Stock Units shall immediately expire, and any rights, payments and benefits with respect to the unvested Stock Units shall be subject to reduction or recoupment in accordance with applicable Company policies and the Plan. For avoidance of doubt, your Service shall also be deemed to have been terminated for Cause by the Company if, after your Service has otherwise terminated, facts and circumstances are discovered that would have justified a termination for Cause, including, without limitation, your violation of Company policies or breach of confidentiality or other restrictive covenants or conditions that may apply prior to or after your Termination Date.	
 	 	 	
7.	  	Termination of
Service due to Death
or Disability	  	If your Service terminates because of your death or Disability, then the unvested portion of your Stock Units shall continue to vest as provided on the cover sheet of this Agreement.	
 	 	 	
8.	  	Leaves of Absence	  	For purposes of this Award, your Service does not terminate when you go on a bona fide leave of absence that was approved by the Company in writing, if the terms of the leave of absence provide for Service crediting, or when Service crediting is required by applicable law. Your Service terminates in any event when the approved leave of absence ends unless you immediately return to active work.
 
The Company determines which leaves of absence count for this purpose (along with determining the effect of a leave of absence on vesting of the Award), and when your Service terminates for all purposes under the Plan.	
 	 	 	
9.	  	Stockholder Rights	  	As a holder of Stock Units, you shall have no rights other than those of a general creditor of the Company. Subject to the terms of this Agreement, a holder of outstanding Stock Units has none of the rights and privileges of a stockholder of the Company. Without limiting the generality of the foregoing, a	
 
-3-

For Use in China, Germany, South Korea, Taiwan and the United Kingdom

 	 	 	
 	  	 	  	holder of outstanding Stock Units has no right to vote or to receive dividends (if any) on the Shares represented by such Stock Units. Subject to the terms and conditions of this Agreement, Stock Units create no fiduciary duty of the Company to you and only represent an unfunded and unsecured contractual obligation of the Company. The Stock Units shall not be treated as property or as a trust fund of any kind.
 
You, or your estate, shall have no rights as a stockholder of the Company with regard to the Award until you have been issued the applicable Shares by the Company and have satisfied all other conditions specified in the Plan. No adjustment shall be made for cash or stock dividends or other rights for which the record date is prior to the date when such applicable Shares are issued, except as provided in the Plan.	
 	 	 	
10.	  	Taxes and
Withholding	  	You will be solely responsible for payment of any and all applicable taxes, including without limitation any penalties or interest based upon such tax obligations, associated with this Award.
 
The delivery to you of any Shares underlying vested Stock Units will not be permitted unless and until you have satisfied any withholding or other taxes that may be due. Any such tax withholding obligations may be settled in the Company’s discretion by the Company withholding and retaining a portion of the Shares from the Shares that would otherwise be deliverable to you under the vesting Stock Units as provided in the next two sentences. Such withheld Shares will be applied to pay the withholding obligation by using the aggregate fair market value of the withheld Shares as of the date of settlement. You will be delivered the net amount of vested Shares after the Share withholding has been effected and you will not receive the withheld Shares. The Company will not deliver any fractional number of Shares.	
 	 	 	
11.	  	Code Section 409A	  	This Award will be administered and interpreted to comply with Code Section 409A. The provisions of the Plan concerning Code Section 409A will apply to this Award to the extent needed.	
 	 	 	
12.	  	Restrictions on
Resale	  	By signing this Agreement, you agree not to sell, transfer, dispose of, pledge, hypothecate, make any short sale of, or otherwise effect a similar transaction of any Shares acquired under this Award (each a “Sale Prohibition”) at a time when applicable laws, regulations or Company or underwriter trading policies prohibit the sale or disposition of Shares.

-4-

For Use in China, Germany, South Korea, Taiwan and the United Kingdom

 	  	 	  	The Company shall have the right to designate one or more periods of time, each of which generally will not exceed one hundred eighty (180) days in length (provided however, that such period may be extended in connection with the Company’s release (or announcement of release) of earnings results or other material news or events), and to impose a Sale Prohibition, if the Company determines (in its sole discretion) that such limitation(s) is/are needed in connection with a public offering of Shares or to comply with an underwriter’s request or trading policy, or could in any way facilitate a lessening of any restriction on transfer pursuant to the Securities Act or any state securities laws with respect to any issuance of securities by the Company, facilitate the registration or qualification of any securities by the Company under the Securities Act or any state securities laws, or facilitate the perfection of any exemption from the registration or qualification requirements of the Securities Act or any applicable state securities laws for the issuance or transfer of any securities. The Company may issue stop/transfer instructions and/or appropriately legend any stock certificates issued pursuant to this Award in order to ensure compliance with the foregoing.
 
If the sale of Shares acquired under this Award is not registered under the Securities Act, but an exemption is available which requires an investment representation or other representation and warranty, you shall represent and agree that the Shares being acquired are being acquired for investment, and not with a view to the sale or distribution thereof, and shall make such other representations and warranties as are deemed necessary or appropriate by the Company and its counsel.
 
You may also be required, as a condition of this Award, to enter into any Company stockholder agreement or other agreements that are applicable to stockholders.	
 	 	 	
13.	  	Clawback Policy
	  	You expressly acknowledge and agree to be bound by Section 15(e) of the Plan, which contains provisions addressing the Company’s policy on recoupment of equity or other compensation.	
 	 	 	
14.	  	No Retention Rights	  	Your Award or this Agreement does not give you the right to be retained by the Company (or any Parent or any Subsidiaries or Affiliates) in any capacity. The Company (or any Parent or any Subsidiaries or Affiliates) reserves the right to terminate your Service at any time and for any reason.

-5-

For Use in China, Germany, South Korea, Taiwan and the United Kingdom

14.	  	No Retention Rights	  	Your Award or this Agreement does not give you the right to be retained by the Company (or any Parent or any Subsidiaries or Affiliates) in any capacity. The Company (or any Parent or any Subsidiaries or Affiliates) reserves the right to terminate your Service at any time and for any reason.
 
In the event you are not an employee of the Company, your Award will not be interpreted to form an employment contract or relationship with the Company; and furthermore, the grant of the Award will not be interpreted to form an employment contract with your employer (or any Parent or any Subsidiaries or Affiliates).	
 	 	 	
15.	  	Extraordinary Compensation	  	This Award and the Shares subject to the Award are not intended to constitute or replace any pension rights or compensation and are not to be considered compensation of a continuing or recurring nature, or part of your normal or expected compensation, and in no way represent any portion of your salary, compensation or other remuneration for any purpose, including but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments.	
 	 	 	
16.	  	Adjustments	  	In the event of a stock split, a stock dividend or a similar change in the Company stock, the number of outstanding Stock Units covered by this Award shall be adjusted (and rounded down to the nearest whole number) pursuant to the Plan. Your Stock Units shall be subject to the terms of the agreement of merger, liquidation or reorganization in the event the Company is subject to such corporate activity.	
 	 	 	
17.	  	Legends	  	All certificates or book entries representing the Common Stock issued under this Award may, where applicable, have endorsed thereon the following notations or legends and any other notation or legend the Company determines appropriate:
 
“THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER AND OPTIONS TO PURCHASE SUCH SHARES SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE REGISTERED HOLDER, OR HIS OR HER PREDECESSOR IN INTEREST. A COPY OF SUCH AGREEMENT IS ON FILE AT THE PRINCIPAL OFFICE OF THE COMPANY AND WILL BE FURNISHED UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY BY THE HOLDER OF RECORD OF THE SHARES REPRESENTED BY THIS CERTIFICATE.”	
 
-6-

For Use in China, Germany, South Korea, Taiwan and the United Kingdom

 	  	 	  	“THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR QUALIFIED UNDER THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR QUALIFICATION UNDER APPLICABLE STATE LAWS OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION OR QUALIFICATION IS NOT REQUIRED.”	
 	 	 	
18.	  	Applicable Law	  	This Agreement will be interpreted and enforced under the laws of the State of Delaware, United States of America without reference to the conflicts of law provisions thereof.	
 	 	 	
19.	  	Regulatory Compliance	  	The issuance of Common Stock pursuant to this Agreement shall be subject to full compliance with all applicable requirements of law and the requirements of any stock exchange or interdealer quotation system upon which the Common Stock may be listed or traded.	
 	 	 	
20.	  	Binding Effect; No Third Party Beneficiaries	  	This Agreement shall be binding upon and inure to the benefit of the Company and you and any respective heirs, representatives, successors and permitted assigns. This Agreement shall not confer any rights or remedies upon any person other than the Company and you and any respective heirs, representatives, successors and permitted assigns. The parties agree that this Agreement shall survive the settlement or termination of the Award.	
 	 	 	
21.	  	Notice	  	Any notice to be given or delivered to the Company relating to this Agreement shall be in writing and addressed to the Company at its principal corporate offices. All notices shall be deemed effective upon personal delivery or upon deposit in the postal mail, postage prepaid and properly addressed to the Company. Any notice to be given or delivered to you relating to this Agreement may be delivered by electronic form including without limitation by email (including prospectuses required by the SEC) as well as all other documents that the Company is required to deliver to its security holders (including annual reports and proxy statements). The Company may also deliver these documents by posting them on a web site maintained by the Company or by a third party under contract with the Company.	
 
-7-

For Use in China, Germany, South Korea, Taiwan and the United Kingdom

22.	  	Voluntary Participant	  	You acknowledge that you are voluntarily participating in the Plan.	
 	 	 	
23.	  	No Rights to Future Awards	  	Your rights, if any, in respect of or in connection with this Award or any other Awards are derived solely from the discretionary decision of the Company to permit you to participate in the Plan and to benefit from a discretionary future Award. By accepting this Award, you expressly acknowledge that there is no obligation on the part of the Company to continue the Plan and/or grant any additional Awards to you or benefits in lieu of other Awards even if Awards have been granted repeatedly in the past. All decisions with respect to future Awards, if any, will be at the sole discretion of the Committee.	
 	 	 	
24.	  	Future Value	  	The future value of the underlying Shares is unknown and cannot be predicted with certainty. If the underlying Shares do not maintain or increase their value after the Date of Award, the Award could have little or no value. If you obtain Shares under this Award, the value of the Shares acquired upon settlement may subsequently increase or decrease in value, and could decrease to a value less than the taxes payable upon settlement.	
 	 	 	
25.	  	No Advice Regarding Award	  	The Company has not provided any tax, legal or financial advice, nor has the Company made any recommendations regarding your participation in the Plan, or your acquisition or sale of the underlying Shares. You are hereby advised to consult with your own personal tax, legal and financial advisors regarding your participation in the Plan before taking any action related to the Plan.	
 	 	 	
26.	  	No Right to Damages	  	You will have no right to bring a claim or to receive damages if any portion of the Award is cancelled or expires. The loss of existing or potential profit in the Award will not constitute an element of damages in the event of the termination of your Service for any reason, even if the termination is in violation of an obligation of the Company or a Parent or a Subsidiary or an Affiliate to you.	
 	 	 	
27.	  	Data Privacy	  	You hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this document by the Company (or any Parent or any Subsidiaries or Affiliates) for the exclusive purpose of implementing, administering and managing your participation in the Plan. You understand that the Company (or any Parent or any	
 
-8-

For Use in China, Germany, South Korea, Taiwan and the United Kingdom

 	  	 	  	Subsidiaries or Affiliates) holds certain personal information about you, including, but not limited to, name, home address and telephone number, date of birth, gender, social security or insurance number or other identification number, salary, nationality, job title, any Shares or directorships held in the Company (or any Parent or any Subsidiaries or Affiliates), details of all Awards or any other entitlement to Shares awarded, cancelled, purchased, exercised, vested, unvested or outstanding in your favor for the purpose of implementing, managing and administering the Plan (“Data”). You understand that the Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in your country or elsewhere and that the recipient country may have different data privacy laws and protections than your country. You authorize the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing your participation in the Plan, including any requisite transfer of such Data, as may be required to a broker or other third party with whom you may elect to deposit any Shares acquired under the Plan. You understand that Data will be held only as long as is necessary to implement, administer and manage participation in the Plan. You understand that you may view your Data, request additional information about the storage and processing of the Data, require any necessary amendments to the Data or refuse or withdraw the consents herein, in any case without cost, by contacting the Chief Financial Officer in writing. You understand that refusing or withdrawing consent may affect your ability to participate in the Plan. For more information on the consequences of refusing to consent or withdrawing consent, you may contact the Chief Financial Officer.	
 	 	 	
28.	  	Legal Compliance	  	The Company (or any Parent or any Subsidiaries or Affiliates) is not responsible for your legal compliance requirements relating to Award, including, but not limited to, tax reporting and the exchange of local currency into or from U.S. dollars.	
 	 	 	
29.	  	Additional Conditions	  	If the Company shall determine, in its sole discretion, that the consent or approval of any governmental authority is necessary or desirable as a condition to the payment of benefits to you pursuant to the Plan, such payment shall not occur until such registration, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Company.	
 
-9-

For Use in China, Germany, South Korea, Taiwan and the United Kingdom

30.	  	Currency Exchange Risk	  	You agree and acknowledge that you will bear any and all risk associated with the exchange or fluctuation of currency associated with the Award (the “Currency Exchange Risk”). You waive and release the Company (or any Parent or any Subsidiaries or Affiliates) from any potential claims arising out of the Currency Exchange Risk.	
 	 	 	
31.	  	Exchange Control Requirements	  	You agree and acknowledge that you will comply with any and all exchange control requirements applicable to the Award and any resulting funds including, without limitation, reporting or repatriation requirements.	
 	 	 	
32.	  	English Language	  	You agree to receive the terms and conditions of this Agreement and any other related communications in English. If you receive this Agreement or any other document related to the Plan translated into a language other than English and if the translated version is different than the English version, the English version will control.	
 	 	 	
33.	  	Electronic Delivery	  	The Company may, in its sole discretion, deliver any documents related to this Award, including materials relating to its Annual Meeting of Stockholders, by electronic means or request your consent to participate in the Plan by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate in the Plan through any on-line or electronic system established and maintained by the Company or another third party designated by the Company.	
 	 	 	
34.	  	Other Information	  	You agree to receive stockholder information, including copies of any annual report, proxy statement and periodic report, from the Company’s website, if the Company wishes to provide such information through its website. You acknowledge that copies of the Plan, Plan prospectus, Plan information and stockholder information are also available upon written or telephonic request to the Plan’s administrator.	
 	 	 	
35.	  	Special Terms for Employees in China	  	Notwithstanding any contrary provision of the Agreement, if you are employed in China, then you acknowledge and agree that:
 
(a) You will not acquire Shares pursuant to this Award, or transfer, assign, sell or otherwise deal with those Shares, except in compliance with applicable laws and the terms of this Agreement.
 
(b) The Company need not issue Shares to you when your Stock Units vest unless and until (i) it determines in its sole discretion that compliance with applicable laws in China will not impose an excessive burden on the Company and (ii) it has set up any procedures it determines in its sole discretion are necessary or desirable to enable it comply with applicable laws in China.	
 
-10-

For Use in China, Germany, South Korea, Taiwan and the United Kingdom

 	  	 	  	(c) The Company may require you to sell promptly following vesting, the Shares you receive when your Stock Units vest. You authorize the Company or its designated brokerage firm to perform this transaction for you, and agree that applicable commissions and fees due in connection with the sale may be deducted from your proceeds. You agree that such Shares will be sold at prevailing market prices and waive any claim based on the timing of the sale or the price received for your Shares. If the Company requires you to sell, or sells, your Shares under this paragraph 35, no Shares will be delivered to you and you would not have any rights as a stockholder of the Company.
 
(d) When your Stock Units vest, if the Company does not require the immediate sale of the Shares you receive, the Company may require that you retain those Shares in your account at the Company’s designated brokerage firm until you sell the Shares, even if you stop working for the Company or an Affiliate. Following your termination of employment, the Company may restrict your ability to sell or transfer those Shares in your account. Within a specified period of time ( e.g.,  90 days) following your termination of employment the Company may sell any Shares in your account that you received from your Stock Units.
 
(e) When the Shares resulting from the vesting of your Stock Units are sold, the proceeds of such sale, after deduction of applicable commissions and fees, may be transferred to China and made available to you through an account maintained by an Affiliate in China.	
 	 	 	
36.	  	Further Assistance	  	You agree to provide assistance reasonably requested by the Company in connection with actions taken by you while providing services to the Company, including but not limited to assistance in connection with any lawsuits or other claims against the Company arising from events during the period in which you rendered service to the Company.	
 	 	 	
37.	  	Legal Compliance	  	The Company (or any Parent or any Subsidiaries or Affiliates)is not responsible for your legal compliance requirements relating to this Award, including, but not limited to, tax reporting.	
 
-11-

For Use in China, Germany, South Korea, Taiwan and the United Kingdom

 	 	 	
38.	  	Additional Conditions	  	If the Company shall determine, in its sole discretion, that the consent or approval of any governmental authority is necessary or desirable as a condition to the payment of benefits to you pursuant to the Plan, such payment shall not occur until such registration, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Company.	
 	 	 	
39.	  	Enforcement	  	The Company will be entitled to enforce its rights under this Agreement specifically, to recover damages by reason of any breach of any provision of this Agreement and to exercise all other rights to which it may be entitled. You agree and acknowledge that money damages may not be an adequate remedy for breach of the provisions of this Agreement and that the Company may in its sole discretion apply to any court of law or equity of competent jurisdiction for specific performance and/or injunctive relief in order to enforce or prevent any violations of the provisions of this Agreement.	
 	 	 	
40.	  	Nondisclosure of Confidential Information	  	You acknowledge that the businesses of the Company is highly competitive and that the Company’s strategies, methods, books, records, and documents, technical information concerning their products, equipment, services, and processes, procurement procedures and pricing techniques, the names of and other information (such as credit and financial data) concerning former, present or prospective customers and business affiliates, all comprise confidential business information and trade secrets which are valuable, special, and unique assets which the Company uses in their business to obtain a competitive advantage over competitors. You further acknowledge that protection of such confidential business information and trade secrets against unauthorized disclosure and use is of critical importance to the Company in maintaining its competitive position. You acknowledge that by reason of your duties to and association with the Company, you have had and will have access to and have and will become informed of confidential business information which is a competitive asset of the Company. You hereby agree that you will not, at any time during or after employment, make any unauthorized disclosure of any confidential business information or trade secrets of the Company, or make any use thereof, except in the carrying out of services responsibilities. You shall take all necessary and appropriate steps to safeguard confidential business information and protect it against disclosure, misappropriation, misuse, loss and theft.	
 
-12-

For Use in China, Germany, South Korea, Taiwan and the United Kingdom

 	  	 	  	Confidential business information shall not include information in the public domain (but only if the same becomes part of the public domain through a means other than a disclosure prohibited hereunder). The above notwithstanding, a disclosure shall not be unauthorized if (i) it is required by law or by a court of competent jurisdiction or (ii) it is in connection with any judicial, arbitration, dispute resolution or other legal proceeding in which your legal rights and obligations as a service provider or under this Agreement are at issue; provided, however, that you shall, to the extent practicable and lawful in any such events, give prior notice to the Company of your intent to disclose any such confidential business information in such context so as to allow the Company an opportunity (which you will not oppose) to obtain such protective orders or similar relief with respect thereto as may be deemed appropriate. Any information not specifically related to the Company would not be considered confidential to the Company. In the event of any conflict in terms between this Section 30 and the terms of any Company confidentiality or proprietary information agreement you have executed, the terms of such other confidentiality or proprietary information agreement shall prevail and govern.	
 
-13-

Exhibit 21
SUBSIDIARIES OF THE REGISTRANT

Subsidiary Name	  	Incorporated
Location	 	Holding Company (1)
or Subsidiary (2)	  	Percentage Owned	
Diodes Taiwan Inc.	  	Taiwan	 	2	  	100%	
BCD Semiconductor (Taiwan) Co., Ltd.	  	Taiwan*	 	2	  	100%	
Shanghai Kaihong Electronic Co., Ltd.	  	China	 	2	  	95%	
Power Analog Microelectronics (Shanghai) Co., Ltd.	  	China	 	2	  	100%	
Diodes FabTech Inc.	  	Delaware	 	2	  	100%	
Diodes Hong Kong Limited	  	Hong Kong	 	2	  	100%	
BCD (Shanghai) Micro-Electronics Limited	  	China	 	2	  	100%	
Diodes Kaihong (Shanghai) Company Limited	  	China	 	2	  	100%	
Diodes (Shanghai) Investment Company Limited	  	China	 	1	  	100%	
Diodes Technology (Chengdu) Company Limited	  	China	 	2	  	95%	
Diodes Electronic (Shenzhen) Company Limited	  	China	 	2	  	100%	
Diodes Shanghai Co., Ltd. (a/k/a Shanghai Kaihong Technology)	  	China	 	2	  	95%	
Shanghai SIM-BCD Semiconductor Manufacturing Co. Ltd.	  	China	 	2	  	100%	
Diodes Japan Kabushiki Kaisha	  	Japan	 	2	  	100%	
Diodes International B.V.	  	Netherlands	 	1	  	100%	
BCD Semiconductor Limited	  	Hong Kong	 	2	  	100%	
Excel Power Technology Limited	  	Hong Kong	 	2	  	100%	
Diodes Hong Kong Holding Company Limited	  	Hong Kong	 	1	  	100%	
Diodes Korea Inc.	  	Korea	 	2	  	100%	
Diodes Investment Company	  	Delaware	 	1	  	100%	
Diodes Holdings UK Limited	  	United Kingdom	 	1	  	100%	
Diodes Zetex Semiconductors Limited	  	United Kingdom	 	2	  	100%	
Diodes Zetex Neuhaus GmbH	  	Germany	 	2	  	100%	
Diodes Zetex GmbH	  	Germany	 	2	  	100%	
BCD Semiconductor Corporation	  	California*	 	2	  	100%	
Zetex Inc.	  	New York*	 	2	  	100%	
Diodes Zetex UK Limited	  	United Kingdom	 	2	  	100%	
Diodes Zetex Limited	  	United Kingdom	 	2	  	100%	
BCD Semiconductor Manufacturing Limited	  	Cayman Islands	 	2	  	100%	
Excel Power Technology Limited	  	Cayman Islands	 	2	  	100%	
Diodes Zetex Asia Pacific Ventures Limited	  	British Virgin Island*	 	2	  	100%	
Diodes Chinatex Limited	  	British Virgin Island*	 	2	  	100%	
Diodes Torus Network Products Limited	  	United Kingdom*	 	2	  	100%	
Diodes Knaves Beech Securities Limited	  	United Kingdom*	 	2	  	100%	
Diodes Seal Semiconductors Limited	  	United Kingdom*	 	2	  	100%	
Diodes Fast Analog Solutions Limited	  	United Kingdom*	 	2	  	100%	
Diodes Zetex Investment Limited	  	United Kingdom*	 	2	  	100%	
Telemetrix Share Scheme Trustees Limited	  	United Kingdom*	 	2	  	100%	
Diodes Telemetrix Investments Limited	  	United Kingdom*	 	2	  	100%	
Diodes Telemetrix Securities Limited	  	United Kingdom*	 	2	  	100%	
Diodes Westward Technology Limited	  	United Kingdom*	 	2	  	100%	
* Dormant subsidiary

Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements of Diodes Incorporated and Subsidiaries of our report dated February 27, 2014, which report expresses an unqualified opinion related to the consolidated financial statements of Diodes Incorporated and Subsidiaries (the “Company”) and the effectiveness of internal control over financial reporting of the Company appearing in this Annual Report (Form 10-K) for the year ended December 31, 2013:
 
 	•	 	Registration Statement on Form S-8 (No. 333-78716) pertaining to the Incentive Bonus Plan and 1993 Non-Qualified Stock Option Plan of Diodes Incorporated;	
 
 	•	 	Registration Statements on Form S-8 (Nos. 333-106775 and 333-124809) pertaining to the 2001 Omnibus Equity Incentive Plan of Diodes Incorporated;	
 
 	•	 	Registration Statement on Form S-8 (No. 333-189298) pertaining to the Diodes Incorporated 2013 Equity Incentive Plan; and	
 
 	•	 	Registration Statement on Form S-8 (No. 333-189299) pertaining to the 2001 Omnibus Equity Incentive Plan of Diodes Incorporated.	
/s/ Moss Adams, LLP
Los Angeles, California
February 27, 2014

Exhibit 31.1
CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Keh-Shew Lu, certify that:
1. I have reviewed this Annual Report on Form 10-K of Diodes Incorporated;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
/s/ Keh-Shew Lu                            
Keh-Shew Lu
Chief Executive Officer
Date: February 27, 2014

Exhibit 31.2
CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Richard D. White, certify that:
1. I have reviewed this Annual Report on Form 10-K of Diodes Incorporated;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
/s/ Richard D. White                            
Richard D. White
Chief Financial Officer
Date: February 27, 2014

Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. 1350 ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Annual Report on Form 10-K for the twelve-month period ended December 31, 2013 of Diodes Incorporated (the “Company”) fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such periodic report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for, the periods presented in such report.
Very truly yours,
/s/ Keh-Shew Lu                    
Keh-Shew Lu
Chief Executive Officer
Date: February 27, 2014
A signed original of this written statement required by Section 906 has been provided to Diodes Incorporated and will be retained by Diodes Incorporated and furnished to the Securities and Exchange Commission or its staff upon request.

Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. 1350 ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Annual Report on Form 10-K for the twelve-month period ended December 31, 2013 of Diodes Incorporated (the “Company”) fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such periodic report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for, the periods presented in such report.
Very truly yours,
/s/ Richard D. White                        
Richard D. White
Chief Financial Officer
Date: February 27, 2014
A signed original of this written statement required by Section 906 has been provided to Diodes Incorporated and will be retained by Diodes Incorporated and furnished to the Securities and Exchange Commission or its staff upon request.